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Abstract  
The proper development, maturation and maintenance of the neuromuscular junction (NMJ) are 
critical for ensuring efficient neurotransmission. Proteins found within the basal lamina of the 
synaptic cleft, namely the laminins family, are heavily involved in maintaining normal structure and 
function of the NMJ. In particular, individual laminin chains such as laminin-β2, -α4 and -α5 play 
essential roles in organisation and maintenance of the NMJ. These laminin chains interact together 
to form three synapse specific laminin heterotrimers; laminin-221 (α2β2γ1), laminin-421 (α4β2γ1) 
and laminin-521 (α5β2γ1). 
 
Laminin-β2 is the common laminin chain found in each of these synapse specific laminin 
heterotrimers. In-vitro it has been shown to play a key role in the organisation of the presynaptic 
elements at the NMJ via its interaction and clustering of the N- and P/Q-type voltage-gated 
calciums (VGCCs). During development of the NMJ, both N- and P/Q-type VGCCs are involved in 
mediating neurotransmitter release. As the NMJ matures, P/Q-type becomes the dominant channel 
involved in release while N-type takes on the role of fine-tuning calcium influx. Laminin-α4, on the 
other hand, ensures proper alignment of presynaptic active zones to postjunctional folds at the NMJ, 
with its loss resulting in misalignment of these specialisations. Furthermore, this laminin chain has 
been shown to be involved in the maintenance of the NMJ with the observation of premature ageing 
features at 6 months of age (6MO) in laminin-α4 deficient mice (lama4-/-), which are commonly 
observed at NMJs from 18 months old (18MO) and onwards. Altered laminins expression such as 
laminin-α4 has been noted at the NMJ of limb muscles from human amytrophic lateral sclerosis 
(ALS) donors. ALS is a neurodegenerative disease which is characterised with the dying of motor 
neurons and degeneration of the NMJ. This finding suggests a possible link between altered laminin 
expression at the NMJ and the progression of NMJ degeneration in ALS. 
 
This study examined the role of laminin-β2 in maturation of the NMJ at both pre- and postsynaptic 
regions utilising immunohistochemical and electrophysiological methods. Immunohistochemical 
results showed retained clusters of N-type VGCCs without upregulation of P/Q-type VGCCs 
clusters at mature NMJs of laminin-β2 deficient mice (lamb2-/-), suggesting a failure in switching 
from N- to P/Q-type VGCCs during NMJ maturation. Immature postsynaptic endplates were also 
noted at lamb2-/- NMJs by postnatal day 35 (P35) suggesting halted postsynaptic maturation of the 
NMJ. Functionally, no improvement in transmission was noted from postnatal day 21 (P21) to P35, 
with maintained lower frequency of spontaneous release, decreased quantal content and higher 
failures in evoked responses. Next, this study investigated the role of laminin-α4 in maintenance of 
the NMJ from adulthood to ageing. Functionally, lama4-/- NMJs displayed perturbed transmission 
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properties that were non-progressive from 3 months old (3MO) young adult to 18-22MO aged 
NMJs. Similar trends were also observed in their hind-limb grip force, with lama4-/- mice 
consistently displaying weaker grip force at all ages investigated. Importantly, findings 
demonstrated that aged wild-type NMJs showed a decline in transmission properties to levels 
resembling that of lama4-/-. These alterations coincided with a decline in hind-limb grip force at 18-
22MO wild-type. This finding was further strengthened by the change in laminin-α4 expression 
prior to any prominent decline in neurotransmission and hind-limb grip force observed in wild-type 
mice. The final study aimed to investigate the role of laminins at the NMJs of TDP43Q331K, a mouse 
model of ALS. Immunohistochemical findings found mislocalised and absent expression of 
laminin-α4 at the NMJs of TDP43Q331K during presymptomatic stage (3MO) which coincided with a 
drop in transmission properties such as lower quantal content, higher intermittence and decreased 
frequency in spontaneous release. Furthermore, altered innervation patterns such as 
polyinnervation, thinning and swollen axons as well as partial denervation were also noted in these 
NMJs. 
 
In conclusion, this thesis has identified the significant roles laminins-α4 and -β2 play at the NMJ 
during development, maturation and maintenance. Results suggest that laminin-β2 is not only an 
important regulator of the presynaptic maturation through the switching of VGCCs and clustering 
of P/Q-type VGCCs, but also equally important for maturation of the postsynaptic apparatus. I 
propose that laminin-β2 is important for the maturation of each component at the NMJ. The altered 
responses in transmission properties presented by aged wild-type NMJs which resembled adult 
lama4-/-, preceded by altered expression of laminin-α4 chain, strongly suggest that laminin-α4 is not 
only important for maintaining proper alignment of pre- to postsynaptic NMJ, but also essentially 
important for maintaining a healthy adult NMJ. Finally, I observed early alterations in expression of 
laminin-α4 at the NMJs in diseased mouse model of ALS prior to any appearance of neuromotor 
impairment, suggesting a potential involvement of laminins in NMJ degeneration associated with 
neuromuscular disorders such as ALS. 
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INTRODUCTION 
The neuromuscular junction (NMJ) is a specialised synapse that allows communication between the 
motor nerve terminal and the skeletal muscle fibre, via an electro-chemical signal (Hall & Sanes, 
1993; Sanes & Lichtman, 1999; Wu et al., 2010). The transmitted signal leads to muscular contraction 
resulting in voluntary movement of the body. In order for neurotransmission to occur rapidly and 
efficiently, the presynaptic nerve terminal and its components associated with transmitter release must 
be precisely aligned with postsynaptic elements on the muscle fibre (Hall & Sanes, 1993; Sanes, 
1995; Sanes & Lichtman, 1999). The presynaptic terminal comprises of a number of specialisations 
including voltage-gated calcium channels, active zones and synaptic vesicles. The postsynaptic 
muscle fibre possesses highly convoluted membrane folds that are lined with high densities of 
acetycholine receptors at each crest (Hall & Sanes, 1993; Sanes, 1995; Sanes & Lichtman, 1999). 
Disruption of these components may result in altered efficiency of neurotransmission at the synapse 
(Li et al., 1995; Knight et al., 2003; Urbano et al., 2003; Depetris et al., 2008; Chand et al., 2015). 
The region between the nerve terminal and the muscle fibre, termed the synaptic cleft, is lined with 
basal lamina (Hunter et al., 1989b; Sanes, 1995; Patton, 2003). Signaling and adhesion molecules 
such as the synaptic laminins found within the basal lamina, are suggested to be involved in the 
organisation and maintenance of key components of the pre- and postsynaptic specialisations (Noakes 
et al., 1995a; Patton et al., 1997; Knight et al., 2003; Nishimune et al., 2004; Carlson et al., 2010; 
Samuel et al., 2012). The synaptic laminin chains (α, β and γ) form the laminin heterotrimers that 
include laminin-221 (α2β2γ1), laminin-421 (α4β2γ1) and laminin-521 (α5β2γ1)(Miner et al., 1997; 
Patton et al., 1997; Patton, 2000). These laminin heterotrimers comprise of individual laminin chains; 
α2, α4, α5, β2 and γ1 (Patton et al., 1997). Laminin-β2 chain is involved in the development and 
maturation of the NMJ via its interaction and subsequent involvement in the developmental switch of 
the voltage-gated calcium channels (Nishimune et al., 2004; Chand et al., 2015). Laminin-α4 is 
suggested to be important for the maintenance of the NMJ, with the loss of this laminin resulting in 
premature ageing (Samuel et al., 2012). 
Research suggests that laminins are associated with a number of NMJ diseases such as Lambert-Eaton 
myasthenic syndrome and congenital myasthenic syndrome (Nishimune et al., 2004; Maselli et al., 
2009). Here we propose that laminins may also be involved in the diseased model of amyotrophic 
lateral sclerosis (ALS) that is characterised with degeneration of the NMJ (Arnold et al., 2013). 
Therefore this study will characterise the functional and structural role of laminin-α4 in maintenance 
of the NMJ, as well as the role of laminin-β2 in maturation of the NMJ. This study will further 
investigate the involvement of laminins at the NMJs in a diseased mouse model of ALS. 
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1.1 The structure of the neuromuscular junction 
Motor neurons of the central nervous system contain long projections of myelinated axons that 
travel through peripheral nerves to target the skeletal muscle fibres. The myelinated axons branch 
out to enter the muscle and lose its myelin sheath once the peripheral nerves of the axons innervate 
the muscle fibres forming the synapse termed the neuromuscular junction (NMJ) (Ruff, 2003). Due 
to its large size and ease of accessibility, the vertebrate NMJ has been extensively studied to better 
understand the structure and function of peripheral synapses (Burden, 1998). 
During embryonic development of the NMJ, peripheral nerves arrive at the skeletal muscle fibre 
leading to the formation of polyinnervated NMJs by embryonic day 12 in the mouse (Sanes & 
Lichtman, 1999; Lin et al., 2001; Burden, 2002; Wu et al., 2010). At this stage, the synapse is 
functional but not proficient enough to induce muscle contraction in a synchronous and precise 
way. To achieve this requires the maturation of the NMJ with loss of polyinnervation and the 
establishment of single innervation (Thompson, 1985; Wyatt & Balice-Gordon, 2003; Chung & 
Barres, 2009; Tapia et al., 2012). During this period, molecular and functional mechanisms 
coordinate the organisation of the pre- and postsynaptic elements that form the NMJ (see Sanes & 
Lichtman, 1999; Wu et al., 2010 for full review). As a result of this, a functional skeletal NMJ is 
organised into three distinct structural components; the presynaptic nerve terminal capped by 
perisynaptic Schwann cells, the synaptic cleft and the postsynaptic skeletal muscle fibre (Sanes & 
Lichtman, 1999). Interestingly, a study suggested a 4th component at the NMJ, termed as kranocytes 
which cap around the NMJ and it is proposed to serve a role in synapse regeneration (Court et al., 
2008). 
Within the presynaptic terminal are synaptic vesicles containing neurotransmitters, which are 
segregated into two distinct pools, the reserve pool and the readily releasable pool (Richards et al., 
2003). The readily releasable pool is located in close proximity to the release sites which are termed 
as active zones (Schikorski & Stevens, 1997; Zhai & Bellen, 2004; Juranek et al., 2006) and the 
reserve pool is located distally from the active zones (Greengard et al., 1993; Sudhof, 2004; Rizzoli 
& Betz, 2005). The active zones are regions composed of cytoskeletal aggregates and vesicular 
associated proteins involved in the docking and release of vesicles for efficient neurotransmission 
(Couteaux & Pecot-Dechavassine, 1970; Harlow et al., 2001; Nagwaney et al., 2009). Adjacent to 
the active zones are localised clusters of voltage-gated calcium channels (VGCCs) (Robitaille et al., 
1990; Nishimune et al., 2016) (Figure 1.1). 
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The synaptic cleft is the region separating the presynaptic nerve terminal and the postsynaptic 
skeletal muscle fibre. Basal lamina fills the synaptic cleft and contain synaptic laminins, which 
serve as ligands for nerve terminal and skeletal muscle fibre thus facilitating anchorage and 
signaling between both regions, which is essential for normal development and maintenance of 
the NMJ (Sanes et al., 1978; Sanes, 1995; Patton et al., 2001; Knight et al., 2003; Nishimune et 
al., 2004; Samuel et al., 2012) (Figure 1.1). 
Directly apposed to the electron dense active zones are high density clusters of acetylcholine 
receptors (AChRs), with approximately 10,000 receptors per µm2 positioned at the crests of the 
postsynaptic membrane folds (Fertuck & Salpeter, 1974) (Figure 1.1). This precise arrangement of 
active zone release sites in direct apposition to the AChRs facilitates fast synaptic transmission and 
promotes a high safety factor (Burden, 1998; Sanes & Lichtman, 1999), that is defined as the 
release of neurotransmitters in excess to ensure efficient and reliable transmission when the NMJ is 
subjected to pathological amd stressful conditions (Wood & Slater, 1997, 2001). 
Mechanism of neurotransmission in skeletal muscle 
The arrival of an action potential at the last node of ranvier and its passive spread throughout the 
nerve terminal triggers the opening of VGCCs, resulting in the influx of calcium ions into the nerve 
terminal. The entry of calcium ions forms a cloud of calcium referred as a microdomain of calcium, 
close to the releasable pool of vesicles.  This increased local concentration of calcium ions results in 
the binding of calcium to the calcium sensor, synaptotagmin. Activation of synaptotagmin leads to 
the fusion of synaptic vesicles to the presynaptic membrane of the nerve terminal that is facilitated 
by Soluble NSF (N-Ethylmaleimide-Sensitive Factor) Attachment Protein Receptor (SNARE) 
proteins. Within a fraction of a milisecond, acetylcholine contained within these synaptic vesicles is 
released into the synaptic cleft, where it diffuses across the cleft and binds to the AChRs at the 
postsynaptic region. The activation of AChRs results in the opening of voltage-gated sodium 
channels that are found at the troughs of the postsynaptic membrane folds, therefore allowing the 
influx of sodium ions (Flucher & Daniels, 1989; Wood & Slater, 1998). The influx of sodium ions 
increases the postsynaptic membrane potential, facilitating the opening of more voltage-gated 
sodium channels. This allows continuous influx of sodium ions that further increases the 
postsynaptic membrane potential towards a threshold that is sufficient to trigger an action potential 
from the muscle, culminating in muscle contraction. Once the acetylcholine is removed from the 
synaptic cleft through hydrolysis by the enzyme acetylcholinesterase (AChE) and diffusion, the 
postsynaptic repolarisation returns the membrane potential to baseline within several milliseconds 
(see Hughes et al., 2006; Fagerlund & Eriksson, 2009; Sine, 2012 for full review). This chapter will 
detail the specific proteins and molecular interactions involved in these processes.
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Figure 1.1 Schematic illustration of the skeletal neuromuscular junction. 
A, shows the neuromuscular junction, which comprised of the nerve terminal, the synaptic cleft and 
the skeletal muscle fibre. The nerve terminal is capped by perisynaptic Schwann cell and contains 
synaptic vesicles concentrated near the active zones (the sites of synaptic vesicle exocytosis). 
Voltage-gated calcium channels (VGCCs) are localised adjacent to the active zones. Laminins are 
localised within the synaptic basal lamina of the synaptic cleft. B, shows details of the pre- and 
postsynaptic membranes with the laminins lining the cleft between them. This panel illustrates the 
release of neurotransmitter acetylcholine (ACh) (dark blue dots) from the presynaptic active zones 
into the synaptic cleft and binding of the neurotransmitters to the acetylcholine receptors (AChRs) 
(red arrows and red structures) that are localised at the crests of the junctional folds of the muscle 
fibre. Voltage-gated sodium channels (VGSCs) are found localised at the troughs of the folds. 
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1.1.1 Presynaptic nerve terminal 
The nerve terminal contains synaptic vesicles that concentrate at the active zones, and 
SNARE proteins located at the active zones are flanked by VGCCs. Upon the influx of 
calcium ions via the VGCCs, docked vesicles at the active zones are primed and fused to the 
presynaptic membrane by SNARE proteins, resulting in exocytosis of vesicular contents 
(Sutton et al., 1998; Betz et al., 2001; Gomez et al., 2010). 
Synaptic vesicles 
Synaptic vesicles are categorised into two distinct pools, the readily releasable pool (RRP) and 
the reserve pool (Pieribone et al., 1995; Kuromi & Kidokoro, 1998; Richards et al., 2000) 
(Figure 1.2). A third pool, termed the releasable pool/recycling pool, is suggested to intermix 
with vesicles from the reserve pool (Rizzoli & Betz, 2005; Denker & Rizzoli, 2010), therefore 
due to this ambiguity this pool will not be discussed specifically as a distinct vesicle pool. The 
RRP is available immediately for quantal release upon stimulation of the nerve (Rizzoli & Betz, 
2005). However, this pool makes up only 20% of the total synaptic vesicles within the nerve 
terminal (Richards et al., 2003). It has been shown in rat hippocampal synapses that the RRP is 
normally found concentrated in close proximity to the active zone regions where they are 
docked (Schikorski & Stevens, 2001). In a study by Rizzoli and Betz (2004) on the frog  NMJ, 
RRP vesicles were grouped into four different compartments; i) vesicles that are localised at the 
active zones within 100 nm, ii) away from the active zones by more than 100 nm but close to 
the presynaptic membrane within 100 nm , iii) vesicles at the core of the RRP and iv) vesicles at 
the edge of the RRP  that are furthest away from the active zones (located more than 100 nm 
from the presynaptic membrane and within 50 nm of the vesicle cluster edge). One would 
assume that RRP vesicles close to the active zones would be first recruited for exocytosis upon 
nerve stimulation in comparison with RRP vesicles that located distally. However, this may not 
be necessarily true as this study demonstrated delayed release of labelled RRP vesicles from the 
cluster core during the first 10 seconds of stimulation, in contrast to the vesicles at the edge of 
RRP that were released faster, in a similar time course to that of vesicles at the active zones and 
presynaptic membrane. The faster rate of vesicles release at the edge of RRP suggests a 
mobilisation process in which these vesicles could be attached to cytoskeletal components such 
as actin (Dunaevsky & Connor, 2000; Shupliakov et al., 2002), which has been shown to be 
more abundant on the outside than the inside of the vesicle clusters, therefore affecting the 
preferential transport of vesicles from the edge of RRP for exocytosis (Rizzoli & Betz, 2004).  
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The reserve pool, which possesses 80-90% of synaptic vesicles in the nerve terminal, is 
located distally from the active zone regions (Greengard et al., 1993; Richards et al., 2003; 
Sudhof, 2004; Rizzoli & Betz, 2005). The involvement of the reserve pool stores in 
neurotransmission has remained elusive, however some studies have suggested that the 
reserve pool is only mobilised for neurotransmission when the synapse is subjected to high 
frequency stimulation and prolonged periods of stimulation (Heuser & Reese, 1973; Delgado 
et al., 2000; Kuromi & Kidokoro, 2000; Richards et al., 2000). For instance, at the frog NMJ 
stimulation frequency at 30 Hz for 10-15 s is required for mobilisation of vesicles from the 
reserve pool to sustain neurotransmission (Richards et al., 2000), while at Drosophila NMJs a 
stimulus of 30 Hz for 30 s was required in order to mobilise these vesicles (Kuromi & 
Kidokoro, 2000). Kuromi and Kidokoro (1998) suggested that mobilisation of vesicles from 
reserve pool could also occur when recycled vesicles are depleted, which was tested on the 
synapse of Drosophila mutant shibire. This particular Drosophila mutant is temperature-
sensitive and unable to recycle vesicles if it is subjected to high temperature at 340C. 
Therefore at high temperature, mobilisation of vesicles from the reserve pool took place 
instead. Similar observation was also noted in frog NMJs when recycled vesicles become 
depleted and mobilisation subsequently involved the reserve pool (Richards et al., 2000; 
Richards et al., 2003). 
Mobilisation of vesicles from the reserve pool to the RRP has been suggested to be associated 
with a family of phosphoproteins, namely the synapsins (Benfenati et al., 1992; Greengard et 
al., 1994; Hilfiker et al., 1999; Hosaka et al., 1999). Synapsins are present in three different 
isoforms; synapsin I, synapsin II and synapsin III in vertebrates (Hosaka & Sudhof, 1998; Kao 
et al., 1999),  with Synapsins I and II predominantly found at the synapse (Kao et al., 1998) 
and Synapsin III at neurons (Ferreira et al., 2000). These proteins are associated with actin-
based cytoskeleton (Bahler & Greengard, 1987; Goold et al., 1995) as well as with the surface 
of the synaptic vesicles, in particular to the vesicles in the reserve pool (Huttner et al., 1983; 
Benfenati et al., 1992; Ceccaldi et al., 1995) (Figure 1.2). Studies showed that the interaction 
of synapsin with actin-based cytoskeleton and vesicles plays an essential role in the 
maintenance and regulation of the reserve pool (Pieribone et al., 1995; Rosahl et al., 1995; 
Hilfiker et al., 1998). Upon the phosphorylation of synapsin I by calcium/calmodulin protein 
kinase II, synapsin I undergoes conformational change which dissociates synapsin I from 
actin-based cytoskeleton, thus releasing the vesicles from reserve pool to RRP and 
subsequently promoting neurotransmitter release (Benfenati et al., 1992; Greengard et al., 
1994; Hosaka et al., 1999). However, the involvement of synapsin in regulating 
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neurotransmitter release through the reserve pool only falls under conditions of high 
frequency stimulus (Llinas et al., 1985; Li et al., 1995; Rosahl et al., 1995; Humeau et al., 
2001). Pieribone et al. (1995) tested this hypothesis by blocking synapsin I completely in the 
reticulospinal axons of lampreys. At low frequency stimulation, evoked release occurred 
normally as vesicles docked at presynaptic active zones were able to sustain neurotransmitter 
release. In contrast, during high frequency stimulation evoked release dropped significantly 
leading to synaptic depression, which suggests that the reserve pool of vesicles are required to 
sustain neurotransmission when subjected to high synaptic activity. Consistent with the 
finding by Pieribone et al. (1995), studies on knockout mice of synapsin I/II also displayed 
synaptic depression under repetitive stimulations (Rosahl et al., 1995). All together findings 
strongly support the role of synapsin in regulating and maintaining the reserve pool of 
vesicles that play an important role in neurotransmitter release when high demand is placed 
on the NMJ due to increased neuronal activity. 
After synaptic vesicles mobilise from reserve pool to RRP, the initial contact between the 
vesicles and the presynaptic membrane proteins occurs, this process is termed as docking 
(Figure 1.2). Rab3A molecule is a small guanosine triphosphote (GTP) binding protein that is 
specifically localised to the surface membrane of the synaptic vesicles (Fischer von Mollard 
et al., 1990) and it is thought to be involved in this docking step (Johnston et al., 1991; 
Fischer von Mollard et al., 1994; Geppert et al., 1994; Nonet et al., 1997; Coleman et al., 
2007). The role of Rab3A has been investigated by observing the synaptic transmission in 
hippocampal CA1 pyramidal cells of Rab3A knockout mice (Geppert et al., 1994). During the 
initial repetitive stimulation at 14 Hz, both mutant and control wild-type cells displayed 
similar responses. However after 10-15 stimuli, the responses in mutants dropped by almost 
50%. This pattern of synaptic depression suggested that docked vesicles had been exhausted 
revealing the essential role of Rab3A in the docking of vesicles. A more recent study by 
Coleman et al. (2007) showed significant reduction in the number of docked vesicles at the 
NMJ of diaphragm muscle in Rab3A mutants, further strengthening the involvement of 
Rab3A in targeting and docking of vesicles to the release sites. 
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Figure 1.2 The mechanism of exocytosis and endocytosis of synaptic vesicles. 
A, vesicles docked and primed at release sites form the readily releasable pool (RRP). Vesicles within the 
RRP are available for immediate release upon stimulation. B, influx of calcium ions via activated voltage-
gated calcium channels (VGCCs) activates the release machinery proteins resulting in fusion of vesicles 
with the presynaptic membrane, and subsequent exocytosis of acetylcholine (ACh) into the synaptic cleft. 
These processes occur in regions termed active zones, which are dense in structural and regulatory 
proteins involved in mediating release. C, release sites must then be cleared to allow for subsequent fusion 
events. D, synaptic vesicle membranes undergo endocytotic retrieval via dynamin and clathrin-dependent 
pathways. E, retrieved vesicles then undergo clathrin uncoating and transmitter re-uptake, and return to the 
releasable pool for clustering. Synaptic vesicles can be separated into two morphologically distinct pools 
based on their locale; the RRP and the reserve pool. The RRP is localised in close proximity to the active 
zones while the reserve pool is localised distally away from the presynaptic membrane. Synaptic vesicles 
are tethered within the reserve pool via synapsins which are bound to actin filaments. F, mobilisation of 
vesicles from the reserve pool to the RRP occurs when synapsin dissociates from the actin filaments. This 
vesicle recruitment is thought to occur under conditions of high frequency stimulus after the RRP has been 
depleted and the recycling of vesicles from the nearby releasable pool cannot maintain the demand of 
replenishment. Note that the releasable pool is also termed as the recycling pool. This pool is often 
intermixed with vesicles from the reserve pool. However, in this figure, releasable pool is illustrated 
separately from the reserve pool for clarity.  
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Active zones 
Active zones are release sites for neurotransmitters at the presynaptic membrane of the nerve 
terminal (Couteaux & Pecot-Dechavassine, 1970; Zhai & Bellen, 2004; Juranek et al., 2006) 
(Figure 1.3). At the mouse NMJ, there are approximately 600-800 active zones and each of 
these are approximately 100-200 nm in length, separated evenly from one another by a 
distance of about 500 nm (Nagwaney et al., 2009; Chen et al., 2012). These release sites are 
arranged in parallel double rows where two docked vesicles are seated in between the rows, 
along with VGCCs and other accessory proteins that are also localised to these regions 
(Fukunaga et al., 1983; Fukuoka et al., 1987; Neher & Sakaba, 2008; Nagwaney et al., 2009; 
Meriney & Dittrich, 2013) (Figure 1.3). With two docked vesicles in each active zone, it is 
estimated that there would be approximately 1200-1600 docked vesicles available for release 
at the mouse NMJ (Nagwaney et al., 2009). However, only 60-80 vesicles are released during 
a single stimulus at low frequency (Wang et al., 2004; Ruiz et al., 2011). This indicates that 
not all active zones participate in neurotransmitter release, of which are termed as the 
“sleepy” active zones (Wang et al., 2010; Ruiz et al., 2011). Therefore, it is estimated that 
only 10% of available active zones participate in low probability release of neurotransmitter 
with the remaining release sites being relatively silent (Wang et al., 2004; Wyatt & Balice-
Gordon, 2008; Ruiz et al., 2011; Meriney & Dittrich, 2013). These very low probabilities of 
transmitter release sites can be made more active when the extracellular calcium 
concentration is increased or when the nerve terminal is stimulated with greater frequency 
(Bennett & Lavidis, 1979). 
The transmitter release machinery interacts with a number of proteins that form the 
cytomatrix of active zone (CAZ) structure. The CAZ structure is comprised of numerous 
proteins such as Rab3A interacting molecule (RIM1), Bassoon, Piccolo, Munc13-1, 
cytomatrix at the active zone-associated structural protein (CAST) and glutamine, leucine, 
lysine and serine-rich protein (ELKS) (Ohtsuka et al., 2002; Takao-Rikitsu et al., 2004; Hida 
& Ohtsuka, 2010) (Figure 1.4). Immunoprecipitation studies have demonstrated association 
between active zone components and CAST suggesting a network of interaction between these 
components (Ohtsuka et al., 2002; Takao-Rikitsu et al., 2004; Hida & Ohtsuka, 2010). 
Furthermore, a most recent study showed that Piccolo is localised at the sides of Bassoon 
forming a network of interaction of Piccolo-Bassoon-Piccolo utilising a method of super 
resolution microscopy (Nishimune et al., 2016). CAST and ELKS have been suggested to be 
the main scaffolding proteins in the CAZ as they bind directly to Bassoon, Piccolo, RIM1 and 
indirectly with Munc13-1 via RIM1 (Ohtsuka et al., 2002; Takao-Rikitsu et al., 2004; Hida & 
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Ohtsuka, 2010) (Figure 1.4). The interaction between RIM1 and Munc13-1 is suggested to 
promote vesicle priming, in which the binding of RIM1 to Munc13-1 acts as a switch for 
induction of vesicle priming once synaptic vesicle docking is achieved at Rab3A molecule via 
RIM1 (Wang et al., 1997; Ozaki et al., 2000; Wang et al., 2000; Betz et al., 2001) (Figure 
1.4). This is consistent with the role of Munc13-1 in altering the conformation of the SNARE 
protein, syntaxin which then allows formation of the SNARE core complex therefore 
facilitating vesicles priming (Brose et al., 1992; Augustin et al., 1999; Ashery et al., 2000; 
Betz et al., 2001). 
Active zone components also interact with voltage-gated calcium channels (VGCCs) as shown 
through the binding of Bassoon to  β1b and β4 subunit of the presynaptic VGCCs, with CAST 
also having direct interaction with β1b subunit (Chen et al., 2011) (See section 1.1.1; 
Voltage-gated calcium channels). This is further supported with the colocalisation of Bassoon 
with P/Q-type VGCCs, in which both displayed similar pattern of distribution at the NMJ 
(Nishimune et al., 2012; Nishimune et al., 2016). The direct interaction between active zone 
components and VGCCs help anchors active zones to the presynaptic membrane (Chen et al., 
2011; Chand et al., 2015). The interaction between the active zone components and the 
VGCCs is also physiologically important as demonstrated in the study by Kiyonaka et al. 
(2007), in which the interaction between the C-terminus of RIM1 and β4 subunit of VGCCs 
suppresses the inhibition of VGCC activation thus allowing further influx of calcium ions. 
Similar observation was made when Bassoon increased the opening time of P/Q-type VGCCs 
to permit greater influx of calcium ions when synapse was repetitively stimulated (Nishimune 
et al., 2012). These findings showed that active zone components are important both 
structurally and functionally in neurotransmission. 
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 Figure 1.3 Arrangement of active zone components at mouse neuromuscular junction. 
A, Acetylcholine receptor endplate (yellow) is innervated by motor nerves (green). Hundreds of active 
zones as represented by small green spots are colocalised with respect to the endplate region. Each of 
these active zones is measured between 100-200 nm in length and they are arranged in linear arrays of 
double rows separated from one another by a distance of 500 nm. The arrival of an action potential 
triggers the opening of calcium channels which open at low probability, allowing the influx of 
calcium ions into the nerve terminal forming an elevated background of calcium ions (light blue 
circle). Further influx of calcium ions leads to the formation of Ca2+ nanodomain (dark blue region) 
which results in fusion of docked vesicles to the presynaptic membrane for transmitter release. B, 
Electron micrographs show electron dense regions of active zones localised close to presynaptic 
membrane as indicated by yellow asterisks (*). C, Freeze-fracture of mouse diaphragm muscle 
displaying arrangement of active zones in parallel double rows as indicated by yellow arrows. Scale 
bar for (B) 0.25 µm. Magnification taken at x 146, 000 for (C). Figures A, adapted from Tarr et al. 
(2013) modified by KK Chand, B, from Patton et al. (2001) and C, from Fukuoka et al. (1987). 
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 Figure 1.4 The network of protein interactions within the active zone region. 
 Cytomatrix at the active zone-associated structural protein (CAST) and glutamine, leucine, lysine and 
serine-rich protein (ELKS) act as the main scaffolding proteins by interacting directly with Piccolo 
and Bassoon through coiled-coil domains, RIM1 through PDZ domain and indirectly with Munc13-1 
via RIM1 at zinc finger domain. RIM1 interacts with the β-subunit of the voltage-gated calcium 
channels as well as synaptic vesicles through Rab3A protein. Munc13-1 also interacts with the 
vesicles through Rab3A protein and with one of the SNARE proteins, syntaxin 1A at C2 domain. 
Syntaxin 1A interconnects with another SNARE protein, namely synaptosome-associated protein of 
25 kDa (SNAP25) which binds to synaptobrevin, also known as VAMP that is bound to the synaptic 
vesicles. This complex interaction of syntaxin 1A-SNAP25-VAMP facilitates exocytosis of vesicles 
upon binding of calcium ions to the calcium sensor, synaptotagmin which is also localised to the 
vesicles. Figure adapted from Hida and Ohtsuka (2010), modified by KK Chand. 
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SNARE proteins 
SNARE proteins are implicated in the process of synaptic vesicle priming and exocytosis (Sutton 
et al., 1998; Bennett, 2001; Betz et al., 2001). Plasma membrane SNARE proteins, syntaxin and 
SNAP25 along with the vesicular SNARE protein, VAMP/synaptobrevin associate together to 
form the SNARE protein core complex upon binding of calcium ions to the calcium sensor, 
synaptotagmin (Sheng et al., 1994; Rettig et al., 1996; Sheng et al., 1996; Charvin et al., 1997; 
Sheng et al., 1997) (Figure 1.4). 
 Syntaxin interacts with VGCCs via its H3 domain with the II-III intracellular loops of α1A and α1B 
subunits of P/Q-type and N-type VGCCs respectively (Sheng et al., 1994; Mochida et al., 1996; 
Rettig et al., 1996; Kim & Catterall, 1997; Sheng et al., 1998). P/Q- and N-type VGCCs are the 
subtypes found close to the active zones at synapses (detailed in next section). This interaction may 
be important for localising the source of calcium ions near the calcium sensor in order to enhance 
the efficiency of neurotransmitter release (Mochida et al., 1996; Rettig et al., 1996). This is 
supported by the findings of Keith et al. (2007) that demonstrated interaction between syntaxin and 
calcium channels in modulating the activation and inactivation of calcium channels.  In the presence 
of docked synaptic vesicles, syntaxin interacts with SNAP25 and synaptobrevin to modulate the 
activation of calcium channels. However, in the absence of docked vesicles, syntaxin inactivates the 
calcium channels. This interaction ensures that influx of calcium ions only occurs at sites with 
readily releasable vesicles to ensure efficient and rapid neurotransmission (Zhong et al., 1999). 
SNAP25 and Synaptotagmin also interact with the II-III intracellular loops of α1A and α1B of P/Q-
type and N-type VGCCs respectively (Walker & De Waard, 1998; Zhong et al., 1999). It is shown 
that SNAP25 specifically inhibits the P/Q-type VGCCs, and that the formation of the SNARE 
protein core complex reactivates the P/Q-type VGCCs (Zhong et al., 1999). 
Voltage-gated calcium channels 
VGCCs are involved in neurotransmitter release by permitting the influx of calcium ions into the 
nerve terminal upon arrival of an action potential. These channels are normally found clustered at 
the presynaptic membrane adjacent to the active zones (Robitaille et al., 1990). The importance of 
calcium ions in the process of neurotransmission came about when Fatt and Katz (1953) 
investigated the electrical properties of crustacean muscle fibres. It was found that the electrical 
response of crustacean muscle reduced significantly or was completely abolished when calcium was 
removed from the bathing solution, whereas increased concentration of calcium resulted in 
enhanced electrical responses. This finding clearly demonstrated the release of transmitter in the 
form of quantal units was dependent on extracellular calcium ions being present during the action 
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potential depolarising the nerve terminal (Fatt & Katz, 1953). Subsequently, other studies discovered a 
group of VGCCs that are distinguished based on electrophysiological and pharmacological properties 
(see Lacinova, 2005 for review). There are five VGCC subtypes that can be categorised into two groups 
based on the level of voltage activation properties, with T-type as the low-voltage activated channel and 
L-, N-, P/Q-, and R-type as the high-voltage activated channels (Nowycky et al., 1985; Fox et al., 1987; 
Tsien et al., 1988; Zhang et al., 1993). Each of these VGCCs is different in terms of function with P/Q- 
and N-type being involved primarily in neurotransmitter release at both central and peripheral synapses 
(Uchitel et al., 1992; Katz et al., 1996; Rosato-Siri & Uchitel, 1999; Rosato-Siri et al., 2002; Zaitsev et 
al., 2007), L-type in excitation-contraction coupling (Zhou & January, 1998), and T-type in controlling 
pacemaker activity of the heart (Le Quang et al., 2013). The exact role of R-type VGCCs however 
remains unclear but suggested to be involved with finer control of calcium influx (Myoga & Regehr, 
2011). 
Despite differences in voltage activation properties and function in these VGCCs, their subunit 
compositions are similar to one another. The pore forming subunit, α1 (Cavα) forms the core of these 
calcium channels along with the presence of auxillary subunits such as β, α2δ and γ (Singer et al., 1991; 
Day et al., 1997; Walker et al., 1998; see Catterall, 2000 & Klugbauer et al., 2003 for review) (Figure 
1.5). The core subunit α1 acts as the ion conducting pore of the channels and contains domains that 
function as voltage sensor for activation of VGCCs (Mori et al., 1991; Starr et al., 1991). This subunit 
also possesses interaction sites for the binding of calcium channels toxins and activators (see Moreno 
Davila, 1999 for review). The auxillary subunits, β, γ and α2δ are essential for increasing the surface 
expression of the VGCCs, modulating kinetics and voltage dependence of the channels as well as 
enhancing recognition site for channel specific toxins and activators (Walker & De Waard, 1998). 
At the NMJ, N- and P/Q-type VGCCs play essential roles in neurotransmitter release (Katz et al., 1996; 
Rosato-Siri & Uchitel, 1999; Rosato-Siri et al., 2002). During the development of the NMJ, 
neurotransmitter release is mediated by both N- and P/Q-type VGCCs (Katz & Shatz, 1996; Rosato-Siri 
& Uchitel, 1999; Rosato-Siri et al., 2002). This was supported by the study which utilised ω-Agatoxin 
IVA (ω-Aga IVA) and ω-conotoxin GVIA (ω-CTX GVIA) to block P/Q- and N-type VGCCs 
respectively, in order to investigate calcium channels involved in neurotransmission (Rosato-Siri & 
Uchitel, 1999). It was found that both ω-Aga IVA and ω-CTX GVIA significantly blocked evoked 
neurotransmitter release at the developing NMJs of neonatal rats (Rosato-Siri & Uchitel, 1999). As the 
NMJ matured by postnatal day 14, evoked release was significantly blocked by ω-Aga IVA, suggesting 
that neurotransmitter release is predominantly mediated by P/Q-type VGCCs at mature NMJs (Katz & 
Shatz, 1996; Rosato-Siri & Uchitel, 1999). In contrast, the blocking effects of ω-CTX GVIA had no 
effect on N-type VGCCs for evoked release at mature NMJs (Rosato-Siri & Uchitel, 1999). 
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The switch from N- to P/Q-type VGCCs, as the predominant calcium channel for neurotransmitter 
release in mature NMJ is associated with its closer localisation to release sites (Urbano et al., 2002; 
Nudler et al., 2003). This is in agreement with the study by Rosato-Siri et al. (2002) which 
demonstrated ineffective binding of BAPTA, a fast calcium ion chelator to calcium ions that enter 
through P/Q-type VGCCs. This indicates that calcium ions which enter through this channel are 
only required to travel a short distance to bind to synaptotagmin at the release sites. In contrast, 
most of the calcium ions which entered through N-type VGCCs were bound by BAPTA (Rosato-
Siri et al., 2002). This suggests the locale of N-type VGCCs is distal from the release sites, 
therefore calcium ions entering through this channel need to travel a greater distance to reach the 
release sites resulting in increased binding of calcium ions by BAPTA (Wu et al., 1999; Nudler et 
al., 2003). Thus, P/Q-type VGCCs are suggested to be the dominant mediator in neurotransmitter 
release at mature and adult NMJs. 
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Figure 1.5 Putative subunit arrangement in voltage-gated calcium channel. 
The VGCC is made up of a pore forming subunit, α1 (Cavα) which acts as voltage sensor and 
binding sites for calcium channels toxins and activators. Depolarisation of the nerve terminal 
leads to activation of VGCCs resulting in Ca2+ influx through the channel. The auxillary 
subunits, β (Cavβ), γ and α2δ are important for modulating the gating properties of the 
channels through the pore forming subunit. The transmembrane δ subunit is linked to the 
extracellular α2 subunit through disulfide bridges that formed between cysteine residues of 
both subunits. The β subunit is localised internally and does not have any transmembrane 
segments unlike the γ subunit with four transmembrane segments. (For review, see Klugbauer 
et al. (2003). Figure edited from Lacinova (2005). 
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1.1.2 Synaptic cleft 
The synaptic cleft is a specialised region separating the pre- and postsynaptic membranes of the 
NMJ by approximately 50-100 nm (Heuser et al., 1979; Wood & Slater, 2001; Hughes et al., 
2006). Basal lamina which comprises part of the basement membrane, fills the entire cleft 
forming the synaptic basal lamina. The synaptic basal lamina comprises a small fraction 
(~0.1%) of the entire muscle fibre membrane (Patton et al., 1997; Pedrosa-Domellof et al., 
2000). 
The basal lamina is a self-assembly complex that comprises groups of glycoproteins known as 
laminins and collagen IV that are linked to nidogens and heparan sulfate proteoglycans, such as 
agrin and perlecan (Tsilibary et al., 1988; Fox et al., 1991; McKee et al., 2007; McKee et al., 
2009). It has been shown that basal lamina is attached to cell surfaces primarily through the 
laminins (Martin & Timpl, 1987). When laminins were expressed in the absence of other 
basement membrane components, the assembly of basement membrane on cell surfaces 
occurred normally (McKee et al., 2007). This suggests that laminins are primarily involved in 
organising the assembly of basement membranes on cell surfaces. In support of this, it was 
shown that knockout of laminin expression in specific tissues resulted in the failure of basement 
membrane formation (Smyth et al., 1999; Miner et al., 2004). For instance, this was seen in 
early embryo where basement membrane of sub-visceral endoderm and Reichert’s membrane 
failed to form when specific laminins were eliminated, thus resulting in embryonic lethality 
(Smyth et al., 1999; Miner et al., 2004). 
Laminins were first isolated from a mouse tumour, Engelbreth-Holm-Swarm sarcoma, which 
produces extracellular matrix of basement membrane (Timpl et al., 1979). The process of 
extraction from the mouse tumour yielded large amount of non-collagenous glycoproteins, the 
laminins which were found localised to basement membrane of normal tissues such as kidney, 
placenta and skin. This strongly supports the localisation of laminins in basement membrane of 
normal tissues. Further study utilising electron microscopy through three techniques such as 
rotary shadowing, negative staining and transmission electron microscopy revealed the 
cruciform structure of the laminins (Engel et al., 1981) (Figure 1.6). The laminins were 
observed as cross-shaped molecules with the presence of a long arm that ended with a large 
protrusion at the tip and three identical short arms with globular units near at each end (Figure 
1.6). Later studies then revealed the long arm of the cross as an α-helical coiled coil that is 
formed from all three genetically distinct but homologous chains of α, β and γ, with each of the 
three short arms representing a single chain (Sasaki & Yamada, 1987; Sasaki et al., 1988; Bruch 
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et al., 1989; Beck et al., 1990) (Figure 1.6). The long arm of the α chain at the distal region 
contains five laminin G-like domains that are represented as LG domains (LG1-5), which 
interact with cellular receptors of cell surfaces and are essential for signal transduction and 
anchorage to cell surfaces (Aumailley et al., 1990; Roskelley et al., 1995; Talts et al., 1999; Ido 
et al., 2004; Yurchenco & Patton, 2009). Specifically, the LG1-3 domains bind to integrins (Ido 
et al., 2004; Ido et al., 2007) and while the LG4-5 domains binds to α-dystroglycan, agrin and 
perlecan (Talts et al., 1999). These receptors, particularly integrins and dystroglycan, act as 
signalling receptors that activate other associated components for the regulation of cell 
functions as well as linking the basement membrane to underlying cytoskeleton that is 
important in maintaining the structure of the NMJ when exposed to strong mechanical stress 
(Ervasti & Campbell, 1993; Delwel et al., 1996; Henry & Campbell, 1996). The three short 
arms of α-, β- and γ-chains are made up of distal laminin N-like domains known as the LN 
domains (Yurchenco & Cheng, 1993). The LN domains of each chain interact together to form a 
ternary node that results in the formation of a laminin network, that is essential for the assembly 
and stability of the basement membrane through cross-linking (Bruch et al., 1989; Yurchenco & 
Cheng, 1993; McKee et al., 2007) (Figure 1.6). 
To date, there are five laminin α-chains, three β-chains and three γ-chains that have been 
identified (Miner & Yurchenco, 2004). At the synaptic basal lamina, the laminin chains are 
comprised of α2, α4, α5, β2 and γ1 that are deposited by muscle fibres (Patton et al., 1997). 
During early development, α2, α4, α5 and β1 are found in both synaptic and extrasynaptic 
regions whereas β2 is restricted specifically to the synaptic basal lamina from its first 
appearance (Miner et al., 1997; Patton et al., 1997). As development progresses, α4 and α5 are 
lost from the extrasynaptic region and become restricted at the synaptic basal lamina, whereas 
α2 remains expressed in both regions (Miner et al., 1997; Patton et al., 1997). Laminin-β1 chain 
on the other hand, is lost from the synaptic basal lamina and becomes restricted to the 
extrasynaptic region (Sanes et al., 1990; Patton et al., 1997). Thus the synaptic basal lamina is 
rich in three synapse specific laminin heterotrimers; laminin-221 (α2β2γ1), laminin-421 
(α4β2γ1) and laminin-521 (α5β2γ1) (Patton et al., 1997; Aumailley et al., 2005; Hohenester & 
Yurchenco, 2013) (Figure 1.6). Laminin-221 promotes fold formation of the postsynaptic 
membrane and synaptic adhesion (Sanes et al., 1990; Patton et al., 1997; Patton, 2000). 
Laminin-421 maintains proper apposition of active zone-VGCCs to postsynaptic junctional 
folds (Patton et al., 2001; Nishimune et al., 2004). Laminin-521 regulates nerve terminal 
differentiation and prevent invasion of Schwann cells into the synaptic cleft (Patton et al., 1998; 
Patton, 2000). Therefore, these laminin heterotrimers of the synaptic basal lamina play essential 
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roles in differentiation, development and maintenance of the NMJ (Sanes et al., 1978; Chiu & 
Sanes, 1984; Knight et al., 2003; Nishimune et al., 2004; Nishimune et al., 2008; Samuel et al., 
2012; Chand et al., 2015). These laminins are also involved in the polymerisation of the laminin 
network at the synaptic basal lamina (Yurchenco & Cheng, 1993; McKee et al., 2007). 
However, laminin-421 is an exception due to its truncated arm of the α4 chain (Aumailley et al., 
2005; Hohenester & Yurchenco, 2013) (Figure 1.6). Studies have shown that the formation of 
ternary nodes for laminin network requires the presence of each short arms of α, β and γ chains 
(Bruch et al., 1989; Schittny & Yurchenco, 1990; Yurchenco & Cheng, 1993; McKee et al., 
2007). Therefore, the truncated arm of α4 chain in laminin-421 limits its ability to polymerise in 
the laminin network, suggests it likely plays a unique role at the synapse. The roles of 
individual laminin chains such as α4, α5 and β2 have also been investigated and they will be 
discussed below. 
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 Figure 1.6 Distribution of specific laminin chains at the synaptic basal lamina of the 
neuromuscular synapse. 
A, Ternary node is formed by the interaction of each subunit chain of α, β and γ through the 
short arms of LN domains. These interactions are essential for the polymerisation of laminin 
network that aids in assembly and stability of the basement membrane. B, Localisation of 
specific laminin chains such as α2, α4, α5, β2 and γ1 at the synaptic cleft of the NMJ. Laminin-
α2 chain is expressed in both synaptic and extrasynaptic regions. Laminin-α4 is expressed 
mainly at the primary clefts whereas laminin-α5, -β2 and -γ1 are localised at primary and 
secondary clefts of the NMJ. C, Laminin chains form three predominant laminin heterotrimers 
such as laminin-221 (α2β2γ1), laminin-421 (α4β2γ1) and laminin-521 (α5β2γ1). The long arm 
of α-helical coiled-coil contains LG1-LG5 domains that are known for their interactions with 
cellular receptors such as dystroglycan, integrins and heparan sulfate proteoglycans for signal 
transduction and cell surface attachment. Laminin-421 has a truncated arm at the α4 chain 
which results in the absence of LN domain. Therefore, laminin-421 is not involved in the 
polymerisation of laminin network. Figures A, adapted from Hohenester and Yurchenco (2013), 
B, from Patton et al. (2001) and C, from McKee et al. (2007). 
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Laminin-β2 
The laminin-β2 chain is present in each of the synapse specific laminin heterotrimers found at 
the NMJ. It is localised in the primary cleft and the postjunctional folds of the skeletal muscle 
fibre (Patton et al., 1997; Patton et al., 2001) (Figure 1.6). Laminin-β2, which was previously 
termed as S-laminin due to its restricted location at the synaptic basal lamina, was first 
discovered by (Hunter et al., 1989b). The generation of antibodies to target specific molecules 
at the synaptic basal lamina identified a homologue of the laminin-β1 chain, now known to be 
laminin-β2 (Hunter et al., 1989b). Previous studies have shown that motor neurons reinnervate 
original synaptic sites after denervation of muscle fibres (Sanes et al., 1978; Laskowski & 
Sanes, 1988) and it was subsequently suggested that laminin-β2 may have directed this selective 
event (Hunter et al., 1989b). This was supported with the findings of a site known as Leu-Arg-
Glu (LRE) in laminin-β2 that is selectively adhesive to motor neuron-like cells (Hunter et al., 
1989a; Hunter et al., 1991). It was demonstrated that the LRE sequence in recombinant 
fragment of laminin-β2 acted as an inhibitory signal for neurite outgrowth that originates from 
motor-neuron like cells using cell culture (Porter et al., 1995). Together, these observations 
suggest that laminin-β2 is involved in the regulation of synaptic growth particularly on the 
motor nerve terminal through LRE tripeptide sequence. 
More recent studies confirmed the early observations which demonstrated laminin-β2 being 
directly involved in maintaining normal presynaptic differentiation during NMJ development 
(Noakes et al., 1995a; Nishimune et al., 2004; Chen et al., 2011; Chand et al., 2015). 
Ultrastructural studies of NMJs in mice lacking laminin-β2 (lamb2-/-) displayed synaptic defects 
such as reduced number of active zones, dispersed synaptic vesicles, invasion of Schwann cell 
processes into the synaptic cleft, and reduced postsynaptic folding at both developing (postnatal 
day 8) and mature (postnatal day 15-20) NMJs (Noakes et al., 1995a; Knight et al., 2003) 
(Figure 1.7). The presynaptic defects contribute to significantly disrupted neurotransmission 
observed at lamb2-/- NMJs such as a significant reduction in the frequency of spontaneous 
transmitter release (Noakes et al., 1995a) and a 50% decrease in quantal content (Knight et al., 
2003). 
In-vitro study has demonstrated binding between laminin-β2 and VGCCs such as N- and P/Q-
type (Nishimune et al., 2004). This was shown through the use of transfected cells with 
complementary deoxyribonucleic acid (cDNA) that contains P/Q-, N-, R- and L-type channels, 
and it was found that a large number of laminin-coated beads were bound to transfected cells 
containing Cav2.1 (P/Q-type) and Cav2.2 (N-type)  rather than on Cav2.3 (R-type) and Cav1.2 
(L-type) (Nishimune et al., 2004). This direct binding occured through the predominant binding 
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site of laminin-β2, the LRE tripeptide with the 11th extracellular loop of the pore forming 
subunits, of the VGCCs; Cav2.2 (N-type) and Cav2.1 (P/Q-type) (Nishimune et al., 2004). This 
interaction is suggested to induce clustering of VGCCs at the presynaptic membrane, which in 
turn maintains the stability of active zones (Nishimune et al., 2004; Chand et al., 2015). 
Alterations in this interaction may explain the reduction of active zones seen in both Cav2.1 
knockout mice at postnatal day 16 and lamb2-/- at postnatal days 4, 8 and 10 (Nishimune et al., 
2004). To further support this, Chen et al. (2011) demonstrated interaction between VGCCs and 
active zone components through immunoprecipitation study, in which β1b and β4 subunits of 
VGCCs were able to interact directly with the active zone component, Bassoon. Thus, 
explaining the reduction in the expression of Bassoon staining at P/Q- and N-type knockout 
NMJs, by 35% and 32% respectively (Chen et al., 2011). More importantly, decreased 
expression of laminin-β2 at the synaptic cleft of double knockout (N- and P/Q-type VGCCs) 
was observed, suggesting the required presence of VGCCs to bind to laminin-β2 in the synaptic 
cleft (Chen et al., 2011). Therefore, the interaction between VGCCs and laminin-β2 is likely 
required to anchor the active zone components at the presynaptic membrane thus contributing to 
assembly and stability of active zone. 
At the postsynaptic region of lamb2-/- NMJs, a decrease in the number of junctional folds was 
observed (Noakes et al., 1995a) (Figure 1.7). The decreased in junctional folds was attributed to 
a corresponding decrease in neural cell adhesion molecule (NCAM), which is normally found at 
the base of the junctional folds (Covault & Sanes, 1986; Noakes et al., 1995a). In support of 
this, NCAM deficient mice also showed fewer numbers of junctional folds suggesting the 
involvement of NCAM in the formation of junctional folds (Moscoso et al., 1998). This 
suggests that laminin-β2 may be involved in the differentiation of the postsynaptic NMJ which 
requires further investigation. 
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Figure 1.7 Ultrastructural and phenotype comparisons of neuromuscular synapse in wild-type 
and lamb2-/-. 
Electron micrographs display morphological defects at lamb2-/- NMJs in comparison with 
normal features of wild-type NMJs. A, Wild-type showed normal capping of perisynaptic 
Schwann cells (S) on nerve terminal (N), with vesicles closely assembled to active zones that 
apposed to junctional folds of the muscle fibre (M). B, In contrast, lamb2-/- showed invasion of 
Schwann cells into the synaptic cleft (as indicated with ‘S’ within the cleft), scattered vesicles 
with decreased number of active zones and reduced junctional folds at the muscle fibre. C, 
Lamb2-/- mouse clearly showed stunted growth in body size in comparison with aged-matched 
wild-type at postnatal day 18. Scale bar represents 0.75 μm for A and B. Figure A and B 
adapted from Patton et al. (1998). 
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Laminin-α4 
Laminin-α4 pairs with laminins-β2 and -γ1 to form laminin-421 where it is localised at the 
primary clefts of the NMJ (Patton et al., 1997; Patton et al., 2001) (Figure 1.6). This laminin 
is found concentrated between the junctional folds of the postsynaptic muscle fibre (Patton et 
al., 2001) (Figure 1.6). The restricted localisation of laminin-α4 between the junctional folds 
has been associated with its instructive role of determining where active zones and junctional 
folds are localised (Patton et al., 2001). The loss of laminin-α4 results in misalignment of 
70% of active zones to junctional folds at the NMJ, suggesting that laminin-α4 plays a role in 
maintaining the proper apposition of active zones to junctional folds at the NMJ (Patton et al., 
2001) (Figure 1.8). Carlson et al. (2010) suggested that laminin-α4 may organise these 
specialisations via its interaction with α3-integrin which is found localised at the active zones 
(Cohen et al., 2000; Suzuki et al., 2005). Additionally, studies on the Torpedo electric organ, 
a model of the NMJ, revealed the isolation of laminin-421 detergent soluble complex with 
VGCCs which was separable from other laminins and presynaptic proteins (Carlson et al., 
2010). This finding is consistent with the interaction of VGCCs with laminin-421 through the 
laminin-β2 chain (Nishimune et al., 2004) and it is suggested to also aid in the guidance of 
active zones to junctional folds (Patton et al., 2001). Therefore, the interaction of laminin-α4 
with integrins or indirectly with VGCCs may help in the guidance of active zones to properly 
appose to junctional folds (Patton et al., 2001) (Figure 1.8). The study by Patton et al. (2001) 
also showed young laminin-α4 knockout mice (lama4-/-) at postnatal day 12 consistently 
displayed misalignment similar to that observed in the adults, suggesting that this defect is 
non-progressive. 
The functional consequences of knocking out laminin-α4 have primarily been observed in 
behavioural studies of these knockout mice (Patton et al., 2001). These mutants displayed 
uncoordinated hind-limb movement when they were held by the tail (Figure 1.8) and were 
noted to drag their hind-limbs while walking, suggestive of skeletal muscle weakness (Patton 
et al., 2001). To further characterise the behavioural movement, 2 months old lama4-/- mice 
were made to walk along a narrow beam with only 11% of them displaying 2 or fewer foot 
slips in contrast to all wild-types which successfully crossed the narrow beam with 2 or fewer 
foot slips (Patton et al., 2001). This suggests altered neuromotor coordination in lama4-/- 
animals. Similarly, 8 months old lama4-/- mice demonstrated consistent results to 2 months old 
knockouts, again indicating that the defects are non-progressive, which supports the 
morphological findings at lama4-/- NMJs (Patton et al., 2001). Interestingly, no significant 
differences were found in any of the parameters tested when the force of muscle contraction 
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was investigated.  However, it has to be taken into consideration that the performance of a 
single muscle particularly the soleus muscle which was chosen for the test, does not 
necessarily reflects the muscle function as a whole in the hind-limbs. Therefore, other 
methods such as hind-limb grip strength would be more appropriate to properly study the 
functional capacity of the hind-limb in these knockouts. Furthermore, this method allows 
proper detection of neuromuscular dysfunction (Burgess et al., 2010). Histological staining of 
the muscle fibres was also conducted and the findings demonstrated normal muscle fibre size 
with no dystrophy, myopathy or degeneration and regeneration of the muscle fibres. Thus, 
these observations suggest that the loss of laminin-α4 does not directly affect the muscles per 
se but solely on the NMJ itself. 
Other than being involved in directing the placement of active zones and junctional folds, a 
more recent study suggested that laminin-α4 also plays an essential role in the maintenance of 
the adult NMJ (Samuel et al., 2012). The NMJs of 6 months old lama4-/- displayed fragmented 
AChRs, denervation, partial innervation, nerve terminal sprouting, axonal swelling and 
multiple innervations which are features of an ageing NMJ (Samuel et al., 2012), and are 
commonly observed in wild-type mice between 1.5 to 2 years of age (Valdez et al., 2010). 
This indicates that the loss of laminin-α4 may accelerate the ageing process in these mice by 
approximately 6 to 10 months earlier suggestive of a disruptive maintenance of the NMJ.  
Furthermore, 2 year old aged wild-type NMJs showed altered distribution of laminin-α4, in 
which certain AChR regions lacked expression of this laminin and with some expressed 
extrasynaptically (Samuel et al., 2012). These findings led to the proposal that altered 
laminin-α4 expression and/or distribution may contribute to the ageing process in a normal 
NMJ or potentially the ageing NMJ may lead to the gradual changes of laminin-α4. The 
prevalence of early ageing features at lama4-/- NMJs may also be due to a higher incidence of 
synaptic remodeling as a counter adaptive response to the early misalignment of pre- and 
postsynaptic specialisations. 
The same study suggested that laminin-α4 is specifically involved in presynaptic maintenance 
of the NMJ (Samuel et al., 2012). At 6 months of age, 50% of lama4-/- NMJs displayed 
swollen terminals and were partially denervated, which are characteristics associated with 
presynaptic defects. However these defects may also be a reflective of remodeling changes in 
response to altered transmission (Prakash et al., 1999; Mantilla & Sieck, 2009). Therefore, 
these morphological changes may likely be an attempt to re-establish normal efficient levels 
of neurotransmission at lama4-/- NMJs. However, the same study suggested the possibility 
that the observed presynaptic changes may have resulted from postsynaptic defects or 
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alterations of the laminin chains in these mice (Samuel et al., 2012). Therefore, this study 
went on to target molecules of the postsynaptic membrane that included agrin, rapsyn and 
dystroglycan as well as laminin chains of β2 and α5. These molecules were found in normal 
expression and level suggesting that laminin-α4 is acting directly on the nerve terminals for 
maintenance of the NMJ. 
Despite observed NMJ defects and abnormal movements in lama4-/-, these mice are healthy 
and viable (Patton et al., 2001) in comparison with lamb2-/- mice which has stunted growth 
and struggle to survive past the age of weaning (postnatal day 21) (Noakes et al., 1995b) 
(Figure 1.7). The decreased survivability of lamb2-/- mice is due to renal kidney failure 
(Noakes et al., 1995b). In fact, patients diagnosed with either Pierson syndrome or congenital 
myasthenic syndrome, both of which are associated with mutation of laminin-β2, survived 
longer after kidney transplants (Maselli et al., 2009). On the other hand, the longer 
survivability of lama4-/- mice compared with lamb2-/- mice could be associated with the fact 
that loss of laminin-α4 only affects a single synapse specific laminin heterotrimer, whereas 
loss of laminin-β2 affects each of the laminin heterotrimers at the NMJ (Patton, 2000). 
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 Figure 1.8 Misapposition of pre- to postsynaptic specialisations at the neuromuscular junction 
and abnormal behavioural movement of lama4-/-. 
Electron microscopy images taken from sternomastoid muscle of adult control wild-type (A and 
C) and lama4-/- (B, D and E). A, Wild-type NMJs showed normal morphology with proper 
apposition of active zones as indicated by red asterisk (*) to junctional folds noted with red 
lines in high magnification in C. B, Lama4-/- NMJs displayed misapposition of active zones (*) 
to junctional folds (indicated by red lines) in D and  E. F, Wild-type displayed normal 
behaviour with splayed legs pushing downwards with force whereas G, lama4-/- demonstrate 
retraction of hind-limbs or in other words, clasping and H, with splayed legs that lifted highly 
backwards. Figures A-E adapted from Patton et al. (2001) and F-H from Yang et al. (2005). 
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Laminin-α5 
Laminin-α5 is localised at primary clefts and secondary clefts of the NMJ in a similar distribution 
to that of the laminin-β2 chain (Patton et al., 1997; Patton et al., 2001). Investigation of the role 
of laminin-α5 at the NMJ has been limited as mice lacking laminin-α5 die during late embryonic 
stage due to several developmental defects (Miner et al., 1998). However, Nishimune et al. 
(2008) was able to investigate the role of laminin-α5 at later stages of the NMJ development and 
maturation utilising a conditional laminin-α5 knockout mice in which laminin-α5 was selectively 
removed from muscle. 
The study demonstrated that laminin-α5 plays an essential role in postsynaptic maturation of the 
NMJ (Nishimune et al., 2008). This was observed in the simple plaque-like morphology of AChR 
clusters in the conditional laminin-α5 knockouts in contrast to the pretzel-like AChR clusters in 
the control NMJs at postnatal day 21. However, postsynaptic maturation was only delayed in 
these knockouts but could later be achieved after postnatal day 40. This led to speculation that 
other laminins may be compensating in the absence of laminin-α5 in postsynaptic maturation. 
Investigators therefore extended the analysis of AChR clusters on double knockouts of laminins-
α4 and -α5, with these knockouts displaying an 80% reduction of complex AChR clusters as 
opposed to control animals with 100% after postnatal day 60, suggesting arrested postsynaptic 
maturation. Furthermore, in-vitro study of cultured myotubes from double knockouts of laminins-
α4 and -α5 demonstrated a 60% decrease in complex pretzel AChR clusters than that of control 
myotubes (Nishimune et al., 2008). This strongly suggests that other laminins, namely laminin-
α4, compensate for the loss of laminin-α5 in postsynaptic maturation. Cultured myotubes from 
single knockout mice of laminins-α4 and -α5 were tested (Nishimune et al., 2008). Interestingly, 
myotubes of lama4-/- showed similar percentage of complex AChR clusters to control, but 
myotubes of laminin-α5 knockouts displayed lower proportion of complex receptor clusters. This 
suggests that laminin-α5 is predominantly involved in postsynaptic maturation and that laminin-
α4 can partially compensate for the role when laminin-α5 is absent. It is yet to be eluded whether 
other laminins such as laminin-α2 are involved in the maturation of the postsynaptic apparatus. 
Previous studies have reported mild morphological defects at laminin-α2 deficient NMJs, but 
these alterations may be attributed to muscle dystrophy as laminin-α2 is also nomally present in 
non-synaptic basal lamina (Law et al., 1983; Desaki et al., 1995; Patton et al., 1997; Patton et al., 
2001). 
The same study further tested the specific involvement of laminin-α5 in postsynaptic maturation 
through rescue defects in a chimera transgenic mice by replacing LG3-5 domain in laminin-α5 
with that of laminin-α1 and found that the immaturity of the postsynaptic endplates is not 
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rescued suggesting the specificity of laminin-α5 in assisting maturation of the postsynaptic 
region (Kikkawa et al., 2002; Nishimune et al., 2008). Laminin-α5 interact with receptors on 
the postsynaptic membrane via its LG4-5 domain and one such receptor is dystroglycan (Timpl 
et al., 2000; Suzuki et al., 2005; Barresi & Campbell, 2006). It is suggested that the binding of 
laminin-α5 to dystroglycan results in the aggregation of dystroglycan at the postsynaptic 
membrane (Nishimune et al., 2008). Laminin-α4 is also suggested to aggregate dystroglycan in 
conjunction with laminin-α5, as reduction in the expression of dystroglycan was observed in the 
double knockouts of laminins-α4 and -α5 (Nishimune et al., 2008). The aggregation of 
dystroglycan at the postsynaptic membrane is suggested to promote postsynaptic maturation 
(see Section 1.1.3; Dystrogylycan). This is supported with the observation of diffuse appearance 
of AChR clusters, an indicator of immature AChR endplates in cultured myotubes produced 
from dystroglycan  null embryonic stem cells (Grady et al., 2000; Jacobson et al., 2001). 
Consistent with this, conditional dystroglycan knockout mice displayed plaque-like appearance 
of AChR clusters at postnatal day 24 and most importantly, expression of laminins-α4 and -α5 
were found to be normal at these NMJs suggesting that laminins are required for the localisation 
of dystroglycan, not vice versa (Nishimune et al., 2008). Therefore, these findings support that 
laminins-α4 and -α5 aggregate dystroglycan at the postsynaptic membrane which in turn 
promotes postsynaptic maturation. 
In addition to the role of laminin-α5 in postsynaptic maturation, it was also suggested that 
laminin-α5 is required for normal presynaptic differentiation. Loss of laminin-α5 resulted in 
partial innervation of motor nerves on AChRs between postnatal days 21 and 40 (Nishimune et 
al., 2008). However, full innervation was later achieved at postnatal day 60 suggesting delayed 
presynaptic differentiation in the absence of laminin-α5. Laminin-α5 exerts its role on 
presynaptic differentiation through its LG1-2 domain that was tested through the use of 
transgenic chimera mice which expressed LG1-2 domain from laminin-α5 and replacement of 
LG3-5 domains from laminin-α5 with that of laminin-α1, the same mice used for the testing of 
specificity on the role of laminin-α5 in postsynaptic maturation (Kikkawa et al., 2002; 
Nishimune et al., 2008). The NMJs of transgenic mice was fully innervated at postnatal day 21 
in contrast to partially innervated endplates in laminin-α5 knockouts which suggests rescue of 
presynaptic defects through LG1-2 domain of laminin-α5 (Nishimune et al., 2008). 
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1.1.3 Postsynaptic region 
A number of proteins are required to ensure that the postsynaptic region of the NMJ develops and 
matures properly. These proteins include agrin, muscle specific receptor tyrosine kinase (MuSK) 
and rapsyn which play essential roles in the clustering of AChRs (Burden, 2002; Ghazanfari et al., 
2011). Proteins that are localised at the postsynaptic membrane such as dystroglycan and integrins 
have also been suggested to be involved in the postsynaptic maturation of the NMJ (Burkin et al., 
1998; Burkin et al., 2000; Nishimune et al., 2008). Podosomes, which are actin-rich organelles may 
also potentially assist in the maturation of the postsynaptic apparatus (Proszynski et al., 2009). 
Maturation of acetylcholine receptor in subunits and morphology 
Acetylcholine receptors (AChRs) are fast acting heteropentamer receptor that comprise of the 
following subunits; α2, β, δ and either γ or ε, in which γ and ε are dependent on the maturation state 
of the AChRs (Takai et al., 1985; Mishina et al., 1986; Missias et al., 1996). As the NMJ matures, 
the embryonic form of AChRs containing the γ-subunit (α2βγδ) is gradually replaced by the adult 
form possessing the ε-subunit (α2βεδ) (Mishina et al., 1986; Gu & Hall, 1988; Missias et al., 1996). 
This is consistent with the findings by Yumoto et al. (2005) which demonstrated adult AChR ε-
subunits being incorporated into the individual endplates that contain embryonic AChR γ-subunits 
and that the γ-subunits were gradually being replaced. The γ- and ε-subunits are different in terms 
of their electrophysiological properties with the adult ε-subunit producing shorter opening times and 
single channel conductance that is 50% higher and enhanced calcium permeability by 3-folds, in 
comparison with γ-subunit (Villarroel & Sakmann, 1996). 
The molecular switch of AChR subunits usually occurs during the first two weeks postnatal in mice 
(Fischbach & Schuetze, 1980; Siegelbaum et al., 1984; Witzemann et al., 1987; Gu & Hall, 1988; 
Martinou & Merlie, 1991).  Interestingly, the switch from the embryonic γ-subunit to adult ε-
subunit occurs differently in terms of timing depending on fibre type (Missias et al., 1996). This is 
supported by the replacement of γ- with ε-subunit within the first postnatal week in fast twitch 
muscles such as tibialis anterior and extensor digitorum longus (EDL) as opposed to the delayed 
switching of AChR subunit by at least a week in slower twitch muscles such as soleus (Missias et 
al., 1996). This suggests that the rate of AChR subunit replacement is correlated with the fibre types 
of the muscle in which downregulation of γ-subunit could occur quickly in fast fibre types but not 
in slow fibre types (Missias et al., 1996). However, recent studies have found that soleus muscle 
contained 50 % fast fibre types; IIA, therefore this muscle may not be considered as slow twitch 
muscle (Chai et al., 2011; Chakkalakal et al., 2012). Therefore the suggestions of the 
downregulation of γ-subunit occurring at a slower rate in soleus muscle would require further 
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studies to be conducted by investigating AChR subunits replacement per individual fibre type 
instead of the testing in whole muscle. But there is a possibility that Type IIA fibres are more prone 
to slower replacement of γ-subunit with ε-subunit, compared with other fast fibre types; IIB and IIX 
which are more highly expressed in tibialis anterior and EDL muscles (Chai et al., 2011; Valdez et 
al., 2012). 
Missias et al. (1996) also looked at the possible correlation between the molecular switching of 
AChR subunits and the complexity of AChR clusters morphology. At birth, the AChR clusters are 
uniform and diffusely distributed in an oval plaque shape (Lanuza et al., 2002) (Figure 1.9). As the 
NMJ develops, the elongated oval plaque AChRs begin showing regions of receptor free “holes” 
(Missias et al., 1996; Lanuza et al., 2002) (Figure 1.9). By the time the NMJ reaches maturity, the 
AChR clusters appear pretzel-like which are folded and branched into regions of high and low 
receptor densities (Lanuza et al., 2002) (Figure 1.9). Missias et al. (1996) showed strong adult ε-
subunit staining on both immature plaque-like AChR clusters and mature pretzel-like AChR 
clusters. Embryonic γ-subunit staining was also observed in both immature and mature AChR 
clusters (Missias et al., 1996). This indicates that molecular switch of AChR subunits and 
transformation of AChR clusters acts independently. The process of AChR clustering is detailed in 
the next section. 
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 Figure 1.9 Transition in acetylcholine receptor clustering at the neuromuscular junction from 
birth to adulthood.  
A, At birth, AChR clusters are diffuse and uniform in an oval plaque shape followed by B, 
non-homogeneity receptor densities in an elongated oval plaque of AChRs at P4. C, At P8, 
non-innervated regions begin to appear as small holes. Higher AChRs densities are localised 
at the border of these regions. D, At P12, convolution begins to form in the oval AChRs 
displaying high and low receptor densities. E, At P28, AChRs clusters show a mature 
branching pattern with high receptor density being innervated while other regions without 
receptor density are not innervated. F, The intercalary growth of the axon terminal leads to 
discontinuous patterning of the AChRs clusters in 3-month-old animals. AChRs are stained 
with rhodamine-conjugated α-bungarotoxin in the levator auris longus muscle of a rat. Scale 
bar = 10µm. Figure adapted from Lanuza et al. (2002). 
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Signalling pathway of AChR clustering  
During development of the NMJ, AChRs are independently formed at the growth centre of the 
embryonic muscle fibre prior to innervation (Bevan & Steinbach, 1977; Lin et al., 2001; Yang 
et al., 2001; Ngo et al., 2007). Upon contact between the nerve terminal and the skeletal muscle 
fibre, the nerve terminal releases neural agrin, a heparin sulfate proteoglycan, into the synaptic 
cleft (Magillsolc & McMahan, 1988; Ngo et al., 2007). 
Neural agrin binds to its co-receptor, low-density lipoprotein receptor related-protein 4 (LRP4), 
which activates the phosphorylation of MuSK located in the postsynaptic membrane (Kim et 
al., 2008; Zhang et al., 2008; Wu et al., 2012) (Figure 1.10). The MuSK activation recruits an 
adaptor docking protein 7 (Dok 7) to the LRP4-MuSK complex which further activates the 
phosphorylation of MuSK (Bergamin et al., 2010). Subsequently, phosphorylated MuSK 
phosphorylates non-receptor tyrosine kinases such as abl and src kinases which in turn, amplify 
the signal of MuSK to increase AChR clustering (Mittaud et al., 2001; Mohamed et al., 2001; 
Smith et al., 2001; Finn et al., 2003; Wang et al., 2006). These kinases also perform additional 
roles by stabilising the initially formed AChR clusters by phosphorylating AChR β-subunit, 
which is required for its association with rapsyn (Mittaud et al., 2004; Borges et al., 2008). 
Rapysn, a peripheral membrane protein, clusters and stabilises the AChRs at the postsynaptic 
membrane (Gautam et al., 1995; Ramarao & Cohen, 1998; Ghazanfari et al., 2011). 
MuSK 
MuSK is a muscle specific receptor tyrosine kinase located postsynaptically and expressed by the 
skeletal muscle (Valenzuela et al., 1995; Barik et al., 2012).  The role of MuSK is implicated in 
the clustering of AChRs via the agrin signalling pathway. However, MuSK itself does not directly 
induce the clustering of AChR per se, instead it signals via rapsyn to cluster AChRs once it is 
phosphorylated (Gautam et al., 1995; Ramarao & Cohen, 1998; Bartoli et al., 2001). MuSK 
knockout mice die at birth and display no evidence of postsynaptic specialisations, as supported 
by the absence of AChR clusters in these mice (DeChiara et al., 1996). This means that no NMJs 
would be formed in these knockout mice consistent with the study by Kong et al. (2004) which 
demonstrated absence of NMJs when mice were subjected to RNAi that blocks MuSK 
transcription. However, the motor nerve ending of these knockout mice are capable of forming 
nerve terminals but fail to mature (Nguyen et al., 2000). 
MuSK is made up of a juxtamembrane domain and an extracellular domain that are both 
important for its numerous functions (Strochlic et al., 2005; Wang et al., 2006; Ghazanfari et al., 
2011; Barik et al., 2012). The juxtamembrane domain is essential for the phosphorylation of 
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MuSK in order for MuSK to exert its role in AChR clustering (Zhou et al., 1999; Herbst & 
Burden, 2000; Strochlic et al., 2005). Interestingly, Mazhar and Herbst (2012) demonstrated that 
the juxtamembrane domain of MuSK failed to cluster AChRs on laminin substrate. Instead, the 
extracellular domain of MuSK is required to cluster the AChRs when laminin substrate is present 
but which laminin isoform is required is not tested in this study (Mazhar & Herbst, 2012). This 
role of AChR clustering is consistent with the function of Ig-4 domain that is part of the 
extracellular domain of MuSK, which possesses an unknown Rapsyn Associated Transmembrane 
Linker (RATL) that draws the rapsyn/AChR complexes into closer proximity to MuSK, in order 
for MuSK to promote AChR clustering (Apel et al., 1997; Zhou et al., 1999; Strochlic et al., 
2005; Mazhar & Herbst, 2012). The Ig-1 domain, which is also part of the extracellular domain, is 
required for the detection of agrin through its binding with agrin co-receptor LRP4 (Glass et al., 
1996; Kim et al., 2008; Zhang et al., 2008). The extracellular domain of MuSK is also associated 
with Collagen Q (ColQ), that is attached to AChE, an enzyme that breaks down acetylcholine at 
the NMJ (Krejci et al., 1991; Krejci et al., 1997; Legay, 2000; Cartaud et al., 2004; Wang et al., 
2006). This interaction between MuSK and AChE-ColQ helps to anchor the AChE at the synaptic 
sites which is consistent with the loss of AChE at the synaptic sites of mice lacking MuSK 
(DeChiara et al., 1996; Cartaud et al., 2004). 
Rapsyn 
Rapsyn is a 43 kDa peripheral membrane protein which is found in skeletal muscle and is directly 
involved in the clustering of AChRs in high densities (Sealock et al., 1984; Phillips et al., 1993; 
Gautam et al., 1996; Martinez-Martinez et al., 2009). Mice lacking rapsyn typically die at birth due 
to neurotransmission failure, which is attributed to the inability of AChRs to clusters at the 
postsynaptic membrane (Gautam et al., 1996). This is supported with the observation of diffuse 
distribution of AChRs in heterologous cells which then become clustered once the AChRs were co-
expressed with rapsyn (Froehner et al., 1990; Phillips et al., 1991). Furthermore, myotubes cultured 
from mice lacking rapsyn also showed absence of AChRs clusters even after treatment with agrin 
(Gautam et al., 1996; Burkin et al., 2000; Marangi et al., 2002). Rapsyn is also required for 
laminin-induced AChR clustering in culture studies (Burkin et al., 2000; Marangi et al., 2002) (see 
Section 1.1.3; Dystroglycan). These findings clearly demonstrate the essential role of rapysn in 
inducing AChR clusters. 
Rapsyn interacts directly with the β-subunit of AChRs through its coiled-coil domain (Burden et al., 
1983; Ramarao & Cohen, 1998; Bartoli et al., 2001) (Figure 1.10). Based on the direct interaction 
between rapsyn and AChRs, Zuber and Unwin (2013) proposed a model that AChRs can bind up to 
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three rapsyn molecules, which is the minimum number required to create a 2D network. If two 
rapsyn molecules bind to AChRs, it will lead to a linear arrangement of AChRs that does not 
interconnect with other AChRs. On the other hand, if more than three rapsyn molecules bind to 
AChRs, this will create an overly stable interconnection of AChRs that does not favour the turnover 
of AChRs (Akaaboune et al., 2002; Gervasio & Phillips, 2005; Zuber & Unwin, 2013). Thus, the 
accommodation of AChR with three rapsyn molecules is the best model to promote clustering of 
AChRs at the postsynaptic membrane without disrupting the normal process of receptors turnover. 
In support of this, previous study by Phillips et al. (1997) showed that overexpression of rapsyn led 
to highly clustered AChRs and reduced turnover of AChRs. 
Besides the interaction with AChRs, rapsyn also interacts directly with β-dystroglycan, one of the 
components of utrophin glycoprotein complex (UGC) through its RING-H2 domain (Deconinck et 
al., 1997; Cartaud, 1998; Grady et al., 2000; Bartoli et al., 2001; Bogdanik et al., 2008) (Figure 
1.10). This interaction helps to maintain the stability of AChR clusters, with rapsyn acting as a 
bridge between the AChRs and the UGC through dystroglycan (Apel et al., 1995; Cartaud, 1998; 
Henry & Campbell, 1999; Bartoli et al., 2001; Winder, 2001) (see Section 1.1.3; Dystroglycan). 
Mice lacking rapsyn display mislocalised dystroglycan, which may contribute to the disorganised 
postsynaptic membrane structure seen in these mice (Gautam et al., 1996).  In addition, utrophin 
binds directly to F-actin, forming a link between AChRs and the actin cytoskeleton, resulting in 
further stabilisation of the AChR clusters at the postsynaptic membrane (Winder & Kendrick-Jones, 
1995; Bartoli et al., 2001) (Figure 1.10). 
Dystroglycan 
Dystroglycan is one of the cytoskeletal proteins of the UGC at the NMJ that is suggested to be 
involved in postsynaptic maturation (Nishimune et al., 2008; Pilgram et al., 2010). Both α-
dystroglycan, the extracellular peripheral membrane protein, and β-dystroglycan, the 
transmembrane protein make up the dystroglycan complex (Ervasti & Campbell, 1991; 
Ibraghimov-Beskrovnaya et al., 1992; Gorecki et al., 1994; Deyst et al., 1995) (Figure 1.10). It 
was initially suggested that agrin signals through α-dystroglycan to induce AChR aggregation 
as agrin binds directly to α-dystroglycan (Grady et al., 2000; Jacobson et al., 2001), but later 
studies showed that myotubes could cluster AChRs in response to agrin in the absence of 
dystroglycan, suggesting that agrin does not signal through α-dystroglycan (Bowe et al., 1994; 
Campanelli et al., 1994; Gee et al., 1994; Cohen et al., 1995). It was later suggested that 
laminins interact with dystroglycan to stabilise the AChR aggregates (Cohen et al., 1997; 
Jacobson et al., 2001; Nishimune et al., 2008) (Figure 1.10). This is supported with the 
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interaction between α-dystroglycan and laminins-α2, -α4, and -α5, with both laminins-α4 and -
α5 capable of aggregating dystroglycan at the postsynaptic membrane to promote postsynaptic 
maturation (Timpl et al., 2000; Nishimune et al., 2008; Pilgram et al., 2010) (see Section 1.1.2; 
Laminin-α5). Fragmented AChR clusters have previously been reported in myotubes and NMJs 
lacking dystroglycan, suggestive of disrupted stability of AChR clusters in the absence of 
dystroglycan (Carbonetto & Lindenbaum, 1995; Jacobson et al., 2001). Furthermore, 
Nishimune et al. (2008) also demonstrated plaque-like AChR clusters in the NMJs of 
conditional dystroglycan knockout mice at postnatal day 24, which is indicative of delayed 
postsynaptic maturation. 
The role of dystroglycan in postsynaptic maturation is further supported by it being part of 
UGC, as this complex is also implicated in postsynaptic maturation (Deconinck et al., 1997; 
Grady et al., 2000; Bogdanik et al., 2008). There is evidence of large AChR clusters but not 
small AChR clusters, being associated with utrophin which also interacts directly with β-
dystroglycan (Phillips et al., 1993). This suggests that dystroglycan has an indirect role in the 
condensation of micro-clusters of AChRs into larger clusters (Phillips et al., 1993; Bartoli et 
al., 2001; Jacobson et al., 2001). Furthermore, β-dystroglycan also interacts with rapsyn which 
is involved in the clustering of AChRs (Apel et al., 1995; Cartaud, 1998; Bartoli et al., 2001) 
(see Section 1.1.3; Rapsyn). These findings strongly suggest that dystroglycan is required for 
the postsynaptic maturation of the NMJ. 
Integrins 
Integrins are a family of cell attachment receptors for molecules of the extracellular matrix which 
link to the underlying cytoskeleton, and through these connections, integrins can activate cellular 
signalling (Schwartz et al., 1995; Hemler, 1999; Hynes, 2002). They are heterodimers that are 
made up of α- and β-subunits (Hynes, 2002). Of note, integrins α3β1, α6β1 and α7β1 interact with 
laminins-α chains at the LG1-3 domain (Belkin & Stepp, 2000; Colognato & Yurchenco, 2000; 
Hirosaki et al., 2000; Yu & Talts, 2003; Ido et al., 2004; Suzuki et al., 2005; Nishiuchi et al., 
2006). 
Individual integrin β1-subunits are present at the NMJ at both the pre- and postsynaptic 
membranes. Specifically at the postsynaptic membrane, β1-subunits pairs with two differently 
spliced isoforms of the α7-subunit; α7a and α7b (Ziober et al., 1993; Martin et al., 1996). 
Interestingly, one of the isoforms, α7b has been shown to be associated with laminin-β2, in which 
the NMJs of lamb2-/- demonstrated loss of expression in α7b subunit (Martin et al., 1996). The 
loss of this integrin subunit in lamb2-/- may have an implication on the postsynaptic maturation of 
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the NMJ. In support of this, in-vitro studies have demonstrated the role of integrins, particularly 
α7β1 in aggregation of AChR clusters which are dependent on laminins (Burkin et al., 1998; 
Burkin et al., 2000). Burkin et al. (1998) showed that integrin α7β1 were colocalised to laminin-
induced AChR clusters but to a lesser degree to agrin-induced AChR clusters. However, both 
laminin and agrin together enhance the interaction of integrin with AChRs subsequently 
increasing the aggregation of AChRs. Further study by Burkin et al. (2000) showed that this 
interaction between laminins and integrin α7β1 reduces the concentration of agrin by 20-fold to 
induce the clustering of AChRs. Thus integrins play a role in regulating the agrin levels of AChR 
clustering that is laminin-dependent. This is further supported with the study by Martin and Sanes 
(1997) which demonstrated the modulatory role of integrins particularly β1-subunit in agrin-
induced AChR clustering. Consistent with this, in-vivo study by Schwander et al. (2004) 
demonstrated that loss of β1-integrin in muscles, results in destabilisation of AChR clusters 
during maturation, which disrupts the innervation between the nerve terminal and the 
postsynaptic skeletal muscle fibre. These defects are also commonly observed in agrin knockout 
mice (Gautam et al., 1996; Lin et al., 2001; Yang et al., 2001), in which the author proposed a 
potential modulatory role for β1-integrin in agrin signalling and consequent stabilisation of AChR 
clusters (Schwander et al., 2004).    
Alternatively, integrins may also be involved in the clustering of AChRs through their interaction 
with proteins such as as talin, paxilin, vinculin and filamin that are also known as podosomes 
(Proszynski et al., 2009), which in turn interact with the actin cytoskeleton underlying the 
postsynaptic membrane (Brakebusch & Fassler, 2003; Guo et al., 2006; Wang et al., 2008; 
Singhal & Martin, 2011) (Figure 1.10) (see Section 1.1.3; Podosomes). These interactions may 
facilitate the mobilisation and anchorage of AChR clusters at the postsynaptic membrane (Dai et 
al., 2000; Dobbins et al., 2006). 
Contradictory to the findings of in-vitro studies regarding the role of integrins in AChR 
clustering, double knockouts of laminins-α4 and -α5 demonstrated no change in the expression of 
integrins β1 and α7 despite the appearance of plaque-like AChRs in these knockouts (Nishimune 
et al., 2008). Furthermore, α7 integrin knockout mice demonstrated no abnormalities at the 
postsynaptic NMJ (Mayer et al., 1997). This may be compensated by the presence of other 
integrin α-subunits. Thus, suggesting that β1 and α7 integrin subunits may not have a role in 
AChR aggregation at the NMJ via interactions with laminins-α4 and -α5. However, there is a 
possibility that laminin-β2 may play a significant role in AChR aggregation via these integrins 
(Darabid et al., 2014). 
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Figure 1.10 The network of interaction among proteins of the postsynaptic region. 
Agrin interacts with MuSK through LRP4 and MuSK interacts with rapsyn through a rapsyn-
associated transmembrane linker (not shown here). Rapsyn interacts directly with acetylcholine 
receptors (AChRs) to induce receptors clustering. Rapsyn also binds directly to one of the 
proteins of the dystroglycan complex, β-dystroglycan. β-dystroglycan is attached to α-
dystroglycan, another protein of the dystroglycan complex. Laminins binds to both α-
dystroglycan and agrin. Agrin and α-dystroglycan also form an interaction together. Utrophin 
acts as the intermediate between AChRs and F-actin by binding directly to both of these 
components. Utrophin also interacts directly with β-dystroglycan. F-actin is bound to 
cytoskeletal proteins known as podosomes that includes paxilin, talin, vinculin and filamin (see 
Section 1.1.3; Podosomes). Integrins localised at the postsynaptic membrane interacts directly 
with these podosome molecules. Laminins also interact directly with the integrins. 
39 
 
Podosomes 
Podosomes are adhesive organelles that are involved in matrix remodelling, cell migration 
and cell invasion which are normally found in smooth muscle cells, dendritic cells and 
many other cell types (Calle et al., 2006; Jurdic et al., 2006; Lener et al., 2006; Ory et al., 
2008; Linder et al., 2011; Murphy & Courtneidge, 2011; Marchisio, 2012). These 
organelles are organised into two different compartments with a core region being 
surrounded by a cortex region. Podosome molecules such as β-actin, Arp2,  Cortactin, 
Amotl2, myosin IIA, dynamin and filamin A are contained within the core region while 
molecules such as vinculin, paxilin, talin, LL5β, and utrophin are found in the cortex 
region (Kaverina et al., 2003; Tehrani et al., 2006; Gimona et al., 2008; Proszynski & 
Sanes, 2013) (Figure 1.11). 
Studies have shown that these podosomes are linked to the actin cytoskeleton of the NMJ 
(Turner et al., 1991; Weaver et al., 2001; Kishi et al., 2005). For example, cortactin has 
been found to cross-link actin filaments and activates Arp2 complex to induce actin 
polymerisation (Weaver et al., 2001). Furthermore, LL5β also interacts with the actin 
cytoskeleton through filamin (Kishi et al., 2005). These interactions may assist in the 
mobilisation and anchorage of AChR clusters at the NMJ (Dai et al., 2000; Dobbins et al., 
2006). Indeed, this is consistent with a myotube cell culture study by Proszynski et al. 
(2009) which discovered a novel role of podosomes in postsynaptic maturation of the NMJ 
by transforming AChR clusters from plaque to pretzel. It was found that perforations of 
the AChR clusters contained podosome-like molecules with distinguished core and cortex 
regions when stained with specific podosome antibodies. Furthermore, pharmacological 
blocking of podosome molecules resulted in the disassembly of AChR clusters. The 
appearance and disappearance of podosomes were also well-correlated to the changes of 
the morphology of AChR clusters. Based on these findings, Proszynski et al. (2009) 
proposed that with local endocytosis and secretion of proteases from enlarged podosomes 
underneath the plaque AChR clusters, postsynaptic components and basal lamina can be 
degraded and removed from that particular region with displacement of AChRs, therefore 
resulting in perforations. Some podosomes would keep growing and moving laterally away 
from the perforations to generate long branches of non-receptor regions that lead to the 
appearance of pretzel-like receptors (Figure 1.11). Therefore, podosomes are suggested to 
be important in determining the architecture of the AChR arrangement into branches and 
spacing between them. 
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The same study also demonstrated the presence of a ring of laminin-α5 staining at the edge 
of the perforations and the same was observed for laminin-β2 (Proszynski et al., 2009). 
These rings of laminins were suggested to play a role in maintaining the perforations of 
the AChR clusters through their interaction with dystrogylcan to help stabilise the AChRs 
(Nishimune et al., 2008). Thus if laminins were absent, perforations would likely collapse 
with the intrusion of AChRs therefore receptors would remain plaque-like resulting in an 
immature synapse morphology. Therefore, it would be interesting to investigate the 
presence of podosomes at mature lamb2-/- NMJs as the endplates in these mutants 
remained plaque-like. Another interesting examination would be to test whether podosome 
molecules would be localised with respect to the junctional folds, given that these laminin 
chains are colocalised to the folds and crests of the folds (Patton et al., 1997; Patton et al., 
2001). 
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Figure 1.11 The role of podosomes in transformation of AChR clusters from plaque to pretzel. 
A, Podosomes are separated into two different regions of core proteins (dark blue) and cortex 
proteins (green). The components such as rapsyn and dystrogylcan cluster together with the 
AChRs (red). Interestingly, β1-integrin is found present with the AChRs as well as in the cortex 
region of the podosomes. B, Muscle deposits synaptic basal lamina components underneath the 
plaque AChR clusters (blue) (1). Podosomes emerge in the AChR clusters (2). Local 
endocytosis with secretion of proteases from enlarged podosomes degrade postsynaptic proteins 
and basal lamina as well as displacing AChR clusters to generate perforations (3). C, Lateral 
movement of podosomes to generate long branches of non-receptor regions leads to pretzel-like 
clusters (4). D, Disappearance of podosomes causes the intrusion of AChRs back into the 
perforations formed (5). Eventually AChR clusters become stabilised and permanent over time 
although podosomes are lost (6). 
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1.2 Maintenance of the neuromuscular junction 
Maintenance of an adult NMJ is essential to allow continued efficient transmission between the nerve 
terminal and the skeletal muscle fibre. However, there is an evident decline in the maintenance of pre- 
and postsynaptic components as the NMJ undergoes ageing (Rosenheimer, 1990; Wokke et al., 1990; 
Balice-Gordon, 1997; Valdez et al., 2010; Chai et al., 2011; Samuel et al., 2012). Valdez et al. (2010) 
compared the NMJ morphology between young adult mice (1-3 months) and aged mice (24 months). 
Young adult NMJs displayed thick and consistent pre-terminal axons as well as smooth formation of 
AChR clusters in pretzel-like appearance that is perfectly aligned with nerve terminals. In contrast, 
aged NMJs displayed faint and fragmented AChRs, partially denervated muscles as well as fully 
denervated muscles. Aged NMJs also displayed some aberrant changes in axonal thickness and some 
endplates were occupied by two axons, a characteristic of polyneuronal innervation that is commonly 
seen at developing NMJ (Sanes & Lichtman, 1999; Valdez et al., 2010). It is suggested that the 
polyneuronal innervation seen at these aged NMJs could be due to the sprouting of axons to partially 
denervated or fully denervated muscles, probably in an attempt to reinnervate these muscles to re-
establish the failing connection with the nerves (Valdez et al., 2010). In support of this, axonal 
sprouting that extended beyond the AChR endplate was observed in these aged mice (Valdez et al., 
2010). Recently, Schwann cells were also shown to be structurally disrupted at aged NMJs by 
partially occupying the endplate and having swollen processes (Chai et al., 2011), alterations which 
may consequently impact neurotransmission properties at these NMJs. Furthermore, aged NMJ of 
human muscle displayed intrusion of Schwann cell processes into the synaptic cleft (Wokke et al., 
1990). Interestingly, Schwann cell processes were also seen to invade the synaptic cleft of postnatal 
day 15-20 lamb2-/- NMJs (Noakes et al., 1995a; Knight et al., 2003). The similarity in Schwann cell 
invasion into the synaptic cleft between aged and lamb2-/- NMJs may suggest a potential involvement 
of laminin-β2 in normal ageing. However, at the adult lama4-/- NMJs in which ageing features were 
accelerated, displayed normal expression of laminin-β2, indicating that laminin-β2 may not have a 
direct role in the ageing process (Samuel et al., 2012). 
Chai et al. (2011) showed that disrupted Schwann cells occurs in EDL, a fast twitch muscle but not in 
slow twitch muscle such as soleus. Current studies showed conflicting results for NMJ degeneration 
associated with ageing such as denervation in fast and slow twitch muscles. (Chai et al., 2011) found 
that the soleus muscle is not as affected as EDL muscle in terms of denervation, while Valdez et al. 
(2012) found equal loss of innervation in both EDL and soleus muscle. However, Chai et al. (2011) 
argued that denervation did occur in the aged soleus but the muscle was reinnervated efficiently as 
there was evidence of increased slow fibre type proportion and also changes in fibre type grouping 
which are associated with the occurrence of denervation and reinnervation (MacIntosh et al., 2006). 
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However these occurrences in the muscles may not be as simple as fast vs. slow twitch muscle due to 
the ongoing debate as to whether the soleus is truly a slow twitch muscle (Chakkalakal et al., 2012). 
Alterations of NMJs during ageing are also apparently dependent on the type of muscle fibres 
innervated. The study by Prakash and Sieck (1998) showed enlarged area of both nerve terminal and 
postsynaptic endplate at type IIB and type IIX fibres of old rat diaphragm muscle despite the 
decreased diameter of these fibres with age, which is an indication of NMJ remodelling during ageing 
(Deschenes et al., 2010; Kulakowski et al., 2011), while NMJs at type I and type IIA displayed 
minimal changes. These findings suggest that type IIB and type IIX fibres are selectively affected 
during ageing while type 1 and type IIA are less affected. Interestingly, type IIB and IIX fast fibres 
are converted to slow fibre types I, which is suggested to prevent muscle fibres from ageing (Pette & 
Staron, 2000). Another study demonstrated that during ageing, damage of muscle fibres led to loss of 
AChR receptors, which were replaced by new receptors that were fragmented in appearance (Li et al., 
2011). Together these findings demonstrate multiple pathways that can lead to NMJ remodelling in 
the ageing mouse.  
Other studies investigated beyond the general morphology of ageing NMJ by looking specifically at 
active zone proteins and synaptic vesicles. The studies by Chen et al. (2012) and Nishimune et al. 
(2016) showed decreased density of active zone Bassoon puncta in aged NMJs, that may explain the 
reduced frequency of miniature endplate potentials (mEPPs) observed in aged mice (Banker et al., 
1983; Alshuaib & Fahim, 1991; Fahim, 1997). The reduced mEPPs frequency (defined as the rate of 
spontaneous transmitter release in a particular period of time) may also be associated with decreased 
synaptic vesicles seen at these aged NMJ (Jang et al., 2010; Wang et al., 2011). However, studies 
suggested that quantal content (defined as the release of transmitters from several number of release 
sites upon stimulation of the nerve) is increased in aged NMJ which does not match with the 
presynaptic changes observed (Alshuaib & Fahim, 1990; Fahim, 1997). It is possible that these aged 
NMJs are not as active in transmission compared with the adult NMJs, therefore with this decreased 
activity at the aged NMJs, synaptic vesicles may build up in the nerve terminal  and as the nerve is 
stimulated, large amounts of ACh would be released which contributes to increased quantal content. 
This idea is consistent with a study by Snider and Harris (1979) which utilised tetrodotoxin to block 
transmission between 8-9 days which resulted in increased release of ACh upon nerve stimulation. 
Furthermore, Mantilla et al. (2007) showed increased density of RRP vesicles when transmission at 
the NMJ was blocked through spinal hemisections. It would therefore be of interest to investigate the 
morphological features of NMJs in lama4-/- mice, including bassoon puncta, synaptic vesicle density 
and neurotransmission, given that previous study has associated its loss to premature ageing at the 
NMJ (Samuel et al., 2012) (see Section 1.1.2; Laminin-α4). 
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1.3 Dying-backward hypothesis in amyotrophic lateral sclerosis 
Defects at the NMJ are not only observed in mice model knockout of specific synaptic adhesion 
molecules but also in diseases such as amyotrophic lateral sclerosis (ALS). ALS is a 
neurodegenerative disease that is attributed to the loss of cortical neurons (upper motor neurons) 
from the motor cortex, and α-motor neurons (lower motor neurons) from the brain stem and spinal 
cord, resulting in skeletal muscle weakness, paralysis and finally death (Cleveland, 1999).  It has 
been widely accepted over many years that ALS disease is initiated from the central nervous system 
down to the peripheral synapse that is known as the “dying-forward” hypothesis (Eisen & Weber, 
2001; Braak et al., 2013). 
However, there is a growing body of evidence that supports the notion that this disease begins with 
the degeneration of the NMJ leading to axonal degeneration and finally to motor neuron loss, 
coined the “dying-backward” hypothesis (Frey et al., 2000; Fischer et al., 2004; Gould, 2006; 
Hegedus et al., 2007; Hegedus et al., 2008; Murray et al., 2008; Kong et al., 2009; Marcuzzo et al., 
2011; Arbour et al., 2015). Fischer et al. (2004) observed denervated endplates in the mice model of 
ALS, SOD1G93A mice at P47 followed by loss of motor axons between P47 and P80 and finally α-
motor neuron loss from the lumbar spinal cord after P80. There were also similar observations of 
denervated medial gastrocnemius muscle in SOD1G93A mice at P45 with another study observing an 
earlier occurrence of denervation at P25 in these mice even before the symptoms of muscle 
weakness and motor neuron loss began (Frey et al., 2000; Gould, 2006). Importantly, Fischer et al. 
(2004) also found similaraties in a human ALS patient who died unexpectedly during the early 
phase of the disease (presymptomatic stage) where denervation at the NMJ had already begun 
before the occurrence of motor neuron loss. 
Studies have reported that denervation of endplates and skeletal muscle weakness persist despite the 
prevention of motor neuron cell body loss in the spinal cord through the deletion of a pro-apoptotic 
gene Bax in cell death pathway of motor neurons in SOD1G93A mice (Gould, 2006). This 
observation suggests that motor neuron survival cannot rescue the degeneration of the NMJs, which 
lead to speculation that other components such as skeletal muscles, nerve terminal or perisynaptic 
Schwann cells (PSCs) may be involved in initiating the breakdown of the NMJ at the very early 
stage of the disease (Dobrowolny et al., 2008; Pansarasa et al., 2014; Arbour et al., 2015). This is 
supported with the recent study by Arbour et al. (2015), which observed changes in decoding ability 
of synaptic transmission in PSCs months before the occurrence of NMJ degeneration at postnatal 
day 120 in the SOD1G37R ALS mouse model . This alteration in decoding ability of PSCs has a 
detrimental effect on the NMJ, as PSCs are not be able to repair and maintain the NMJ properly as 
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part of their normal function (Reynolds & Woolf, 1992; Georgiou et al., 1994; Son et al., 1996; 
O'Malley et al., 1999; Reddy et al., 2003; Feng & Ko, 2008), thereby contributing to the early 
breakdown of the NMJ in ALS. This finding suggests that PSCs may have a role in the onset and 
progression of ALS disease. Furthermore, the study by Carrasco et al. (2010) showed that muscle is 
not required for NMJ degeneration as the breakdown still occurs in SOD1G93A  despite being 
transplanted with wild-type muscles, suggesting that Schwann cells and motor nerve terminals are 
sufficient enough to cause the breakdown of NMJ. In addition, a study by Liu et al. (2013) 
demonstrated decreased expression of S100b, a marker for PSCs in ALS donor. However, this 
altered expression was observed at the end-stage of the disease therefore it is difficult to distinguish 
whether it was a direct cause or secondary changes from the disease itself. 
The alterations in Schwann cells and nerve terminal in ALS could be linked to changes in laminins 
expression. For example, laminin-521 (α5β2γ1) are thought to act as a stop signal to prevent 
invasion of PSCs into synaptic cleft (Patton et al., 1998). Thus loss or altered expression may 
interfere with this signal leading to changes at the PSCs hence contributing to progression of ALS.  
Indeed, the study by Liu et al. (2011) found missing expression of laminin-α4 at the NMJs of limb 
muscles and laminins-α2 and -β2 at the NMJs of extraocular muscles in ALS donors. In order to 
investigate whether the decreased expression of laminins-α2 and -β2 at the NMJ was the result of 
denervation, the same study conducted a further observation on the distribution of synaptophysin 
and neurofilament, which are markers for nerve terminal and motor axons respectively, and found 
that most NMJs were strongly labelled with the respective markers indicating normal innervation. 
Therefore this study concluded that NMJs lacking laminins-α2 and -β2 were normally innervated 
suggesting changes in laminin distribution or expression before denervation begins in ALS, which 
indirectly supports the “dying-backward hypothesis”. To further the investigation whether laminins 
have a potential role in the NMJ degeneration in ALS disease states, I used the TDP43Q331K mouse 
model of ALS. Further details on TDP43Q331K and its role in ALS will be discussed below. 
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1.4 The involvement of transactive response DNA binding protein 43 kDa in amyotrophic 
lateral sclerosis 
Transactive response DNA binding protein 43 kDa (TDP43), which is found in the nucleus has been 
suggested to be involved in the pathological disease of ALS (Gitcho et al., 2008; Kabashi et al., 
2008; Sreedharan et al., 2008; Barmada et al., 2010; Arnold et al., 2013). Indeed, it was found that 
mutations in the gene encoding for TDP43 are responsible for 4% of familial cases and 1.5% of 
sporadic cases in ALS (Mackenzie et al., 2010). 
TDP43 plays multiple functions in splicing, transcription, transport and translation of mRNAs 
(Lagier-Tourenne et al., 2010). It binds to more than 6000 pre-mRNAs, regulates the concentration 
of 600 mRNAs and induces splicing of another 950 mRNAs (Polymenidou et al., 2011). In 
particular, studies have shown that TDP43 binds to mRNA of presynaptic proteins that are found at 
the NMJ, such as synaptic vesicle protein 2 (SV2), synaptophysin, syntaxin IIb, synapsin II and 
Bassoon which are important elements for maintaining normal synaptic transmission (Sephton et 
al., 2011; Narayanan et al., 2013). To further support this, Narayanan et al. (2013) showed presence 
and localisation of TDP43 at the presynaptic nerve terminal of the NMJ, suggesting its potential 
role in processing of proteins involved in transmitter release. The study by Strong et al. (2007) also 
showed that TDP43 interacts with axonal mRNA binding proteins such as 68 kDa neurofilament 
mRNA. Through this interaction, TDP43 is able to regulate growth of axons either through the 
processing of neurofilament mRNA or transporting of neurofilament mRNA from motor neurons to 
distal axonal compartments such as the nerve terminal (Narayanan et al., 2013; Tripathi et al., 
2014). This finding is consistent with the study by Fallini et al. (2012), which demonstrated the 
active transportation of TDP43 within live motor neurons to motor axons where it interacts with a 
number of mRNA transcripts. 
Mutation in TDP43 plays a disruptive role in mRNA processing by altering the splicing and/or 
transport of mRNA transcripts (Polymenidou et al., 2012; Ling et al., 2013), which consequently 
leads to improper production of presynaptic proteins that may disrupt the normal synaptic function 
at the NMJ (Narayanan et al., 2013). Indeed, a study on the TDP43Q331K mouse model of ALS, 
containing a mutated human TDP43 gene with glutamine to lysine substitution at amino acid 
position 331, displayed disruptive neuromuscular responses when subjected to electromyography 
without stimulation, which is associated with denervation as well as degeneration and regeneration 
of motor units (Arnold et al., 2013). To further support this, morphological investigation of the 
NMJ in these mice revealed denervated endplates with reduction in the total number of NMJs and 
appearance of distorted postsynaptic endplates. With these abnormalities at the NMJ, it is not 
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suprising if laminins are altered as well in these mutants, which could occur during the progression 
of the disease which causes more detrimental effects on the NMJ. In support of this, evidence is 
found on the interaction between TDP43 and the mRNA transcript of laminin-γ1 chain (Sephton et 
al., 2011). Laminin-γ1 is found in each of the laminin heterotrimers at the synapse, and loss of this 
laminin results in failed formation of the laminin heterotrimers (Miner et al., 2004). Furthermore, 
absence of this laminin causes embryonically lethal phenotypes as early as embryonic day 5 (Smyth 
et al., 1999). It would be interesting to study the expression of laminins which are associated with 
laminin-γ1 in TDP43Q331K mice. This study is important because changes in laminin chains could be 
one of the causes associated with the NMJ degeneration seen in ALS, which may subsequently 
affects the progression of the disease. This is supported by the study of Liu et al. (2011) which 
demonstrated altered laminins expression in ALS donors suggesting the potential involvement of 
laminins in NMJ degeneration of ALS (see Section 1.3; Dying-backward hypothesis in amyotrophic 
lateral sclerosis). 
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1.5 Rationale 
There is evidence showing that mutation or loss of laminins may be the underlying cause of a 
number of neuromuscular diseases such as congenital myasthenic syndrome (CMS), Pierson 
syndrome and congenital muscular dystrophy (CMD) (Cohn et al., 1997; Zenker et al., 2004; 
Zenker et al., 2005; Maselli et al., 2009). For instance, the study by Maselli et al. (2009) 
demonstrated mutations in laminin-β2 are responsible for a severe form of CMS, which is a 
neuromuscular disorder characterised by muscle weakness resulting from defects at the NMJ and 
weakened neurotransmission (Hantai et al., 2004; Engel & Sine, 2005; Maselli et al., 2012). 
Electrodiagnostic testing revealed decreased amplitudes in compound muscle action potentials 
when subjected to repetitive nerve stimulation at high frequency, which was believed to be due to 
lower density of vesicles (Maselli et al., 2012).  Indeed, observation of human muscle biopsies 
showed disrupted NMJ features such as reduced density of vesicles. decreased junctional folds at 
the postsynaptic membrane, smaller terminal size, invasion of Schwann cells into the synaptic 
cleft, larger synaptic cleft as well as decreased areas of apposition between the nerve terminal and 
the skeletal muscle fibre, which are features that are similarly observed at lamb2-/- NMJs (Noakes 
et al., 1995a; Maselli et al., 2009). Furthermore, laminin-β2 is also mutated in Pierson Sydrome, 
resulting in ocular abnormalities and muscular developmental defects, consistent with the 
disrupted function and structure of the NMJ observed in lamb2-/- (Zenker et al., 2004; Zenker et 
al., 2005; Miner, 2006). Besides the mutation of laminin-β2 in diseases, mutation of laminin-α2 is 
also found as the cause of CMD (Cohn et al., 1997), a neuromuscular disorder that occurs at or 
near birth attributed to mutation in genes encoding for proteins of basal membrane and 
extracellular matrix (Bertini et al., 2011). Interestingly, the mutation of laminin-α2 in CMD 
results in the secondary loss of laminin-β2 (Cohn et al., 1997). 
Other diseases such as Lambert-Eaton Myasthenic Syndrome (LEMS) were also found to be 
associated with altered laminin interactions. LEMS, an autoimmune disorder that leads to skeletal 
muscle weakness is characterised by defects such as reduced active zones and decreased 
probability release of neurotransmitters that are also observed in lamb2-/- (Fukuoka et al., 1987; 
Nagel et al., 1988; Maselli et al., 2012). These defects are suggestive of autoimmune attack on 
the VGCCs in LEMS patients, which may also result from disrupted binding between VGCCs and 
laminin-β2 (Nishimune et al., 2004). Consistent with this, the discovery of autoantibodies bound 
against the 11th extracellular loop of P/Q-type VGCCs, which is the predominant binding site for 
laminin-β2 is found in the LEMS patients (Fukuoka et al., 1987). It is likely that the 
autoantibodies disrupt the binding between P/Q-type VGCCs and laminin-β2 therefore resulting 
in the disassembly of the active zones and impaired entry of calcium ions into the nerve terminal. 
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Maselli et al. (2012) proposed that entry of high concentration of calcium ions into the nerve 
terminal would improve neurotransmission at the NMJ, if high frequency stimulation is induced 
on LEMS patients. Cerebral palsy is a disease characterised by impaired motor ability due to 
damage in the brain region that controls body movement (Badawi et al., 1998). Robinson et al. 
(2013) found a disruption in expression of laminin-β2 in cerebral palsy patients, implicating the 
loss of this laminin chain in the altered NMJ structure and impaired motor ability in these 
patients. However, the knowledge on the extent of this laminin being involved in cerebral palsy in 
still limited due to minimal investigations that were conducted. 
In ALS disease, missing expression of laminin-α4 was found at the NMJs of limb muscles in ALS 
donors highlighting the possible involvement of this laminin in the progression or initiation of 
this disease (Liu et al., 2011). This change in laminin-α4 expression in ALS disease was only 
recently noted and has yet to be investigated sufficiently. It is therefore important to investigate 
whether altered expression of laminin-α4 is also observed in other neuromuscular diseases, as 
well as the potential involvement of this and other laminins in progression of disease states. In 
addition, altered expression of laminin-α4 was also noted in aged synapses which may reflect its 
involvement in the normal ageing process of the NMJ (Samuel et al., 2012). Understanding the 
progression of normal ageing NMJs is of benefit to better treatment and care of an ageing 
population. 
With the involvement of laminins in diseases and ageing process, it is essentially important to 
understand what specific roles these laminins play at the NMJ and how mutation or loss of these 
laminins may result in disrupted NMJ development and maintenance, as they may potentially 
serve as novel therapeutic targets for synaptic diseases in the future. 
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1.6 Overall Aims 
1. To evaluate the role of laminin-β2 in maturation of the NMJ at developing (postnatal day 
8), mature (postnatal day 18 and 21) and adult (postnatal day 35) NMJs in lamb2-/- mice. 
2. To functionally and morphologically investigate the role of laminin-α4 in maintenance 
of the NMJ from young adult (3 months) to aged (18-22 months) in wild-type and lama4-/- 
mice. 
3. To functionally and morphologically characterise the TDP43Q331K mutation and 
subsequently investigate the role of laminins in this disease during presymptomatic 
(3 months) and onset (10 months) stages. 
1.7 Overall hypotheses 
1. (a) Lamb2-/- NMJs present arrested pre- and postsynaptic maturation contributing to 
maintained poor neurotransmission. 
  1.(b) Lamb2-/- NMJS display decreased expression in components responsible for 
postsynaptic maturation. 
 
2. (a)  Lama4-/- NMJs display altered neurotransmission properties such as decreased mEPP 
frequency and higher intermittence commonly observed in aged NMJs. 
  1.(b) Lama4-/- NMJs display morphological features that are indicative of premature 
ageing with decreased density of active zone markers and synaptic vesicles. 
  
3. (a) TDP43Q331K NMJs present altered expression of laminins resulting in disrupted pre- 
and postsynaptic components. 
1. (b) TDP43Q331K NMJs display altered neurotransmission properties such as decreased 
mEPP frequency, higher failures in evoked release and lower quantal content.  
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Chapter 2 
General Methodology 
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General methodology 
This chapter outlines the general methodology used throughout the thesis. All specific details 
associated with particular experiments are explained in depth in this chapter. 
2.1 Animals 
The present study utilised wild-type animals (with two normal copies of all laminin genes) and 
homozygous mutants (with no normal copies of either laminin-α4 or -β2 genes). Homozygous 
laminin-β2 mutant mice (lamb2-/-) have poor survivability past weaning age and are thus not viable 
for breeding. Therefore, mating of heterozygous males and females were done to obtain litter-
matched wild-types and lamb2-/- pups. Laminin-α4 deficient mice (lama4-/-) were obtained from the 
mating of homozygous males and females. All mice were maintained on a defined C57BL/6-129SvJ 
genetic background and had been backcrossed for over ten generations, thus all mice are C57BL/6 
with the mutated locus being 129-SvJ (i.e. recombinant strain). The day of birth was termed 
postnatal day zero (P0) (Theiler, 1989). Identification of mice genotype was established by using a 
tail tip DNA tail assay (Hanley & Merlie, 1991). All wild-types and lamb2-/- were litter-matched 
and used at the age groups of developing postnatal day 8 (P8), mature postnatal day 18 (P18) and 
postnatal day 21 (P21), and adult postnatal day 35 (P35). A minimum of three animals was used at 
P8 and P18 for histological procedures and at P21 and P35 for both electrophysiology and 
histological procedures (Chapter 3). The survivability of lamb2-/- mice was prolonged to P35 by 
feeding the animals with high fat diet in order to counter their proteinuria deficiency resulted from 
kidney failure (Noakes et al., 1995b; Patton et al., 1998; Patton et al., 2001). Lama4-/- and age-
matched wild-types were used at the age groups of 3 months old (3MO), 6 months old (6MO), 12 
months old (12MO) and 18-22 months old (MO). The age group of 18-22MO is categorised as aged 
animals. A minimum of three animals was used at each age group for electrophysiology, 
histological procedures and behavioural studies (Chapter 4). The present study also utilised age-
matched wild-type mice and transgenic mice expressing mutated human TDP43 gene, TDP43Q331K 
(referring to substitution of glutamine to lysine at amino acid position of 331) at 3MO 
(presymptomatic) and 10MO (onset) for electrophysiology and histological procedures (Chapter 5). 
A minimum of three animals was used at each age group for electrophysiology and histological 
procedures (Chapter 5). All mice were anaesthesised with a rising concentration of carbon dioxide 
and then euthanised by cervical dislocation. The University of Queensland Animal Care and Ethics 
Committee approved all procedures undertaken (Ethics number (188/15) and (393/13)) and were in 
accordance with the Queensland Government Animal Research Act 200, associated Animal Care and 
Protection Regulations (2002 and 2008), as well as the Australian Code for the Care and Use of 
Animals for Scientific Purposes, 8th Edition (National Health and Medical Research Council, 2013). 
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2.2 Functional recordings of the neurotransmission at the neuromuscular junctions of lamb2-/-, 
lama4-/- and TDP43Q331K  
2.2.1 Tissue preparation for electrophysiology 
Whole diaphragms were dissected out with intact phrenic nerves and pinned to a bed of cured 
silicon rubber (Sylgard, Dow Corning Corp., MI, USA). Diaphragms were then separated into 
hemi-diaphragms after the removal of connective tissues and pinned out on the organ bath (Figure 
2.1). Hemi-diaphragms were bathed in Tyrode’s solution (NaCl 123.4 mM; KCl 4.7 mM; MgCl2 1.0 
mM; NaH2PO4 1.3 mM; NaHCO3 16.3 mM; CaCl2 0.3 mM; and D-glucose 7.8 mM) at a rate of 3 
ml per minute with a constant room temperature of 22 ± 20C. The reservoir supplying the organ 
bath was continuously bubbled with carbogen (95% O2 and 5% CO2). The procedure above was 
performed similarly for extensor digitorum longus (EDL) muscle with its intact peroneal nerve in 
Chapters 4 and 5 (Figure 2.1). All chemicals were sourced from Sigma Aldrich (St. Louis, MO, 
USA) unless specified. 
2.2.2 Electrical stimulation 
The phrenic nerve of hemi-diaphragm muscle was sucked gently into a glass pipette filled with 
Tyrode’s solution which acted as a stimulating electrode with two silver chloride wires, one passing 
within the electrode as a positive electrode and the other wrapped around outside of the electrode as 
a negative electrode. The nerve was stimulated with a square wave pulse of 0.08 ms duration and 
10-20 V amplitude at a frequency of 0.2 Hz using a Grass Instruments stimulator (SD48) (Natus 
Neurology Inc., RI, USA). The peroneal nerve of the EDL muscle was stimulated with a square 
wave pulse of 0.1 ms duration and 10-20 V amplitude at a frequency of 0.5 Hz. Contraction of 
muscles were blocked with the use of sodium channel blocker, µ-Conotoxin GIIIB (Alomone, 
Israel) in the range of 0.5-2 µM for diaphragm and (100-300 nM) for EDL. For estimation of RRP 
size (Chapter 4), the EDL was stimulated using 100 Hz trains of one second under conditions of 
elevated extracellular Ca2+ (2.0 mM). 
2.2.3 Intracellular recordings 
Fine tipped glass microelectrodes (30 to 50 MΩ) filled with 2M KCl were used to record endplate 
potentials (EPPs), miniature endplate potentials (mEPPs) and resting membrane potentials (RMPs). 
Electrodes were manipulated to impale muscle fibres within 0.5 mm of the endplate region. 
Proximity to endplate regions was confirmed through rise times of EPPs and mEPPs, sites with rise 
times greater than 1.5 ms were rejected. During recordings the initial resting membrane potential 
(RMP) values fell within the range of 70-85 mV with these values undergoing a gradual decrease to 
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steady values between 55-65 mV. Recordings were terminated if the RMP fluctuated by more than 
10% from the steady values. After a site was located stimulus was ceased for a rest period of ten 
minutes before recording of site in order to allow replenishment of vesicle pools. Recorded signals 
were amplified using an Axoclamp 2B amplifier with a single head stage (Molecular Devices, CA, 
USA) and digitised to > 10 kHz sampling rate using MacLab system and Scope software (version 
3.5.5, A/D Instruments, CO, USA). The digitised data was stored on computer for later analysis. A 
minimum of five to six sites were recorded for a 10-15 minute period each per muscle preparation. 
Paired-pulse facilitation. EDL muscles were stimulated at a frequency of 0.5 Hz with 0.1 ms 
duration for paired pulse facilitation studies. The facilitation of wild-type and lama4-/- NMJs was 
investigated by applying twin pulses at 10 and 100 ms delays with Tyrode’s solution containing 2 
mM [Ca2+] and 1 mM [Mg2+] (Chapter 4). For facilitation of wild-type and TDP43Q331K NMJs, twin 
pulse at 10 ms delay was applied under the same conditions as above (Chapter 5). The degree of 
facilitation was evaluated using the facilitation index (fi): fi = A2/A1 where A2 is the average of the 
EPP amplitudes elicited by the second stimulus and A1 is the average of the EPP amplitudes elicited 
by the first stimulus (Rosato-Siri et al., 2002). A total of 4 wild-type mice (NMJs = 15) and 4 
lama4-/- mice (NMJs = 13) at 12MO were utilised for this study. A total of 3 wild-type mice (NMJs 
= 15) and 3 TDP43Q331K mice (NMJs = 17) at 10MO were studied. 
2.2.4 Extracellular recordings 
Glass recording electrodes (2-10 µm) filled with Tyrode’s solution was used to record nerve 
terminal impulse (NTI), endplate currents (EPCs), and miniature endplate currents (mEPCs). The 
position of the electrode was manipulated until both EPCs and mEPCs with rise times less than 1 
ms were detected. Frequency of EPCs and mEPCs was monitored as the lowering of recording 
electrode could produce electrode pressure that could give rise to increased frequency of 
spontaneous activity (Fatt & Katz, 1952; Bennett et al., 1986a; Bennett et al., 1986b). Stimulation 
was halted for ten minutes once a site was located before recording EPCs and mEPCs. A minimum 
of five to six sites were recorded for a 10-15 minute period per muscle preparation. Extracellular 
recordings were used to determine rise times and amplitudes of both EPCs and mEPCs as well as 
nerve terminal impulse (NTI) in diaphragm muscles of Chapter 4. 
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 Figure 2.1 Muscle preparations and electrophysiology set-up. 
Muscles with their intact innervating nerves were dissected out and stretched out on the Sylgard 
coat chamber of the organ bath by pinning, as shown in A, hemi-diaphragm muscle and B, extensor 
digitorum longus with their respective innervating nerves as indicated in yellow arrows. C, depicts 
the electrophysiology set-up for muscles recording. Tyrode’s solution flowed from the reservoir 
bubbled with carbogen (1) to the organ bath set-up that contained the stretched out muscle (2). This 
allowed tissue to be continuously bathed with fresh Tyrode’s. Image was recorded through an 
image intensifying camera (3) which allowed the preparation to be visualised. The electrode 
manipulator (4) allowed for the repositioning of the recording electrode in order to obtain a suitable 
site (Images taken and modified by KK Chand). 
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2.3 Morphological investigation of the neuromuscular junctions in lamb2-/-, lama4-/- and 
TDP43Q331K utilising immunofluorescence methods  
2.3.1 Section immunohistochemistry 
Muscles were extracted and fixed immediately with 4% paraformaldehyde (PFA) /phosphate 
buffered saline (PBS) followed by multiple washing with 0.1% glycine/PBS. The muscles 
were immersed in 15% sucrose/PBS overnight followed by 30% sucrose/PBS overnight. 
Next, the muscles were embedded in optimal cutting temperature (OCT) medium and 
snapped frozen in liquid nitrogen. The muscle blocks were sectioned longitudinally at 30 
µm using cryostat and ready for staining. 
For Chapter 3, EDL muscle sections were subjected to double immunofluorescence staining 
with a number of different presynaptic proteins and laminin chains in relation to the 
postsynaptic AChRs endplates such as: i) the active zone marker, Bassoon; ii) SNARE 
proteins, SNAP25 and Syntaxin 1A; iii) VGCCs, N- and P/Q-type; and iv) laminin chains, 
laminin-α4 and -α5. Cryosections were blocked with either 2% bovine serum albumin 
(BSA), 2% goat serum and 0.1% Triton X-100 (TX-100)/PBS or 2% BSA and 0.1% TX-
100/PBS. For the detection of laminin-α5, blocking buffer of 3% BSA, 5% goat serum and 
0.1% TX-100/PBS was used and for P/Q-type VGCCs, cryosections were blocked with 1% 
BSA, 5% goat serum and 0.1% TX-100/PBS. This was followed by overnight incubation of 
primary antibodies at 40C; mouse anti-Bassoon at 1:100 (Enzo Life Sciences; SAP7F407 
clone; Nishimune et al., 2004; Chen et al., 2011; Chand et al., 2015), mouse anti-SNAP25 
at 1:5000 (Sigma; Sadakata et al., 2006; Hata et al., 2007), mouse anti-Syntaxin 1A at 1:500 
(Sigma; clone HPC-1; Pardo et al., 2006), rabbit anti-Cav2.2 (N-type VGCC) at 1:1000 
(Alomone; Pagani et al., 2004), rabbit anti-Cav2.1 (P/Q-type VGCC) at 1.500 (Alomone; 
(Alomone; Pagani et al., 2004), and rabbit anti-laminin-α4 (ID# 1100) at 1.500 and rabbit 
anti-laminin-α5 (ID# 8948) at 1.1000 (antibodies kindly provided by Professor Jeffrey 
Miner). For Chapter 4, EDL cryosections were stained for detection of laminin-α4 chain, 
while in Chapter 5, tibialis anterior (TA) muscle sections were stained for the detection of 
laminins-α4 and -α5. The following day, the sections were incubated with a combination of 
Alexa Fluor 555 alpha-bungaratoxin (α-BTX) diluted at 1:5000 (Molecular Probes, 
Invitrogen, Eugene OR, USA) and with the appropriate Alexa Fluor secondary antibodies 
(either goat anti-rabbit or goat anti-mouse) diluted at 1:1000 (Molecular Probes, Invitrogen) 
for 2 hours at room temperature. Tissues were then rinsed with PBS, mounted with Prolong 
gold antifade reagent (Molecular Probes, Invitrogen) and cover-slipped. All antibodies were 
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diluted in 2% BSA and 0.1% TX-100/PBS except for laminin-α5 antibody which was 
diluted in 3% BSA and 0.1% TX-100/PBS and P/Q-type VGCC antibody which was diluted 
in 1% BSA and 0.1% TX-100/PBS. 
 
Omission of primary antibody was used as a negative control thus allowing elucidation of 
the degree of non-specific background staining by the secondary antibody, as shown as an 
example in Figure 2.2. The process of primary antibodies optimisation was also performed 
to determine the best dilution for optimal staining shown in Figure 2.3 as an example. 
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 Figure 2.2 No staining detected in negative control. 
Red fluorescence staining represents the labelling for postsynaptic acetylcholine receptors whereas 
green fluorescence represents the staining for laminin-α5 chain. Right panel shows the positive 
staining of laminin-α5 antibody which is well-colocalised to the postsynaptic endplate, Left panel 
represents the negative control with omission of laminin-α5 antibody with display of no green 
fluorescence staining on the neuromuscular junction. The negative control validates the specificity 
of the primary antibody. Scale bar = 10 µm. 
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 Figure 2.3 Optimisation of primary antibody for immunofluorescence. 
A, presents a sample graph of a dilution curve for rabbit anti-laminin-α4 antibody to determine the 
optimal concentration for immunostaining. B, At low concentration, there is no immunostaining of 
laminin-α4 as there is insufficient primary antibody to bind to the respective antigens. D, At high 
concentration, there is too much background staining as primary antibody binds non-specifically to 
other regions in the muscle sections. C, shows the ideal concentration to be used for laminin-α4 
antibody which produces the optimal staining. Scale bar = 5µm. 
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2.3.2 Wholemount immunohistochemistry 
Muscles were incubated with Alexa Fluor 555-α-BTX at 1:1000/PBS followed by fixation with 2% 
PFA/PBS. In Chapter 3, hemi-diaphragm tissues were blocked with 3% BSA, 5% goat serum and 0.5% 
TX-100/PBS for the detection of mouse anti-β-dystroglycan at 1:250 (Developmental Studies 
Hybridoma Bank (DSHB); MANDAG27D11; Nishimune et al., 2008) and with 2% BSA, 2% goat 
serum and 0.1% TX-100/PBS for the detection of mouse anti-Bassoon at 1:600. For Chapter 4, hemi-
diaphragm muscles were also stained for the detection of Bassoon with the similar protocol above, 
however at 1:300 dilution. EDL muscles were blocked with 2% BSA, 2% goat serum and 0.5% TX-
100/PBS for the detection of mouse anti-synaptic vesicle 2 (SV2) at 1:200 (DSHB; Knight et al., 2003) 
and with 2% BSA and 0.5% TX-100/PBS for the combination of mouse anti-SV2 at 1:200 plus rabbit 
anti-neurofilament at 1:500 (Sigma Aldrich; N41402; Itoh et al., 2011). In Chapter 5, TA muscles were 
also stained with the combination of mouse anti-SV2 and rabbit anti-neurofilament following the same 
protocol described above. After the blocking step, muscles were washed consecutively with 0.5% TX-
100 before being incubated with the primary antibodies overnight at 40C. The following day, tissues 
were again permeabilised prior to incubation with the appropriate Alexa Fluor 488-conjugated 
secondary antibodies diluted at 1:1000 for 5 hours at 40C. Muscles were then washed with PBS, 
mounted in Prolong Gold antifade reagent and cover-slipped. All antibodies were diluted in 0.5% TX-
100/PBS. 
2.3.3 Fibre type staining conducted in lama4-/- mice 
Gastrocnemius muscles were embedded in OCT medium and freshly snapped frozen. Frozen blocks of 
muscles were cut transversely at 10 µm in the mid-belly region using cryostat. The cryosections were 
firstly blocked with mouse on mouse (M.O.M.) IgG blocking buffer (Vector Lab)/PBS for 1 hour before 
incubated with the following primary antibodies overnight at 40C; mouse anti-BA-D5 which stains the 
myosin heavy chain Type I at 1:100, mouse anti-SC-71 which stains the myosin heavy chain Type IIA at 
1:100, and mouse anti-BF-F3 which stains the myosin heavy chain Type IIB at 1:80. These primary 
antibodies were sourced from DSHB and diluted in 0.5% BSA/PBS. The remaining unstained fibres were 
grouped as Type IIX, as noted by other researchers (Chai et al., 2011; Dyar et al., 2014). The tissues were 
then incubated for 1 hour at room temperature with the appropriate specific secondary antibodies in 
combination of Alexa Fluor 647 AffiniPure Goat Anti-mouse IgG, Fcy subclass 2b specific, Alexa Fluor 
594 AffiniPure Fab Fragment Goat Anti-mouse IgM, u chain specific and Alexa Fluor 488 AffiniPure 
Goat Anti-mouse IgG, Fcy subclass 1 specific (1:200 dilution). All secondary antibodies were purchased 
from Jackson Immunoresearch, and diluted in 0.5% BSA and 2% goat serum/PBS. Cryosections were 
then washed with PBS, mounted with Prolong Gold antifade reagent and cover-slipped. 
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2.4 Measurement of fibre diameter investigated in lamb2-/- mice 
Fixed and frozen blocks of hemi-diaphragm muscles were cut transversely at 30 µm using cryostat. 
Cryosections were then stained with haematoxylin and eosin to enable clear visualisation of the 
fibres appearance and most importantly the outer boundary of individual fibres. These sections were 
imaged with Nikon Eclipse 50i upright microscope fitted with a 10x/0.25 objective (Nikon) and 
captured using a Nikon DS-Fi1 camera. Image J software (NIH) was used to measure the diameter 
of the fibres (Abramoff et al., 2004). 
2.5 Image acquisition and analysis 
In Chapter 3, stained EDL sections against N-type, P/Q-type, SNAP25, syntaxin 1A and Bassoon 
were imaged using Axio Imager microscope equipped with an AxioCamMRm CCD-camera 
running on AxioVision 4.8 software (Carl Zeiss, Jena, Germany). Images were acquired with a 63x/ 
1.4 Oil Plan-Apochromat objective at a Z-step size of 0.3 μm, in combination with ApoTome to 
provide optical sectioning and improved resolution of fine structures (Bauch & Schaffer, 2006). The 
images acquired using this configuration had a lateral pixel resolution of 0.1 μm with point-spread 
function at approximately 0.31 μm in X-Y plane and 0.8 μm in Z plane. This configuration was 
appropriate for the determination of small VGCC sized puncta (0.40-0.69 μm) and large VGCC 
sized puncta (0.70-1.00 μm). Exposure times and settings were set identically to capture images 
amongst different slides with the same antibody. Captured Z-stacked images of VGCCs were 
subjected to analysis for quantification of VGCC puncta and volume of postsynaptic endplate using 
Imaris x64 7.1.1 (Bitplane, South Windsor, CT, USA) to measure density of VGCCs. Fluorescently 
stained postsynaptic AChR endplates with Alexa Fluor 555-αBTX were remodelled into a 3-
dimensional (3D) solid structure using a surface rendering tool. The whole 3D reconstructed AChR 
endplate region inclusive of interstitial space was defined as the endplate volume. Fluorescently 
stained VGCCs with Alexa Fluor 488 were remodelled into 3D spot structures at the corresponding 
reconstructed postsynaptic endplates (Fogarty et al., 2013; Chand et al., 2015). The number of 
reconstructed 3D VGCC puncta in relation to the respective 3D remodelled endplates was 
determined and grouped according to their diameter size; total puncta (≥0.4 μm), large puncta (0.7-
1.0 μm) and small puncta (subtraction of large puncta from total puncta). The density of VGCCs at 
each NMJ was measured through the division of the total number of puncta (based on each 
grouping stated) over the endplate volumes. Endplate volume was used as this parameter provide a 
more accurate determination of the VGCC puncta with respect to the three dimensional expansion 
of the endplate (Johnson & Connor, 2011). 
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In Chapter 3, all other remaining stained tissues were imaged with an Olympus Fluoview FV1000 
confocal laser scanning microscope, equipped with two excitation diode laser lines (473 nm and 
559 nm) running on Fluoview FV10-ASW software version 01.07C. Images were taken at a 
resolution of 1024 by 1024 pixels, using a 100x/ 1.35 NA Oil Iris UPlan-Apochromat objective 
with a Z-step size of 0.3 µm. Images were captured using identical laser power levels, 
photomultiplier gain levels, scanning speed and pinhole size amongst different slides using the same 
antibody. In Chapters 4 and 5, the same microscope was used following the same settings as 
described. In Chapter 3, imaged postsynaptic AChR endplates at P35 were used for measurement of 
different parameters. Image J software was used to measure the area of each individual postsynaptic 
AChR endplates (Abramoff et al., 2004) as well as the perimeter length of the endplates inclusive of 
the perforations within the synapses (example of the measurement of perimeter length is shown at 
results section of Chapter 3; the top panel of Figure 3.5B). The postsynaptic endplates were also 
grouped according to appearances; pretzel, partially differentiated and plaque (Shi et al., 2010). 
In Chapter 4, Imaris 8.1.2. (Bitplane, South Windsor, CT, USA) was used to analyse Z-stacked 
images for volume measurement of synaptic vesicles and postsynaptic endplates. Synaptic vesicles 
targeted by mouse anti-SV2, stained with Alexa Fluor 488-conjugated secondary antibody and 
postsynaptic AChR endplates stained with Alexa Fluor 555-α-BTX, were reconstructed into 3D 
solid structures as described earlier. The estimation of vesicles density at each junction was 
determined by dividing the volume of the 3D reconstruced SV2-stained region over the 3D 
reconstructed endplate volumes.  Postsynaptic AChR endplates from these captured images were 
also measured for a number of different parameters such as synapse area (stained AChRs only), 
endplate expansion area (the surrounding exterior region of the stained postsynaptic endplate) and 
dispersion of AChRs (measured through the division of synapse area over endplate expansion area 
followed by multiplication with 100; (Rudolf et al., 2014).  Tissues labelled for the detection of 
nerve terminal and axons with respect to the postsynaptic endplates were imaged with the same 
microscope above. Selected fields were imaged with a 40x/0.95 NA Uplan-Apochromat objective 
with a Z-step size of 0.5 µM. The criteria for scoring of ageing features was based on the study by 
(Valdez et al., 2010). Tissues stained for fibre types were also imaged with Olympus Fluoview 
FV1000 confocal microscope, using a 10x/0.40 NA UPlan-Apochromat objective. In order to 
achieve high resolution of Bassoon puncta in tissues from older mice > 3MO, a spinning-disk 
confocal system (Marianas; 3I, Inc.) consisting of a Axio Observer Z1 (Carl Zeiss) equipped with a 
CSU-W1 spinning-disk head (Yokogawa Corporation of America) and ORCA-Flash4.0 v2 sCMOS 
camera (Hamamatsu Photonics) was used. Image acquisition was performed using SlideBook 6.0 
(3I, Inc) with a Z-step size of 0.13 µm, using 100x 1.4 NA PlanApo objective at a resolution of 
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1280 by 1280 pixels. The captured images were subjected to deconvolution software in order to 
restore the images for better resolution to enable accurate puncta analysis (Shaw, 2006). Imaris 
8.1.2 was used to analyse the images for counts of Bassoon puncta and volume of postsynaptic 
endplate, similarly performed and described for Chapter 3. The density of Bassoon for each junction 
was then determined by dividing the total number of Bassoon puncta over the reconstructed 
endplate volumes. 
In Chapter 5, estimation of vesicle density was performed similarly as described for Chapter 4, 
however at the NMJs of TDP43Q331K, these synapses were also stained for motor axons. After 
reconstruction of the synapses into 3D models, the rendered 3D motor axons were carefully and 
accurately cut off from 3D reconstructed vesicles in order to solely quantify the volume of synaptic 
vesicles. Subsequently, the estimation of the density of synaptic vesicles for each junction was 
measured by dividing the volume of 3D reconstructed SV2-stained synaptic vesicles (after deletion 
of 3D reconstructed neurofilament-stained motor axons) over the volume of 3D reconstructed 
postsynaptic endplates. Endplates displaying signs of partial denervation were included in analysis 
for estimation of vesicle density, however denervated regions were carefully cut away from the 3D 
reconstructed endplates so as to not influence the measurement of density. Thus analysis of vesicle 
density only accounted for fully innervated regions of endplates.    
In Chapters 4 and 5, composite images for laminins staining were generated using a modified 
protocol to that previously described by (Pratt et al., 2015). In brief, image Z-stacks were projected 
into single maximum intensity projections (Image>Stacks>Z Project>Max Intensity) using Image J 
software (Sleigh et al., 2014). Background was subtracted (Process>Subtract Backgroud) with the 
rolling ball radius adjusted to appropriate pixel values so as to not to interfere with true signal (50-
80 pixels). Following this process images underwent noise despeckling (Process>Noise>Despeckle) 
and a standard Gaussian Blur filter (σ = 2.00) was applied. A colour threshold was then applied to 
the presynaptic laminin stained region and next to the postsynaptic AChR stained region 
(Image>Adjust>Color Threshold) with a Moments thresholding method. Thresholding was adjusted 
to ensure the relevant regions were superimposed by the selected thresholding method. Composite 
overlays were created by merging individual channels (Image>Color>Merge Channels). This 
process was conducted on images that best represent the morphological phenotypes qualitatively 
described in text. In addition to this, 3D reconstruction of laminin-α4 staining with respect to 
postsynaptic endplate was conducted using Imaris software, on aged wild-type NMJ in Chapter 4 as 
similarly performed for 3D reconstruction of synaptic vesicles and postsynaptic endplates.  
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2.6 Neuromotor behavioural investigation using hind-limb grip force test in lama4-/- mice 
Before commencing the test of hind-limb grip force, mice were weighed for their body weight. A 
DPS-0.5R digital force gauge (Imada, Japan) with extension shaft and T-bar was used to measure 
maximal hind-limb grip force. Mice were held by their tail and lowered until their hind-limbs grip 
the T-bar (Figure 2.4). Once the mice were positioned horizontally, they were pulled away from the 
bar with consistent pull in order to release their grip on the T-bar. The hind-limb grip force was 
measured in Newton force with 10 trials performed on each mouse to give a mean of hind-limb grip 
force which was then normalised to body weight. Hind-limb grip force was investigated rather than 
fore-limb as prior study (Patton et al., 2001) as well as my behavioural observations noted only 
hind-limb dysfunction. 
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 Figure 2.4 Assessment of hind-limb grip force using digital force gauge. 
Mice were placed horizontally onto the T-bar of the digital force gauge. Once their hind-limbs 
gripped the T-bar, the mice were gently pulled away from the bar with consistent force. This 
procedure was performed in 10 trials for each mouse. 
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2.7 Data analysis 
Extracellular recording sites were analysed if the frequency of EPCs and mEPCs did not change as 
a result of electrode pressure and if a single EPC was recorded within the first ten stimuli. 
Intracellular recordings were included if at least 100 EPPs and 30 mEPPs were recorded.  Quantal 
content (m) was determined using method of failures (Del Castillo & Katz, 1954): m = loge (number of 
stimuli/ number of failures) utilising intracellular electrophysiological recordings for recordings with 
greater than 30% failures, or using  m  = mean EPP amplitude/ mean mEPP amplitude for all other 
recordings. Binomial parameters were calculated from intracellular recording data using methods 
previously described by Bennett and Florin (1974). All image analysis was completed under double 
blinded conditions. In Chapter 3, transmission properties such as amplitudes of spontaneous and 
evoked  release, frequency and decay time of spontaneous release, intermittence and quantal content 
were calculated for each experimental group. Two-way ANOVA with Tukey’s post-hoc test was used 
to compare the mean values of wild-type and lamb2-/- junctions for electrophysiological and 
morphological data unless otherwise specified. 
In Chapter 4, estimation of the readily releasable pool (RRP) size was conducted using a previously 
described method and model of assumptions (Ruiz et al., 2011; Ruiz et al., 2014). In short, the 
model assumed that all vesicles are initially sourced from the RRP and, upon its exponential depletion, 
recruitment is maintained at a steady state plateau. RRP size is estimated by plotting quantal content on 
the y-axis against the accumulated quantal content on the x-axis. A straight line is then drawn through 
the declining phase, where the x-axis intercept gives the estimate RRP size (Ruiz et al., 2011; Ruiz et 
al., 2014). The rise times, decay times, amplitude and frequency of evoked and spontaneous releases 
were calculated for each experimental group. Unpaired Student’s t-tests (two-tailed) were performed to 
compare mean values of wild-type and lama4-/- mice for electrophysiological, behavioural and 
morphological data unless otherwise specified. In Chapter 5, the decay times, amplitude and frequency 
of evoked and spontaneous releases were determined and grouped for each experimental group. 
Unpaired Student’s t-tests (two-tailed) were performed to compare mean values of wild-type and 
TDP43Q331K mice unless otherwise specified. Results are expressed as mean ± SEM with statistical 
significance accepted at P < 0.05. 
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Chapter 3 
The Role of Laminin-β2 in 
Maturation of the 
Neuromuscular Junction 
 
  
Data presented in Figures 3.1, 3.2 and 3.3 are from the following publication and was 
produced by KM Lee. 
Chand, K.K., Lee, KM., Schenning, M.P., Lavidis, N.A., and Noakes, P.G. (2015) Loss of β2-
laminin Alters Calcium Sensitivity and Voltage Gated Calcium Channel Maturation of 
Neurotransmission at the Neuromuscular Junction. J Physiol. 593(1), 245-65. 
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ABSTRACT 
The loss of laminin-β2 chain has been associated with severe disruption at the nerve terminal 
supporting its role in organisation of the presynaptic elements. In-vitro study demonstrated the 
interaction between laminin-β2 and voltage-gated calcium channels (VGCCs) such as N- and P/Q-
type VGCCs, which is implicated in the clustering of these channels. The clustering of these 
VGCCs is suggested to be vital for the organisation of the presynaptic elements, in particular the 
active zones at the neuromuscular junction (NMJ). The present study aimed to investigate how loss 
of laminin-β2 would affect the distribution of VGCCs during maturation and how these changes in 
distribution of VGCCs would then affect the localisation of the presynaptic proteins in laminin-β2 
deficient mice (lamb2-/-). Further study was then taken to investigate lamb2-/- mice past weaning age 
at postnatal day 35 (P35) in order to determine whether maturation of the NMJ would eventually be 
achieved in these mutants. Results demonstrated retained clusters of N-type VGCCs with no 
upregulation of P/Q-type VGCC clusters at mature postnatal day 18 lamb2-/- NMJs suggesting 
failure in switching over of N- to P/Q-type VGCCs when laminin-β2 is lost. This in turn resulted in 
the disruption of the localisation of the presynaptic elements at these mutant NMJs. At P35, 
postsynaptic endplates retained immature appearance at lamb2-/- NMJs suggesting arrested 
maturation of the postsynaptic endplates. Poor functional capacity in neurotransmission was 
maintained from mature postnatal day 21 to adult P35 suggesting lack of maturation functionally. 
These findings support that laminin-β2 is essentially important for the maturation of the NMJ at 
both pre- and postsynaptic regions, with its loss resulting in halted maturation. 
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3.1 INTRODUCTION 
The neuromuscular junction (NMJ) is a specialised synapse that comprises the nerve terminal, the 
synaptic cleft and the skeletal muscle fibre. To ensure efficient and rapid transmission, the 
presynaptic release sites machinery has to be organised and aligned correctly to the postsynaptic 
skeletal muscle fibre (Hall & Sanes, 1993; Sanes, 1995; Sanes & Lichtman, 1999). This process is 
highly dependent on a group of signalling and adhesion molecules found within the basal lamina of 
the synaptic cleft, known as the laminins (Noakes et al., 1995a; Patton et al., 1997; Nishimune et 
al., 2004; Carlson et al., 2010; Samuel et al., 2012). The laminins are a family of heterotrimers 
formed by α, β and γ chains (Patton et al., 1997). There are five laminin chains; α2, α4, α5, β2 and 
γ1 which form three laminin heterotrimers at the NMJ such as laminin-221 (α2βγ1), laminin-421 
(α4βγ1) and laminin-521 (α5βγ1) (Miner et al., 1997; Patton et al., 1997; Patton, 2000). 
The laminin-β2 chain is present in each of these laminin heterotrimers at the NMJ. It has been 
shown that laminin-β2 acts as a stop signal for neurite outgrowth suggesting its involvement in 
nerve terminal growth or differentiation (Porter et al., 1995). This is confirmed in the study by 
Noakes et al. (1995a) which demonstrated severe disruptions at the nerve terminal with loss of 
active zones and dispersed vesicles, and to a certain extent, disruption at the muscle fibre with lower 
numbers of junctional folds in laminin-β2 deficient mice (lamb2-/-). These disruptive morphological 
changes led to impairment of neurotransmission at postnatal day 18 (P18) lamb2-/- NMJs (Knight et 
al., 2003). The functional study on lamb2-/- NMJs was followed up by Nishimune et al. (2004), 
which revealed the role of laminin-β2 in ensuring normal presynaptic differentiation through the 
clustering of voltage-gated calcium channels (VGCCs). In-vitro study showed that laminin-β2 
coated beads were bound specifically to VGCCs such as N- and P/Q-type, which helps to cluster 
these channels at cultured motor neurons (Nishimune et al., 2004). To further support this, a study 
has shown a direct interaction of laminin-β2 with N- and P/Q-type for the arrangement of active 
zones at the presynaptic membrane (Chen et al., 2011). During development of the NMJ, N- and 
P/Q-type are primary VGCCs involved in neurotransmitter release (Katz et al., 1996; Rosato-Siri & 
Uchitel, 1999; Rosato-Siri et al., 2002). As the NMJ matures, there is a switch to P/Q-type VGCC 
dependence for transmitter release (Katz et al., 1996; Rosato-Siri & Uchitel, 1999). 
The proper organisation of the presynaptic elements like the appropriate VGCCs at the NMJ is 
important as this process ensures maturation of the synapse proceeds normally. Therefore if 
laminin-β2 is lost at the NMJ, presynaptic differentiation would be disrupted, which subsequently 
influences the maturation of the NMJ. But how does the clustering of VGCCs by laminin-β2 
influence the normal presynaptic differentiation? It is also unclear as to how these interactions may 
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affect the progression of maturation at lamb2-/- NMJs, as these animals do not survive past postnatal 
day 21 (P21) due to kidney failure (Noakes et al., 1995b), therefore limiting studies on laminin-β2 
to less than P21. The present study aimed to extend our understanding of the involvement of 
laminin-β2 in maturation of the NMJ into early adulthood. Do lamb2-/- NMJs display a delay or 
complete cessation in maturation if they are able to survive up to early adulthood at postnatal day 
35 (P35)? In order to address these questions, I utilised immunofluorescence techniques to study the 
distribution of VGCCs and other presynaptic proteins, as well as the morphology of postsynaptic 
endplates at lamb2-/- NMJs.  I also characterised the neurotransmission properties in these mice at 
P21 and P35 to determine whether mutant NMJs would gain functional capacity compared to those 
previously reported at younger age groups. My findings demonstrated retained clusters of N-type 
VGCCs with no upregulation of P/Q-type VGCCs at mature lamb2-/- NMJs, with decreased 
colocalisation of presynaptic proteins in relation to postsynaptic endplates. Postsynaptic endplates 
remained immature in appearance at adult lamb2-/- NMJs at P35. Significantly, deficits in 
transmission properties were maintained from P21 to P35 at lamb2-/- NMJs. 
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3.2 RESULTS 
3.2.1 Lamb2-/- neuromuscular junctions maintained clustering of N-type VGCCs with 
dispersed P/Q-type VGCCs at postnatal day 18 
During development of the NMJ both N- and P/Q-type VGCCs are involved in neurotransmitter 
release (Katz et al., 1996; Rosato-Siri & Uchitel, 1999; Rosato-Siri et al., 2002). As the NMJ 
matures, P/Q-type VGCCs become the primary channel that is essential for bulk release of 
neurotransmitters while N-type VGCCs are suggested to take on the role of fine-tuning of calcium 
influx (Katz et al., 1996; Rosato-Siri & Uchitel, 1999). The study by Chand et al. (2015) 
demonstrated the predominant role N-type VGCCs play in neurotransmitter release at mature NMJ 
when laminin-β2 is lost, using electrophysiology. My interest here was to determine whether there 
was a re-distribution of N- and P/Q-type VGCCs which would be linked to a change in the 
dependence of transmitter release on VGCCs at these mutant NMJs. Both wild-type and lamb2-/- 
NMJs showed similar patterns of staining for N-type VGCCs during development (Figure 3.1A and 
B). The distribution of small puncta, large puncta and total puncta was similar between postnatal 
day 8 (P8) wild-type (small puncta; 0.31 ± 0.028 puncta/µm3, large puncta; 0.06 ± 0.01 puncta/µm3 
and total puncta; 0.37 ± 0.02 puncta/µm3) and P8 lamb2-/- (small puncta; 0.24 ± 0.02 puncta/µm3, 
large puncta; 0.07 ± 0.01 puncta/µm3 and total puncta; 0.31 ± 0.03 puncta/µm3)(P > 0.05 for each 
category; Figure 3.1C). By P18, distinct clusters of N-type VGCCs were seen colocalised to the 
endplate of lamb2-/- (Figure 3.1B) with significantly higher number of large puncta (P < 0.05, 0.06 
± 0.01 puncta/µm3) when compared with P18 wild-type (0.03 ± 0.01 puncta/µm3; Figure 3.1D). 
Interestingly, the large clusters of N-type VGCCs at lamb2-/- NMJs did not increase from P8 to P18 
(P > 0.05) while in wild-type NMJs, the large clusters of N-type VGCCs decreased significantly 
from P8 to P18 (P < 0.001). Wild-type on the other hand, appeared to maintain a similar pattern of 
staining to that at P8 (Figure 3.1A) with no significant difference found when compared with P18 
lamb2-/- NMJs for small puncta (P  > 0.05; wild-type; 0.29 puncta/µm3 ± 0.03 vs. lamb2-/-; 0.18 ± 
0.04 puncta/µm3) and total puncta (P  > 0.05; wild-type; 0.33 ± 0.04 puncta/µm3 vs. lamb2-/-; 0.24 ± 
0.04 puncta/µm3; Figure 3.1D). 
Wild-type and lamb2-/- NMJs at P8 showed similar pattern of P/Q-type VGCC staining (Figure 3.2A 
and B). There was no significant difference found for each category; small puncta (P > 0.05; wild-
type; 0.19 ± 0.02 puncta/µm3 vs. lamb2-/-; 0.22 ± 0.01 puncta/µm3), large puncta (P > 0.05; wild-
type; 0.07 ± 0.01 puncta/µm3 vs. lamb2-/-; 0.07 ± 0.01 puncta/µm3) and total puncta (P  > 0.05; 
wild-type; 0.26 ± 0.02 puncta/µm3 vs. lamb2-/-; 0.29 ± 0.02 puncta/µm3; Figure 3.2C). Interestingly, 
the total puncta and small puncta of P/Q-type VGCCs at P8 appeared to be lower than that of N-
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type VGCCs at P8, which is likely a reflection of the more prominent role N-type VGCC plays in 
transmission during early NMJ development (Figure 3.1C and 3.2C).  As the NMJ matures, P18 
wild-types revealed increased distinct clusters of P/Q-type VGCC staining to endplate (Figure 3.2 
A) whereas mature lamb2-/- NMJ displayed similar pattern of staining to that at P8 (Figure 3.2B). 
Each puncta classification increased significantly at P18 wild-type when compared with P18 lamb2-
/-; small puncta (P < 0.05; wild-type; 0.22 ± 0.02 puncta/µm3 vs. lamb2-/-; 0.16 ± 0.01 puncta/µm3), 
large puncta (P < 0.001; wild-type; 0.09 ± 0.01 puncta/µm3 vs. lamb2-/-; 0.05 ± 0.01 puncta/µm3) 
and total puncta (P < 0.01; wild-type; 0.31 ± 0.02 puncta/µm3 vs. lamb2-/-; 0.21 ± 0.01 puncta/µm3; 
Figure 3.2D). 
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 Figure 3.1 Higher distinct clusters of N-type VGCCs at mature postnatal day 18 lamb2-/- 
neuromuscular junctions in comparison with age-matched wild-type. 
A, wild-type and B, lamb2-/- NMJs at developing P8 and mature P18 labelled for N-type VGCCs (green) 
with respect to postsynaptic AChR endplates (red). Both developing wild-type and lamb2-/- NMJs displayed 
similar pattern of N-type VGCCs staining in relation to the postsynaptic endplates. As the NMJ matures to 
P18, lamb2-/- NMJs showed distinct clusters of N-type VGCCs which colocalised well with the postsynaptic 
endplate (as indicated by white arrows in the bottom right panel). On the other hand, mature wild-type NMJs 
maintained similar pattern of staining to that of P8. C, both genotypes during NMJ development showed no 
significance difference in each puncta categorisation; small puncta, large puncta and total puncta. Example of 
small puncta is indicated with single arrowhead and large puncta is indicated with double arrowheads in B. 
D, at mature P18, mutant NMJs displayed significantly higher proportion of endplates with large puncta of 
N-type VGCCs in comparison with P18 wild-type, while other puncta classification such as small and total 
puncta remained similar between both genotypes. For C, P8: wild-type; n = 5, NMJs = 65 and lamb2-/-; n = 6, 
NMJs = 80. For D, P18: wild-type; n = 6, NMJs = 83 and lamb2-/-; n = 6, NMJs = 72. Values are presented 
as mean ± SEM; Two-way ANOVA with Tukey’s post hoc test; * P < 0.05. Scale bar = 5 µm. 
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 Figure 3.2 Decreased clusters of P/Q-type VGCCs at mature lamb2-/- neuromuscular junctions 
in comparison with age-matched wild-type. 
A, wild-type and B, lamb2-/- NMJs at developing P8 and mature P18 labelled for P/Q-type VGCCs 
(green) with respect to postsynaptic AChR endplates (red). Developing wild-type and lamb2-/- 
NMJs presented similar patterns of P/Q-type VGCC staining. By P18, wild-type increased in 
clusters of P/Q-type VGCCs which colocalised strongly to the postsynaptic endplate (as indicated in 
white arrows in bottom left panel). In contrast, age-matched mutant NMJs presented similar 
patterns of staining to that observed at P8.  C, during NMJ development, no significant difference 
was found in each puncta category; small puncta, large puncta and total puncta. Example of small 
puncta is indicated with single arrowhead and large puncta is indicated with double arrowheads in 
A. D, P18 wild-type displayed significantly higher densities for each puncta category investigated 
compared with mutant terminals. For C, P8: wild-type; n = 6, NMJs = 95 and lamb2-/-; n = 5, NMJs 
= 67. For D, P18: wild-type; n = 9, NMJs = 102 and lamb2-/-; n = 9, NMJs = 100. Values are 
presented as mean ± SEM; Two-way ANOVA with Tukey’s post hoc test; * P < 0.05, ** P < 0.01 
and *** P < 0.001. Scale bar = 5 µm. 
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3.2.2 Mature lamb2-/- neuromuscular junctions displayed decreased colocalisation of 
presynaptic proteins in relation to postsynaptic endplates 
The proper organisation of presynaptic elements at the NMJ is partly dependent on the clustering of 
VGCCs at the presynaptic nerve terminal (Nishimune et al., 2004; Chand et al., 2015). The 
consequences of maintained N-type rather than P/Q-type VGCC clustering at lamb2-/- NMJs is yet to 
be investigated. Here, I examined the distribution and expression of the presynaptic proteins; 
SNAP25, Syntaxin 1A and Bassoon with respect to the postsynaptic endplates (Figure 3.3). At P18, 
lamb2-/- NMJs displayed decreased colocalisation of SNAP25 and Syntaxin 1A in relation to the 
postsynaptic endplates (Figure 3.3). Qualitatively, the number of Bassoon puncta was also found to be 
lower at mutant NMJs by comparison with wild-types (Figure 3.3). By contrast, mature wild-type 
NMJs maintained good colocalisation of each presynaptic protein investigated with respect to the 
postsynaptic acetylcholine receptor (AChR) endplates (Figure 3.3). In addition to the decreased 
expression of presynaptic proteins at mature lamb2-/- NMJs, I also observed maintained “plaque-like” 
appearance of postsynaptic endplates (Figure 3.3). Mature mutant endplates displayed little change in 
morphology to those seen at P8 (Figure 3.1 and 3.2), in contrast to P18 wild-types, which displayed 
convoluted branching of postsynaptic endplates, forming a “pretzel-like” appearance (Figure 3.3). 
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 Figure 3.3 Decreased colocalisation of presynaptic proteins in relation to postsynaptic 
endplates at mature postnatal day 18 lamb2-/- neuromuscular junctions. 
Immunohistochemical staining of presynaptic proteins; SNAP25, Syntaxin 1A (STX 1A) and 
Bassoon (all in green) with respect to postsynaptic AChR endplates (red). Mature P18 wild-type 
NMJs displayed good colocalisation of each presynaptic protein in relation to the postsynaptic 
endplates. In contrast, mature lamb2-/- NMJs presented decreased colocalisation of each presynaptic 
protein tested with respect to the postsynaptic endplates. In particular, qualitative observations 
indicate a significant reduction in the number of Bassoon puncta at lamb2-/- NMJs in comparison 
with wild-type. Scale bar = 5 µm. 
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3.2.3 Poor transmission maintained from mature postnatal day 21 to adult postnatal day 35 at 
lamb2-/- neuromuscular junctions 
I observed failure in switching over of N- to P/Q-type VGCCs and decreased presynaptic proteins at 
mature lamb2-/- NMJs, which is associated either with delayed or arrested maturation. I next 
investigated the transmission properties in these mice in order to determine whether there would be 
improvement in functional capacity during adulthood as this would reflect the maturation of the 
NMJ in these mutants. 
The amplitude of spontaneous release (miniature endplate potentials; mEPPs) and evoked release 
(endplate potential; EPPs) appeared to be smaller at lamb2-/- NMJs when compared with wild-type 
at P21 (Figure 3.4A). However, no significant difference was found between both genotypes at this 
age in mEPP amplitude (P > 0.05; wild-type; 0.93 ± 0.02 mV vs. lamb2-/-; 0.80 ± 0.06 mV) and EPP 
amplitude (P > 0.05; wild-type; 1.93 ± 0.16 mV vs. lamb2-/-; 1.39 ± 0.17 mV). At P35, a similar 
trend was observed with no significant difference found between wild-type and lamb2-/- for mEPP 
amplitude (P > 0.05; 1.03 ± 0.06 mV vs. 1.07 ± 0.07 mV) and EPP amplitude (P > 0.05; 1.81 ± 0.20 
mV vs. 1.40 ± 0.11 mV). Timing parameters such as mEPP decay time was also similar between 
both genotypes at both ages (P21: P > 0.05; wild-type; 5.15 ± 0.25 ms vs. lamb2-/-; 6.75 ± 0.59 ms 
and P35: P > 0.05; wild-type; 6.60 ± 0.43 ms vs. lamb2-/-; 6.62 ± 0.25 ms). 
The frequency of spontaneous release was significantly lower (P < 0.01) at P21 lamb2-/- NMJs by 
80.06 % when compared with aged-matched wild-type. This trend was maintained consistently with 
80.95% drop in mEPPs frequency at P35 lamb2-/- NMJs in comparison with P35 wild-type (P < 
0.01; Figure 3.4B), suggesting no improvement in functional capacity.  A similar trend was also 
observed in failures of evoked release with lamb2-/- NMJs having consistently higher intermittence 
from P21 (62.72 ± 2.84 %) to P35 (65.25 ± 3.56 %, P > 0.05; Figure 3.4B). Wild-types at P21 
(28.43 ± 5.64 %) and P35 (23.90 ± 5.10 %) were significantly lower in intermittence in comparison 
with P21 (P < 0.001) and P35 (P < 0.0001) lamb2-/- NMJs, respectively (Figure 3.4B). I also 
observed a decline in quantal content at P21 lamb2-/- NMJs which was maintained similarly at P35 
lamb2-/- NMJs (P > 0.05; P21; 0.49 ± 0.06 vs. P35; 0.48 ± 0.06; Figure 3.4B). Wild-types at both 
ages; P21 and P35 remained significantly higher in quantal release when compared with lamb2-/- 
NMJs at P21 and P35, respectively (P < 0.01; P21: wild-type; 1.53 ± 0.26 vs. lamb2-/-; 0.49 ± 0.06, 
P < 0.01; P35: wild-type; 1.44 ± 0.24 vs. lamb2-/-; 0.48 ± 0.06). In binomial parameter analysis of 
transmitter release, quantal content was reduced by 66.60 % (P < 0.0001) at P35 lamb2-/- NMJs 
when compared with wild-type NMJs. This was due to a 61.78 % (P < 0.001) decrease in the 
number of active release sites at mutant terminals, which displayed a lower probability of release 
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(47.46 %; P < 0.0001) when compared with wild-type junctions (Figure 3.4C). These differences in 
transmission properties suggest defects at the presynaptic nerve terminal consistent with previous 
functional studies on lamb2-/- NMJs (Knight et al., 2003; Chand et al., 2015). Furthermore, my 
morphological findings displayed notable decrease in the number and expression of Bassoon puncta 
at P35 lamb2-/- NMJs in contrast to age-matched wild-type with uniformly distributed Bassoon 
puncta at the endplate (Figure 3.4D). This morphological change strongly supports my functional 
data suggesting that the decrease in transmission properties is largely due to a decrease in the 
number of active zones, with the remaining sites being less active and possessing a lower 
probability of release. 
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 Figure 3.4 Disrupted transmission properties at mature postnatal day 21 lamb2-/- 
neuromuscular junctions remained perturbed at adult postnatal day 35. 
A, sample traces from intracellular recordings of 10 consecutive mEPPs and 10 consecutive EPPs 
for wild-type and lamb2-/- NMJs at mature P21. B, frequency of spontaneous release (mEPPs) was 
significantly reduced at P21 which was maintained similarly at P35 in these mutant NMJs. 
Significantly higher intermittence was observed at P21 lamb2-/- NMJs which remained similar at 
P35 lamb2-/- NMJs. Same trend was also seen in quantal content in which both age groups of mutant 
NMJs consistently produced lower quantal content in comparison with age-matched wild-types. C, 
binomial parameter analysis revealed that lower quantal content (m) at P35 was resulted from the 
lower number of active sites (n) with decreased probability release of neurotransmitters (p) at the 
remaining active sites. Binomial parameters are normalised to P35 wild-types, as represented by 
dashed lines at 100%. D, adult P35 lamb2-/- NMJs displayed lower number of Bassoon puncta 
(green) with respect to the postsynaptic endplates (red), in comparison with age-matched wild-type, 
which showed uniform distribution of Bassoon puncta in relation to the postsynaptic endplate. For 
B and C, P21: wild-type; n = 3, NMJs = 31 and lamb2-/-; n = 6, NMJs = 44, P35: wild-type; n = 6, 
NMJs = 45 and lamb2-/-; n = 6, NMJs = 40. Values are presented as mean ± SEM; Two-way 
ANOVA with Tukey’s post hoc test for B and Unpaired Student’s t-tests (two-tailed) for C; 
** P < 0.01, *** P < 0.001 and **** P < 0.001. Scale bar = 10 µm. 
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3.2.4 Postsynaptic endplates remained plaque-like even at adult postnatal day 35 at lamb2-/- 
neuromuscular junctions 
My morphological findings showed plaque-like appearance of postsynaptic endplates at P18 lamb2-/- 
NMJs, which is indicative of an immature synapse. I further investigated the morphology of 
postsynaptic endplates between P21 and P35, in order to determine whether maturation of the 
postsynaptic apparatus may eventually be achieved at adult lamb2-/- NMJs. 
Wild-type showed pretzel-like appearance of postsynaptic endplates at both P21 and P35 (Figure 
3.5A). On the other hand, postsynaptic endplates of lamb2-/- remained plaque-like in appearance 
from P21 to P35 suggesting no progression in maturation of the postsynaptic apparatus (Figure 
3.5A).  At P35, approximately 43.86 ± 3.72 % of wild-type NMJs displayed pretzel-like endplates, 
which was significantly higher than age-matched lamb2-/- with only 0.68 ± 0.68 % (P < 0.0001; 
Figure 3.5B). A high proportion of lamb2-/- NMJs displayed plaque-like endplates at 84.48 ± 2.84 % 
when compared with wild-types which only had about 16.04 ± 2.35 % (P < 0.0001; Figure 3.5B). 
Wild-types displayed greater proportion of partially differentiated endplates (defined as only part of 
the endplate with pretzel-like or convoluted appearance (Shi et al., 2010) in comparison with age-
matched mutants (P < 0.01; wild-type; 40.10 ± 2.89 % vs. lamb2-/-; 14.85 ± 2.64 %; Figure 3.5B). 
Analysis of the endplate perimeter length further strengthened our findings of poor postsynaptic 
maturation at lamb2-/- NMJs. A highly convoluted and branched endplate region is an indicator of 
mature endplates and thus a greater perimeter length. Mutant endplates consistently presented 
plaque-like morphology resulting in significantly shorter perimeter lengths  (P < 0.0001; 94.23 ± 
4.24 µm) in comparison with wild-types, which mostly had pretzel-like and partially differentiated 
postsynaptic endplates (159.50 ± 7.56 µm; Figure 3.5C). 
In addition to the lack of maturation of the postsynaptic endplates, adult lamb2-/- NMJs also 
displayed significantly smaller synapse area (P < 0.0001; 172.9 ± 7.1 µm2) in comparison with age-
matched wild-types (284.2 ± 11.1 µm2; Figure 3.5C). The smaller synapse area observed was 
attributed to the smaller fibre diameter of the muscles in these mutants (P < 0.0001; wild-type; 
14.01 ± 0.23 µm vs. lamb2-/-; 7.81 ± 0.10 µm; Figure 3.5C). 
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 Figure 3.5 Postsynaptic endplates remained immature at adult postnatal day 35 lamb2-/- 
neuromuscular junctions. 
A, wild-type at mature P21 and adult P35 displayed fully pretzel-like appearances in postsynaptic 
endplates. In contrast, lamb2-/- NMJs maintained plaque-like appearance from P21 to P35. B, 
categorisation of postsynaptic endplates; pretzel, partially differentiated and plaque at adult P35 wild-
type and lamb2-/- NMJs. Adult P35 wild-type showed significantly higher proportion of postsynaptic 
endplates with pretzel-like appearance in comparison with P35 mutant NMJs which barely had pretzel-
like postsynaptic endplates. Wild-type also had higher number of postsynaptic endplates which were 
partially differentiated when compared with mutant NMJs. These mutant NMJs showed significantly 
larger proportion of endplates with plaque-like appearances in comparison with wild-types. C, perimeter 
length is defined as the boundary length which encapsulates the postsynaptic endplates externally 
inclusive of the perforations formed within. Example of the measurement of perimeter length by 
delineation was shown in B. Adult P35 wild-types showed significantly higher perimeter length of the 
postsynaptic endplates in comparison with age-matched mutant NMJs. Adult mutant NMJs presented 
significantly smaller endplate area in comparison with wild-type which was attributed to the 
significantly smaller fibre diameter observed in these mutants. For B and C, P35: wild-type; n = 3, 
NMJs = 97 and lamb2-/-; n = 4, NMJs = 114 for categorisation of postsynaptic endplate appearances, 
perimeter length and endplate area. For C, P35: wild-type; n = 3, fibres measured = 458 and lamb2-/-; n 
= 3, fibres measured = 437. Values are presented as mean ± SEM; Unpaired Student’s t-tests (two-
tailed); ** P < 0.01 and **** P < 0.001. Scale bar = 10 µm. 
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3.2.5 Loss of laminin-α5 but normal expression of laminin-α4 and dystroglycan at lamb2-/- 
neuromuscular junctions 
The observation of immature postsynaptic endplates at adult lamb2-/- NMJs could have been 
resulted from certain proteins being lost or mislocalised. I first looked at a number of different 
laminin chains which are known to associate with laminin-β2 at the NMJ, such as laminins-α4 and -
α5 (Miner et al., 1997; Patton et al., 1997; Patton, 2000). Both wild-type and lamb2-/- NMJs at P35 
displayed normal presence and colocalisation of laminin-α4 chain with respect to the postsynaptic 
endplates (Figure 3.6A). Adult lamb2-/- NMJs, however displayed no presence of laminin-α5 
staining in contrast to wild-type NMJs which displayed normal colocalisation of laminin-α5 in 
relation to the postsynaptic endplates (Figure 3.6B), suggesting loss of laminin-α5 in the absence of 
laminin-β2. As previous study by Nishimune et al. (2008) showed that aggregation of dystroglycan 
by laminins are implicated in the maturation of the postsynaptic apparatus, I also investigated the 
expression of dystroglycan at mutant NMJs. Adult lamb2-/- NMJs displayed normal presence and 
colocalisation of dystroglycan to postsynaptic endplates, which was similarly observed at age-
matched wild-types (Figure 3.7). 
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 Figure 3.6 Loss of laminin-α5 at adult postnatal day 35 lamb2-/- neuromuscular junctions. 
Immunohistochemical staining of laminins-α4 and -α5 (green) with respect to the postsynaptic 
AChR endplates (red) at P35 wild-type and lamb2-/- NMJs.  A, adult wild-type and mutant NMJs 
displayed normal expression and colocalisation of laminin-α4 chain in relation to the postsynaptic 
endplates. B, adult lamb2-/- NMJs showed no expression of laminin-α5 chain at the postsynaptic 
endplate while age-matched wild-type displayed normal colocalisation of laminin-α5 chain with 
respect to the postsynaptic endplate. Scale bar = 10 µm. 
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 Figure 3.7 Normal expression of dystroglycan at adult postnatal day 35 lamb2-/- 
neuromuscular junctions. 
Immunohistochemical staining of dystroglycan (green) with respect to the postsynaptic AChR 
endplates (red) at P35 wild-type and lamb2-/- NMJs Both wild-type and mutant NMJs displayed 
normal expression and good colocalisation of dystroglycan in relation to the postsynaptic endplates. 
Scale bar = 10 µm. 
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3.3 DISCUSSION 
Previous in-vitro study showed that laminin-β2 is involved in the clustering of VGCCs, which is 
required for the organisation of presynaptic elements (Nishimune et al., 2004). The correct 
organisation of presynaptic specialisations is essential for normal maturation at the NMJ and 
consequently promotes efficient transmitter release. In my study, I aimed to investigate the role of 
laminin-β2 in maturation of the NMJ. Here, I examined the expression of VGCCs and associated 
presynaptic molecules at the terminals of wild-type and lamb2-/- NMJs. We then characterised and 
compared the neurotransmission properties at P21 and P35 mutant NMJs with age-matched wild-
types. Finally, we investigated the morphology of the postsynaptic endplate region and molecules 
involved with maturation of this apparatus in wild-type and mutant NMJs. My findings demonstrated 
failure in switching over from N- to P/Q-type VGCCs which consequently decreased the 
colocalisation of presynaptic components at the endplates in mature lamb2-/- NMJs. Disrupted 
transmission was also maintained from mature to adult lamb2-/- NMJs in conjunction with the 
observation of immature postsynaptic endplates, which suggest completely arrested maturation of the 
NMJ. These findings strongly support that laminin-β2 is not only involved in the maturation of the 
presynaptic nerve terminal, but also in the maturation of the postsynaptic apparatus. 
3.3.1 Failure in switching of N- to P/Q-type VGCC clusters at mature lamb2-/- neuromuscular 
junctions disrupts organisation of presynaptic proteins 
During development of the NMJ, N- and P/Q-type VGCCs are the main calcium channels involved in 
neurotransmitter release (Katz et al., 1996; Rosato-Siri & Uchitel, 1999; Rosato-Siri et al., 2002). It 
has been shown in-vitro that laminin-β2 interacts directly with these VGCCs, which is important for 
the clustering of VGCCs at cultured motor neurons (Nishimune et al., 2004). My findings presented 
similar distribution of N- and P/Q-type VGCCs clusters between P8 lamb2-/- and P8 wild-type NMJs. 
These findings are consistent with our previous functional investigation which demonstrated a similar 
contribution of both N- and P/Q-type VGCCs in neurotransmitter release in both wild-type and 
mutant NMJs during early NMJ development (Chand et al., 2015). I did however observe higher 
number of total puncta and small puncta of N-type VGCCs in comparison with P/Q-type VGCCs at 
P8 in both genotypes, which reflects the prominent role N-type has in neurotransmission during this 
stage (Chand et al., 2015). These findings suggest that during early developmental stages, VGCCs 
clustering and consequently transmission may not be dependent on laminin-β2. 
As NMJ reached maturation, P/Q-type VGCCs act as the dominant calcium channel in 
neurotransmitter release whereas N-type VGCCs are relegated to roles of regulating feedback and 
fine-tuning of calcium influx (Katz et al., 1996; Rosato-Siri & Uchitel, 1999). This is consistent 
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with my morphological findings, which demonstrated increased clustering of P/Q-type 
VGCCs with no upregulation of N-type VGCCs clusters at mature P18 wild-type NMJs. The 
morphological observations are consistent with our functional study that demonstrated 
increased contribution of P/Q-type in neurotransmitter release at mature NMJ (Chand et al., 
2015). By contrast, mature lamb2-/- NMJs retained clusters of N-type VGCCs with no 
upregulation of P/Q-type VGCCs clusters suggesting failure in switching from N- to P/Q-
type VGCCs when laminin-β2 is absent. This explained the minimal involvement of P/Q-
type VGCCs in neurotransmitter release while N-type VGCCs were highly involved in 
transmission at mature lamb2-/- NMJs (Chand et al., 2015). These observations suggest that 
the clustering of P/Q-type VGCC is highly dependent on its interaction with laminin-β2 
while the clustering of N-type VGCCs is not dependent on laminin-β2. As the NMJ grows 
during maturation, we propose that newly expressed P/Q-type VGCCs are preferentially 
clustered on the newly expanded regions of the NMJ, which are more precisely organised 
via their interaction with laminin-β2. Therefore if laminin-β2 is lost, additional P/Q-type 
VGCCs would not be clustered correctly thus leading to retained clusters of N-type VGCCs. 
I showed that the presence of laminin-β2 is important for the clustering of VGCCs 
particularly the P/Q-type VGCC. The study by Nishimune et al. (2004) suggested that the 
clustering of VGCCs at the presynaptic membrane of the nerve terminal is essential for the 
proper organisation of the presynaptic elements. Therefore it is not surprising that I found 
decreased colocalisation of a number of different presynaptic proteins such as Bassoon, 
SNAP25 and Syntaxin 1A at mature lamb2-/- NMJs, where decreased clusters of P/Q-type 
were found. To further support this, studies have found colocalisation of P/Q-type VGCCs 
with Bassoon, and these components were distributed in similar pattern (Nishimune et al., 
2012; Nishimune et al., 2016).  In agreement with my findings, others have also shown a 
decrease in the active zone marker Bassoon at lamb2-/- NMJs (Nishimune et al., 2004). 
Despite the presence of highly clustered N-type VGCCs at mature lamb2-/- NMJs, it appears 
that N-type VGCCs are not sufficient enough to organise the presynaptic elements of the 
NMJ correctly, and consequently, we observed a decrease in the number of active zones. 
The clustering of P/Q-type VGCCs in the presence of laminin-β2 results in the proper 
organisation and colocalisation of presynaptic specialisations with the postsynaptic endplate 
at wild-type NMJs. Thus, P/Q-type VGCCs and the direct interaction with laminin-β2 are 
necessary for efficient organisation of active zone elements. This could be due to the closer 
localisation of P/Q-type to release sites, being more favourable in interaction with 
presynaptic components in comparison with N-type VGCCs which are localised further 
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away from the release sites (Urbano et al., 2002; Nudler et al., 2003) despite both VGCCs 
having direct interaction with presynaptic proteins such as Bassoon, SNAP25 and Syntaxin 
1A (Kim & Catterall, 1997; Zhong et al., 1999; Chen et al., 2011; Nishimune et al., 2012). 
Therefore my findings suggest the required presence and interaction of laminin-β2 with 
VGCCs to ensure proper organisation of the presynaptic components at the NMJ. 
3.3.2 No improvement in functional transmission despite lamb2-/- survive till adult postnatal 
day 35 
My morphological findings demonstrate a failure in the switching of VGCCs, which may be 
associated with either delayed or arrested presynaptic maturation at lamb2-/- NMJs. This led 
to my next question as to whether maturation of the NMJ could be achieved if survival of 
mutants were to be prolonged. In order to test this, I performed intracellular recordings on 
mature (P21) and adult (P35) NMJs. I observed lower frequency of spontaneous release at 
mutant terminals compared with wild-type at both P21 and P35. Lamb2-/- NMJs displayed a 
higher intermittence of transmitter release, which was maintained from P21 to P35. 
Furthermore, the drop in quantal content was also maintained similarly at both P21 and P35 
lamb2-/- NMJs. In addition, binomial parameter analysis of transmitter release revealed 
decrease in the number of active sites in conjunction with decreased probability of 
neurotransmitters release from the remaining sites, as contributors to the drop in quantal 
content at P35 lamb2-/- NMJs. The observed transmission properties suggest no 
improvement in transmission at these mutant NMJs, which reflects arrested maturation of 
the NMJ. The study by Patton et al. (2001) supports my functional findings with their 
ultrastructural observations of maintained defects such as lower number of active zones and 
junctional folds, scattered vesicles and invasion of Schwann cells into the synaptic cleft at 
P35 lamb2-/- NMJs, in which these defects were similarly observed at postnatal day 14 
mutant NMJs (Noakes et al., 1995a). Furthermore, my morphological findings showed lower 
numbers of Bassoon puncta at P35 lamb2-/- NMJs which supports the previous 
ultrastructural observations (Patton et al., 2001). 
3.3.3 Postsynaptic maturation is completely arrested at adult lamb2-/- neuromuscular 
junctions 
In addition to the perturbed maturation of the presynaptic region at lamb2-/- NMJs, we also 
noted a high prevalence of plaque-like postsynaptic endplates in these mutants. This diffuse 
morphological characteristic is normally associated with an immature endplate region, thus 
suggesting that lamb2-/- NMJs may be displaying signs of either delayed or arrested 
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maturation of the postsynaptic apparatus. On further investigation I noted that the 
postsynaptic endplates of lamb2-/- remained plaque-like even at P35. In addition, other 
measurement such as perimeter length, which is another indicator of the maturation status of 
the postsynaptic endplates, showed significantly smaller perimeter length at P35 lamb2-/- 
NMJs. The transformation of postsynaptic endplates from plaque to pretzel is associated with 
increased number of junctional findings, which in turn helps to improve neurotransmission 
(Marques et al., 2000; Lanuza et al., 2002; Slater, 2008). Previous studies found that 
increased number of junctional foldings enhance signal propagation due to higher expression 
of voltage-gated sodium channels (VGSCs) at the depth of these folds (Wood & Slater, 1997; 
Slater, 2008). The study by Patton et al. (2001) showed fewer numbers of junctional foldings 
at P35 lamb2-/- NMJs, which indicated lower expression of VGSCs thus explaining the poor 
mobility of these mice. Therefore arrested maturation of the postsynaptic regions in these 
mutant NMJs is partly responsible for the deficits in transmission, other than being caused by 
the defects at the presynaptic regions. 
What exactly causes the postsynaptic endplates to remain plaque-like at these mutant NMJs? Is 
laminin-β2 involved directly in postsynaptic maturation or is it a result of secondary loss of other 
synaptic proteins? Arrested maturation of the postsynaptic apparatus has previously been shown in 
double knockouts of laminins-α4 and -α5, suggesting the involvement of both laminins at 
postsynaptic maturation (Nishimune et al., 2008) (see Chapter 1, Section 1.1.2.; Laminin-α5). 
Laminins-α4 and -α5 acts through the aggregation of dystroglycan at the postsynaptic membrane in 
order to assist the maturation of the postsynaptic apparatus (Nishimune et al., 2008). Dystroglycan 
which is part of the utrophin glycoprotein complex at the NMJ, interacts directly with rapsyn that is 
involved in the clustering of AChRs (Apel et al., 1995; Deconinck et al., 1997; Cartaud, 1998; 
Grady et al., 2000; Bartoli et al., 2001; Bogdanik et al., 2008) (see Chapter 1, Section 1.1.3; 
Dystroglycan). Indeed, my findings showed a loss in laminin-α5 chain at P35 lamb2-/- NMJs which 
was also previously observed in these mutant NMJs at P14 (Patton et al., 1997). I therefore next 
investigated the expression of dystroglycan at mutant NMJs and found similar consistent expression 
patterns of dystroglycan at lamb2-/- NMJs to those observed at wild-types. Furthermore, the 
expression of rapsyn was previously shown to be normally expressed in these mutants (Noakes et 
al., 1995a). These findings suggest that the loss of laminin-α5 does not influence the expression of 
dystroglycan nor its interaction with rapsyn to cluster AChRs. This could be partly attributed to the 
maintained expression of laminin-α4 chain at lamb2-/- NMJs, which may be able to compensate to 
some degree for the loss of laminin-α5 and aid in the aggregation of dystroglycan (Nishimune et al., 
2008), thus explaining the normally expressed dystroglycan observed in these mutants NMJs. 
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Interestingly, immature postsynaptic endplates at lamb2-/- NMJs persisted despite the normal 
presence of both laminin-α4 and dystroglycan. This suggests that 1) laminin-α4 was not 
capable of compensating for the loss of laminin-α5, which is thought to be the dominant α-
chain in maturation of the postsynaptic apparatus at lamb2-/- NMJs; 2) the presence of 
laminin-β2 may be required for defining the interaction of laminin-α4 chain with dystroglycan 
to promote postsynaptic maturation; and 3) other proteins could be involved in the maturation 
of the postsynaptic apparatus that may be acting directly through laminin-β2. Proteins such as 
integrins particularly integrin-α7 could be interacting directly with laminin-β2 to guide 
postsynaptic maturation as study has found loss of integrin-α7b subunit expression in these 
NMJs (Martin et al., 1996) or it could be involving podosome molecules, which may be acting 
through either or both laminins-β2 and -α5 for clustering of AChRs from plaque to pretzel 
(Proszynski et al., 2009). An in-vitro study by Proszynski et al. (2009) demonstrated the 
presence of podosome molecules underneath plaque-like endplates, which expanded in size 
thus driving the arrangement of the AChRs clusters into branching and convoluted pattern. To 
prevent the collapse of these formed structures, the podosome molecules interact with 
laminins such as α5 and β2 to help anchor these podosomes in place at the external region of 
the formed structures. Thus if laminins-α5 and -β2 are lost, podosomes would not be able to 
stay in place after the displacement of the AChR clusters resulting in plaque-like endplates 
(see Chapter 1, Section 1.1.3; Podosomes). 
3.4 CONCLUSION 
The loss of laminin-β2 results in failed morphological switching from N- to P/Q-type VGCCs, 
resulting in poor organisation of the presynaptic elements at the NMJ and consequently 
perturbed maturation of the presynaptic terminal. Transmission properties support the 
morphological defects seen with no improvement functionally from mature to adult synapses 
in lamb2-/-. I also showed immature postsynaptic endplates during adulthood at lamb2-/- NMJs, 
which is an indicator of arrested maturation of the postsynaptic apparatus in the absence of 
laminin-β2. These findings strongly suggest that laminin-β2 is not only involved in the 
maturation of the presynaptic apparatus but also in postsynaptic maturation. In other words, 
laminin-β2 is essential for the maturation of the whole NMJ.  
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Chapter 4 
The Role of Laminin-α4 in 
Maintenance of the 
Neuromuscular Junction 
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ABSTRACT 
Laminin-α4 has been shown to be important for the alignment of active zones to postjunctional 
folds at the neuromuscular junction (NMJ). Prior study has revealed an additional role of 
laminin-α4 in maintenance of the NMJ, with the observations of premature NMJ ageing features 
in adult laminin-α4 deficient mice (lama4-/-) at 6 months of age (6MO). The present study 
aimed to further investigate the role of laminin-α4 in maintenance of the NMJ by functional 
characterisation of transmission properties, morphological investigation of synaptic proteins 
including synaptic laminin laminin-α4 and neuromotor behavioural testing. Results showed 
maintained perturbed synaptic transmission properties at lama4-/- NMJs from adult 3 months 
(3MO) to aged 18-22 months (18-22MO), such as lower frequency of spontaneous release, 
higher failures in evoked release, and large amplitudes of spontaneous and evoked releases. In 
addition, neuromotor behaviour such as hind-limb grip force demonstrated similar trends as 
transmission properties, with maintained weaker grip force across age groups in mutant mice. 
Interestingly, transmission properties and hind-limb grip force in aged wild-types resembled the 
trends observed in adult lama4-/-. Most significantly altered expression of the laminin-α4 chain 
was noted at the wild-types before the prominent decline in transmission properties were 
observed. This particular finding suggests that changes in laminin-α4 expression precede the 
decline in transmission properties in ageing wild-types. These findings provide significant 
support for the role of laminin-α4 in maintaining a normal and healthy NMJ, and ensuring 
efficiency in transmission. 
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4.1 INTRODUCTION 
In the previous chapter, I investigated the role of laminin-β2 in maturation of the neuromuscular 
junction (NMJ). In this study, I will be focusing on another laminin chain, namely the laminin-α4 
which forms part of the laminin-421 heterotrimer. Laminin-α4 is found concentrated between the 
folds of the muscle fibre and it is suggested to play an instructive role in the placement of the active 
zones directly appose to the postjunctional folds of the NMJ (Patton et al., 2001). Mice deficient in 
laminin-α4 (lama4-/-) had a high proportion of NMJs with misalignment of active zones to 
postjunctional folds by 70%, strongly suggesting the significant role laminin-α4 plays in 
maintaining proper alignment of active zones to junctional folds (Patton et al., 2001). Further to 
this, recent studies conducted on 6 month old (6MO) lama4-/- mice found features of premature 
ageing at the NMJs, such as fragmentation of acetylcholine receptors (AChRs), denervation, partial 
innervation, sprouting of axons, axonal dsytrophy and multiple innervations which increased with 
age (Samuel et al., 2012). These features are commonly observed in normal ageing NMJs between 
18-24MO (Valdez et al., 2012). The same study found loss and mislocalisation of laminin-α4 
expression at the NMJs from 24MO wild-type mice. Together these findings indicate a potential 
role of laminin-α4 in the maintenance of normal and healthy adult NMJs (Samuel et al., 2012). 
Morphologically ageing is accelerated at adult NMJs when laminin-α4 is absent, but how these 
changes impact on neurotransmission is not known and whether transmission properties at lama4-/- 
NMJs match those observed at normal ageing NMJs is yet to be determined. The present study 
functionally compared neurotransmission at adult and aged lama4-/- NMJs to those of aged-matched 
wild-type NMJs. Additionally, I tested the neuromotor behaviour of these lama4-/- mice to 
investigate whether changes in transmission were reflected in their hind-limb grip force. Finally, I 
tested whether changes in distribution and expression of laminin-α4 chain by 
immunohistochemistry at wild-type NMJs was related to altered neurotransmission. My results 
showed impaired transmission at lama4-/- NMJs that remained consistent with increasing age. Aged 
wild-type NMJs (18-22MO) revealed similar transmission properties to that of lama4-/- NMJs, 
which coincided with evident altered laminin-α4 expression. Similar trends were also observed in 
terms of the behavioural phenotypes, with lama4-/- mice displaying weaker hind-limb grip force 
across age groups with wild-types demonstrating an age-dependent decline. I observed alterations in 
the expression of synaptic proteins which supported my functional studies at lama4-/- NMJs. 
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4.2 RESULTS 
4.2.1 Altered neurotransmission properties remained constant at lama4-/- neuromuscular 
junctions which was associated with lower number of active zones 
A previous study by Samuel and colleagues (2012) have shown that lama4-/- NMJs prematurely 
developed morphological features associated with ageing and became more prevalent in an age-
dependent manner. Here I asked the question how the higher prevalence of these features would 
affect neurotransmission in these mice as they aged.  Lama4-/- NMJs at 3MO showed larger 
amplitudes of spontaneous release (miniature endplate potentials; mEPPs) and evoked release 
(endplate potentials; EPPs) (Figure 4.1A). Timing parameters such as mEPP decay time were 
significantly longer at 3MO lama4-/- NMJs (P < 0.01; 5.57 ± 0.35 ms) when compared with 3MO 
wild-type (3.86 ± 0.19 ms; Figure 4.1A). The longer mEPP decay time at lama4-/- NMJs was 
maintained across the other ages investigated (6MO: P < 0.0001; wild-type; 4.13 ± 0.15 ms vs. 
lama4-/; 5.77 ± 0.15 ms, 12MO : P < 0.0001; wild-type; 4.30 ± 0.17 ms vs. lama4-/; 6.01 ± 0.18 ms, 
Aged: P < 0.0001; wild-type; 4.03 ± 0.07 ms vs. lama4-/; 5.01 ± 0.09 ms). Frequency of 
spontaneous release was also significantly reduced and persisted similarly at all ages investigated 
for lama4-/- NMJs in comparison with wild-type NMJs (3MO: P < 0.01; wild-type; 22.08 ± 1.04 
min-1 vs. lama4-/-; 14.78 ± 1.31 min-1, 6MO: P < 0.0001; wild-type; 24.54 ± 1.41 min-1 vs. lama4-/; 
12.13 ± 0.87 min-1, 12MO: P < 0.0001; wild-type; 20.91 ± 1.23 min-1 vs. lama4-/; 10.60 ± 0.45 min-
1, Aged: P < 0.001; wild-type; 21.65 ± 0.87 min-1 vs. lama4-/; 14.47 ± 0.81 min-1; Figure 4.1B, top 
left). 
Lama4-/- NMJs displayed a higher number of failures in evoked responses, which remained 
unchanged across the age groups, when compared with wild-type NMJs (3MO: P < 0.05; wild-
type; 34.69 ± 2.52% vs. lama4-/; 48.84 ± 5.64% and 6MO: P < 0.01; wild-type; 37.90 ± 1.50% 
vs. lama4-/; 46.32 ± 1.61%; Figure 4.1B, top right). Intermittence of neurotransmitter release 
gradually increased with age at wild-type NMJs until 12MO, where no significant difference 
was observed when compared with age-matched lama4-/- NMJs (P > 0.05; wild-type; 42.58 ± 
2.89% vs. lama4-/-; 50.46 ± 1.75%; Figure 4.1B, top right). At aged NMJs, wild-types (45.78 ± 
0.96%) had reached a similar level of intermittence to that of lama4-/- (P > 0.05; 46.56 ± 1.16%; 
Figure 4.1B, top right). This increased failure of evoked responses could be the result of 
impaired action potential propagation or in the depolarisation-secretion mechanisms which 
ultimately leads to altered transmitter release. Quantal content was significantly different 
between both genotypes at 3MO (P < 0.01; wild-type; 1.90 ± 0.10 vs. lama4-/-; 1.25 ± 0.07) and 
6MO (P < 0.05; wild-type; 1.75 ± 0.10 vs. lama4-/-; 1.47 ± 0.06; Figure 4.1B, bottom left). At 
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12MO and aged NMJs, no significant difference in quantal content was found between wild-
type and lama4-/- NMJs (12MO: P > 0.05; wild-type; 1.94 ± 0.10 vs. lama4-/-; 1.76 ± 0.08 and 
Aged: P > 0.05; wild-type; 1.65 ± 0.10 vs. lama4-/-; 1.68 ± 0.08; Figure 4.1B, bottom left). 
Based on normalised binomial parameter analysis, the lower quantal content at 3MO lama4-/- 
NMJs (69.1 ± 6.89% of wild-type, P < 0.01) occurred as a result of a decrease in the number of 
active sites by 34.08 ± 4.69% (P < 0.05), with normal probability release of neurotransmitters at 
108.3 ± 9.16% (P > 0.05) (Figure 4.1B, bottom right). These functional changes correlated with 
the observed drop in density of the active zone marker Bassoon (Figure 4.2). At 3MO, wild-
type NMJ showed uniform distribution of Bassoon puncta colocalised to the postsynaptic 
endplate whereas aged-matched lama4-/- NMJ displayed regions void of Bassoon puncta 
(indicated with arrowheads; Figure 4.2A). Quantification of expression showed a 40.32% (P < 
0.0001) higher density at wild-type NMJs (2.98 ± 0.07 puncta/µm3) compared with lama4-/- 
NMJs (1.78 ± 0.07 puncta/µm3; Figure 4.2B). Aged wild-types NMJs displayed a decrease in 
Bassoon density by approximately 19% from that observed at 3MO wild-type NMJs (P < 
0.0001; Aged; 2.43 ± 0.08 puncta/µm3 vs. 3MO; 2.98 ± 0.07 puncta/µm3; Figure 4.2A and B). 
Despite the drop in Bassoon density, aged wild-type Bassoon density remained significantly 
higher (P < 0.0001) than that of aged lama4-/- (1.54 ± 0.11 puncta/µm3; Figure 4.2B). The 
density of Bassoon in lama4-/- NMJs remained consistently low showing no age-dependent 
decline (P > 0.05; Figure 4.2B), a finding similar to the trends observed with our functional 
investigation of neurotransmission at lama4-/- NMJs (Figure 4.1B). 
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Figure 4.1 Altered transmission properties at lama4-/- neuromuscular junctions from 
adulthood to ageing. 
A, sample traces from intracellular recordings of 10 consecutive mEPPs and 10 consecutive 
EPPs for wild-type and lama4-/- NMJs at 3MO. Decay time of mEPPs was noted at the 3MO 
mEPP traces. Note that aged group represents 18-22MO. B, lama4-/- NMJs displayed 
consistently lower mEPPs frequency and higher failures in evoked release across age groups. 
Wild-types increased in intermittence as they aged. Lama4-/- NMJs had lower quantal content 
at 3MO and 6MO whereas aged wild-type dropped in quantal content to the similar level of 
mutant NMJs. Normalised binomial parameter analysis displayed decreased quantal content 
(m) at 3MO lama4-/- NMJs, which was resulted from lower number of active sites (n) with 
normal probability release of neurotransmitters (p). Binomial parameter analysis is normalised 
to 3MO wild-types, as represented by dashed lines at 100%.  For A, stimulus artefacts have 
been omitted for clarity. For B, 3MO: wild-type; n = 5, NMJs = 28 and lama4-/-; n = 4, NMJs 
= 30,  6MO: wild-type; n = 5, NMJs = 32 and lama4-/-; n = 6, NMJs = 25,  12MO: wild-type; 
n = 6, NMJs = 33 and lama4-/-; n = 5, NMJs = 39,  aged: wild-type; n = 6, NMJs = 45 and 
lama4-/-; n = 4, NMJs = 28.  Values are presented as mean ± SEM; Unpaired Student’s t-tests 
(two-tailed); * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.001. 
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 Figure 4.2 Decreased density of active zone marker Bassoon at lama4-/- neuromuscular 
junctions during adulthood and ageing. 
A, wild-type at 3MO presented uniformly distributed Bassoon puncta in relation to the 
postsynaptic endplates. Lama4-/- NMJs at the same age displayed region void of bassoon 
puncta which was also seen at aged lama4-/- NMJs (as indicated with arrowheads). While aged 
wild-type maintained uniformly distributed bassoon puncta, there were also regions with no 
bassoon puncta found (as indicated with arrowheads). B, Lama4-/- NMJs had significantly 
lower density of Bassoon which remained unchanged from 3MO to aged NMJs. Aged wild-
type remained higher in density in comparison with aged lama4-/- despite the drop from 3MO 
wild-types. Note that aged represents 18-22MO. For B, 3MO: wild-type; n = 3, NMJs = 55 
and lama4-/-; n = 3, NMJs = 69, aged: wild-type; n = 3, NMJs = 47 and lama4-/-; n = 3, NMJs 
= 33. Values are presented as mean ± SEM; Two-way ANOVA with Tukey’s post hoc test; 
**** P < 0.0001. Scale bar = 10 µm. 
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4.2.2 Unaltered propagation of terminal action potential and larger quantal size at lama4-/- 
neuromuscular junctions 
The higher intermittence of transmitter release at mutant NMJs may be the result of failed action 
potential propagation or possibly defects in depolarisation-secretion coupling at the terminal itself. I 
therefore investigated the propagation of the signal using extracellular recordings which allowed 
examination of the nerve terminal impulse (NTI). Based on my findings, NTIs were present and 
remained consistent throughout the recordings in lama4-/- at 3MO (Figure 4.3A, arrows). These 
findings suggest there was no issue with action potential propagation, but rather a defect at the NMJ 
itself as the cause of the higher failure rate of evoked release at lama4-/- NMJs. 
At 3MO, lama4-/- displayed larger amplitudes of miniature endplate potential currents (mEPCs) and 
endplate potential currents (EPCs) compared with wild-type (Figure 4.3A). Spontaneous amplitude 
remained constant at 3MO, 6MO and 12MO age groups at lama4-/- NMJs (3MO: P < 0.05; wild-
type; 110.7 ± 2.8 µV vs. lama4-/-; 144.1 ± 14.1 µV, 6MO: P < 0.05; wild-type; 116.6 ± 3.1 µV vs. 
lama4-/-; 140.2 ± 8.0 µV and 12MO; P < 0.05; wild-type; 110.5 ± 8.8 µV vs. lama4-/-; 145.2 ± 5.9 
µV; Figure 4.3B, top panel). On the other hand, aged wild-type NMJs (150.3 ± 11.3 µV) increased 
significantly from values observed at 12MO wild-types by 36% (P < 0.05), with no significant 
difference found when compared with aged lama4-/- NMJs (P > 0.05; 138.4 ± 16.0 µV; Figure 4.3B, 
top panel). Similar trends were also observed for EPC amplitudes with significantly higher but 
maintained quantal size at lama4-/- NMJs across age groups (3MO: P < 0.001; wild-types; 264.5 ± 
18.4 µV vs. lama4-/-; 467.2 ± 23.1 µV, 6MO: P < 0.05; wild-types; 270.9 ± 37.0 µV vs. lama4-/-; 
514.7 ± 60.9 µV and 12MO: P < 0.05; wild-types; 331.4 ± 37.4 µV vs. lama4-/-; 579.6 ± 87.9 µV; 
Figure 4.3B, bottom panel). At aged group, wild-type increased in EPC amplitude significantly (P < 
0.05; 491.8 ± 33.0 µV) from 12MO and was similar to the amplitude of aged lama4-/- (P > 0.05; 
558.6 ± 69.3 µV; Figure 4.3B, bottom panel). 
Timing parameters such as mEPC rise time was similar in both genotypes at each age group 
investigated (3MO: P > 0.05; wild-types; 0.26 ± 0.01 ms vs. lama4-/-; 0.29 ± 0.02 ms, 6MO: P > 
0.05; wild-types; 0.27 ± 0.02 ms vs. lama4-/-; 0.28 ± 0.02 ms, 12MO: P > 0.05; wild-types; 0.25 ± 
0.01 ms vs. lama4-/-; 0.30 ± 0.03 ms and Aged: P > 0.05; wild-types; 0.24 ± 0.01 ms vs. lama4-/-; 
0.25 ± 0.00 ms). Rise time of EPCs were also similar in both wild-type and lama4-/- NMJs at all 
ages (3MO: P > 0.05; wild-types; 0.54 ± 0.03 ms vs. lama4-/-; 0.60 ± 0.04 ms, 6MO: P > 0.05; wild-
types; 0.50 ± 0.04 ms vs. lama4-/-; 0.55 ± 0.01 ms, 12MO: P > 0.05; wild-types; 0.55 ± 0.03 ms vs. 
lama4-/-; 0.55 ± 0.06 ms and Aged: P > 0.05; wild-types; 0.50 ± 0.02 ms vs. lama4-/-; 0.49 ± 0.01 
ms).  
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Figure 4.3 Normal action potential propagation with larger quantal size at lama4-/- 
neuromuscular junctions. 
A, sample traces from extracellular recordings of 10 averaged consecutive mEPCs 
recordings and 10 averaged consecutive EPCs recordings for wild-type and lama4-/- NMJs at 
3MO. Wild-type and lama4-/- NMJs displayed consistent presence of nerve terminal impulse 
(NTI) without any variation. B, lama4-/- NMJs maintained larger quantal size for both 
spontaneous release (mEPCs) and evoked release (EPCs) across age groups. Wild-type, on 
the other hand increased in amplitude size for both mEPCs and EPCs as they reached the 
aged group. Note that aged group represents 18-22MO. For B, 3MO: wild-type; n = 6, NMJs 
= 36 and lama4-/-; n = 5, NMJs = 40, 6MO: wild-type; n = 4, NMJs = 34 and lama4-/-; n = 5, 
NMJs = 37,  12MO: wild-type; n = 5, NMJs = 38 and lama4-/-; n = 5, NMJs = 36,  aged: 
wild-type; n = 5, NMJs = 33 and lama4-/-; n = 6, NMJs = 42. Values are presented as mean ± 
SEM; Unpaired Student’s t-tests (two-tailed); * P < 0.05 and *** P < 0.001. 
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4.2.3 Weakening of hind-limb grip force in lama4-/- 
Patton and colleagues (2001) showed uncoordinated hind-limb movement in lama4-/- mice, 
suggesting neuromuscular dysfunction. I further explored the neuromuscular function disturbances 
of these animals through assessment of hind-limb grip force in order to investigate the link between 
impaired transmission and neuromuscular function. Lama4-/- mice were 10.82% and 14.64% 
heavier than age-matched wild-types at 6MO and 12MO respectively, but these differences were 
not significant which I attributed them to increased body fat (Figure 4.4A, left panel). 
Normalisation of peak hind-limb force to body weight revealed significantly weaker force 
production in lama4-/- mice compared with wild-types at 3MO, 6MO and 12MO  (3MO: P < 0.001; 
wild-type; 35.92 ± 1.01 mN/g vs. lama4-/-; 27.35 ± 1.34 mN/g, 6MO: P < 0.0001; wild-type; 34.54 
± 1.13 mN/g  vs. lama4-/-; 20.59 ± 1.11 mN/g and 12MO: P < 0.0001; wild-type; 31.07 ± 1.30 mN/g 
vs. lama4-/-; 19.04 ± 1.69 mN/g; Figure 4.4A, right panel). At aged group, wild-types (19.97 ± 1.15 
mN/g) had declined significantly (P < 0.0001) from 12MO by 33.8% with no significant difference 
found when compared with aged lama4-/- (P > 0.05; 18.63 ± 0.68 mN/g; Figure 4.4A, right panel). 
The weaker hind-limb grip force in lama4-/- may be associated with changes in fibre type 
compositions or disrupted neurotransmission at the NMJs. In order to determine this, I stained for 
expression of different myosin fibre types in the gastrocnemius muscle, as plantar flexion of the 
foot is involved in the force production measured in the hind-limb grip force test (Garlich et al., 
2010). No differences were found between wild-type and lama4-/- at 3MO for each different fibre 
types; type I (P > 0.05; wild-type; 11.16 ± 1.60% vs. lama4-/-; 10.26 ± 1.40%), type IIA (P > 0.05; 
wild-type; 41.93 ± 2.89% vs. lama4-/-; 36.76 ± 3.26%), type IIB (P > 0.05; wild-type; 36.11 ± 
4.19% vs. lama4-/-; 38.71 ± 3.91%) and type IIX (P > 0.05; wild-type; 10.80 ± 1.12% vs. lama4-/-; 
14.26 ± 1.85%) (Figure 4.4B and C, top panel). At aged muscles, type I fibres increased 
significantly in both wild-type (P < 0.05; 18.04 ± 2.22) and lama4-/- (P < 0.01; 18.06 ± 1.39%) in 
comparison with 3MO wild-type (11.16 ± 1.60) and 3MO lama4-/- (10.26 ± 1.40%) respectively 
(Figure 4.4C, compare top vs. bottom panels). Aged wild-type (26.35 ± 3.29%) had a non-
significant decrease in type IIB fibres from 3MO wild-type (P > 0.05; 36.11 ± 4.19%) (Figure 4.4C, 
compare top vs. bottom panels). Aged lama4-/- NMJs had a significant decrease in type IIB fibres 
from 3MO lama4-/- by 38.70% (P < 0.05) (Figure 4.4C, compare top vs. bottom panels). However, 
no changes were found when comparing each different fibre types between aged wild-types and 
lama4-/- (Type I: wild-type; 18.04 ± 2.22% vs. lama4-/-; 18.06 ± 1.39%, Type IIA: wild-type; 43.68 
± 3.11% vs. lama4-/-; 44.18 ± 2.12%, Type IIB: wild-type; 26.35 ± 3.29% vs. lama4-/-; 23.73 ± 
3.19%, and Type IIX: wild-type; 11.94 ± 1.42% vs. lama4-/-; 14.03 ± 2.02%) (P > 0.05 between 
wild-type and lama4-/- for every fibre type) (Figure 4.4B and C, bottom panel). 
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 Figure 4.4 Weaker hind-limb grip force but normal distribution of different fibre types in 
lama4-/-. 
A, lama4-/- animals were slightly heavier in body weight in comparison with wild-types at 6MO and 
12MO. The normalised grip force over body weight was weaker in lama4-/- animals across the ages 
investigated. Aged wild-type dropped in grip force/body weight tremendously and reached the similar 
level of motor performance to that of lama4-/-. B, Triple labelling staining for different fibre types at 
3MO and aged group; blue staining represents Type I, green represents Type IIA, red represents Type 
IIB and unstained fibres represents Type IIX. C, Distribution of each different fibre types was normal in 
both genotypes at both age groups investigated. Not that aged group represents 18-22MO. For A, 3MO: 
wild-type; n = 8 and lama4-/-; n = 8, 6MO: wild-type; n = 8 and lama4-/-; n = 8,  12MO: wild-type; n = 8 
and lama4-/-; n = 8,  aged: wild-type; n = 8 and lama4-/-; n = 8.  For C, 3MO: wild-type, n = 5, fibres 
counted = 1359 and lama4-/-, n = 5, fibres counted = 1251, aged: wild-type, n = 5, fibres counted = 1541 
and lama4-/-, n = 5, fibres counted = 1027. Values are presented as mean ± SEM; Unpaired Student’s t-
tests (two-tailed); *** P < 0.001 and **** P < 0.0001. Scale bar = 100 μm. 
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4.2.4 Increased depression in transmitter release during high frequency stimulation and 
reduced facilitation during twin pulses stimulation are associated with lower density of 
vesicles at the neuromuscular junctions in lama4-/- 
My findings showed that weakening of hind-limb grip force in lama4-/- are not a result of altered 
fibre type distribution, suggesting that transmission in hind-limb muscles of lama4-/- may be 
responsible for the weaker grip force observed in mutants. In order to confirm these changes, I used 
intracellular electrophysiology to record transmission in the hind-limb extensor digitorum longus 
(EDL) muscle under physiological levels of extracellular calcium (2mM). 
Paired-pulse (PP) facilitation study was performed by comparing the first stimuli (conditioning 
pulse) with the second stimuli (test pulse) at 10 ms and 100 ms delays between each pulse, to 
determine the level of facilitation at 12MO NMJs. During 10 ms PP, wild-type NMJs demonstrated 
high facilitation with the amplitude response of the second stimuli being 26.2% higher than the first 
amplitude response (Figure 4.5A). On the other hand, lama4-/- NMJs had a lower level of 
facilitation with the second response being 12.8 % higher than the first response (Figure 4.5A). 
Wild-types produced a significantly higher levels of facilitation (10.6%) compared with lama4-/- 
NMJs (P < 0.0001; wild-type; 1.26 ± 0.03 vs. lama4-/-; 1.13 ± 0.02; Figure 4.5B). The lower 
facilitation observed at lama4-/- NMJs suggests an issue with the release of vesicles or a decrease in 
the availability of vesicles from the readily releasable pool (RRP). As the interval of PP was 
increased to 100 ms, the level of facilitation declined to a similar level in both wild-type and lama4-/- 
NMJs (Figure 4.5A). No significant difference was found in facilitation between either genotype at 
100 ms delay (P > 0.05; wild-type; 1.07 ± 0.01 vs. lama4-/-; 1.08 ± 0.01; Figure 4.5B). These 
findings suggest that lama4-/- NMJs cannot efficiently meet high demanding neurotransmission 
signalling. 
Thus, I next examined neurotransmission at lama4-/- NMJs under high frequency stimulation (HFS). 
At 100 Hz stimulation for 1s, wild-type displayed a gradual drop in EPP amplitude to reach a steady 
state plateau (Figure 4.5C, top left). In contrast, lama4-/- showed a rapid decline in EPP amplitude 
and reached a highly depressed steady state plateau (Figure 4.5C, bottom left). In order to estimate 
the size of RRP in both genotypes, a model was used by plotting quantal content (y-axis) against 
cumulative quantal content (x-axis) and drawing a straight line in the declining phase which 
intercepts the x-axis, providing an estimation of the RRP size (Figure 4.5C, right panel; (Ruiz et al., 
2011; Ruiz et al., 2014). Lama4-/- NMJs (471.1 ± 45.0) had significantly smaller RRP size in 
comparison with wild-type (P < 0.01; 912.3 ± 139.0; Figure 4.5D, top left). We then looked at the 
peak quantal release, mPeak which was measured during the first ten stimuli and found no significant 
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difference (P > 0.05) between wild-type (17.67 ± 1.93) and lama4-/- NMJs (13.40 ± 1.26) suggesting 
that the delivery and release of vesicles during initial release was normal in mutant NMJ (Figure 
4.5D, bottom left). Analysis of quantal release during steady-state (mss), found lama4-/- NMJs were 
significantly lower than wild-type by 63.7% (P < 0.001; wild-type; 13.19 ± 1.79 vs. lama4-/-; 4.78 ± 
0.59), indicating either a lower availability of vesicles from the reserve pool or an issue with the 
delivery of vesicles from the reserve pool to RRP (Figure 4.5D, top right). Based on the ratio of 
mss/ mPeak, lama4-/- was significantly lower than wild-type (P < 0.0001; wild-type; 0.73 ± 0.04 
vs. lama4-/-; 0.36 ± 0.03), indicating impaired mobilisation of vesicles during periods of 
sustained release. 
I next investigated the expression of synaptic vesicle protein 2 (SV2) in order to examine the 
density of synaptic vesicles at the presynaptic terminal. At 12MO, wild-type NMJs displayed 
densely packed vesicles which were colocalised to the postsynaptic endplates (Figure 4.5E). In 
contrast, lama4-/- NMJs showed an observable decrease in vesicle density in relation to the 
postsynaptic endplate (Figure 4.5E). The density of vesicles at lama4-/- remained consistently lower 
across all age groups. In contrast, wild-type NMJs gradually increased in vesicles density as they 
aged (Figure 4.5F).  No significant difference was found between 3MO wild-type and lama4-/- (P > 
0.05; wild-type; 0.53 ± 0.01 SV2 µm3/AChR µm3 vs. 0.49 ± 0.02 SV2 µm3/AChR µm3). At 6MO, 
12MO and aged, wild-types had significantly higher vesicle density in comparison with lama4-/- 
(6MO: P < 0.01; wild-type; 0.61 ± 0.02 SV2 µm3/AChR µm3 vs. lama4-/-; 0.51 ± 0.02 SV2 
µm3/AChR µm3, 12MO: P < 0.0001; wild-type; 0.64 ± 0.02 SV2 µm3/AChR µm3 vs. lama4-/-, 0.48 
± 0.02 SV2 µm3/AChR µm3 and Aged: P < 0.0001; wild-type; 0.63 ± 0.02 SV2 µm3/AChR µm3 vs. 
lama4-/-, 0.46 ± 0.02 SV2 µm3/AChR µm3; Figure 4.5F). 
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Figure 4.5 Lower facilitation and higher synaptic depression associated with decreased 
vesicle density at 12MO lama4-/- neuromuscular junctions. 
A, sample traces of paired-pulse facilitation at 10 ms and 100 ms delay for 12MO wild-
type and lama4-/- NMJs. B, plot of facilitation ratio against paired-pulse delay times at 10 
ms and 100 ms. Mutant NMJs had lower facilitation ratio in comparison with wild-type at 
10 ms delay. As delay times increased to 100 ms, the facilitation ratio of wild-type had 
decreased to the similar ratio of lama4-/-. C, representative EPPs recordings during 100 Hz 
stimulation for 1s duration at 12MO wild-type and lama4-/- NMJs. Estimation of RRP size 
was determined by plotting the y-axis (quantal content) over the x-axis (cumulative 
quantal content) and extrapolating the linear declining phase at x-axis. D, Lama4-/- NMJs 
had smaller RRP size, reduced quantal release during steady state plateau (mss) and a non-
significant decrease in quantal release during the first ten stimuli (mPeak). The ratio of mss to 
mPeak was also lower at lama4-/- NMJs. E, representative staining of synaptic vesicle 2 
(SV2) in green with respect to postsynaptic AChRs endplate in red. Wild-type at 12MO 
displayed dense staining of SV2 which colocalised well with the postsynaptic endplate 
while lama4-/- NMJs had decrease staining of SV2 with respect to the postsynaptic 
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endplate. F, Lama4-/- NMJs at 12MO had reduced vesicle density in comparison with 
12MO wild-type (as indicated in red dashed line box). The lower density at lama4-/- NMJs 
remained consistently lower across all ages investigated. Wild-type, on the other hand 
increased in vesicle density with age and reached a plateau when aged. Note that aged 
represents 18-22MO. For B, wild-type; n = 4, NMJs = 15 and lama4-/-; n = 4, NMJs = 13. 
For D, n = 4, NMJs = 12 for both genotypes. For F, 3MO: wild-type; n = 3, NMJs = 67 
and lama4-/-; n = 3, NMJs = 72, 6MO: wild-type; n = 3, NMJs = 61 and lama4-/-; n = 3, 
NMJs = 61,  12MO: wild-type; n = 3, NMJs = 51 and lama4-/-; n = 3, NMJs = 55,  aged: 
wild-type; n = 3, NMJs = 69 and lama4-/-; n = 3, NMJs = 82. Values are presented as mean 
± SEM; Two-way ANOVA with Tukey’s post hoc test for B, and Unpaired Student’s t-tests 
(two-tailed) for D and F; ** P < 0.01, *** P < 0.001, and ****P < 0.0001. Scale bar = 10 µm. 
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4.2.5 Accelerated ageing of neuromuscular junctions in hind-limb muscles of lama4-/- animals 
Studies have found an association between changes in NMJ morphology as remodelling incidents or 
adaptation responses to altered neurotransmission (Prakash & Sieck, 1998; Mantilla & Sieck, 2009). 
My functional findings displayed impaired transmission properties in EDL, which may affect the 
general morphology of the NMJ at lama4-/-. In order to investigate this, I examined the innervation 
patterns of the nerve terminal in relation to the postsynaptic endplates. 
Wild-type NMJs at 3MO showed mono-axonal innervation, with a single axon entering the nerve 
terminal which colocalised well with the pretzel shaped postsynaptic endplate (Figure 4.6A). In 
contrast, lama4-/- NMJs had higher proportion of fragmented receptors in comparison with wild-
types across the ages investigated (3MO: P < 0.0001; wild-type; 1.79 ± 1.79% vs. lama4-/-; 67.39 
± 6.62%, 6MO: P < 0.0001; wild-type; 7.87 ± 5.41% vs. lama4-/-; 60.54 ± 6.52%, 12MO: P < 
0.0001; wild-type; 7.14 ± 3.89% vs. lama4-/-; 72.40 ± 6.30% and Aged: P < 0.0001; wild-type; 
17.07 ± 6.53% vs. lama4-/-; 77.42 ± 6.60%) (Figure 4.6B, top and bottom panels). Endplates with 
altered axonal size, which takes into account of swollen and thinning axons remained consistently 
higher at lama4-/- NMJs in comparison with wild-types (3MO: P < 0.05; wild-type; 9.65 ± 3.83% 
vs. lama4-/-; 31.01 ± 8.13%, 6MO: P < 0.001; wild-type; 6.02 ± 4.46% vs. lama4-/-; 40.91 ± 7.63% 
and 12MO: P < 0.05; wild-type; 8.21 ± 3.83% vs. lama4-/-; 31.67 ± 9.03%; Figure 4.6C, top and 
bottom panels). At aged NMJs, no significant difference was found between genotypes (P > 0.05; 
wild-type; 16.37 ± 4.79% vs. lama4-/-; 26.25 ± 7.56%; Figure 4.6C, top and bottom panels). 
Lama4-/- NMJs displayed a non-significant increase in the number of polyinnervated endplates 
(3MO: P > 0.05; wild-type; 5.36 ± 3.64% vs. lama4-/-; 15.22 ± 6.65% and 6MO: P > 0.05; wild-
type; 6.20 ± 2.89% vs. lama4-/-; 13.09 ± 3.95%; Figure 4.6D, top and bottom panels). Interestingly, 
wild-type NMJs at 12MO (22.38 ± 6.85%) increased significantly (P < 0.05) in proportion of 
polyinnervated endplates from 6MO by 16.18% (Figure 4.6D, top and bottom panels). Proportion of 
polyinnervated endplates in 12MO wild-type was also slightly higher than that of 12MO lama4-/- 
NMJs (P > 0.05; 15.90 ± 3.44%; Figure 4.6D, top and bottom panels). At aged group, the 
proportion of polyinnervated endplates in wild-types declined to the similar level of lama4-/- NMJs 
(P > 0.05; wild-type; 16.33 ± 4.65% vs. lama4-/-; 11.82 ± 4.05%; Figure 4.6D, top and bottom 
panels). Interestingly, lama4-/- NMJs showed a different trend in denervated endplates from the 
other features discussed. Denervated endplates remained low in proportion at both genotypes from 
3MO to 12MO, however at aged NMJs there was a 9.9 fold increase in the number denervated 
endplates at lama4-/- NMJs when compared with age-matched wild-type NMJs (P > 0.05) (Figure 
4.6E, top and bottom panels).  
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 Figure 4.6 Accelerated ageing features at 3MO lama4-/- neuromuscular junctions. 
A, representative staining of axons and nerve terminal (green) in relation to postsynaptic 
endplates (red). Wild-type at 3MO showed normal innervation pattern with single axon entering 
the nerve terminal which colocalised well with the pretzel appearance of the postsynaptic endplate. 
B, lama4-/- NMJs at 3MO had fragmented islands of postsynaptic receptors (as indicated by 
arrows). Lama4-/- NMJs had higher incidence of fragmented endplates in comparison with wild-
types across all ages investigated. C, lama4-/- NMJs at 3MO displayed altered axonal size with 
thinning (as indicated by arrowheads) with some endplates displaying swollen axons (not shown). 
Lama4-/- NMJs showed higher prevalence of altered axonal size across all age groups. Aged wild-
type increased in alteration of axonal size almost to the similar level of lama4-/-. D, Polyinnervation 
or multiple axons entering the nerve terminal (as indicated with asterisk) was observed at 3MO 
lama4-/- NMJs. This feature was commonly observed at lama4-/- NMJs throughout the ages 
investigated. Aged wild-types declined to the similar level of lama4-/-. E, lama4-/- NMJs at 3MO 
showed completely denervated endplate. This feature was noted prominently in aged lama4-/- 
NMJs. Note that aged represents 18-22MO. For B-D, 3MO: wild-type; n = 3, NMJs = 80 and 
lama4-/-; n = 3, NMJs = 72, 6MO: wild-type; n = 3, NMJs = 65 and lama4-/-; n = 3, NMJs = 109,  
12MO: wild-type; n = 3, NMJs = 63 and lama4-/-; n = 3, NMJs = 73,  aged: wild-type; n = 3, NMJs 
= 77 and lama4-/-; n = 3, NMJs = 77. Values are presented as mean ± SEM; Unpaired Student’s t-
tests (two-tailed); * P < 0.05, *** P < 0.001, and ****P < 0.0001. Scale bar = 10 µm. 
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4.2.6 Larger AChRs postsynaptic endplate in area, expansion and dispersion at lama4-/- 
neuromuscular junctions 
The high prevalence of fragmented receptors warranted further investigation of the postsynaptic 
AChR endplates. I measured the postsynaptic endplates using different parameters such as stained 
endplate area only, expanded region of the endplate and dispersion of AChRs, as these parameters 
may provide greater details on the extent of the remodelling incidents in these mice (Yee & 
Pestronk, 1987; Deschenes et al., 2010; Kulakowski et al., 2011). 
At 3MO, wild-type and lama4-/- NMJs had similar synapse area (P > 0.05, wild-type; 433.1 ± 16.8 
µm2 vs. lama4-/-; 464.9 ± 20.7 µm2) and expanded region of the postsynaptic endplate (P > 0.05, 
wild-type; 704.0 ± 31.5 µm2 vs. lama4-/-; 685.8 ± 33.1 µm2) (Figure 4.7A and B, top and middle 
panels). Interestingly, lama4-/- NMJs (69.55 ± 1.33%) at this age had significantly larger dispersion 
of AChRs in comparison with wild-types (P < 0.05; 64.39 ± 1.58%) (Figure 4.7B, bottom panel). 
By 6MO, wild-types declined significantly in both synapse area (P < 0.0001, 333.7 ± 13.3 µm2) and 
endplate expansion (P < 0.0001, 525.8 ± 29.5 µm2) from 3MO wild-types, and also significantly 
smaller in both of these parameters when compared with 6MO lama4-/- (synapse area; P < 0.0001, 
424.8 ± 17.87 µm2 and endplate expansion; P < 0.05, 614.0 ± 29.78 µm2) (Figure 4.7B, top and 
middle panels). Lama4-/- NMJs (72.06 ± 2.16%) at this age remained significantly larger in AChRs 
dispersion in comparison with wild-type (P < 0.001; 57.76 ± 3.32%; Figure 4.7B, bottom panel). 
Both genotypes maintained similar trends at 12MO and aged groups with lama4-/- NMJs having 
larger synapse area (12MO; P < 0.05; wild-type; 346.7 ± 16.4 µm2 vs. lama4-/-; 414.5 ± 21.2 µm2, 
Aged; P < 0.001; wild-type; 332.5 ± 12.35 µm2 vs. lama4-/-; 401.5 ± 11.98 µm2) and larger 
expanded endplate region (12MO; P > 0.05; wild-type; 570.5 ± 35.0 µm2 vs. lama4-/-; 649.9 ± 40.1 
µm2, Aged; P < 0.05; wild-type; 531.8 ± 27.86 µm2 vs. lama4-/-; 622.0 ± 23.93 µm2) (Figure 4.7A 
and B, top and middle panels). Interestingly, wild-type at 12MO (64.23 ± 1.65%) increased in 
dispersion of AChRs almost to the similar level of lama4-/- NMJs (P > 0.05; 67.16 ± 1.58%) (Figure 
4.7B, bottom panel). At aged group, wild-type endplates (67.10 ± 1.89 %) had reached the similar 
level of AChRs dispersion as lama4-/- NMJs (P > 0.05; 67.03 ± 1.24%; Figure 4.7B, bottom panel). 
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Figure 4.7 Larger postsynaptic endplates in area, expansion and dispersion of AChRs at 
lama4-/- neuromuscular junctions. 
A, wild-type and lama4-/- NMJs at 3MO had similar synapse area and endplate expansion. Aged  lama4-
/- NMJs maintained large synapse area and expansion similarly to 3MO whereas aged wild-type 
appeared smaller in area and expansion in comparison with both genotypes at 3MO and aged lama4-/- 
NMJs. B, lama4-/- NMJs maintained larger synapse area and endplate expansion at all ages investigated. 
Wild-type dropped in endplate area and expansion by 6MO, which was maintained throughout the other 
ages tested. Lama4-/- NMJs had consistently greater dispersion of AChRs across all age groups. Wild-
type NMJs increased in AChRs dispersion as they aged and peaked to the similar level of lama4-/- 
NMJs. Note that aged represents 18-22MO. For B, 3MO: wild-type; n = 3, NMJs = 67 and lama4-/-; 
n = 3, NMJs = 72, 6MO: wild-type; n = 3, NMJs = 61 and lama4-/-; n = 3, NMJs = 61,  12MO: 
wild-type; n = 3, NMJs = 51 and lama4-/-; n = 3, NMJs = 55,  aged: wild-type; n = 3, NMJs = 69 
and lama4-/-; n = 3, NMJs = 82. Values are presented as mean ± SEM; Unpaired Student’s t-tests 
(two-tailed); * P < 0.05, *** P < 0.001, and ****P < 0.0001. Scale bar = 10 µm. 
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4.2.7 Altered expression of laminin-α4 at wild-type neuromuscular junctions during ageing 
Aged wild-type NMJs displayed functional, behavioural and morphological characteristics similar 
to those observed at lama4-/- NMJs. This could suggest that these alterations at wild-type NMJs may 
be associated with a change in expression of laminin-α4 leading to a loss in NMJ integrity and 
efficiency. I therefore examined laminin-α4 staining at the NMJs from wild-type mice. At 3MO 
wild-type NMJs displayed normal expression and colocalisation of laminin-α4 with respect to the 
postsynaptic endplates (Figure 4.8A), which coincided with normal neurotransmission and 
morphology seen in wild-type NMJs at this age group. By 12MO, wild-type NMJs displayed 
mislocalised laminin-α4 expression extrasynaptically as well as postsynaptic endplate regions void 
of laminin-α4 expression (Figure 4.8A). These observations became further evident in aged wild-
type NMJs (Figure 4.8A and B), and coincided with the prominent changes observed functionally, 
behaviourally and morphologically at this age. 
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 Figure 4.8 Altered expression of laminin-α4 at 12MO wild-type became more evident when 
aged at the neuromuscular junctions. 
A and C, examples of representative staining of laminin-α4 chain (green) with respect to 
the postsynaptic endplates (red). Far right panel showed colocalisation of laminin-α4 chain 
with postsynaptic endplate = yellow, extrasynaptic localisation of laminin-α4 = green and 
missing laminin-α4 expression at postsynaptic region = red. A, wild-type at 3MO showed 
normal colocalisation of laminin-α4 chain with respect to the postsynaptic endplates. 
Asterisk (*) is an indication of a nerve entering the nerve terminal of the 3MO wild-type, 
therefore it is not considered as an extrasynaptic localisation of the laminin-α4 chain. By 
12MO, wild-type began to display missing expression of laminin-α4 (observed with more 
red on far right panel) and mislocalised laminin-α4 expression (green) in comparison with 
3MO wild-type. As the NMJ aged, wild-type showed drastic changes in laminin-α4 
expression with highly expressed laminin-α4 at the extrasynaptic region (high degree of 
green) and lacking laminin-α4 (high degree of red) in comparison with 12MO wild-type (* 
is an indication of a nerve entering the nerve terminal at aged wild-type NMJs, therefore it 
is not accounted for extrasynaptic localisation of laminin-α4). The overlapping of laminin-
α4 to postsynaptic endplates (yellow) at aged wild-type NMJ was at a much lesser degree 
in comparison with 12MO wild-type. B, 3D reconstruction of laminin-α4 staining (green) 
in relation to postsynaptic endplate (red) of aged wild-type NMJ from A, in three different 
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planes of view; en face, below and lateral. En face view is reflective of the image shown 
in A. Below and lateral views confirmed that non-colocalised laminin-α4 staining was 
purely expressed at the extrasynaptic basal lamina region, not by non-muscle cells. C, 
lama4-/- NMJs at 12MO displayed no expression of laminin-α4 chain. Note that aged 
represents 18-22MO. Scale bar = 10 µm. 
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4.3 DISCUSSION 
Previous studies have demonstrated the premature appearance of morphological features associated 
with ageing at adult 6MO lama4-/- NMJs. The early appearances of these features suggest the 
involvement of laminin-α4 in maintaining a normal healthy NMJ during adulthood and ageing.  The 
present study further explored this theory by examining the role of laminin-α4 in maintenance using 
functional transmission, morphological investigation of synaptic molecules and behavioural 
characterisation. My findings demonstrated non-progressive defects in transmission at lama4-/- 
NMJs consistent with the changes seen in synaptic proteins. I also observed non-progressive weaker 
hind-limb grip force in lama4-/- animals. Interestingly, aged (18-22MO) wild-types declined in both 
transmission and behavioural movement to levels comparable to lama4-/-. Furthermore, missing and 
mislocalised expression of laminin-α4 were noted at wild-type NMJs before the evident declines in 
transmission and behavioural movement occurred. These findings strongly support the role of 
laminin-α4 in maintenance of the NMJ. 
4.3.1 Non-progressive defects in neurotransmission and morphology despite accelerated 
ageing neuromuscular junctions in lama4-/- 
Morphological studies demonstrated early ageing features at 6MO lama4-/- NMJs which increased 
with age in diaphragm muscles (Samuel et al., 2012). Interestingly, my functional findings in this 
muscle demonstrated non-progressive disrupted transmission properties despite the worsening of 
ageing features observed by others in these mutants. My observations demonstrated consistently 
lower frequency in spontaneous release and higher failures in evoked release across each age group 
investigated at lama4-/- NMJs. Furthermore, these mutant NMJs showed decreased quantal content 
which was due to the lower number of active release sites, suggesting alterations at the presynaptic 
nerve terminal as the contributor to impaired neurotransmission. This is consistent with my 
morphological findings which showed the decline in the density of the active zone marker Bassoon 
at lama4-/- NMJs, which remained at similar levels from 3MO to aged mice. Interestingly, the 
findings by Patton et al. (2001) showed no change in active zone number at adult lama4-/- NMJs. 
This discrepancy in results could be explained by the different techniques used to quantify the 
active zone number. The study by Patton et al. (2001) utilised electron microscopy which only took 
into account of a single section of the synapse and therefore may not provide a true representation 
of the entire structure as only a small number of active zones would be accounted for quantification. 
In the present study I employed wholemount immunostaining, which allowed for staining of active 
zones over the entire endplate region providing a more accurate reflection of active zone 
distribution.  
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The increased intermittence in evoked release at mutant NMJs may have been due to the failure in 
action potential propagation to the nerve terminals, as studies have found altered myelination 
patterns at the perineural sheathing of the peripheral nerve when laminin-α4 is absent at this region 
(Patton et al., 1997; Rasi et al., 2010). However, my findings demonstrated consistent presence of 
the NTI at lama4-/- NMJs even though intermittence had increased, which suggests normal 
propagation of action potential to the nerve terminal. Therefore, higher intermittence was directly as 
a result of defects at the level of depolarisation-secretion coupling at lama4-/- NMJs (Knight et al., 
2003). What is interesting here is the observation that transmission and morphological changes in 
lama4-/- NMJs although initially perturbed at 3MO, do not show an age-dependent improvement or 
decline after this age, despite other researchers observing progressive increase in features of ageing 
during their lifespan (Samuel et al., 2012). The maintenance of transmission may be due to counter 
adaptive mechanisms inherent at the highly plastic NMJ. For example, higher amplitudes in both 
EPCs and mEPCs at lama4-/- NMJs could be an indicator of compensatory mechanisms, where 
levels of AChE may have dropped to allow for a higher degree of neurotransmitter binding to 
AChRs. This is supported by slower mEPP decay times seen across all age groups at mutant NMJs. 
Furthermore, the study by Chand and colleagues (Chand et al., 2016 data in preparation)  showed 
that AChE was indeed affected in lama4-/- at P18, as tested through the blocking of AChE by 
antagonist (physotigmine) at P18 wild-type NMJs, resulting in slower mEPP decay times similarly 
to that of mutants. Other timing parameters such as mEPC and EPC rise times were similar 
reflecting normal synchronous release of neurotransmitters across the age groups between wild-type 
and lama4-/- NMJs. 
4.3.2 Weaker grip force in lama4-/- was not due to changes in fibre type composition  
I observed functional and morphological changes that remained constant from 3MO to aged group at 
lama4-/- NMJs. Here, I also observed similar trends in the force of hind-limb grip force, with lama4-/- 
consistently producing weaker force in comparison with wild-types. In support of my findings of altered 
neuromuscular function, Patton and colleagues (2001) observed uncoordinated hind-limb movement 
when walking and when hind-limbs were lifted off the ground in lama4-/- animals. The consistently 
weakened grip force suggests a non-progressive defect, which is in agreement with the coordination and 
body balance studies previously conducted by (Patton et al., 2001). Weaker grip force could result from 
alterations in fibre type compositions involving increased proportion of slow fibre types (Type I) with 
downregulation of fast fibre types (Coley et al., 2012; Lamboley et al., 2015). In order to determine this, 
I looked at fibre type expression in gastrocnemius muscles at 3MO and aged mice. Lama4-/- displayed 
normal fibre type composition at both age groups suggesting weaker grip force in these animals is not 
due to altered fibre type expression, but rather a result of impaired neurotransmission. 
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4.3.3 Disrupted transmission in hind-limb muscles is associated with drop in vesicle density at 
lama4-/- neuromuscular junctions 
As I observed weaker hind-limb grip force in lama4-/-, I examined the capacity of NMJs to 
sustain transmitter release during paired-pulse facilitation and higher frequency stimulation of 
the hind-limb EDL muscle at 12MO.  Lama4-/- NMJs displayed lower facilitation which may 
reflect an issue with the release of vesicles from the RRP. Our unpublished data on younger 
P18 lama4-/- NMJs displayed normal presence of vesicular associated proteins, such as 
synapsin 1, syntaxin 1A and SNAP25. This suggests that while these proteins may be present, 
the interaction between them may be dysfunctional and thus interfering with the proper 
release of vesicles during facilitation. Alternatively, perturbed neurotransmission may have 
resulted from a decrease in the availability of synaptic vesicles, which is consistent with our 
morphological findings that showed lower vesicle density at lama4-/- NMJs. 
Under high frequency conditions, neurotransmitter release from the NMJs of both genotypes 
underwent depression and reached a steady-state plateau, but lama4-/- NMJs displayed a rapid 
decline and lower plateau in comparison with wild-type NMJs. The rapid drop in transmitter 
release may suggest a faster depletion of vesicles from the RRP, which matched the smaller 
estimated size of RRP at lama4-/- NMJs (Bennett, 2001; Rizzoli & Betz, 2004, 2005; Ruiz et 
al., 2011; Ruiz et al., 2014). The lower plateau of neurotransmitter release reflects issue with 
the replenishment of synaptic vesicles from the reserve pool which could be explained by the 
lower number of vesicles available from this pool (Bennett, 2001; Rizzoli & Betz, 2004, 
2005; Ruiz et al., 2011; Ruiz et al., 2014). Indeed, my morphological findings support this 
idea and are consistent with the observed functional changes during conditions of high 
demand in transmitter release. 
4.3.4 Remodelling occurrences associated with morphological changes at lama4-/- 
neuromuscular junctions 
Higher incidence of premature ageing features such as fragmented receptors, changes in 
axonal size and polyinnervation occurred earlier in EDL muscle at 3MO lama4-/- NMJs. In 
contrast, Samuel and colleagues showed these NMJ features became prominent later, namely 
at 6MO lama4-/- NMJs from diaphragm muscle (Samuel et al., 2012). The difference between 
these two sets of results, could be that the hind-limb EDL is a fast twitch muscle, which 
comprised mainly of fast fibre types therefore being more susceptible to degeneration or 
remodelling of the NMJ (Valdez et al., 2012), whereas diaphragm is a mixed fibre type 
muscle which is probably more resistant to changes at the NMJ (Prakash & Sieck, 1998). 
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Therefore, it is likely that EDL muscles undergo early and faster remodelling when laminin-α4 is 
lost. A higher proportion of NMJs were seen to be fully denervated at aged lama4-/- EDL muscles. I 
proposed that during the absence of laminin-α4 in EDL muscle, NMJs are constantly remodelling, 
but are not able to maintain this level of constant adaptation, which would be energy demanding  
thus resulting in full retraction of the nerve terminal from the endplate. 
I also noted alterations in the morphology of the postsynaptic AChR endplate, with increased AChR 
area, expansion and dispersion at lama4-/- NMJs. Alterations to endplate morphology may be 
associated with compensation of a failing NMJ and/or potentially remodelling of the synapse (Yee 
& Pestronk, 1987; Deschenes et al., 2010; Kulakowski et al., 2011). It is plausible that failing 
transmission at lama4-/- NMJs results in counter-adaptive mechanisms employing the addition of 
AChRs to the endplate region, providing more receptors for released transmitter to bind to and 
consequently increase the likelihood of signal propagation, which may explain the higher 
amplitudes seen in these mice. Studies have found that neuromuscular inactivity tested through the 
blockade of synaptic transmission by tetradotoxin leads to larger endplate areas (Brown & Ironton, 
1977), while blockade of presynaptic transmission by Botulinum toxin resulted in greater dispersion 
of the existing AChRs as well as addition of newly formed AChRs at the postjunctional folds (Yee 
& Pestronk, 1987). Similar occurrences were also observed when AChRs were subjected to 
blocking with bungarotoxin or curare (Akaaboune et al., 1999). I propose that the higher 
intermittence of transmitter release and decrease in spontaneous frequency at lama4-/- NMJs mimics 
that of neuromuscular inactivity, resulting in synaptic remodelling of the postsynaptic AChR 
endplate as a compensatory mechanism to enhance neurotransmission. 
4.3.5 Laminin-α4 is required for the maintenance of the adult neuromuscular junction 
My findings indicate an association between the loss of laminin-α4 at the NMJ and perturbed 
transmission, morphology and behavioural movement from adulthood to ageing. Here I asked 
whether alterations in laminin-α4 expression at wild-type NMJs may be related to the functional 
neurotransmission and behavioural changes I noted at aged mice. I first noted missing and 
mislocalised laminin-α4 expression at 12MO wild-type NMJs which preceded any prominent signs 
of decline in neurotransmission. At aged NMJs, the changes in laminin-α4 expression became more 
evident and coincided with decreased transmission properties and weakened hind-limb grip force to 
levels resembling that of lama4-/- NMJs. Based on these observations, it appears that changes in 
laminin-α4 expression at wild-type NMJs preceded the alterations in its functional transmission, and 
these alterations resembled the trends evident at lama4-/- NMJs. These findings support the idea that 
laminin-α4 is required for the maintenance of the adult NMJs. 
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At aged wild-type NMJs, I noted a significant decrease in the density of the active zone 
marker Bassoon, consistent with prior study investigating active zones at aged NMJs (Chen et 
al., 2012; Nishimune et al., 2016). This decrease in active zones coincided with the altered 
laminin-α4 expression, suggesting a role for laminin-α4 in aligning presynaptic apparatus to 
postjunctional folds, and thus aiding the NMJ maintenance. Interestingly, I observed an 
increase in synaptic vesicle density at aged wild-type NMJs, which were in contrast to a 
subtle decrease in vesicle density within lama4-/- nerve terminals. My findings are consistent 
with others that show a relative increase in synaptic vesicles at aged terminals (Smith & 
Rosenheimer, 1982; Deschenes et al., 2013). I propose that the lower vesicle density in 
lama4-/- nerve terminals is a maintained phenotype from early perturbations of 
neurotransmission, while the increase in density at wild-type NMJs is a result of adaptive 
synaptic remodelling. The increased vesicle density may be a remodelling mechanism as a 
result of inefficient transmitter release at a failing terminal. Prior studies have shown that 
disuse of muscles through hind-limb suspension in aged animals resulted in the expansion of 
synaptic vesicles as an adaption or remodelling process at the synapses (e.g see Deschenes & 
Wilson, 2003). Furthermore, another study demonstrated accumulation of vesicles resulted 
from failure in synaptic transmission (Mantilla et al., 2007), which supports my findings as 
my aged control NMJs had increased failures in evoked release. 
4.4 CONCLUSION 
Loss of laminin-α4 leads to non-progressive impaired neurotransmission and premature 
morphological alterations normally associated with an ageing NMJ. Aged wild-type NMJs 
demonstrated similar functional and morphological characteristics to those observed at lama4-
/- NMJs. Most importantly, alterations in laminin-α4 expression at wild-type NMJs occurred 
prior to the appearance of these functional impairments, suggesting that changes in laminin-
α4 expression precede changes associated with ageing. My results support the role of laminin-
α4 in the maintenance of the adult NMJ.  
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Chapter 5 
The Role of Laminins in 
Degeneration of the Neuromuscular 
Junction in TDP43Q331K 
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ABSTRACT 
Amytrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterised by the loss 
of motor neurons and degeneration of the neuromuscular junction (NMJ). Transactive DNA binding 
protein 43 (TDP43) has been shown to be involved in the pathological disease of ALS. Studies 
found that mutation of this protein is responsible for approximately 4% of familial cases and 1.5% 
of sporadic cases in ALS. TDP43 functions in mRNA processing by splicing and transporting of 
mRNA transcripts. TDP43 has recently been shown to be expressed at the presynaptic terminal of 
the NMJ, suggesting a potential role in transporting and translating of mRNAs at the NMJ itself. Of 
note, studies have found that TDP43 interacts with mRNA of laminin chains. Interestingly, a recent 
study has shown absent expression of the laminin-α4 chain at NMJs of limb muscles in human ALS 
donors. This finding suggests a potential link between changes in the expression of laminin chains 
and the progression of NMJ degeneration in ALS disease. The present study aimed to functionally 
and morphologically characterise the TDP43Q331K mutation and subsequently determine the 
potential involvement of laminins in the mouse model of ALS, TDP43Q331K during presymptomatic 
(3 months) and onset (10 months) stages. Results showed perturbed transmission properties during 
the presymptomatic stage at TDP43Q331K NMJs, such as lower frequency of spontaneous release, 
decreased quantal content and higher intermittence, which are suggestive of presynaptic defects at 
the nerve terminal. Altered innervation patterns such as polyinnervation, thinning and swollen 
axons as well as partial denervation were also noted at these NMJs during the presymptomatic 
stage. In addition, a high prevalence of fragmented receptors was also observed in these mice 
compared with age-matched wild-types. Importantly, these changes in both functional transmission 
and morphological structure at the NMJ of TDP43Q331K coincided with the evident alterations of 
laminin-α4 chain, suggesting the potential involvement of laminin-α4 in the degenerative defects of 
the NMJ in ALS disease. 
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5.1 INTRODUCTION 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterised with the loss 
of upper (corticospinal) and lower α-motor neurons consequently leading to muscle denervation, 
skeletal muscle weakness and eventual death (Cleveland, 1999). Degeneration of the neuromuscular 
junction (NMJ), leading to denervation, is a significant early feature associated with this disease (Frey 
et al., 2000; Fischer et al., 2004; Gould, 2006; Arbour et al., 2015).  Prior studies have observed 
muscle denervation in the SOD1G93A mouse model of ALS, during the presymptomatic phase between 
the postnatal days 45-47 (P45-47) (Frey et al., 2000; Fischer et al., 2004), while others have shown an 
even earlier occurrence of denervation at P25 (Gould, 2006). What is intriguing is the fact that 
denervation occur before any signs of α-motor neuron loss, supporting the dying-backward 
hypothesis of ALS disease, where degeneration of the NMJ precedes the loss of motor axons resulting 
in the eventual loss of α-motor neurons from the central nervous system (Frey et al., 2000; Fischer et 
al., 2004; Hegedus et al., 2007; Hegedus et al., 2008; Marcuzzo et al., 2011; Arbour et al., 2015). 
Numerous molecules may influence the structural integrity of the NMJ and in particular lead to the 
progression of ALS. The transactive response DNA binding protein (TDP43) is one such molecule. In 
ALS, missense mutations of TDP43 results in the formation of cytoplasmic aggregates, which in turn 
lead to a depletion of TDP43 in the normally enriched cell nucleus (Kabashi et al., 2008; Sreedharan 
et al., 2008; Mackenzie et al., 2010). The aggregation of TDP43 may result in dysfunction of this 
protein, which is critical for mRNA processing to ensure normal production of proteins (Lagier-
Tourenne et al., 2010). Interestingly, Arnold et al. (2013) demonstrated impairment of mRNA 
processing in the absence of TDP43 aggregates which is suggested to be resulted from loss- and gain-
of-function in mutated TDP43. These findings suggest that any dysfunction in TDP43 either from 
mutation or aggregation, may disrupt the ability of TDP43 to perform its normal role in mRNA 
processing. 
Altered mRNA processing of presynaptic mRNAs within the nucleus could result in perturbation of 
NMJ function. Alternatively, another proposed role for TDP43 is in the transport of presynaptic 
mRNA transcripts to distal neuronal compartments such as nerve terminals for local translation 
(Moloney et al., 2014).  Support for this idea comes from the study by Alami et al. (2014) which 
showed transport of neurofilament mRNA by TDP43 along the axons to growth cones in mouse 
cortical neurons. In regards to neuromuscular synapses, Narayanan et al. (2013) demonstrated 
presence of TDP43 within the motor nerve terminal of mice, supporting the possibility of local 
translation that is further supported by studies of fly neuromuscular synapses.  At these synapses 
TDP43 has been shown to deliver mRNAs to the motor nerve terminal for translation of presynaptic 
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mRNAs such as Futsch (Coyne et al., 2014). To further support this, a most recent study by 
Romano et al. (2016) dissected out the mechanism for translation of Futsch mRNA.  
Specifically they have shown that TDP43 interacts with Futsch mRNA via UG-rich sequence 
within its 5’ UTR for distal translation, a mechanism they claimed is conserved in human 
TDP43 and its interaction with MAP1B (the human homolog of Futsch; Hummel et al., 2000). 
Together these studies support the potential occurrence of local translation of presynaptic 
mRNA transcripts by TDP43.    
Taken together the above would suggest that the impairment of mRNA processing, transport 
and/or translation by TDP43 may have detrimental effects on the synaptic function of the NMJ. 
Indeed it is known that TDP43 can bind to a number of presynaptic mRNA transcripts such as 
neurofilament, SV2, Bassoon, synaptophysin, synapsin II and syntaxin IIb (Sephton et al., 
2011; Narayanan et al., 2013). In regards to the laminins, Sephton et al. (2011) have 
demonstrated that TDP43 can bind to the mRNA transcript of laminin-γ1. The laminin-γ1 is 
critical in the formation of the synapse specific laminin heterotrimers-221 (α2β2γ1), -421 
(α4β2γ1) and -521 (α5β2γ1) (Miner & Yurchenco, 2004). Mutation of TDP43 may disrupt its 
role in the transport and translation of laminin-γ1, and presynaptic mRNAs. Altered transport 
and translation of mRNA constructs may consequently affect the production and expression of 
these proteins themselves, in turn disrupting interactions with associated molecules that are 
expressed independently of TDP43 activity. Loss of these interactions may then impair 
neurotransmission, leading to remodelling and culminating in premature degeneration of the 
NMJ. 
A recent study by Liu et al. (2011) found absent expression of laminin-α4 at the NMJs of limb 
muscles in ALS patients. This novel finding highlighted the potential involvement of laminins 
in ALS disease states. The laminins are a family of signalling and adhesion molecules which 
have been shown to promote structural integrity and ensure efficient neurotransmission at the 
NMJ (Patton, 2000; Burgess, 2006; Singhal & Martin, 2011). This study used the transgenic 
mouse model of ALS, TDP43Q331K, which expresses the mutated human form of TDP43 with 
glutamine to lysine substitution at amino acid position of 331 (Sreedharan et al., 2008; Arnold 
et al., 2013). The use of this transgenic model will allow for better understanding of 
alterations in laminin proteins and their influence on the progression of ALS using a human 
mutation in a rodent model. The aim of the present study is to examine the morphology and the 
functional properties of the NMJ in TDP43Q331K mice and subsequently investigate the potential 
roles laminins may have in the progression of the disease. Here I utilised electrophysiological  
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recordings to investigate the neurotransmission properties in these mice, to measure their 
functional capacity during presymptomatic (3 months; 3MO) and onset (10 months; 10MO) 
disease stages. A molecular morphological study was then conducted to investigate the 
expression and distribution of synaptic proteins and laminin chains at the NMJ using 
immunostaining technique. Transmission properties were disrupted during presymptomatic 
stage in TDP43Q331K mice, which worsened as they aged (onset stage). Altered innervation 
patterns along with changes in axonal diameter size were also observed in these NMJs during 
presymptomatic and onset stages. Changes in expression and distribution of laminin-α4 chain 
coincided with the functional and morphological changes seen during presymptomatic stage in 
TDP43Q331K. 
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5.2 RESULTS 
5.2.1 Disrupted transmission properties begin during presymptomatic stage in TDP43Q331K 
Previous study by Arnold et al. (2013) showed increased frequency of spontaneous firing 
in the gastrocnemius muscle of TDP43Q331K mice, recorded using resting 
electromyography. They associated this finding with denervation as well as degeneration 
and regeneration of motor units.  However, in order to better understand the specific 
changes that occur at the NMJ in TDP43Q331K, I investigated the neurotransmission 
properties utilising intracellular sharp recordings from presymptomatic to onset stages in 
these mice. During the presymptomatic stage (3MO), altered transmission properties were 
clearly visible in TDP43Q331K. The amplitude of spontaneous release (miniature endplate 
potentials; mEPPs) appeared to be larger in TDP43Q331K in comparison with wild-type 
(Figure 5.1A). Mutant NMJs had 15.31% larger mEPP amplitude compared with wild-
types (P < 0.05; TDP43Q331K; 0.54 ± 0.02 mV vs. wild-type; 0.47 ± 0.02 mV respectively). 
The mEPP decay time was however similar between both genotypes (P > 0.05; wild-type; 
4.59 ± 0.10 ms vs. TDP43Q331K; 4.33 ± 0.09 ms). 
Frequency in spontaneous release was significantly lower (P < 0.01) at TDP43Q331K NMJs 
(24.28 ± 1.04 min-1) in comparison with wild-types (29.30 ± 1.64 min-1; Figure 5.1B, top 
left). Although mean evoked release (endplate potential; EPP) amplitudes were similar 
between wild-type and TDP43Q331K (Figure 5.1A), I observed a greater variability in 
response amplitudes in TDP43Q331K. Importantly, I noted a significant increase in failures 
of evoked release at mutant NMJs (P < 0.001; 17.23 ± 0.78%) when compared with wild-
type NMJs (12.56 ± 0.95%; Figure 5.1B, top right). Quantal content at TDP43Q331K NMJs 
(1.29 ± 0.07) was also significantly lower when compared with wild-type (P < 0.001; 1.88 
± 0.12; Figure 5.1B, bottom left). These changes in transmission properties suggest 
presynaptic defects at the NMJs of TDP43Q331K mice. Binomial parameters of 
neurotransmitter release indicated that the 34.06 ± 7.89% (P < 0.01) decrease in quantal 
content was due to a 34.17 ± 8.50% (P < 0.01) decrease in probability of release at 
TDP43Q331K terminals, when compared with wild-type terminals (Figure 5.1B, bottom 
right). A significant 8.00 ± 0.90% increase (P < 0.001) in the number of active release 
sites was noted at TDP43Q331K NMJs compared with wild-type (Figure 5.1B, bottom right). 
During onset disease at 10MO, mEPPs amplitude decreased significantly at TDP43Q331K 
NMJs (P < 0.01; 0.37 ± 0.01 mV) in comparison with wild-type NMJs (0.42 ± 0.01 mV; 
Figure 5.2A).  The decay time of spontaneous release at TDP43Q331K NMJs (4.25 ± 0.09 
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ms) was significantly faster than wild-type (P < 0.05; 4.55 ± 0.10 ms). The frequency of 
mEPPs at TDP43Q331K NMJs (22.91 ± 0.91 min-1) remained significantly lower when 
compared with wild-type NMJs (P < 0.0001; 30.24 ± 1.43 min-1; Figure 5.2B, top left). 
The mean EPP amplitude decreased significantly at 10MO TDP43Q331K NMJs (P < 0.0001, 
0.49 ± 0.02 mV) when compared with age-matched wild-type NMJs (0.71 ± 0.04 mV; 
Figure 5.2A). TDP43Q331K NMJs showed a 45.12% decrease in mean EPP amplitude when 
compared with responses at 3MO TDP43Q331K NMJs (P < 0.0001). Failures in evoked 
release remained significantly higher at TDP43Q331K NMJs (P < 0.001; 21.41 ± 0.82%) 
compared with wild-type NMJs (17.01 ± 0.78%; Figure 5.2B, top right). This level of 
intermittence at TDP43Q331K NMJs was also significantly increased (24.26%) compared 
with 3MO TDP43Q331K NMJs (P < 0.001). Quantal content in TDP43Q331K mice (1.35 ± 
0.05) remained significantly lower than that of wild-type controls (P < 0.001; 1.73 ± 0.09; 
Figure 5.2B, bottom left). Interestingly, in normalised binomial parameter, the significant 
decline in quantal content in TDP43Q331K at 69.62 ± 1.62% (P < 0.0001) of wild-type was 
attributed to significantly lower number of active sites at 66.81 ± 2.15% (P < 0.0001). 
Mutant terminals displayed a significant increase in probability release of 
neurotransmitters to 125.90 ± 5.47% (P < 0.01) of values observed at wild-type NMJs 
(Figure 5.2B, bottom right). 
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Figure 5.1 Perturbed neurotransmission properties during presymptomatic stage (3MO) at 
TDP43Q331K neuromuscular junctions. 
A, sample traces from intracellular recordings of 10 consecutive mEPPs and 10 
consecutive EPPs for wild-type and TDP43Q331K NMJs at 3MO. TDP43Q331K NMJs 
displayed larger mEPP amplitudes with no significant difference in EPP amplitude 
compared with wild-type, though a higher degree of variance in response amplitude was 
noted. B, TDP43Q331K NMJs displayed lower frequency of spontaneous release, higher 
intermittence and lower quantal content when compared with wild-type NMJs. Dashed 
line, represents wild-types at 100% in binomial parameter analysis of transmitter release. 
The drop in quantal content (m) at TDP43Q331K NMJs was attributed to lower probability 
release of neurotransmitters (p) with increased in the number of active sites (n). For A, 
stimulus artefacts have been omitted for clarity. For B, wild-type; n = 4, NMJs = 32 and 
TDP43Q331K; n = 4, NMJs = 37. Values are presented as mean ± SEM; Unpaired Student’s 
t-tests (two-tailed);* P < 0.05, ** P < 0.01 and *** P < 0.001. 
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Figure 5.2 Disrupted neurotransmission properties during onset stage (10MO) at TDP43Q331K 
neuromuscular junctions. 
A, sample traces from intracellular recordings of 10 consecutive mEPPs and 10 
consecutive EPPs for wild-type and TDP43Q331K NMJs at 10MO. B, TDP43Q331K NMJs 
displayed lower frequency of mEPPs, higher failures in evoked release and lower quantal 
content in comparison with wild-type NMJs. Dashed lines represents wild-type NMJs at 
100 % in binomial parameter analysis. The drop in quantal content (m) at TDP43Q331K 
NMJs was resulted from lower number of active sites (n) with increased probability 
release of neurotransmitters (p). For A, stimulus artefacts have been omitted for clarity. 
For B, wild-type; n = 5, NMJs = 43 and TDP43Q331K; n = 5, NMJs = 47. Values are 
presented as mean ± SEM; Unpaired Student’s t-tests (two-tailed); ** P < 0.01, *** P < 0.001 
and **** P < 0.0001. 
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5.2.2 Reduced facilitation in transmitter release was associated with a decrease in vesicle 
density during onset disease in TDP43Q331K 
The defective transmission we observed suggests changes at the presynaptic terminal, potentially in 
the handling of intracellular calcium and vesicular dynamics at the active zone. I therefore 
employed paired-pulse (PP) facilitation study to test the degree of facilitation in these mice. This 
was conducted by comparing the amplitudes of test pulse (second stimuli) with conditioning pulse 
(first stimuli). At 10 ms test-conditioning interval, wild-type showed a 32.2% increase in the 
conditioning pulse when compared with the first stimuli (Figure 5.3A). Mutant NMJs also displayed 
facilitation however the second stimuli elicited a 19.3% larger response to that of the first response 
(Figure 5.3A). Therefore, TDP43Q331K NMJs had a lower facilitation index by 9.76% in comparison 
with wild-type (P < 0.01; Figure 5.3B), suggesting either lower availability of vesicles or issues 
with the delivery of vesicles for release. 
I next investigated the density of vesicles by examining the staining of synaptic vesicles 2 (SV2) 
with respect to the postsynaptic acetylcholine receptor (AChR) rich endplate. At 3MO, both wild-
type and TDP43Q331K NMJs displayed dense synaptic vesicles staining at the nerve terminal (Figure 
5.3C). Wild-type nerve terminals at 10MO maintained densely packed vesicle staining with respect 
to the postsynaptic endplates, in contrast to 10MO TDP43Q331K  nerve terminals which clearly had 
regions void of vesicle staining with respect to their endplates (Figure 5.3C). Statistically, 3MO 
TDP43Q331K NMJs (0.62 ± 0.02 SV µm3/AChR µm3) had a non-significant 12.42% increase in 
vesicle density when compared with age-matched wild-type controls (P > 0.05; 0.55 ± 0.02 SV 
µm3/AChR µm3; Figure 5.3D). However, the density of vesicles dropped significantly (P < 0.0001) 
from 3MO to 10MO at TDP43Q331K nerve terminals by 21.73%, and the 10MO TDP43Q331K 
terminals were significantly lower than age-matched wild-type terminals by 18.39% (P < 0.001; 
Figure 5.3D). 
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Figure 5.3 Reduced facilitation associated with lower density of synaptic vesicles at 
TDP43Q331K neuromuscular junctions during onset disease (10MO). 
A, representative traces of paired-pulse facilitation at 10 ms delay for 10MO wild-type and 
TDP43Q331K NMJs. B, plot of facilitation ratio against paired-pulse delay time at 10 ms 
between 10MO wild-type and TDP43Q331K NMJs. C, representative staining of synaptic 
vesicles and neurofilament (green) with respect to postsynaptic AChR endplate (red). Both 
wild-type and TDP43Q331K NMJs at 3MO showed densely packed vesicle staining which 
colocalised well with the postsynaptic endplate. Wild-type at 10MO maintained dense 
vesicle staining in relation to the postsynaptic endplates while 10MO TDP43Q331K NMJs 
clearly showed regions without vesicle staining at the postsynaptic endplate (as indicated 
with arrowheads). D, TDP43Q331K NMJs at 3MO had a slightly higher vesicle density in 
comparison with age-matched wild-type which then dropped significantly by 10MO. On the 
other hand, wild-type maintained normal vesicle density from 3MO to 10MO. TDP43Q331K 
NMJs at 10MO had a lower vesicle density in comparison with age-matched wild-type. For 
B, 10MO; wild-type; n = 3, NMJs = 15 and TDP43Q331K; n = 3, NMJs = 17. D, 3MO; wild-
type; n = 3, NMJs = 31 and TDP43Q331K; n = 3, NMJs = 30 and 10MO; wild-type; n = 3, 
NMJs = 30 and TDP43Q331K; n = 3, NMJs = 32. Values are presented as mean ± SEM; 
Unpaired Student’s t-tests (two-tailed) for B and Two-way ANOVA with Tukey’s post hoc 
test for D; *** P < 0.001, and ****P < 0.0001. Scale bar = 10 µm. 
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5.2.3 Altered innervation patterns occurred during presymptomatic stage at TDP43Q331K 
neuromuscular junctions 
As the presymptomatic changes in neurotransmission became increasingly worse with onset 
of the disease at TDP43Q331K NMJs, I next investigated what general morphological changes 
at the NMJs of these mice that may be associated with the disruption in neurotransmission 
demonstrated. I first investigated the colocalisation of the nerve terminal to the postsynaptic 
endplate and in particular, the innervation patterns in these mice. At 3MO, wild-type NMJs 
displayed normal innervation of single axon and good colocalisation of nerve terminals to 
postsynaptic AChR endplates (Figure 5.4A). In contrast, TDP43Q331K NMJs displayed 
altered innervation patterns with more than one axon entering the motor endplate region 
(Figure 5.4B). Furthermore, a high incidence of other abnormal innervation patterns such as 
thinning of axons, swollen axons and partial denervation were also seen at these NMJs 
(Figure 5.4C and D). Altered innervation patterns seen at 3MO TDP43Q331K NMJs persisted 
through to onset stage (10MO) TDP43Q331K NMJs, with higher incidence of partial 
denervation and emergence of axonal sprouting (Figure 5.4F).  In contrast, wild-type NMJs 
maintained normal innervation with single axon and well-colocalised nerve terminals to 
postsynaptic endplates during this period (Figure 5.4E). I further examined the diameter of 
primary axons before entering the endplate and found a non-significant increase in the 
diameter of axons during presymptomatic stage at TDP43Q331K NMJs (P > 0.05; 1.26 ± 0.14 
µm) when compared with age-matched wild-type controls (0.97 ± 0.09 µm; Figure 5.4G). 
By 10MO, the diameter of axons decreased significantly (P < 0.05; 0.89 ± 0.08 µm) at 
TDP43Q331K NMJs from 3MO by 29.06%, but was similar in diameter to 10MO wild-type (P > 
0.05; 0.93 ± 0.06 µm; Figure 5.4G). 
In addition to the noted changes in presynaptic regions of TDP43Q331K NMJs, I also 
observed a higher incidence (~15.80% increase) of fragmented endplates in these mice at 
3MO when compared with age-matched wild-types (Figure 5.4B). Some of the NMJs at 
10MO TDP43Q331K displayed irregular looking postsynaptic endplates and faint AChRs 
(Figure 5.5A). This observation led me to closely examine the volume of AChRs at 
TDP43Q331K NMJs as previous studies have proposed that faint AChRs are indicative of 
lower density of AChRs. Using 3D rendering of immunostained postsynaptic endplates, the 
volume of this region was calculated.  At 3MO, the volume of postsynaptic AChRs was 
similar between wild-type (P > 0.05; 583.7 ± 32.3 µm3) and TDP43Q331K (549.0 ± 32.68 
µm3) which matches the normal appearance of postsynaptic endplates at this stage (Figure 
5.5B). In contrast, the volume of postsynaptic AChRs at 10MO TDP43Q331K NMJs (410.5 ± 
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27.13 µm3) had decreased by 44.65% when compared with 10MO wild-type NMJs (P < 
0.0001; 741.6 ± 56.74 µm3; Figure 5.5B). When comparing the NMJs from both genotypes 
from 3MO to 10MO, the AChR volume from wild-type NMJs increased by 27.60% (P < 
0.05) while the TDP43Q331K NMJs decreased in volume by 25.23% (P > 0.05; Figure 5.5B). 
The altered volume in postsynaptic AChRs corresponded to the irregular and faint AChRs 
seen at the postsynaptic endplates in TDP43Q331K. 
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Figure 5.4 Altered innervation patterns at the neuromuscular junctions of TDP43Q331K. 
A, representative staining of synaptic vesicles and neurofilament (green) with respect to 
postsynaptic AChR endplate (red) during presymptomatic (3MO) and onset stages (10MO) at 
wild-type and TDP43Q331K NMJs. A, Wild-type at 3MO displayed normal innervation pattern 
with a single axon entering the nerve terminal. B, On the other hand, 3MO TDP43Q331K NMJs 
had two axons innervating the nerve terminal (as indicated with two asterisks *). In addition 
fragmentation of receptors into small islands were also noted at these NMJs (as indicated with 
plus “+” signs). C, 3MO TDP43Q331K NMJs also showed swollen axons (as indicated with an 
arrow) and thinning axon (as indicated with an arrowhead). D, partial denervation was also 
observed (as indicated with two arrowheads). E, By 10MO, wild-type maintained normal 
monoinnervation at the endplate. F, In contrast, axonal sprouting was noted at age-matched 
TDP43Q331K NMJs (as indicated with “#”). G, 3MO TDP43Q331K had larger diameter of 
primary axons in comparison with age-matched wild-type which then decreased significantly 
by 10MO. At 10MO, both wild-type and TDP43Q331K had similar diameter size in primary 
axons. For G, 3MO; wild-type; n = 3, axons measured = 55 and TDP43Q331K; n = 3, axons 
measured = 59 and 10MO; wild-type; n = 3, axons measured = 52 and TDP43Q331K; n = 3, 
axons measured = 67.  Values are presented as mean ± SEM; Two-way ANOVA with Tukey’s 
post hoc test; * P < 0.05. Scale bar = 10 µm. 
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 Figure 5.5 Faint AChRs and irregular appearances in postsynaptic endplates of TDP43Q331K 
during onset stage (10MO). 
Representative staining of postsynaptic endplate (red) in wild-type and TDP43Q331K NMJs at 
10MO. A, Wild-type displayed normal and well-defined postsynaptic endplate appearance. In 
contrast, TDP43Q331K NMJs showed faint receptors with irregular appearances of postsynaptic 
endplate which are not well-defined in comparison with wild-type NMJ.  C, wild-type and 
mutant NMJs at 3MO presented similar volume of AChRs. By 10MO, the AChR volume at 
TDP43Q331K NMJs decreased from 3MO and was significantly smaller in comparison with 
10MO wild-type. On the other hand, the AChR volume of wild-type increased significantly 
from 3MO to 10MO.  For B, 3MO; wild-type; n = 3, NMJs = 31 and TDP43Q331K; n = 3, 
NMJs = 30 and 10MO; wild-type; n = 3, NMJs = 30 and TDP43Q331K; n = 3, NMJs = 32. 
Values are presented as mean ± SEM; Two-way ANOVA with Tukey’s post hoc test; * P < 0.05 
and ****P < 0.0001. Scale bar = 10 µm. 
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5.2.4 Altered expression of laminin-α4 before onset disease in TDP43Q331K neuromuscular 
junctions 
In this study, I observed disrupted neurotransmission and morphological defects during 
presymptomatic stage at TDP43Q331K NMJs. Here, I examine the possibility that these 
changes may be associated with altered expression of laminins. During the 
presymptomatic stage (3MO), I observed prominent changes in laminin-α4 expression at 
TDP43Q331K NMJs. Qualitative examination demonstrated the absence of laminin-α4 at 
certain regions in relation to the postsynaptic endplate as well as extrasynaptic 
mislocalisation at TDP43Q331K NMJs (Figure 5.6). In contrast, wild-type NMJs displayed 
normal laminin-α4 expression that was colocalised well with the postsynaptic endplates. 
At onset stage (10MO), the absence and mislocalisation of laminin-α4 expression at the 
NMJ persisted in TDP43Q331K (Figure 5.7). Comparatively, wild-type maintained normal 
colocalisation of laminin-α4 to the postsynaptic endplates (Figure 5.7). 
I next looked at the expression of laminin-α5 chain and found normal expression of laminin-
α5 at the NMJs of both wild-type and TDP43Q331K during presymptomatic stage (3MO) 
(Figure 5.8). The expression and distribution of laminin-α5 chain was well-colocalised with 
the postsynaptic endplates in both genotypes. During the onset stage (10MO), TDP43Q331K 
NMJs showed regions void in laminin-α5 as well as mislocalised expression of this laminin 
(Figure 5.9). In contrast, wild-type NMJs maintained normal expression and colocalisation 
of laminin-α5 in relation to the postsynaptic endplates (Figure 5.9). 
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 Figure 5.6 Changes in laminin-α4 expression during presymptomatic stage (3MO) at 
TDP43Q331K neuromuscular junctions. 
Examples of representative staining of laminin-α4 chain (green) in relation to postsynaptic 
AChR endplate (red). Far right panel (composite) displayed colocalisation of laminin-α4 to 
postsynaptic endplate = yellow, extrasynaptic localisation of laminin-α4 = green and 
missing expression of laminin-α4 from postsynaptic endplate = red. Wild-type at 3MO 
presented normal expression and distribution of laminin-α4 which colocalised well with the 
postsynaptic endplate. On the other hand, TDP43Q331K NMJs displayed postsynaptic regions 
with missing laminin-α4 chain (indicated by the high degree of red patches on the composite 
panel) and mislocalised laminin-α4 expression (as indicated by green patches on the 
composite panel). Scale bar = 10 µm.  
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Figure 5.7 Altered expression of laminin-α4 persisted during onset disease (10MO) at 
TDP43Q331K neuromuscular junctions. 
Examples of representative staining of laminin-α4 chain (green) with respect to postsynaptic 
AChR endplate (red). Far right panel displayed colocalisation of laminin-α4 to postsynaptic 
endplate = yellow, extrasynaptic localisation of laminin-α4 = green and missing expression 
of laminin-α4 = red. Wild-type at 10MO showed normal expression and colocalisation of 
laminin-α4 chain with respect to the postsynaptic endplate. In contrast, 10MO TDP43Q331K 
NMJs displayed absent expression of laminin-α4 chain at certain regions of the postsynaptic 
endplate (as observed with high degree of red on far right panel) and mislocalised 
expression of laminin-α4 chain extrasynaptically (as observed with a few green patches on 
far right panel). Scale bar = 10 µm. 
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Figure 5.8 Normal expression and distribution of laminin-α5 chain during presymptomatic 
stage (3MO) at TDP43Q331K neuromuscular junctions. 
Examples of representative staining of laminin-α5 (green) with respect to postsynaptic 
AChR endplate (red). Far right panel (composite) showed colocalisation of laminin-α5 chain 
with postsynaptic endplate = yellow, extrasynaptic localisation of laminin-α5 = green and 
missing laminin-α5 expression at postsynaptic region = red. Both wild-type and TDP43Q331K 
NMJs displayed normal expression and colocalisation of laminin-α5 chain in relation to the 
postsynaptic endplate (as indicated by yellow in composite panels). Scale bar = 10 µm. 
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Figure 5.9 Altered expression of laminin-α5 during onset stage (10MO) at TDP43Q331K 
neuromuscular junctions. 
Examples of representative staining of laminin-α5 (green) with respect to postsynaptic 
AChRs endplate (red). Far right panel (composite) showed colocalisation of laminin-α5 
chain with postsynaptic endplate = yellow, extrasynaptic localisation of laminin-α5 = green 
and missing laminin-α5 expression at postsynaptic region = red. Wild-type at 10MO showed 
normal expression and well-colocalisation of laminin-α5 chain in relation to the 
postsynaptic endplate. In contrast, 10MO TDP43Q331K NMJs displayed extrasynaptic 
localisation of laminin-α5 chain (indicated on corresponding panels with white arrows, 
green regions on composite panel) and missing expression of laminin-α5 at certain regions 
of the postsynaptic endplate (indicated by asterisk * on corresponding panels, red regions on 
composite panel). Scale bar = 10 µm. 
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5.3 DISCUSSION 
Amyotrophic lateral sclerosis is characterised by motor neuron loss and degeneration of the 
NMJ, however the cause of this degeneration still eludes researchers. I hypothesise that 
changes in expression of laminins may be a key factor contributing to the NMJ degeneration 
observed in ALS disease states. In the present study, I examined the neurotransmission 
properties and the morphology of the synapses in TDP43Q331K during presymptomatic (3MO) 
and onset (10MO) stages.  The expression of different laminin chains at each of these stages 
of the disease in TDP43Q331K was then investigated. My observations showed early deficits in 
neurotransmission properties in addition to morphological changes at the NMJ during the 
presymptomatic stage, which coincided with the changes in laminin-α4 expression. These 
findings suggest an association between the changes in laminin-α4 expression and the NMJ 
defects seen in both transmission and morphology. I conclude that laminins could be one of 
the important contributors to NMJ degeneration in ALS disease. 
5.3.1 Functional defects are present during the presymptomatic stage and worsened by onset 
stage at TDP43Q331K neuromuscular junctions 
Presymptomatic phase is a disease stage before any obvious signs of symptoms are displayed. 
Interestingly, my findings show perturbed neurotransmission during the presymptomatic stage 
at TDP43Q331K NMJs. Decreased frequency in spontaneous transmitter release, lower quantal 
content and higher failures in evoked release at TDP43Q331K NMJs suggest presynaptic 
defects. However, I observed an increased density of synaptic vesicles, which is likely a 
compensatory mechanism for the decreased neurotransmission at TDP43Q331K NMJs. This 
change in vesicle density could also be an indicator of a larger than normal vesicle size which 
increases the quantal package of neurotransmitters to be released. If that is the case, this may 
explain the higher amplitude seen in spontaneous release at TDP43Q331K NMJs. This is 
consistent with the study by Rocha et al. (2013) which demonstrated enhanced transmission in 
certain properties such as increased mEPP amplitudes during presymptomatic stage in 
SOD1G93A NMJs, which authors suggested was a compensatory mechanism. In addition, the 
increased mEPP amplitude in TDP43Q331K could also be due to the lower levels of 
acetylcholinesterase (AChE), an enzyme that is required to break down the neurotransmitters. 
But based on mEPP decay time in TDP43Q331K, this timing parameter is similar to that of the 
wild-types therefore eliminating the second factor. The third factor could be due to the change 
in the postsynaptic AChRs density, but the appearance and the volume of the postsynaptic 
endplates appeared to be normal. 
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Based on the calculations of binomial parameters, the lower quantal content observed was 
attributed to lower probability of neurotransmitter release with slightly higher number of 
active release sites. The lower probability release of neurotransmitters may partly 
contributed to the higher failures seen in the TDP43Q331K NMJs. Higher failures in evoked 
release is suggestive of  failure in neurotransmission. The study by Mantilla et al. (2007) 
showed that when synaptic transmission was blocked with tetrodotoxin, synaptic vesicles 
were built-up at the nerve terminal in response to the failed transmission. This is consistent 
with my study, which also showed increased density of synaptic vesicles which may also be 
resulted from the failure in neurotransmission at the TDP43Q331K NMJs. 
As the disease progresses to onset stage in TDP43Q331K, disrupted neurotransmission 
becomes more severe with time.  At this stage, evoked release amplitude decreased 
significantly and there was a significant increase in the intermittence of transmitter release 
when compared with the presymptomatic stage. Furthermore, binomial parameters revealed 
that fewer active release sites were contributing to decreased quantal content at TDP43Q331K 
NMJs. This is in agreement with the morphological findings that showed a decline in the 
density of synaptic vesicles in TDP43Q331K. The altered vesicle density may partly explain 
the poor facilitation that was observed at this stage of the disease. I propose that the decrease 
in vesicle density is responsible for the decrease in PP facilitation at TDP43Q331K NMJs. The 
decline in vesicle density may also be a reflective of lower filling of transmitters within the 
vesicles thus when spontaneously released, smaller mEPPs amplitude would be generated at 
these NMJs. However, this change in mEPPs amplitude may be also a consequence of the 
change in AChRs distribution and density as morphological observations revealed irregular 
and faint AChRs in postsynaptic endplate as well as decreased AChRs volume. 
5.3.2 Mutation in TDP43 is linked to the morphological defects at the neuromuscular 
junctions 
During the presymptomatic stage, qualitative examination of TDP43Q331K NMJ morphology 
demonstrated altered innervation patterns including; polyinnervation, partial denervation, 
swollen axons and thinning of axons. As the TDP43Q331K NMJs reached onset stage, these 
morphological defects persisted with increased observations of partial denervation and 
occurrence of axonal sprouting. In addition, axonal diameter at TDP43Q331K NMJs during 
presymptomatic stage was found to be larger than normal, which then decreased by onset 
stage and was equivalent to age-matched wild-type NMJs. I suggest that these changes in 
innervation pattern and axonal diameter could be directly linked with the mutation in 
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TDP43. TDP43 is a transactive DNA binding protein that is important for transporting and 
processing mRNA transcripts, including the neurofilament mRNA (Strong et al., 2007; 
Fallini et al., 2012). Mutation of TDP43 may disrupt the proper transportation or translation 
of neurofilament mRNA as functional axons. Therefore this may explain the observed 
changes in innervation pattern and axonal diameter in which regulation of the axonal growth 
could have been dysregulated in TDP43Q331K.  I also observed changes in vesicle density 
during presymptomatic and onset stages at TDP43Q331K NMJs, which may be associated 
with TDP43 mutation. In support of this idea, a study by Sephton et al. (2011) found 
evidence of the interaction between TDP43 with mRNA targets of synaptic vesicle such as 
SV2A and SV2B. Therefore mutation in TDP43 may have altered the transport or translation 
of the vesicles mRNA resulting in different amount of vesicles being produced. 
The postsynaptic endplate of the NMJ in TDP43Q331K during onset stage revealed irregular 
appearances with no intact outline surrounding the exterior region of the endplates. What 
could cause this irregularity in the postsynaptic endplate? I propose that alterations in 
calcium/calmodulin protein kinase II (CaMKII) may have led to the irregularity in the 
postsynaptic endplates. The study by (Martinez-Pena y Valenzuela et al., 2010) 
demonstrated the role of CaMKII in regulating the recycling of nicotinic AChRs at the 
NMJs. When CaMKII was inhibited through blockade with an antagonist, recycling of 
AChRs were disrupted and internalised AChRs become highly concentrated within the NMJ. 
Consequently this may lead to lower density of AChRs at the NMJ as a result from AChRs 
not being able to recycle to the postsynaptic membrane.  There is a possibility that CaMKII 
may have been altered at the NMJs of TDP43Q331K, as normal TDP43 regulates the mRNA 
processing of CaMKII (Narayanan et al., 2013). Thus if TDP43 is mutated, mRNA of 
CaMKII may not be processed correctly as a functional protein therefore leading to 
disrupted recycling of AChRs to postsynaptic membrane, which subsequently results in 
irregularity of postsynaptic endplates and faint AChRs. 
Although changes at both pre- and postsynaptic NMJ may be linked directly with the 
mutation in TDP43, there is also a possibility that these defects could be resulted from other 
factors. What I observed at the NMJs in TDP43Q331K also reflects destabilisation of the NMJ 
with increased synaptic remodelling, which could be due to the loss of key regulatory 
proteins such as the laminins. 
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5.3.3 Are laminins one of the contributing factors to NMJ degeneration in ALS disease? 
Synaptic laminins are signalling and adhesion molecules found at the synaptic cleft, and are important 
for the development, maturation and maintenance of the NMJ (Noakes et al., 1995a; Patton et al., 
2001; Knight et al., 2003; Nishimune et al., 2004; Carlson et al., 2010; Samuel et al., 2012; Chand et 
al., 2015). In the present study, I characterised the expression of different laminin chains at the NMJs 
of TDP43Q331K. During the presymptomatic stage, wild-type endplates presented normal expression 
and colocalisation of laminin-α4 expression with respect to the postsynaptic endplates, while 
TDP43Q331K NMJs presented evident alterations in laminin-α4 expression with absent expression of 
laminin-α4 at regions of the postsynaptic endplates and in some cases, mislocalised expression of this 
laminin. This change in laminin-α4 expression coincided with perturbed neurotransmission properties 
and changes in NMJ morphology observed in TDP43Q331K mice.  At onset stage, the changes in 
laminin-α4 expression persisted at TDP43Q331K NMJs. My findings are consistent with a study by Liu 
et al. (2011) which revealed absent laminin-α4 expression particularly at the NMJs of limb muscles 
from human ALS donors. Furthermore, this study showed that alteration in laminins expression was 
present before the occurrence of NMJ denervation in these tissues. This raises the possibility of 
altered laminins expression preceding the NMJ defects in ALS disease. However in my study, I am 
uncertain if this is the case, in order to examine this possibility I would have to extend this study to 
younger animals before the occurrence of NMJ degeneration. 
Absence and extrasynaptic localisation of laminin-α4 at the NMJ may result in altered NMJ 
morphology and compromised neurotransmission. Laminin-α4 plays an important role in ensuring 
the proper alignment of nerve terminals to postsynaptic endplates (Patton et al., 2001). If laminin-
α4 is lost or not localised in its correct position where it is normally highly concentrated between 
the folds of the muscle fibre (Patton et al., 2001), this alignment becomes compromised and thus 
increasingly destabilised with age (Samuel et al., 2012). This in turn would lead to increased 
plasticity and higher incidence of synaptic remodelling which explains why TDP43Q331K NMJs 
presented features of polyinnervations, thickening of axons, thinning of axons, sprouting of axons, 
partial denervation and fragmented receptors. These NMJ features could also be an indicator of 
accelerated ageing in TDP43Q331K. For example, the study by Samuel et al. (2012) and of my own 
(see Chapter 4) showed early ageing features at the NMJs of adult laminin-α4 deficient mice 
(lama4-/-), which were also commonly observed in SOD1G93A (Valdez et al., 2012). Furthermore, 
alterations in laminin-α4 expression were observed in aged wild-types at 2 years of age (Samuel et 
al., 2012). These altered laminin-α4 expression in TDP43Q331K and aged wild-types suggest that 
ALS disease and ageing share similarities in molecular changes where laminin-α4 may serve a 
common central role involving the maintenance of the NMJs. 
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In contrast, laminin-α5 expression was normal and colocalised well with the postsynaptic 
endplates during presymptomatic stage in TDP43Q331K, suggesting no involvement of altered 
laminin-α5 expression in the changes of innervation patterns and disrupted transmission seen 
in TDP43Q331K. At onset stage, laminin-α5 expression was found to be mislocalised and lost at 
certain regions of the postsynaptic endplate. These changes coincided with the irregularity 
appearances of the postsynaptic endplates in TDP43Q331K. This is not surprising since it has 
been suggested that laminin-α5 is involved in the maturation of the postsynaptic apparatus via 
the transition of AChRs clusters from plaque to pretzel (Nishimune et al., 2008). I propose 
that the change in laminin-α5 expression at the NMJ may have resulted in irregular 
postsynaptic endplates appearances in TDP43Q331K, in which clustering of the AChRs may 
have been disrupted.  In addition, the altered expression of laminin-α4 chain which persisted 
at onset stage may have also further contributed to the disruptive appearance of postsynaptic 
endplate, as this laminin is also shown to assist in postsynaptic maturation through the 
clustering of AChRs (Nishimune et al., 2008). However there is also the possibility that the 
irregularity of the postsynaptic endplates may be secondary changes from the NMJ 
degeneration seen at TDP43Q331K. 
The study by Sephton et al. (2011) showed an interaction between TDP43 and the laminin-γ1 
chain, with its loss leading to embryonic lethality and failure in the formation of the synapse 
specific laminin heterotrimers (Smyth et al., 1999; Miner et al., 2004). While the present 
study did not specifically investigate the expression of the laminin-γ1 chain, I propose that 
there is not a significant change in its expression or locale. TDP43Q331K mice survive past the 
embryonic stage and have good survivability at old age groups supporting the early and 
maintained presence of laminin-γ1 at the NMJ. This is supported by the fact that TDP43Q331K 
mice develop NMJs with relatively sound morphology albeit with impaired 
neurotransmission. Furthermore, a study by Chen and Strickland (2003) showed that laminin-
γ1 is required for the role of Schwann cells in myelination and regeneration of peripheral 
nerves in a conditional knockout of laminin-γ1, implicating that this laminin may not be as 
important in development and maintenance of the NMJ itself. Interestingly, these conditional 
knockouts developed severe muscle weakness as early as 4 weeks old and displayed signs of 
mild hind-limb paralysis by 3MO (Chen & Strickland, 2003). These functional changes are in 
contrast to those observed in TDP43Q331K mice, which only developed significant muscle 
weakness by 10MO (Arnold et al., 2013). Together these contrasting functional alterations 
likely suggest that laminin-γ1 is not significantly altered at NMJs of TDP43Q331K mice. 
However it cannot be discounted that a subtle change in laminin-γ1 may be sufficient to 
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destabilise the other synaptic laminins, which may explain the observation of altered 
laminins-α4 and -α5 expression at TDP43Q331K NMJs. Therefore, future experiments will be 
conducted to investigate the expression of this laminin at TDP43Q331K NMJs. Subtle 
alterations in expression of the laminin-γ1 chain may be difficult to ascertain using the 
immunofluorescence techniques employed in the present study. Thus molecular approaches 
such as western blot and qPCR would have to be employed to investigate this chain.  
5.4 CONCLUSION 
The present study has demonstrated significant defects in neurotransmission and morphology 
of the NMJs in TDP43Q331K. These changes may be secondary to altered expression of key 
laminins that have an important role in organising pre- and postsynaptic specialisations. If 
laminins are indeed one of the factors leading to NMJ degeneration in ALS, it can be 
potentially used as a therapeutic target to treat the symptoms of skeletal muscle weakness in 
order to lessen the suffering of ALS patients. 
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Chapter 6 
General Discussion 
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6.1 Thesis Summary 
This thesis has revealed a number of significant observations, which have contributed to our 
understanding of the specific roles laminins-α4 and -β2 play at the neuromuscular junction (NMJ) 
during its maturation and maintenance. My findings demonstrate that loss of laminin-β2 resulted 
in the failure in switch from N- to P/Q-type voltage-gated calcium channel (VGCC) clustering at 
the nerve terminal, consequently leading to a disruption in the localisation of presynaptic proteins 
involved in mediating transmitter release. I have furthered the study of laminin-β2 by 
demonstrating that its loss results in arrested development rather than a delay in maturation, as 
observed by the maintained immature postsynaptic endplate morphology and impaired 
neurotransmission at postnatal day 35 (P35) at laminin-β2 deficient mice (lamb2-/-) NMJs. 
Together, these findings support the role of laminin-β2 in maturation of both the pre- and 
postsynaptic specialisations at the NMJ. Following on from this, I investigated laminin-α4, which 
has been implicated in maintaining the NMJ during adulthood and ageing. This study found that 
loss of laminin-α4 resulted in impaired neurotransmission, which was maintained from adult 
(3 months; 3MO) to aged mice (18-22MO). Interestingly, this study demonstrated similar 
transmission properties in aged wild-type controls when compared with adult laminin-α4 deficient 
mice (lama4-/-) NMJs. Significantly, alterations in laminin-α4 expression occurred prior to the 
prominent decline in transmission at control wild-type NMJs. These findings suggest altered 
expression of laminin-α4 chain precedes the decline in functional transmission properties in 
normal aged animals, therefore strongly supporting the role of laminin-α4 in maintenance of the 
NMJ. The final study of this thesis investigated the potential involvement of laminins in the 
degeneration of the NMJ in the TDP43Q331K mouse model of amyotrophic lateral sclerosis (ALS). 
During the presymptomatic stage (3MO), NMJs displayed perturbed neurotransmission, increased 
innervation patterns and alterations in laminin-α4 expression, suggesting that laminin-α4 may 
play a role in the NMJ degeneration of the ALS disease states. Overall my findings not only 
demonstrated the importance of laminins during NMJ maturation and maintenance, but also the 
potential role that these laminins may have in the progression of NMJ degeneration in ALS 
disease. This chapter will discuss the summary of the findings from this thesis, together with 
previous literature and other work conducted in our laboratory. 
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6.2 Loss of laminin-β2 results in arrested maturation of the neuromuscular junction 
During development of the NMJ, VGCCs such as N- and P/Q-type are involved in transmitter 
release (Katz et al., 1996; Rosato-Siri & Uchitel, 1999; Rosato-Siri et al., 2002). As the NMJ 
matures, there is a switch over of N- to P/Q-type as the predominant calcium channel involved 
in synaptic transmission (Katz et al., 1996; Rosato-Siri & Uchitel, 1999). In addition, these 
VGCCs are also suggested to be involved in the organisation of the presynaptic elements at 
the NMJ, which is dependent on their interaction with laminin-β2 (Nishimune et al., 2004; 
Chen et al., 2011). For example, an in-vitro study showed that laminin-β2 coated beads 
interacted with VGCCs such as N- and P/Q-type to aid in their clustering in motor neurons 
(Nishimune et al., 2004). The VGCC clusters in turn organise presynaptic elements such as 
the active zones at the NMJ, enabling presynaptic maturation of motor nerve terminals at the 
NMJ (Nishimune et al., 2004; Chen et al., 2011). The study presented herein, further explored 
these observations by examining the distribution and expression of these VGCCs in-vivo at 
lamb2-/- NMJs, and investigated how changes in distribution of these channels affected the 
localisation of presynaptic proteins involved with transmitter release. The findings 
demonstrated P/Q-type VGCCs were highly clustered at mature wild-type NMJs, displaying 
the characteristic switch from N- to P/Q-type VGCC clusters associated with maturation. This 
supports our functional investigations, which demonstrated the predominant dependence of 
transmission on P/Q-type VGCCs at mature wild-type NMJs (Chand et al., 2015). In contrast, 
distinct clusters of N-type but dispersed P/Q-type VGCCs were observed at mature lamb2-/- 
NMJs, which matched the dominance of N-type VGCCs in neurotransmitter release at these 
mutant NMJs (Chand et al., 2015). This observation suggests failure in switching from N- to 
P/Q-type VGCCs at mature lamb2-/- NMJs. Although the study by Nishimune et al. (2004) 
suggested the involvement of the clustering of both VGCCs in the arrangement of the active 
zones, my study revealed that clustered N-type VGCCs were not sufficient enough to organise 
the presynaptic elements at lamb2-/- NMJs to allow for efficient neurotransmitter release. In 
contrast, presynaptic proteins were properly organised where highly clustered P/Q-type 
VGCCs were found at mature wild-type NMJs. I proposed that the proper organisation of the 
presynaptic molecules requires the interaction of laminin-β2 with P/Q-type VGCCs to ensure 
efficient transmitter release. As the NMJ expands in size during maturation, P/Q-type VGCCs 
would be expressed in the newly expanded region of the NMJ that require the presence and 
interaction with laminin-β2. Therefore if laminin-β2 is lost, P/Q-type VGCCs would not be 
expressed and clustered properly at the NMJ therefore disrupting the normal organisation of 
presynaptic molecules, such as Bassoon. Consequently, maturation of the presynaptic 
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apparatus would be either delayed or halted completely. Hence my findings support the idea 
that laminin-β2 is vital for the maturation of the presynaptic release sites through the 
switching over of N- to P/Q-type VGCCs. 
Studies on the role of laminin-β2 have largely been limited to younger age groups due to the 
short lifespan of lamb2-/- animals resulting from kidney failure by weaning (approximately 
postnatal day 21; see (Noakes et al., 1995b). However, the survivability of these animals 
could be prolonged up to P35 if they are fed with high fat chow to counter their proteinuria 
deficiency (Patton et al., 1997). In this study, I was able to characterise the transmission 
properties of lamb2-/- at P35, in order to test whether maturation of the NMJ would eventually 
be achieved in a functional and/or morphological capacity. My findings revealed maintained 
perturbed transmission properties with decreased frequency in spontaneous release, higher 
intermittence of evoked release, and decreased quantal content at lamb2-/- NMJs, suggesting 
lack of functional maturation. Furthermore, my morphological findings showed defects at the 
presynaptic release sites with lower numbers of Bassoon puncta at P35 mutant NMJs, 
contributing to the poor transmission. These morphological characteristics are supported by 
previous ultrastructural observations reported by (Patton et al., 2001). I also noted that P35 
lamb2-/- NMJ had retained a plaque-like appearance of postsynaptic endplates, suggesting 
arrested maturation of the postsynaptic apparatus. This finding was of particular interest as I 
observed the maintained presence of dystroglycan and laminin-α4, two molecules which are 
thought to be involved in promoting postsynaptic maturation at the NMJ (Nishimune et al., 
2008). The study by Nishimune et al. (2008) found that laminin-α4 was able to compensate 
for the loss of laminin-α5 predominance in postsynaptic maturation in conditional lama5 
knockouts. The same study further showed arrested postsynaptic maturation in double 
knockouts of laminins-α4 and -α5, supporting the involvement of laminin-α4 in conjunction 
with laminin-α5 in maturation of the postsynaptic apparatus. However, in my study it appears 
that the maintained presence of laminin-α4 was not capable of compensating for the loss of 
laminin-α5 in maturation of the postsynaptic apparatus in lamb2-/- mice. Based on the 
observations in the study by Nishimune et al. (2008) and of my own, it is possible that the 
involvement of laminins in postsynaptic maturation may not be dependent solely on the 
laminin-α chains. Perhaps laminin-β2, found in each of the synapse laminin heterotrimers, is 
required to help guide these interactions of laminin-α chains with receptors on the 
postsynaptic membrane to facilitate proper maturation of the postsynaptic region. It is also 
likely that other proteins such as integrins or podosomes act via laminin-β2 to promote 
postsynaptic maturation. 
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Overall these findings suggest that laminin-β2 is not only important for the maturation of the 
presynaptic region but also for the maturation of the postsynaptic endplate. Furthermore, 
ongoing studies being conducted in the Noakes laboratory also implicate laminin-β2 in the 
functional maturation the perisynaptic Schwann cell (PSC) at the NMJ; namely a loss of 
laminin-β2 results in maintained PSC dependence on the functionally immature purinergic 
receptors rather than the mature muscarinic receptors in the decoding of transmission signals. 
Therefore, I conclude that laminin-β2 is indeed required for the maturation of each of the 
three key cellular elements of the NMJ; the presynaptic nerve terminal, PSC, and the 
postsynaptic endplate region. 
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6.3 Loss of laminin-α4 disrupts the maintenance of the neuromuscular junction 
Previous study by Patton et al. (2001) showed misalignment of active zones to junctional folds 
at lama4-/- NMJs, suggesting that the laminin-α4 chain is required for the proper apposition of 
pre- to postsynaptic regions at the NMJ. A more recent study by Samuel et al. (2012) revealed 
an additional role of laminin-α4 in maintenance of the NMJ through morphological observation 
of accelerated appearance of ageing features at 6MO lama4-/- NMJs, alterations which are 
commonly detected at aged wild-types between 18-24MO (Valdez et al., 2010). Based on the 
findings by Samuel et al. (2012), I furthered these findings by studying the role of laminin-α4 in 
maintenance of the NMJ using several methodologies including; electrophysiology, neuromotor 
behaviour testing, as well as gross and molecular morphology which included the spatial and 
temporal expression of several synaptic proteins including the synaptic laminin-α4 in lama4-/- 
mice and age-matched wild-type mice from adult to aged (18-22MO) groups. 
The findings showed non-progressive disrupted transmission properties such as decreased 
frequency of spontaneous release, increased failures in evoked release and lower quantal 
content at lama4-/- from adult through to aged NMJs. These altered transmission properties were 
indicative of presynaptic defects at the nerve terminal, which was supported by my 
morphological findings with a decrease in density of the active zone marker Bassoon at lama4-/- 
NMJs. In addition, lama4-/- animals consistently displayed weaker hind-limb grip force which 
was attributed to the impaired neurotransmission I observed, as there were no alterations in 
fibre type composition. Ageing features at the synapse such as fragmented acetylcholine 
receptors (AChRs), polyinnervation, thinning and swollen motor axons were commonly 
observed at 3MO lama4-/- NMJs. Furthermore, lama4-/- NMJs showed highly dispersed AChRs, 
which is thought to be a compensatory response to impaired transmission (Prakash & Sieck, 
1998). Therefore, I proposed that the morphological changes involving accelerated ageing 
features together with larger dispersion of AChRs were the result of remodelling or adaptation 
in response to altered transmission observed at these mutant NMJs. This idea was further 
supported with our other work in the laboratory, which showed that young lama4-/- NMJs had 
disrupted synaptic transmission properties as early as postnatal day 8 (P8), well before the 
appearance of obvious morphological alterations. This suggests that weaker neurotransmission 
precedes NMJ remodelling when laminin-α4 is lost. 
What was intriguing in my comparison of NMJ transmission was that the transmission 
properties at aged (18-22MO) control NMJs, resembled the transmission properties at adult 
lama4-/- NMJs, suggesting accelerated NMJ ageing in the absence of laminin-α4, as supported 
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by the morphological findings of Samuel et al. (2012) and of my own. In support of this, my 
neuromotor behaviour testing demonstrated significantly lower hind-limb grip force production 
in adult lama4-/- mice compared with age-matched wild-types. This level remained consistent 
and did not show any age related changes. Most interestingly, wild-type mice demonstrated age 
related decline, with the aged cohort producing weakened hind-limb grip force at levels 
comparable to those observed at adult lama4-/- mice. As both our functional and morphological 
findings in aged wild-type mice resemble those observed in adult lama4-/- mice, I propose that 
altered laminin-α4 expression may be a key mediator associated with these changes. This 
proposal was supported by my study which demonstrated missing and mislocalised expression 
of laminin-α4 at 12MO wild-type NMJs, which preceded the decline of NMJ transmission 
properties at 18-22MO. This critical finding suggests that a change in expression of laminin-α4 
at ageing wild-type NMJs precedes the changes in synaptic transmission, which subsequently 
affects NMJ morphology and muscle strength, in a similar manner to what was observed at 
adult NMJs lacking laminin-α4 (i.e. NMJs from 3MO lama4-/- mice). 
Collectively the above observations suggest that if laminin-α4 is lost or mislocalised from its 
normal position at the NMJ, the stability of the synapse may be weakened, consequently 
disrupting the normal transmission properties at the synapse. In order to sustain a degree of 
functional transmission, the synapse undergoes remodelling to counter such alterations in 
neurotransmission. It is plausible that over time the NMJ is not able to sustain this high energy 
demanding task of constant remodelling, and it becomes more energy efficient to breakdown the 
NMJ and attempt to form a new connection. Therefore, I conclude that normal expression and 
distribution of laminin-α4 at the NMJ is critical to the maintenance of a normal and healthy 
adult NMJ. 
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6.4 Interaction of laminin chains with pre- and postsynaptic receptors to promote structural 
integrity at the neuromuscular junction and involvement of laminin heterotrimers in the 
formation of basement membrane 
Laminin chains promote their function at the NMJ via interactions with cellular receptors at the 
pre- and postsynaptic membranes of the synapse. For example, laminin-β2 interacts directly 
with receptors at the presynaptic membrane such as VGCCs, which in turn aids in the 
organisation of the active zone elements at the NMJ (Nishimune et al., 2004; Chen et al., 2011; 
Chand et al., 2015) (Figure 6.1). In particular, the interaction between P/Q-type VGCCs and 
laminin-β2 is required for this organisational process, with the loss of laminin-β2 resulting in 
the failure of the clustering of P/Q-type VGCCs at the presynaptic nerve terminal (Chand et al., 
2015) (see Chapter 3). This consequently leads to decrease active zones and severe disruption at 
the presynaptic nerve terminal (Noakes et al., 1995a; Nishimune et al., 2004; Chand et al., 
2015).  Laminin-α4 which is highly concentrated between the junctional folds binds directly to 
α3-integrin that is localised at the active zones of the presynaptic region (Cohen et al., 2000; 
Patton et al., 2001; Suzuki et al., 2005; Carlson et al., 2010) (Figure 6.1). This interaction helps 
to pattern the active zone components in the presynaptic membrane, which in turn determines 
the placement of junctional folds directly appose to the active zones (Patton et al., 2001). There 
is also a possibility that a postsynaptic membrane receptor is involved in this alignment of 
specialisations through laminin-α4. One such receptor is α-dystroglycan, which has been shown 
to interact with other laminin chains such as α2 and α5 (Shimizu et al., 1999; Talts et al., 1999). 
However, no studies have conclusively suggested that α-dystroglycan is the postsynaptic 
receptor for laminin-α4 to maintain synaptic adhesion. Studies have shown that laminin-α4 
demonstrate minimal binding to α-dystroglycan, which may make it an unlikely candidate as a 
potential receptor for synaptic adhesion (Talts et al., 2000; Timpl et al., 2000). Furthermore, 
this minimal binding likely explains the inability of laminin-α4 to compensate for the loss of 
laminin-α5 in maturation of the postsynaptic apparatus at lamb2-/- NMJs (see Chapter 3). 
Another proposed postsynaptic membrane receptor for laminin-α4 in synaptic adhesion would 
be α6β1 integrin (Talts et al., 2000; Fujiwara et al., 2001), however this integrin is only present 
in young myotubes and disappears during maturation (von der Mark et al., 1991; Sorokin et al., 
2000). The study by Nishimune et al. (2008) showed that β1-integrin expression is unperturbed 
when both laminins-α4 and -α5 are absent. It is possible that laminin-α4 interacts with both α-
dystroglycan and β1-integrin to promote adhesion and structural integrity, with the latter being 
expressed during periods of denervation and reinnervation (Werner et al., 2000), however this 
idea is purely speculative. It is clear that there must be other postsynaptic membrane receptors 
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which likely interact with laminin-α4 for synaptic adhesion, an area that warrants further 
investigation. Other laminin chains; α2 and α5 interact with α7β1 integrin and dystroglycan at 
the postsynaptic membrane of the NMJ (Shimizu et al., 1999; Talts et al., 1999; Talts & Timpl, 
1999; Smirnov et al., 2002; Ido et al., 2004; Nishiuchi et al., 2006) (Figure 6.1). These 
interactions are suggested to be implicated in the clustering of AChRs, via interaction of these 
receptors with cytoskeleton underlying the postsynaptic membrane (Dai et al., 2000; 
Brakebusch & Fassler, 2003; Dobbins et al., 2006; Guo et al., 2006; Wang et al., 2008; Singhal 
& Martin, 2011)(see Chapter 1, Section 1.1.3; Dystroglycan and Integrins). 
While individual laminin chains have the ability to interact directly with receptors at the pre- 
and postsynaptic membranes of the synapse, these individual laminin chains together as laminin 
heterotrimers such as laminin-221 and laminin-521 interact together to form ternary nodes 
which comprises of single α, β and γ chains (Bruch et al., 1989; Schittny & Yurchenco, 1990; 
Yurchenco & Cheng, 1993; McKee et al., 2007). This interaction promotes the polymerisation 
of the laminin network. Interestingly, laminin-421 is not involved in the formation of this 
laminin network due to the short-arm of the laminin-α4 chain, which does not possess an LN 
domain to interact with other laminin chains (Aumailley et al., 2005; Hohenester & Yurchenco, 
2013). This distinctive formation and inability to interact with other chains suggests a unique 
role for the laminin-421 heterotrimer at the NMJ. The laminin network at the basement 
membrane is anchored to cell surface via the interaction of cellular receptors with the long arms 
of the laminin-α chains (Aumailley et al., 1990; Roskelley et al., 1995; Talts et al., 1999; Ido et 
al., 2004; Higginson & Winder, 2005; Yurchenco & Patton, 2009) (Figure 6.1). Other basal 
lamina components such as nidogens, collagens IV and heparan sulphate proteoglycan; agrin 
and perlecan contain direct and indirect interaction with the laminin network to help maintain 
the structural integrity of the basement membrane (Tsilibary et al., 1988; Fox et al., 1991; 
McKee et al., 2007; McKee et al., 2009) (Figure 6.1). Consequently, the proper maintenance 
and formation of the basement membrane as well as maintained structural integrity of the NMJ 
by laminins, ensures normal structure and function at the neuromuscular junction. 
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 Figure 6.1 Interaction of laminin chains with pre- and postsynaptic receptors at the 
neuromuscular junction and the involvement of laminin heterotrimers in laminin network 
formation. 
A, at the presynaptic region of the NMJ, laminins-β2 and -α4 as part of the laminin heterotrimer-421 
interacts directly with the VGCCs and α3-integrin at the active zones, respectively. B, at the postsynaptic 
muscle fibre of the NMJ, receptors such as α-dystroglycan and α7β1 integrin interact directly with the 
laminin-α chains. These interactions are implicated in the clustering of AChRs involving a number of 
essential proteins underlying the cytoskeleton of the postsynaptic membrane (not shown here). C, 
polymerisation of the laminin network at the basement membrane involved the ternary node formation by 
laminin-221 and laminin-521. The laminin network is anchored to the cell surface through binding of the 
laminin-α chains with cellular receptors at the surface such as integrin, α-dystroglycan and sulfatides.  
Heparan sulphate proteoglycans such as agrin and perlecan interact directly with α-dystroglycan and 
sulfatides as well. Agrin also has the capability to bind to laminins directly at the helical region. These 
heparan sulphate proteoglycans along with other basal lamina components such as nidogens helps to 
interconnect the laminin network with collagen IV network contributing to the stability of basement 
membrane. Figure C, is adapted from Hohenester and Yurchenco (2013). 
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6.5 Laminins may play a role in neuromuscular junction degeneration and in turn the 
progression of the amyotrophic lateral sclerosis disease state 
ALS disease is widely accepted as a dying-forward neurodegenerative disease, which begins 
with the loss of motor neurons preceding the breakdown of the NMJ (Cleveland, 1999). 
However recent studies have suggested that ALS disease may progress in a dying-backward 
process, with degeneration of the NMJ preceding the dying of motor neurons (Frey et al., 
2000; Hegedus et al., 2007; Hegedus et al., 2008; Marcuzzo et al., 2011; Arbour et al., 
2015). One particular study showed loss of laminin-α4 expression at the NMJs of limb 
muscles in human ALS donors (Liu et al., 2011), suggesting the possible involvement of 
laminins in the NMJ degeneration in ALS disease. This led to my interest in investigating 
the involvement of laminins in TDP43Q331K mouse model of ALS during presymptomatic 
(3MO) and onset stages (10MO). 
TDP43 is a transactive response DNA binding protein which is involved in the splicing and 
transport of mRNA targets such as laminin-γ1 (Sephton et al., 2011). Here I studied other 
laminins chains such as α4 and α5 which are known to associate with laminin-γ1 at the 
NMJs of TDP43Q331K, as these laminins have been implicated in maturation and 
maintenance of the NMJ (Patton et al., 2001; Nishimune et al., 2008; Samuel et al., 2012) 
(see Chapter 4). Missing and mislocalised expression of laminin-α4 chain was found at 
TDP43Q331K NMJs during presymptomatic stage (3MO). This change in laminin-α4 
expression coincided with the drop in neurotransmission properties and a higher incidence 
of altered neuromuscular innervation patterns and fragmentation of postsynaptic AChRs in 
TDP43Q331K. These features are commonly observed in adult 3MO NMJs lacking laminin-α4 
(see Chapter 4), and also in aged NMJs where absent and mislocalised expression of 
laminin-α4 was found (see Chapter 4). Taken together these observations support the 
absence and mislocalised expression of laminin-α4 in triggering the degenerative defects at 
TDP43Q331K NMJs. However, a setback of this study is the uncertainty of whether the 
functional defects occur prior to the morphological alterations or vice versa at TDP43Q331K 
NMJs. Based on the findings of our own (Chand et al., 2016 data in preparation), young 
lama4-/- animals at P8 displayed perturbed transmission properties before morphological 
defects were seen, and normal ageing wild-types displayed altered transmission properties 
before increased incidence of remodelling synapses. To sufficiently address this conundrum 
this study must be extended to include a younger age cohort of TDP43Q331K mice. 
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Absent and mislocalised expression of laminin-α5 was observed during disease onset 
(10MO), coinciding with irregular appearances of postsynaptic endplates in TDP43Q331K. 
Laminin-α5, in conjunction with laminin-α4 has previously been shown to assist in 
maturation of the postsynaptic apparatus through the clustering of AChRs (Nishimune et al., 
2008). There is a possibility that this change in laminin-α5 expression leads to its 
dysfunction in proper clustering of AChRs therefore resulting in irregular looking 
postsynaptic endplates. Furthermore, the altered expression of laminin-α4 which persisted 
from presymptomatic to onset stages, may have also further exacerbated the clustering of 
AChRs at these NMJs. Overall, I conclude that laminins in particularly laminin-α4 may have 
a potential role in NMJ degeneration of ALS disease in TDP43Q331K, however this would 
require further investigation to validate this. 
155 
 
6.6 Limitations of current studies and future directions 
Although the studies presented in this thesis have furthered the understanding of the 
significant role laminins-α4 and -β2 play at the NMJ, there are a few key limitations which 
should be addressed. Investigation into the role of laminin-β2 has been limited to 
developmental and early maturation stages of the NMJ due to the restricted survivability of 
lamb2-/- mice as a result of renal failure (Noakes et al., 1995b). Similarly, study of laminin-
α5 deficient mice (lama5-/-) was limited due to this knockout line being embryonically lethal 
(Miner et al., 1998). Development of a conditional lama5-/- line was successful using the 
Cre/loxP system, which targeted the deletion of the lama5 gene from desired tissue and 
enabled prolonged survivability (Nguyen et al., 2005; Nishimune et al., 2008). Creation of a 
conditional lamb2-/- using a similar system would allow for longer survivability of lamb2-/- 
and would consequently permit proper validation of the role of laminin-β2 in NMJ 
maturation. Investigation of ageing lamb2-/- NMJs may also provide insight into their 
potential role in maintenance of a functional NMJ throughout adulthood. Our study on the 
role of laminin-α4 in maintenance of the NMJ would also benefit from the production of 
conditional lama4-/- in which the deletion of the lama4 gene could be targeted during 
adulthood thus allowing the verification of its role. 
In the laminin-β2 study, I proposed that podosome molecules may be one of the components 
involved in the maturation of the postsynaptic apparatus through laminin-β2. I was unable to 
successfully optimise the antibodies for podosome markers in the tissue collected from 
knockouts. Thus future studies may use in-vitro techniques to study the involvement of 
podosome molecules in postsynaptic maturation in myotubes cultured from lamb2-/- mice. 
Although the study by (Nishimune et al., 2008) showed normal complex clusters of AChRs 
in myotubes cultured from lamb2-/- mice, my study showed absence of complex clusters of 
AChR at lamb2-/- NMJs. This discrepancy may reflect in-vitro vs. in-vivo techniques 
providing conflicting results. In order to have a better understanding of what postsynaptic 
molecules may interact with laminin-β2 to assist in postsynaptic maturation, it would be 
ideal to utilise immunoprecipitation study or binding assays to determine what postsynaptic 
molecules bind directly to laminin-β2, a similar application used in a study to identify 
proteins that interact directly with the VGCCs complex (Carlson et al., 2010). This could 
then be followed up by in-vitro technique to study the molecules which interact directly 
with laminin-β2 by testing how these molecules would act to cluster the AChRs in the 
absence and presence of laminin-β2 in cultured myotubes. 
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In the final study, we showed the potential involvement of laminins in NMJ degeneration of 
ALS disease observed through the alteration of laminin-α4 expression which coincided with 
perturbed transmission and increased innervation patterns during presymptomatic stage at 
TDP43Q331K NMJs. During this stage, innervation patterns had already changed drastically 
when the expression and distribution of laminin-α4 chain was altered. Therefore it is unclear 
whether this change in laminin-α4 expression is a result of the secondary loss of the NMJ 
defects observed. Future studies should determine the expression of the laminins at younger 
TDP43Q331K at postnatal day 30 before the occurrence of NMJ defects and motor neuron loss. 
This will ascertain whether the changes in laminins expression would indeed have a role in 
the NMJ degeneration of ALS disease and this would also answer the question of whether 
ALS disease is indeed a dying-backward or dying-forward disease. In addition, the expression 
of laminin-β2 was also not shown in this study due to difficulty of optimising the antibodies 
on older rodent tissue, therefore this would require further work on the optimisation process. 
Subtle changes in laminin-γ1 expression as a result of the TDP43 mutation, may still be 
sufficient to cause disruption of other laminin chain interactions, thus contributing to the 
changes seen in laminin-α4 and -α5. Ongoing experiments will attempt to optimise the 
laminin-γ1 antibody for immunofluorescence study; however it should be noted that subtle 
changes may be difficult to discern. Finally, the generation of a double mutant mouse line 
combining TDP43Q331K and lama4-/- would allow for a more comprehensive study into the role 
of laminins, specifically laminin-α4, in the progression of ALS disease. 
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6.7 Conclusion 
Synaptic laminins such as α4 and β2 play significant roles in maturation and maintenance of 
the NMJ by precisely organising molecular elements, which in turn ensures efficient 
neurotransmission. Each of these chains appears to play key roles in these processes at 
different temporal stages in the lifespan of the rodent NMJ. Laminin-β2, the common laminin 
chain found in each of the synapse laminin heterotrimers, plays an essential role in maturation 
of the NMJ. Loss of laminin-β2 resulted in perturbed development of the pre- and 
postsynaptic regions of the NMJ. Significantly, when the lifespan of lamb2-/- mice was 
prolonged to P35, I observed no change in maturation both functionally and morphologically. 
I conclude that the loss of laminin-β2 resulted in arrested development of the NMJ as a whole. 
Investigation of lama4-/- NMJs demonstrated milder alterations in morphology and functional 
deficits when compared with lamb2-/- NMJs. Notably, aged wild-type NMJs demonstrated 
altered neurotransmission that was comparable to adult lama4-/- NMJs. Importantly, these 
alterations coincided with aberrant expression of the laminin-α4 chain as wild-type NMJs 
aged. These findings suggest that laminin-α4 is critical in ensuring proper maintenance of the 
NMJ during the ageing process by maintaining the integrity of the NMJ. Combined, I 
conclude that a decrease or loss in expression of either laminins-α4 or β2 significantly impairs 
the integrity and efficiency of the NMJ during maturation and maintenance. In the 
TDP43Q331K mouse model of ALS disease, missing and mislocalised expression of laminin-α4 
coincided with functional and morphological defects, suggesting that laminin-α4 is also 
required for maintaining a normal and healthy NMJ in a diseased model. This particular 
finding in ALS disease acts as a platform for future studies on the involvement of laminins 
not only in ALS disease, but also in other neuromuscular diseases. 
158 
 
References 
Abramoff MD, Magalhaes PJ & Ram SJ. (2004). Image Processing with ImageJ. Biophotonics 
International 11, 36-42. 
 
Akaaboune M, Culican SM, Turney SG & Lichtman JW. (1999). Rapid and reversible effects of 
activity on acetylcholine receptor density at the neuromuscular junction in vivo. Science 
286, 503-507. 
 
Akaaboune M, Grady RM, Turney S, Sanes JR & Lichtman JW. (2002). Neurotransmitter receptor 
dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands. Neuron 34, 
865-876. 
 
Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SS, Kiskinis E, Winborn B, 
Freibaum BD, Kanagaraj A, Clare AJ, Badders NM, Bilican B, Chaum E, Chandran S, 
Shaw CE, Eggan KC, Maniatis T & Taylor JP. (2014). Axonal transport of TDP-43 mRNA 
granules is impaired by ALS-causing mutations. Neuron 81, 536-543.  
 
Alshuaib WB & Fahim MA. (1990). Effect of exercise on physiological age-related change at 
mouse neuromuscular junctions. Neurobiology of Aging 11, 555-561. 
 
Alshuaib WB & Fahim MA. (1991). Depolarization reverses age-related decrease of spontaneous 
transmitter release. Journal of applied physiology (Bethesda, Md : 1985) 70, 2066-2071. 
 
Apel ED, Glass DJ, Moscoso LM, Yancopoulos GD & Sanes JR. (1997). Rapsyn is required for MuSK 
signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron 18, 623-635. 
 
Apel ED, Roberds SL, Campbell KP & Merlie JP. (1995). Rapsyn may function as a link between 
the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein 
complex. Neuron 15, 115-126. 
 
Arbour D, Tremblay E, Martineau E, Julien JP & Robitaille R. (2015). Early and persistent 
abnormal decoding by glial cells at the neuromuscular junction in an ALS model. Journal of 
Neuroscience 35, 688-706. 
 
Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz 
HB, McAlonis-Downes M, Platoshyn O, Parone PA, Da Cruz S, Clutario KM, Swing D, 
Tessarollo L, Marsala M, Shaw CE, Yeo GW & Cleveland DW. (2013). ALS-linked TDP-
43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without 
aggregation or loss of nuclear TDP-43. Proceedings of the National Academy of Sciences 
USA 110, E736-745. 
 
Ashery U, Varoqueaux F, Voets T, Betz A, Thakur P, Koch H, Neher E, Brose N & Rettig J. 
(2000). Munc13-1 Acts as a Priming Factor for Large Dense-Core Vesicles in Bovine 
Chromaffin Cells. The EMBO Journal 19, 3586-3596. 
 
Augustin I, Rosenmund C, Sudhof TC & Brose N. (1999). Munc13-1 is essential for fusion 
competence of glutamatergic synaptic vesicles. Nature 400, 457-461. 
 
Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, 
Engvall E, Hohenester E & Jones JC. (2005). A Simplified Laminin Nomenclature. Matrix 
Biology 24, 326-332. 
159 
 
Aumailley M, Timpl R & Sonnenberg A. (1990). Antibody to Integrin α6 Subunit Specifically 
Inhibits Cell-Binding to Laminin Fragment 8. Experimental cell research 188, 55-60. 
 
Badawi N, Watson L, Petterson B, Blair E, Slee J, Haan E & Stanley F. (1998). What constitutes 
cerebral palsy? Developmental medicine and child neurology 40, 520-527. 
 
Bahler M & Greengard P. (1987). Synapsin I bundles F-actin in a phosphorylation-dependent 
manner. Nature 326, 704-707. 
 
Balice-Gordon R. (1997). Age-Related Changes in Neuromuscular Innervation. Muscle & Nerve 
5, S83-S87. 
 
Banker BQ, Kelly SS & Robbins N. (1983). Neuromuscular transmission and correlative 
morphology in young and old mice. Journal of Physiology (Cambridge) 339, 355-377. 
 
Barik A, Xiong WC & Mei L. (2012). MuSK: A kinase critical for the formation and maintenance 
of the neuromuscular junction. Protein Kinase Technologies: Neuromethods, ed. Mukai H, 
pp. 203-217. Springer US, Boston, MA.  
 
Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY & Finkbeiner S. (2010). Cytoplasmic 
mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with 
familial amyotrophic lateral sclerosis. Journal of Neuroscience 30, 639-649. 
 
Barresi R & Campbell KP. (2006). Dystroglycan: from biosynthesis to pathogenesis of human 
disease. Journal of Cell Science 119, 199-207. 
 
Bartoli M, Ramarao MK & Cohen JB. (2001). Interactions of the rapsyn RING-H2 domain with 
dystroglycan. Journal of Biological Chemistry 276, 24911-24917. 
 
Bauch H & Schaffer J. (2006). Optical Sections by means of “Structured Illumination”: Background 
and Application in Fluorescence Microscopy. Photonik International 5, 86-88. 
 
Beck K, Hunter I & Engel J. (1990). Structure and Function of Laminin: Anatomy of a 
Multidomain Glycoprotein. The FASEB journal 4, 148-160. 
 
Belkin AM & Stepp MA. (2000). Integrins as receptors for Laminins. Microscopy Research and 
Technique 51, 280-301. 
 
Benfenati F, Valtorta F, Rubenstein JL, Gorelick FS, Greengard P & Czernik AJ. (1992). Synaptic 
vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for 
synapsin I. Nature 359, 417-420. 
 
Bennett M. (2001). Mechanisms of Depression of Transmitter Release at Synapses. Neuroreport 12, 
A15-A20. 
 
Bennett M & Florin T. (1974). A Statistical Analysis of the Release of Acetylcholine at Newly 
Formed Synapses in Striated Muscle. Journal of Physiology 238, 93-107. 
 
Bennett M, Jones P & Lavidis N. (1986a). Transmitter Secretion Varies Between Visualized 
Release Sites at Amphibian Neuromuscular Junctions. Neuroscience Letters 65, 311-315. 
 
160 
 
Bennett MR, Jones P & Lavidis NA. (1986b). The Probability of Quantal Secretion Along 
Visualized Terminal Branches at Amphibian (Bufo marinus) Neuromuscular Synapses. 
Journal of Physiology-London 379, 257-&. 
 
Bennett MR & Lavidis NA. (1979). Effect of Calcium-Ions on the Secretion of Quanta Evoked by 
an Impulse at Nerve-Terminal Release Sites. Journal of General Physiology 74, 429-456. 
 
Bergamin E, Hallock PT, Burden SJ & Hubbard SR. (2010). The cytoplasmic adaptor protein Dok7 
activates the receptor tyrosine kinase MuSK via dimerization. Molecular  Cell 39, 100-109. 
 
Bertini E, D'Amico A, Gualandi F & Petrini S. (2011). Congenital muscular dystrophies: a brief 
review. Seminars in pediatric neurology 18, 277-288. 
 
Betz A, Thakur P, Junge HJ, Ashery U, Rhee JS, Scheuss V, Rosenmund C, Rettig J & Brose N. 
(2001). Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic 
vesicle priming. Neuron 30, 183-196. 
 
Bevan S & Steinbach JH. (1977). The distribution of alpha-bungarotoxin binding sites of 
mammalian skeletal muscle developing in vivo. Journal of Physiology 267, 195-213. 
 
Bogdanik L, Framery B, Froelich A, Franco B, Mornet D, Bockaert J, Sigrist SJ, Grau Y & 
Parmentier ML. (2008). Muscle Dystroglycan Organizes the Postsynapse and Regulates 
Presynaptic Neurotransmitter Release at the Drosophila Neuromuscular Junction. PLoS One 3. 
 
Borges LS, Yechikhov S, Lee YI, Rudell JB, Friese MB, Burden SJ & Ferns MJ. (2008). 
Identification of a motif in the acetylcholine receptor beta subunit whose phosphorylation 
regulates rapsyn association and postsynaptic receptor localization. The Journal of 
Neuroscience 28, 11468-11476. 
 
Bowe MA, Deyst KA, Leszyk JD & Fallon JR. (1994). Identification and purification of an agrin 
receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the 
dystroglycans. Neuron 12, 1173-1180. 
 
Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ & Del Tredici K. (2013). 
Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nature reviews 
Neurology 9, 708-714. 
 
Brakebusch C & Fassler R. (2003). The integrin-actin connection, an eternal love affair. The EMBO 
Journal 22, 2324-2333. 
 
Brose N, Petrenko AG, Sudhof TC & Jahn R. (1992). Synaptotagmin: a Calcium Sensor on the 
Synaptic Vesicle Surface. Science 256, 1021-1025. 
 
Brown MC & Ironton R. (1977). Motor neurone sprouting induced by prolonged tetrodotoxin block 
of nerve action potentials. Nature 265, 459-461. 
 
Bruch M, Landwehr R & Engel J. (1989). Dissection of laminin by cathepsin G into its long-arm 
and short-arm structures and localization of regions involved in calcium dependent 
stabilization and self-association. European journal of biochemistry / FEBS 185, 271-279. 
 
Burden SJ. (2002). Building the verterbrate neuromuscular synapse. Journal of Neurobiology 53, 
501-511.  
161 
 
Burden SJ. (1998). The formation of neuromuscular synapses. Genes and Development 12, 133-
148. 
 
Burden SJ, DePalma RL & Gottesman GS. (1983). Crosslinking of proteins in acetylcholine 
receptor-rich membranes: association between the beta-subunit and the 43 kd subsynaptic 
protein. Cell 35, 687-692. 
 
Burgess RW. (2006). The Formation of the Vertebrate Neuromuscular Junction: Roles for the 
Extracellular Matrix in Synaptogenesis. In Molecular Mechanisms of Synaptogenesis, ed. 
Dityatev A & El-Husseini A, pp. 13-27. Springer US, Boston, MA. 
 
Burgess RW, Cox GA & Seburn KL. (2010). Neuromuscular disease models and analysis. Methods 
in molecular biology (Clifton, NJ) 602, 347-393. 
 
Burkin DJ, Gu M, Hodges BL, Campanelli JT & Kaufman SJ. (1998). A functional role for specific 
spliced variants of the alpha7beta1 integrin in acetylcholine receptor clustering. Journal of 
Cell Biology 143, 1067-1075. 
 
Burkin DJ, Kim JE, Gu M & Kaufman SJ. (2000). Laminin and alpha7 beta1 integrin regulate 
agrin-induced clustering of acetylcholine receptors. Journal of Cell Science 113 ( Pt 16), 
2877-2886. 
 
Calle Y, Burns S, Thrasher AJ & Jones GE. (2006). The leukocyte podosome. European Journal of 
Cell Biology 85, 151-157. 
 
Campanelli JT, Roberds SL, Campbell KP & Scheller RH. (1994). A role for dystrophin-associated 
glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77, 663-674. 
 
Carbonetto S & Lindenbaum M. (1995). The basement membrane at the neuromuscular junction: a 
synaptic mediatrix. Current Opinion in Neurobiology 5, 596-605. 
 
Carlson SS, Valdez G & Sanes JR. (2010). Presynaptic Calcium Channels and α3-Integrins are 
Complexed with Synaptic Cleft Laminins, Cytoskeletal Elements and Active Zone 
Components. Journal of Neurochemistry 115, 654-666. 
 
Carrasco DI, Bichler EK, Seburn KL & Pinter MJ. (2010). Nerve terminal degeneration is 
independent of muscle fiber genotype in SOD1 mice. PLoS One 5, e9802. 
 
Cartaud A. (1998). Evidence for in Situ and in Vitro Association between beta -Dystroglycan and 
the Subsynaptic 43K Rapsyn Protein. Consequence for Acetylcholine Receptor Clustering at 
the Synapse. Journal of Biological Chemistry 273, 11321-11326. 
 
Cartaud A, Strochlic L, Guerra M, Blanchard B, Lambergeon M, Krejci E, Cartaud J & Legay C. 
(2004). MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. 
Journal of Cell Biology 165, 505-515. 
 
Catterall WA. (2000). Structure and regulation of voltage-gated Ca2+ channels. Annual Review of 
Cell and Developmental Biology 16, 521-555. 
 
Ceccaldi PE, Grohovaz F, Benfenati F, Chieregatti E, Greengard P & Valtorta F. (1995). 
Dephosphorylated synapsin I anchors synaptic vesicles to actin cytoskeleton: an analysis by 
videomicroscopy. Journal of Cell Biology 128, 905-912. 
162 
 
Chai RJ, Vukovic J, Dunlop S, Grounds MD & Shavlakadze T. (2011). Striking Denervation of 
Neuromuscular Junctions without Lumbar Motoneuron Loss in Geriatric Mouse Muscle. 
PLoS One 6. 
 
Chakkalakal JV, Kuang S, Buffelli M, Lichtman JW & Sanes JR. (2012). Mouse transgenic lines 
that selectively label Type I, Type IIA, and Types IIX+B skeletal muscle fibers. Genesis 
(New York, NY : 2000) 50, 50-58. 
 
Chand KK, Lee KM, Schenning MP, Lavidis NA & Noakes PG. (2015). Loss of beta2-laminin 
alters calcium sensitivity and voltage-gated calcium channel maturation of 
neurotransmission at the neuromuscular junction. Journal of Physiology 593, 245-265. 
 
Charvin N, Leveque C, Walker D, Berton F, Raymond C, Kataoka M, ShojiKasai Y, Takahashi M, 
DeWaard M & Seagar MJ. (1997). Direct Interaction of the Calcium Sensor Protein 
Synaptotagmin I with a Cytoplasmic Domain of the α1A Subunit of the P/Q-type Calcium 
Channel. The EMBO Journal 16, 4591-4596. 
 
Chen J, Billings SE & Nishimune H. (2011). Calcium Channels Link the Muscle-Derived Synapse 
Organizer Laminin β2 to Bassoon and CAST/Erc2 to Organize Presynaptic Active Zones. 
Journal of Neuroscience 31, 512-525. 
 
Chen J, Mizushige T & Nishimune H. (2012). Active Zone Density is Conserved During Synaptic 
Growth but Impaired in Aged Mice. Journal of Comparative Neurology 520, 434-452. 
 
Chen ZL & Strickland S. (2003). Laminin gamma1 is critical for Schwann cell differentiation, axon 
myelination, and regeneration in the peripheral nerve. Journal of Cell Biology 163, 889-899. 
 
Chiu AY & Sanes JR. (1984). Development of Basal Lamina in Synaptic and Extrasynaptic 
Portions of Embryonic Rat Muscle. Developmental Biology 103, 456-467. 
 
Chung WS & Barres BA. (2009). Selective remodeling: refining neural connectivity at the 
neuromuscular junction. PLoS Biology 7, e1000185. 
 
Cleveland DW. (1999). From Charcot to SOD1: mechanisms of selective motor neuron death in 
ALS. Neuron 24, 515-520. 
 
Cohen MW, Hoffstrom BG & DeSimone DW. (2000). Active Zones on Motor Nerve Terminals 
Contain α3β1 Integrin. The Journal of Neuroscience 20, 4912-4921. 
 
Cohen MW, Jacobson C, Godfrey EW, Campbell KP & Carbonetto S. (1995). Distribution of 
alpha-dystroglycan during embryonic nerve-muscle synaptogenesis. Journal of Cell Biology 
129, 1093-1101. 
 
Cohen MW, Jacobson C, Yurchenco PD, Morris GE & Carbonetto S. (1997). Laminin-Induced 
Clustering of Dystroglycan on Embryonic Muscle Cells: Comparison With Agrin-Induced 
Clustering. Journal of Cell Biology 136, 1047-1058. 
 
Cohn RD, Herrmann R, Wewer UM & Voit T. (1997). Changes of Laminin β2 Chain Expression in 
Congenital Muscular Dystrophy. Neuromuscular Disorders 7, 373-378. 
 
Coleman WL, Bill CA & Bykhovskaia M. (2007). Rab3a deletion reduces vesicle docking and 
transmitter release at the mouse diaphragm synapse. Neuroscience 148, 1-6. 
163 
 
Coley W, Rayavarapu S, Pandey GS, Sabina RL, Van der Meulen JH, Ampong B, Wortmann RL, 
Rawat R & Nagaraju K. (2012). The molecular basis of skeletal muscle weakness in a 
mouse model of inflammatory myopathy. Arthritis and rheumatism 64, 3750-3759. 
 
Colognato H & Yurchenco PD. (2000). Form and Function: the Laminin Family of Heterotrimers. 
Developmental Dynamics 218, 213-234. 
 
Court FA, Gillingwater TH, Melrose S, Sherman DL, Greenshields KN, Morton AJ, Harris JB, 
Willison HJ & Ribchester RR. (2008). Identity, developmental restriction and reactivity of 
extralaminar cells cappting mammalian neuromuscular junctions. Journal of Cell Science 
121, 3901-3911.  
 
Couteaux R & Pecot-Dechavassine M. (1970). Synaptic vesicles and pouches at the level of "active 
zones" of the neuromuscular junction. Comptes rendus hebdomadaires des séances de 
l'Académie des sciences 271, 2346-2349. 
 
Covault J & Sanes JR. (1986). Distribution of N-CAM in synaptic and extrasynaptic portions of 
developing and adult skeletal muscle. Journal of Cell Biology 102, 716-730. 
 
Coyne AN, Siddegowda BB, Estes PS, Johannesmeyer J, Kovalik T, Daniel SG, Pearson A, Bowser 
R & Zarnescu DC. (2014). Futsch/MAP1B mRNA is a translational target of TDP-43 and is 
neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. Journal of 
Neuroscience 34, 15962-15974.  
 
Dai Z, Luo X, Xie H & Peng HB. (2000). The actin-driven movement and formation of 
acetylcholine receptor clusters. Journal of Cell Biology 150, 1321-1334. 
 
Darabid H, Perez-Gonzalez AP & Robitaille R. (2014). Neuromuscular Synaptogenesis: 
Coordinating Partners with Multiple Functions. Nature Reviews Neuroscience 15, 703-718. 
 
Day NC, Wood SJ, Ince PG, Volsen SG, Smith W, Slater CR & Shaw PJ. (1997). Differential 
Localization of Voltage-Dependent Calcium Channel α1 Subunits at the Human and Rat 
Neuromuscular Junction. Journal of Neuroscience 17, 6226-6235. 
 
DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, 
Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ & 
Yancopoulos GD. (1996). The Receptor Tyrosine Kinase MuSK is Required for 
Neuromuscular Junction Formation In Vivo. Cell 85, 501-512. 
 
Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, Metzinger L, Vincent A, 
Slater CR & Davies KE. (1997). Postsynaptic abnormalities at the neuromuscular junctions 
of utrophin-deficient mice. Journal of Cell Biology 136, 883-894. 
 
Del Castillo J & Katz B. (1954). Quantal Components of the End-Plate Potential. Journal of 
Physiology-London 124, 560-573. 
 
Delgado R, Maureira C, Oliva C, Kidokoro Y & Labarca P. (2000). Size of vesicle pools, rates of 
mobilization, and recycling at neuromuscular synapses of a Drosophila mutant, shibire. 
Neuron 28, 941-953. 
 
164 
 
Delwel GO, Hogervorst F & Sonnenberg A. (1996). Cleavage of the alpha 6A subunit is essential 
for activation of the alpha 6A beta 1 integrin by phorbol 12-myristate 13-acetate. Journal of 
Biological Chemistry 271, 7293-7296. 
 
Denker A & Rizzoli SO. (2010). Synaptic vesicle pools: an update. Frontiers in Synaptic 
Neuroscience 2, 1-12. 
 
Depetris RS, Nudler SI, Uchitel OD & Urbano FJ. (2008). Altered Synaptic Synchrony in Motor 
Nerve Terminals Lacking P/Q-Calcium Channels. Synapse 62, 466-471. 
 
Desaki J, Matsuda S & Sakanaka M. (1995). Morphological changes of neuromuscular junctions in 
the dystrophic (dy) mouse: a scanning and transmission electron microscopic study. Journal 
of electron microscopy 44, 59-65. 
 
Deschenes MR, Hurst TE, Ramser AE & Sherman EG. (2013). Presynaptic to Postsynaptic 
Relationships of the Neuromuscular Junction are Held Constant Across Age and Muscle 
Fiber Type. Developmental neurobiology 73, 744-753. 
 
Deschenes MR, Roby MA, Eason MK & Harris MB. (2010). Remodeling of the neuromuscular 
junction precedes sarcopenia related alterations in myofibers. Exp Gerontol 45, 389-393. 
 
Deschenes MR & Wilson MH. (2003). Age-related differences in synaptic plasticity following 
muscle unloading. Journal of Neurobiology 57, 246-256. 
 
Deyst KA, Bowe MA, Leszyk JD & Fallon JR. (1995). The alpha-dystroglycan-beta-dystroglycan 
complex. Membrane organization and relationship to an agrin receptor. Journal of 
Biological Chemistry 270, 25956-25959. 
 
Dobbins GC, Zhang B, Xiong WC & Mei L. (2006). The role of the cytoskeleton in neuromuscular 
junction formation. Journal of Molecular Neuroscience 30, 115-118. 
 
Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, Belia S, 
Wannenes F, Nicoletti C, Del Prete Z, Rosenthal N, Molinaro M, Protasi F, Fano G, Sandri 
M & Musaro A. (2008). Skeletal muscle is a primary target of SOD1G93A-mediated 
toxicity. Cell metabolism 8, 425-436. 
 
Dunaevsky A & Connor EA. (2000). F-actin is concentrated in nonrelease domains at frog 
neuromuscular junctions. Journal of Neuroscience 20, 6007-6012. 
 
Dyar KA, Ciciliot S, Wright LE, Bienso RS, Tagliazucchi GM, Patel VR, Forcato M, Paz MI, 
Gudiksen A, Solagna F, Albiero M, Moretti I, Eckel-Mahan KL, Baldi P, Sassone-Corsi P, 
Rizzuto R, Bicciato S, Pilegaard H, Blaauw B & Schiaffino S. (2014). Muscle insulin 
sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. Molecular 
metabolism 3, 29-41. 
 
Eisen A & Weber M. (2001). The motor cortex and amyotrophic lateral sclerosis. Muscle & nerve 
24, 564-573. 
 
Engel AG & Sine SM. (2005). Current understanding of congenital myasthenic syndromes. Current 
Opinion in Pharmacology 5, 308-321. 
 
165 
 
Engel J, Odermatt E, Engel A, Madri JA, Furthmayr H, Rohde H & Timpl R. (1981). Shapes, 
Domain Organizations and Flexibility of Laminin and Fibronectin, Two Multifunctional 
Proteins of the Extracellular Matrix. Journal of molecular biology 150, 97-120. 
 
Ervasti JM & Campbell KP. (1991). Membrane organization of the dystrophin-glycoprotein 
complex. Cell 66, 1121-1131. 
 
Ervasti JM & Campbell KP. (1993). A Role for the Dystrophin-Glycoprotein Complex as a 
Transmembrane Linker Between Laminin and Actin. Journal of Cell Biology 122, 809-823. 
 
Fagerlund MJ & Eriksson LI. (2009). Current concepts in neuromuscular transmission. British 
Journal of Anaesthesia 103, 108-114. 
 
Fahim MA. (1997). Endurance exercise modulates neuromuscular junction of C57BL/6NNia aging 
mice. Journal of applied physiology (Bethesda, Md : 1985) 83, 59-66. 
 
Fallini C, Bassell GJ & Rossoll W. (2012). The ALS disease protein TDP-43 is actively 
transported in motor neuron axons and regulates axon outgrowth. Human Molecular 
Genetics 21, 3703-3718. 
 
Fatt P & Katz B. (1952). Spontaneous Subthreshold Activity at Motor Nerve Endings. Journal of 
Physiology-London 117, 109-128. 
 
Fatt P & Katz B. (1953). The Electrical Properties of Crustacean Muscle Fibres. Journal of 
Physiology-London 120, 171-204. 
 
Feng Z & Ko C-P. (2008). The Role of Glial Cells in the Formation and Maintenance of the 
Neuromuscular Junction. Annals of the New York Academy of Sciences 1132, 19-28. 
 
Ferreira A, Kao HT, Feng J, Rapoport M & Greengard P. (2000). Synapsin III: developmental 
expression, subcellular localization, and role in axon formation. Journal of Neuroscience 20, 
3736-3744. 
 
Fertuck HC & Salpeter MM. (1974). Localization of Acetylcholine Receptor by 125I-Labeled α-
Bungarotoxin Binding at Mouse Motor Endplates. Proceedings of the National Academy of 
Sciences 71, 1376-1378. 
 
Finn AJ, Feng G & Pendergast AM. (2003). Postsynaptic requirement for Abl kinases in assembly 
of the neuromuscular junction. Nature Neuroscience 6, 717-723. 
 
Fischbach GD & Schuetze SM. (1980). A post-natal decrease in acetylcholine channel open time at 
rat end-plates. Journal of Physiology-London 303, 125-137. 
 
Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA 
& Glass JD. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice 
and man. Experimental Neurology 185, 232-240. 
 
Fischer von Mollard G, Mignery GA, Baumert M, Perin MS, Hanson TJ, Burger PM, Jahn R & 
Sudhof TC. (1990). rab3 is a small GTP-binding protein exclusively localized to synaptic 
vesicles. Proceedings of the National Academy of Sciences USA 87, 1988-1992. 
 
166 
 
Fischer von Mollard G, Stahl B, Li C, Sudhof TC & Jahn R. (1994). Rab proteins in regulated 
exocytosis. Trends in biochemical sciences 19, 164-168. 
 
Flucher BE & Daniels MP. (1989). Distribution of Na+ channels and ankyrin in neuromuscular 
junctions is complementary to that of acetylcholine receptors and the 43 kd protein. Neuron 
3, 163-175. 
 
Fogarty MJ, Hammond LA, Kanjhan R, Bellingham MC & Noakes PG. (2013). A Method for the 
Three-Dimensional Reconstruction of Neurobiotin™-Filled Neurons and the Location of 
their Synaptic Inputs. Frontiers in Neural Circuits 7. 
 
Fox A, Nowycky M & Tsien R. (1987). Kinetic and Pharmacological Properties Distinguishing 
Three Types of Calcium Currents in Chick Sensory Neurones. Journal of Physiology 394, 
149-172. 
 
Fox J, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, Mann K, Timpl R, Krieg T 
& Engel J. (1991). Recombinant Nidogen Consists of Three Globular Domains and 
Mediates Binding of Laminin to Collagen Type IV. The EMBO Journal 10, 3137-3146. 
 
Frey D, Schneider C, Xu L, Borg J, Spooren W & Caroni P. (2000). Early and selective loss of 
neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. 
Journal of Neuroscience 20, 2534-2542. 
 
Froehner SC, Luetje CW, Scotland PB & Patrick J. (1990). The postsynaptic 43K protein clusters 
muscle nicotinic acetylcholine receptors in Xenopus oocytes. Neuron 5, 403-410. 
 
Fujiwara H, Kikkawa Y, Sanzen N & Sekiguchi K. (2001). Purification and Characterization of 
Human Laminin-8. Journal of Biological Chemistry 276, 17550-17558. 
 
Fukunaga H, Engel AG, Lang B, Newsom-Davis J & Vincent A. (1983). Passive Transfer of 
Lambert-Eaton Myasthenic Syndrome with IGg from Man to Mouse Depletes the 
Presynaptic Membrane Active Zones. Proceedings of the National Academy of Sciences 80, 
7636-7640. 
 
Fukuoka T, Engel AG, Lang B, Newsom‐Davis J, Prior C & W‐Wray D. (1987). Lambert‐Eaton 
Myasthenic Syndrome: I. Early Morphological Effects of IGg on the Presynaptic Membrane 
Active Zones. Annals of neurology 22, 193-199. 
 
Garlich MW, Baltgalvis KA, Call JA, Dorsey LL & Lowe DA. (2010). Plantarflexion contracture in 
the mdx mouse. American journal of physical medicine & rehabilitation / Association of 
Academic Physiatrists 89, 976-985. 
 
Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP & J.R. S. (1996). Defective 
Neuromuscular Synaptogenesis in Agrin-Deficient Mutant Mice. Cell 85, 525-535 
 
Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR & Merlie JP. (1995). Failure of 
Postsynaptic Specialization to Develop at Neuromuscular Junctions of Rapsyn-Deficient 
Mice. Nature 377, 232-236. 
 
Gee SH, Montanaro F, Lindenbaum MH & Carbonetto S. (1994). Dystroglycan-alpha, a dystrophin-
associated glycoprotein, is a functional agrin receptor. Cell 77, 675-686. 
 
167 
 
Georgiou J, Robitaille R, Trimble WS & Chariton MP. (1994). Synaptic Regulation of Glial Protein 
Expression In Vivo. Neuron 12, 443-455. 
 
Geppert M, Bolshakov VY, Siegelbaum SA, Takei K, Decamilli P, Hammer RE & Sudhof TC. 
(1994). The Role of Rab3a in Neurotransmitter Release. Nature 369, 493-497. 
 
Gervasio OL & Phillips WD. (2005). Increased Ratio of Rapsyn to ACh Receptor Stabilizes 
Postsynaptic Receptors at the Mouse Neuromuscular Synapse. Journal of Physiology 562, 
673-685. 
 
Ghazanfari N, Fernandez KJ, Murata Y, Morsch M, Ngo ST, Reddel SW, Noakes PG & Phillips 
WD. (2011). Muscle Specific Kinase: Organiser of Synaptic Membrane Domains. The 
International Journal of Biochemistry and Cell Biology 43, 295-298. 
 
Gimona M, Buccione R, Courtneidge SA & Linder S. (2008). Assembly and biological role of 
podosomes and invadopodia. Current Opinion in Cell Biology 20, 235-241. 
 
Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, 
3rd, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, 
Goate AM & Cairns NJ. (2008). TDP-43 A315T mutation in familial motor neuron disease. 
Annals of Neurology 63, 535-538. 
 
Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, 
Burden SJ, DiStefano PS, Valenzuela DM, DeChiara TM & Yancopoulos GD. (1996). 
Agrin Acts via a MuSK Receptor Complex. Cell 85, 513-523. 
 
Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, 
Frederik P, Molenaar PC, Martinez-Martinez P, De Baets MH & Losen M. (2010). 
Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular 
junction. Autoimmunity 43, 353-370. 
 
Goold R, Chan KM & Baines AJ. (1995). Coordinated regulation of synapsin I interaction with F-
actin by Ca2+/calmodulin and phosphorylation: inhibition of actin binding and bundling. 
Biochemistry 34, 1912-1920. 
 
Gorecki DC, Derry JM & Barnard EA. (1994). Dystroglycan: brain localisation and chromosome 
mapping in the mouse. Human Molecular Genetics 3, 1589-1597. 
 
Gould TW. (2006). Complete Dissociation of Motor Neuron Death from Motor Dysfunction by Bax 
Deletion in a Mouse Model of ALS. Journal of Neuroscience 26, 8774-8786. 
 
Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP & Sanes JR. (2000). Maturation 
and Maintenance of the Neuromuscular Synapse: Genetic Evidence for Roles of the 
Dystrophin-Glycoprotein Complex. Neuron 25, 279-293. 
 
Greengard P, Benfenati F & Valtorta F. (1994). Synapsin I, an actin-binding protein regulating 
synaptic vesicle traffic in the nerve terminal. Advances in second messenger and 
phosphoprotein research 29, 31-45. 
 
Greengard P, Valtorta F, Czernik AJ & Benfenati F. (1993). Synaptic Vesicle Phosphoproteins and 
Regulation of Synaptic Function. Science 259, 780-785. 
 
168 
 
Gu Y & Hall ZW. (1988). Immunological Evidence for a Change in Subunits of the Acetylcholine 
Receptor and Denervated Rat Muscle. Neuron 1, 117-125. 
 
Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G & Giancotti FG. (2006). Beta 4 
integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126, 489-502. 
 
Hall ZW & Sanes JR. (1993). Synaptic structure and development: the neuromuscular junction. Cell 
72 Suppl, 99-121. 
 
Hanley T & Merlie JP. (1991). Transgene detection in unpurified mouse tail DNA by polymerase 
chain reaction. Biotechniques 10, 56-56. 
 
Hantai D, Richard P, Koenig J & Eymard B. (2004). Congenital myasthenic syndromes. Current 
opinion in neurology 17, 539-551. 
 
Harlow ML, Ress D, Stoschek A, Marshall RM & McMahan UJ. (2001). The Architecture of 
Active Zone Material at the Frog's Neuromuscular Junction. Nature 409, 479-484. 
 
Hata K, Polo-Parada L & Landmesser LT. (2007). Selective Targeting of Different Neural Cell 
Adhesion Molecule Isoforms During Motoneuron Myotube Synapse Formation in Culture 
and the Switch from an Immature to Mature form of Synaptic Vesicle Cycling. The Journal 
of Neuroscience 27, 14481-14493. 
 
Hegedus J, Putman CT & Gordon T. (2007). Time course of preferential motor unit loss in the 
SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease 28, 
154-164. 
 
Hegedus J, Putman CT, Tyreman N & Gordon T. (2008). Preferential motor unit loss in the SOD1 
G93A transgenic mouse model of amyotrophic lateral sclerosis. Journal of Physiology 586, 
3337-3351. 
 
Hemler ME. (1999). Dystroglycan versatility. Cell 97, 543-546. 
 
Henry MD & Campbell KP. (1996). Dystroglycan: An Extracellular Matrix Receptor Linked to the 
Cytoskeleton. Current Opinion in Cell Biology 8, 625-631. 
 
Henry MD & Campbell KP. (1999). Dystroglycan inside and out. Current Opinion in Cell Biology 
11, 602-607. 
 
Herbst R & Burden SJ. (2000). The juxtamembrane region of MuSK has a critical role in agrin-
mediated signaling. The EMBO Journal 19, 67-77. 
 
Heuser J, Reese T, Dennis M, Jan Y, Jan L & Evans L. (1979). Synaptic Vesicle Exocytosis 
Captured by Quick Freezing and Correlated with Quantal Transmitter Release. Journal of 
Cell Biology 81, 275-300. 
 
Heuser JE & Reese TS. (1973). Evidence for recycling of synaptic vesicle membrane during 
transmitter release at the frog neuromuscular junction. Journal of Cell Biology 57, 315-344. 
 
Hida Y & Ohtsuka T. (2010). CAST and ELKS Proteins: Structural and Functional Determinants of 
the Presynaptic Active Zone. Journal of Biochemistry 148, 131-137. 
 
169 
 
Higginson JR & Winder SJ. (2005). Dystroglycan: a multifunctional adaptor protein. Biochemical 
Society transactions 33, 1254-1255. 
 
Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ & Greengard P. (1999). Synapsins as 
regulators of neurotransmitter release. Philosophical transactions of the Royal Society of 
London Series B, Biological sciences 354, 269-279. 
 
Hilfiker S, Schweizer FE, Kao HT, Czernik AJ, Greengard P & Augustine GJ. (1998). Two sites of 
action for synapsin domain E in regulating neurotransmitter release (vol 1, pg 29, 1998). 
Nature Neuroscience 1, 329-329. 
 
Hirosaki T, Mizushima H, Tsubota Y, Moriyama K & Miyazaki K. (2000). Structural requirement 
of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell 
adhesion and migration by laminin-5. Journal of Biological Chemistry 275, 22495-22502. 
 
Hohenester E & Yurchenco PD. (2013). Laminins in Basement Membrane Assembly. Cell 
Adhesion and Migration 7, 56-63. 
 
Hosaka M, Hammer RE & Sudhof TC. (1999). A Phospho-Switch Controls the Dynamic 
Association of Synapsins with Synaptic Vesicles. Neuron 24, 377-387. 
 
Hosaka M & Sudhof TC. (1998). Synapsin III, a Novel Synapsin with an Unusual Regulation by 
Ca2+. Journal of Biological Chemistry 273, 13371-13374. 
 
Hughes BW, Kusner LL & Kaminski HJ. (2006). Molecular Architecture of the Neuromuscular 
Junction. Muscle & nerve 33, 445-461. 
 
Humeau Y, Doussau F, Vitiello F, Greengard P, Benfenati F & Poulain B. (2001). Synapsin 
controls both reserve and releasable synaptic vesicle pools during neuronal activity and 
short-term plasticity in Aplysia. Journal of Neuroscience 21, 4195-4206. 
 
Hummel T, Krukkert K, Roos J, Davis G & Kla¨mbt C. (2000). Drosophila Futsch/22C10 is a 
MAP1B-like protein required for dendritic and axonal development. Neuron 26, 357–370. 
 
Hunter DD, Cashman N, Morris-Valero R, Bulock JW, Adams SP & Sanes JR. (1991). An LRE 
(leucine-arginine-glutamate)-dependent mechanism for adhesion of neurons to S-laminin. 
Journal of Neuroscience 11, 3960-3971. 
 
Hunter DD, Porter BE, Bulock JW, Adams SP, Merlie JP & Sanes JR. (1989a). Primary Sequence 
of a Motor Neuron Selective Adhesive Site in the Synaptic Basal Lamina Protein S-
Laminin. Cell 59, 905-913. 
 
Hunter DD, Shah V, Merlie JP & Sanes JR. (1989b). A Laminin-like Adhesive Protein 
Concentrated in the Synaptic Cleft of the Neuromuscular-Junction. Nature 338, 229-234. 
 
Huttner WB, Schiebler W, Greengard P & De Camilli P. (1983). Synapsin I (protein I), a nerve 
terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a 
highly purified synaptic vesicle preparation. Journal of Cell Biology 96, 1374-1388. 
 
Hynes RO. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687. 
 
170 
 
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW & Campbell KP. 
(1992). Primary structure of dystrophin-associated glycoproteins linking dystrophin to the 
extracellular matrix. Nature 355, 696-702. 
 
Ido H, Harada K, Futaki S, Hayashi Y, Nishiuchi R, Natsuka Y, Li S, Wada Y, Combs AC & 
Ervasti JM. (2004). Molecular Dissection of the α-Dystroglycan-and Integrin-Binding Sites 
within the Globular Domain of Human Laminin-10. Journal of Biological Chemistry 279, 
10946-10954. 
 
Ido H, Nakamura A, Kobayashi R, Ito S, Li S, Futaki S & Sekiguchi K. (2007). The Requirement of 
the Glutamic Acid Residue at the Third Position from the Carboxyl Termini of the Laminin 
γ Chains in Integrin Binding by Laminins. Journal of Biological Chemistry 282, 11144-
11154. 
 
Itoh A, Horiuchi M, Wakayama K, Xu J, Bannerman P, Pleasure D & Itoh T. (2011). ZPK/DLK, a 
mitogen-activated protein kinase kinase kinase, is a critical mediator of programmed cell 
death of motoneurons. Journal of Neuroscience 31, 7223-7228. 
 
Jacobson C, Côté PD, Rossi SG, Rotundo RL & Carbonetto S. (2001). The dystroglycan complex is 
necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and 
formation of the synaptic basement membrane. Journal of Cell Biology 152, 435-450. 
 
Jang YC, Lustgarten MS, Liu Y, Muller FL, Bhattacharya A, Liang H, Salmon AB, Brooks SV, 
Larkin L, Hayworth CR, Richardson A & Van Remmen H. (2010). Increased superoxide in 
vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and 
neuromuscular junction degeneration. The FASEB Journal 24, 1376-1390. 
 
Johnson AM & Connor NP. (2011). Effects of Electrical Stimulation on Neuromuscular Junction 
Morphology in the Aging Rat Tongue. Muscle & Nerve 43, 203-211. 
 
Johnston PA, Archer BT, Robinson K, Mignery GA, Jahn R & Sudhof TC. (1991). Rab3a 
Attachment to the Synaptic Vesicle Membrane Mediated by a Conserved Polyisoprenylated 
Carboxy-Terminal Sequence. Neuron 7, 101-109. 
 
Juranek J, Mukherjee K, Rickmann M, Martens H, Calka J, Südhof TC & Jahn R. (2006). 
Differential Expression of Active Zone Proteins in Neuromuscular Junctions Suggests 
Functional Diversification. European Journal of Neuroscience 24, 3043-3052. 
 
Jurdic P, Saltel F, Chabadel A & Destaing O. (2006). Podosome and sealing zone: specificity of the 
osteoclast model. European Journal of Cell Biology 85, 195-202. 
 
Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, 
Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N & 
Rouleau GA. (2008). TARDBP mutations in individuals with sporadic and familial 
amyotrophic lateral sclerosis. Nature Genetics 40, 572-574. 
 
Kao H-T, Porton B, Czernik AJ, Feng J, Yiu G, Häring M, Benfenati F & Greengard P. (1998). A 
Third Member of the Synapsin Gene Family. Proceedings of the National Academy of 
Sciences 95, 4667-4672. 
 
171 
 
Kao HT, Porton B, Hilfiker S, Stefani G, Pieribone VA, DeSalle R & Greengard P. (1999). 
Molecular Evolution of the Synapsin Gene Family. Journal of Experimental Zoology 285, 
360-377. 
 
Katz E, Ferro PA, Weisz G & Uchitel OD. (1996). Calcium Channels Involved in Synaptic 
Transmission at the Mature and Regenerating Mouse Neuromuscular Junction. Journal of 
Physiology-London 497, 687-697. 
 
Katz LC & Shatz CJ. (1996). Synaptic Activity and the Construction of Cortical Circuits. Science 
274, 1133-1138. 
 
Kaverina I, Stradal TE & Gimona M. (2003). Podosome formation in cultured A7r5 vascular 
smooth muscle cells requires Arp2/3-dependent de-novo actin polymerization at discrete 
microdomains. Journal of Cell Science 116, 4915-4924. 
 
Keith RK, Poage RE, Yokoyama CT, Catterall WA & Meriney SD. (2007). Bidirectional 
Modulation of Transmitter Release by Calcium Channel/Syntaxin Interactions In Vivo. 
Journal of Neuroscience 27, 265-269. 
 
Kikkawa Y, Moulson CL, Virtanen I & Miner JH. (2002). Identification of the binding site for the 
Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric 
laminin chains in vivo. Journal of Biological Chemistry 277, 44864-44869. 
 
Kim DK & Catterall WA. (1997). Ca2+-Dependent and-Independent Interactions of the Isoforms of 
the α1A Subunit of Brain Ca2+ Channels with Presynaptic SNARE Proteins. Proceedings of 
the National Academy of Sciences 94, 14782-14786. 
 
Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML & 
Burden SJ. (2008). Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135, 
334-342. 
 
Kishi M, Kummer TT, Eglen SJ & Sanes JR. (2005). LL5beta: a regulator of postsynaptic 
differentiation identified in a screen for synaptically enriched transcripts at the 
neuromuscular junction. Journal of Cell Biology 169, 355-366. 
 
Kiyonaka S, Wakamori M, Miki T, Uriu Y, Nonaka M, Bito H, Beedle AM, Mori E, Hara Y, De 
Waard M, Kanagawa M, Itakura M, Takahashi M, Campbell KP & Mori Y. (2007). RIM1 
Confers Sustained Activity and Neurotransmitter Vesicle Anchoring to Presynaptic Ca2+ 
Channels. Nature Neuroscience 10, 691-701. 
 
Klugbauer N, Marais E & Hofmann F. (2003). Calcium Channel Alpha(2)Delta Subunits: 
Differential Expression, Function, and Drug Binding. Journal of Bioenergetics and 
Biomembranes 35, 639-647. 
 
Knight D, Tolley LK, Kim DK, Lavidis NA & Noakes PG. (2003). Functional Analysis of 
Neurotransmission at β2-laminin Deficient Terminals. Journal of Physiology-London 546, 
789-800. 
 
Kong L, Wang X, Choe DW, Polley M, Burnett BG, Bosch-Marce M, Griffin JW, Rich MM & 
Sumner CJ. (2009). Impaired synaptic vesicle release and immaturity of neuromuscular 
junctions in spinal muscular atrophy mice. Journal of Neuroscience 29, 842-851. 
 
172 
 
Kong XC, Barzaghi P & Ruegg MA. (2004). Inhibition of synapse assembly in mammalian muscle 
in vivo by RNA interference. EMBO reports 5, 183-188. 
 
Krejci E, Coussen F, Duval N, Chatel JM, Legay C, Puype M, Vandekerckhove J, Cartaud J, Bon S 
& Massoulie J. (1991). Primary Structure of a Collagenic Tail Peptide of Torpedo 
Acetylcholinesterase: Co-Expression with Catalytic Subunit Induces the Production of 
Collagen-Tailed Forms in Transfected Cells. The EMBO Journal 10, 1285-1293. 
 
Krejci E, Thomine S, Boschetti N, Legay C, Sketelj J & Massoulie J. (1997). The Mammalian Gene 
of Acetylcholinesterase-Associated Collagen. Journal of Biological Chemistry 272, 22840-
22847. 
 
Kulakowski SA, Parker SD & Personius KE. (2011). Reduced TrkB expression results in 
precocious age-like changes in neuromuscular structure, neurotransmission, and muscle 
function. Journal of applied physiology (Bethesda, Md : 1985) 111, 844-852. 
 
Kuromi H & Kidokoro Y. (1998). Two distinct pools of synaptic vesicles in single presynaptic 
boutons in a temperature-sensitive Drosophila mutant, shibire. Neuron 20, 917-925. 
 
Kuromi H & Kidokoro Y. (2000). Tetanic stimulation recruits vesicles from reserve pool via a 
cAMP-mediated process in Drosophila synapses. Neuron 27, 133-143. 
 
Lacinova L. (2005). Voltage-Dependent Calcium Channels. General physiology and biophysics 24 
Suppl 1, 1-78. 
 
Lagier-Tourenne C, Polymenidou M & Cleveland DW. (2010). TDP-43 and FUS/TLS: emerging 
roles in RNA processing and neurodegeneration. Human Molecular Genetics 19, R46-64. 
 
Lamboley CR, Wyckelsma VL, Dutka TL, McKenna MJ, Murphy RM & Lamb GD. (2015). 
Contractile properties and sarcoplasmic reticulum calcium content in type I and type II 
skeletal muscle fibres in active aged humans. Journal of Physiology 593, 2499-2514. 
 
Lanuza MA, Garcia N, Santafe M, Gonzalez CM, Alonso I, Nelson PG & Tomas J. (2002). Pre- and 
Postsynaptic Maturation of the Neuromuscular Junction During Neonatal Synapse 
Elimination Depends on Protein Kinase C. Journal of Neuroscience Research 67, 607-617. 
 
Laskowski MB & Sanes JR. (1988). Topographically selective reinnervation of adult mammalian 
skeletal muscles. Journal of Neuroscience 8, 3094-3099. 
 
Law PK, Saito A & Fleischer S. (1983). Ultrastructural changes in muscle and motor end-plate of 
the dystrophic mouse. Experimental Neurology 80, 361-382. 
 
Le Quang K, Benito B, Naud P, Qi XY, Shi YF, Tardif JC, Gillis MA, Dobrev D, Charpentier F & 
Nattel S. (2013). T-type calcium current contributes to escape automaticity and governs the 
occurrence of lethal arrhythmias after atrioventricular block in mice. Circulation Arrhythmia 
and electrophysiology 6, 799-808. 
 
Legay C. (2000). Why so many forms of acetylcholinesterase? Microscopy Research and Technique 
49, 56-72. 
 
Lener T, Burgstaller G, Crimaldi L, Lach S & Gimona M. (2006). Matrix-degrading podosomes in 
smooth muscle cells. European Journal of Cell Biology 85, 183-189. 
173 
 
Li L, Chin L-S, Shupliakov O, Brodin L, Sihra TS, Hvalby O, Jensen V, Zheng D, McNamara JO & 
Greengard P. (1995). Impairment of Synaptic Vesicle Clustering and of Synaptic 
Transmission, and Increased Seizure Propensity, in Synapsin I-Deficient Mice. Proceedings 
of the National Academy of Sciences 92, 9235-9239. 
 
Li Y, Lee YI & Thompson WJ. (2011). Changes in aging mouse neuromuscular junctions are 
explained by degeneration and regeneration of muscle fiber segments at the synapse. 
Journal of Neuroscience 31, 14910-14919.  
 
Lin WC, Burgess RW, Dominguez B, Pfaff SL, Sanes JR & Lee KF. (2001). Distinct Roles of 
Nerve and Muscle in Postsynaptic Differentiation of the Neuromuscular Synapse. Nature 
410, 1057-1064. 
 
Linder S, Wiesner C & Himmel M. (2011). Degrading devices: invadosomes in proteolytic cell 
invasion. Annual Review of Cell and Developmental Biology 27, 185-211. 
 
Ling SC, Polymenidou M & Cleveland DW. (2013). Converging mechanisms in ALS and FTD: 
disrupted RNA and protein homeostasis. Neuron 79, 416-438. 
 
Liu JX, Brannstrom T, Andersen PM & Pedrosa-Domellof F. (2011). Different Impact of ALS on 
Laminin Isoforms in Human Extraocular Muscles Versus Limb Muscles. Investigative 
Ophthalmology & Visual Science 52, 4842-4852. 
 
Liu JX, Brannstrom T, Andersen PM & Pedrosa-Domellof F. (2013). Distinct changes in synaptic 
protein composition at neuromuscular junctions of extraocular muscles versus limb muscles 
of ALS donors. PLoS One 8, e57473. 
 
Llinas R, McGuinness TL, Leonard CS, Sugimori M & Greengard P. (1985). Intraterminal injection 
of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter 
release at the squid giant synapse. Proceedings of the National Academy of Sciences USA 
82, 3035-3039. 
 
Mackenzie IR, Rademakers R & Neumann M. (2010). TDP-43 and FUS in amyotrophic lateral 
sclerosis and frontotemporal dementia. The Lancet Neurology 9, 995-1007. 
 
Magillsolc C & McMahan UJ. (1988). Motor neurons contain agrin-like molecules. Journal of Cell 
Biology 107, 1825-1833. 
 
Mantilla C, Rowley K, Zhan W-Z, Fahim M & Sieck G. (2007). Synaptic Vesicle Pools at 
Diaphragm Neuromuscular Junctions Vary with Motoneuron Soma, not Axon Terminal, 
Inactivity. Neuroscience 146, 178-189. 
 
Mantilla CB & Sieck GC. (2009). Neuromuscular Adaptations to Respiratory Muscle Inactivity. 
Respiratory Physiology & Neurobiology 169, 133-140. 
 
Marangi PA, Wieland ST & Fuhrer C. (2002). Laminin-1 redistributes postsynaptic proteins and 
requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine 
receptors. Journal of Cell Biology 157, 883-895. 
 
Marchisio PC. (2012). Fortuitous birth, convivial baptism and early youth of podosomes. European 
Journal of Cell Biology 91, 820-823. 
 
174 
 
Marcuzzo S, Zucca I, Mastropietro A, de Rosbo NK, Cavalcante P, Tartari S, Bonanno S, Preite L, 
Mantegazza R & Bernasconi P. (2011). Hind limb muscle atrophy precedes cerebral 
neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a 
longitudinal MRI study. Experimental Neurology 231, 30-37. 
 
Marques MJ, Conchello J-A & Lichtman JW. (2000). From Plaque to Pretzel: Fold Formation and 
Acetylcholine Receptor Loss at the Developing Neuromuscular Junction. The Journal of 
Neuroscience 20, 3663-3675. 
 
Martin GR & Timpl R. (1987). Laminin and other basement membrane components. Annual review 
of cell biology 3, 57-85. 
 
Martin PT, Kaufman SJ, Kramer RH & Sanes JR. (1996). Synaptic Integrins in Developing, Adult, 
and Mutant Muscle: Selective Association of β1, α7A, and α7B Integrins with the 
Neuromuscular Junction. Developmental Biology 174, 125-139. 
 
Martin PT & Sanes JR. (1997). Integrins Mediate Adhesion to Agrin and Modulate Agrin 
Signaling. Development 124, 3909-3917. 
 
Martinez-Martinez P, Phernambucq M, Steinbusch L, Schaeffer L, Berrih-Aknin S, Duimel H, 
Frederik P, Molenaar P, De Baets MH & Losen M. (2009). Silencing rapsyn in vivo 
decreases acetylcholine receptors and augments sodium channels and secondary 
postsynaptic membrane folding. Neurobiology of Disease 35, 14-23. 
 
Martinez-Pena y Valenzuela I, Mouslim C & Akaaboune M. (2010). Calcium/calmodulin kinase II-
dependent acetylcholine receptor cycling at the mammalian neuromuscular junction in vivo. 
Journal of Neuroscience 30, 12455-12465. 
 
Martinou JC & Merlie JP. (1991). Nerve-Dependent Modulation of Acetylcholine Receptor 
Epsilon-Subunit Gene Expression. Journal of Neuroscience 11, 1291-1299. 
 
Maselli R, Ng J, Anderson J, Cagney O, Arredondo J, Williams C, Wessel H, Abdel-Hamid H & 
Wollmann R. (2009). Mutations in LAMB2 Causing a Severe Form of Synaptic Congenital 
Myasthenic Syndrome. Journal of medical genetics 46, 203-208. 
 
Maselli RA, Arredondo J, Ferns MJ & Wollmann RL. (2012). Synaptic basal lamina-associated 
congenital myasthenic syndromes. Annals of the New York Academy of Sciences 1275, 36-
48. 
 
Mayer U, Saher G, Fassler R, Bornemann A, Echtermeyer F, von der Mark H, Miosge N, Poschl E 
& von der Mark K. (1997). Absence of integrin alpha 7 causes a novel form of muscular 
dystrophy. Nature Genetics 17, 318-323. 
 
Mazhar S & Herbst R. (2012). The formation of complex acetylcholine receptor clusters requires 
MuSK kinase activity and structural information from the MuSK extracellular domain. 
Molecular and Cell Neuroscience 49, 475-486. 
 
Macintosh BR, Gardiner PF & McCormasm AJ (2006). Recovery of Muscle Innervation. In 
Skeletal muscle: form and function, pp. 257-270. Human Kinetics US.  
 
175 
 
McKee KK, Capizzi S & Yurchenco PD. (2009). Scaffold-forming and Adhesive Contributions of 
Synthetic Laminin-binding Proteins to Basement Membrane Assembly. Journal of 
Biological Chemistry 284, 8984-8994. 
 
McKee KK, Harrison D, Capizzi S & Yurchenco PD. (2007). Role of Laminin Terminal Globular 
Domains in Basement Membrane Assembly. Journal of Biological Chemistry 282, 21437-
21447. 
 
Meriney SD & Dittrich M. (2013). Organization and Function of Transmitter Release Sites at the 
Neuromuscular Junction. Journal of Physiology 591, 3159-3165. 
 
Miner JH. (2006). Transgenic isolation of skeletal muscle and kidney defects in laminin β2 mutant 
mice: implications for Pierson syndrome. Development 133, 967-975. 
 
Miner JH, Cunningham J & Sanes JR. (1998). Roles for Laminin in Embryogenesis: Exencephaly, 
Syndactyly, and Placentopathy in Mice Lacking the Laminin a5 Chain. Journal of Cell 
Biology 143, 1713-1723. 
 
Miner JH, Li C, Mudd JL, Go G & Sutherland AE. (2004). Compositional and structural 
requirements for laminin and basement membranes during mouse embryo implantation and 
gastrulation. Development 131, 2247-2256. 
 
Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG & Sanes JR. 
(1997). The Laminin Alpha Chains: Expression, Developmental Transitions, and 
Chromosomal Locations of α1-5, Identification of Heterotrimeric Laminins 8-11, and 
Cloning of a Novel α3 Isoform. Journal of Cell Biology 137, 685-701. 
 
Miner JH & Yurchenco PD. (2004). Laminin Functions in Tissue Morphogenesis. Annual Review of 
Cell and Developmental Biology 20, 255-284. 
 
Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, Methfessel C & Sakmann B. (1986). 
Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. 
Nature 321, 406-411. 
 
Missias AC, Chu GC, Klocke BJ, Sanes JR & Merlie JP. (1996). Maturation of the acetylcholine 
receptor in skeletal muscle: Regulation of the AChR gamma-to-epsilon switch. 
Developmental Biology 179, 223-238. 
 
Mittaud P, Camilleri AA, Willmann R, Erb-Vögtli S, Burden SJ & Fuhrer C. (2004). A Single Pulse 
of Agrin Triggers a Pathway that Acts to Cluster Acetylcholine Receptors. Molecular and 
cellular biology 24, 7841-7854. 
 
Mittaud P, Marangi PA, Erb-Vogtli S & Fuhrer C. (2001). Agrin-induced activation of 
acetylcholine receptor-bound Src family kinases requires Rapsyn and correlates with 
acetylcholine receptor clustering. Journal of Biological Chemistry 276, 14505-14513. 
 
Mochida S, Sheng ZH, Baker C, Kobayashi H & Catterall WA. (1996). Inhibition of 
neurotransmission by peptides containing the synaptic protein interaction site of N-type 
Ca2+ channels. Neuron 17, 781-788. 
 
176 
 
Mohamed AS, Rivas-Plata KA, Kraas JR, Saleh SM & Swope SL. (2001). Src-class kinases act 
within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, 
cytoskeletal anchoring, and clustering. Journal of Neuroscience 21, 3806-3818. 
 
Moloney EB, de Winter F & Verhaagen J. (2014). ALS as a distal axonopathy: molecular 
mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the 
disease. Frontiers in Neuroscience 8, 252.  
 
Moreno Davila H. (1999). Molecular and Functional Diversity of Voltage-Gated Calcium Channels. 
Annals of the New York Academy of Sciences 868, 102-117. 
 
Mori Y, Friedrich T, Kim MS, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, 
Furuichi T, Mikoshiba K, Imoto K, Tanabe T & Numa S. (1991). Primary structure and 
functional expression from complementary DNA of a brain calcium channel. Nature 350, 
398-402. 
 
Moscoso LM, Cremer H & Sanes JR. (1998). Organization and reorganization of neuromuscular 
junctions in mice lacking neural cell adhesion molecule, tenascin-C, or fibroblast growth 
factor-5. Journal of Neuroscience 18, 1465-1477. 
 
Murphy DA & Courtneidge SA. (2011). The 'ins' and 'outs' of podosomes and invadopodia: 
characteristics, formation and function. Nature reviews Molecular cell biology 12, 413-426. 
 
Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K & Gillingwater TH. (2008). Selective 
vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the 
neuromuscular junction in mouse models of spinal muscular atrophy. Human Molecular 
Genetics 17, 949-962. 
 
Myoga MH & Regehr WG. (2011). Calcium microdomains near R-type calcium channels control 
the induction of presynaptic long-term potentiation at parallel fiber to purkinje cell synapses. 
Journal of Neuroscience 31, 5235-5243. 
 
Nagel A, Engel AG, Lang B, Newsom-Davis J & Fukuoka T. (1988). Lambert-Eaton myasthenic 
syndrome IgG depletes presynaptic membrane active zone particles by antigenic 
modulation. Annals of Neurology 24, 552-558. 
 
Nagwaney S, Harlow ML, Jung JH, Szule JA, Ress D, Xu J, Marshall RM & McMahan UJ. (2009). 
Macromolecular Connections of Active Zone Material to Docked Synaptic Vesicles and 
Presynaptic Membrane at Neuromuscular Junctions of Mouse. Journal of Comparative 
Neurology 513, 457-468. 
 
Narayanan RK, Mangelsdorf M, Panwar A, Butler TJ, Noakes PG & Wallace RH. (2013). 
Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse 
brain. Amyotrophic lateral sclerosis & frontotemporal degeneration 14, 252-260. 
 
Neher E & Sakaba T. (2008). Multiple Roles of Calcium Ions in the Regulation of Neurotransmitter 
Release. Neuron 59, 861-872. 
 
Ngo ST, Noakes PG & Phillips WD. (2007). Neural Agrin: A Synaptic Stabiliser. International 
Journal of Biochemistry & Cell Biology 39, 863-867. 
 
177 
 
Nguyen NM, Kelley DG, Schlueter JA, Meyer MJ, Senior RM & Miner JH. (2005). Epithelial 
Laminin α5 is Necessary for Distal Epithelial Cell Maturation, VEGF Production, and 
Alveolization in the Developing Murine Lung. Developmental biology 282, 111-125. 
 
Nguyen QT, Son YJ, Sanes JR & Lichtman JW. (2000). Nerve terminals form but fail to mature 
when postsynaptic differentiation is blocked: in vivo analysis using mammalian nerve-
muscle chimeras. Journal of Neuroscience 20, 6077-6086. 
 
Nishimune H, Badawi Y, Mori S & Shigemoto K. (2016). Dual-color STED microscopy reveals a 
sandwich structure of Bassoon and Piccolo in active zones of adult and aged mice. Scientific 
reports 6, 27935. 
 
Nishimune H, Numata T, Chen J, Aoki Y, Wang Y, Starr MP, Mori Y & Stanford JA. (2012). 
Active Zone Protein Bassoon Co-Localizes with Presynaptic Calcium Channel, Modifies 
Channel Function, and Recovers from Aging Related Loss by Exercise. PLoS One 7, 
e38029. 
 
Nishimune H, Sanes JR & Carlson SS. (2004). A Synaptic Laminin-Calcium Channel Interaction 
Organizes Active Zones in Motor Nerve Terminals. Nature 432, 580-587. 
 
Nishimune H, Valdez G, Jarad G, Moulson CL, Muller U, Miner JH & Sanes JR. (2008). Laminins 
Promote Postsynaptic Maturation by an Autocrine Mechanism at the Neuromuscular 
Junction. Journal of Cell Biology 182, 1201-1215. 
 
Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, Sanzen N, Tsuji T, Yamada M & Sekiguchi K. 
(2006). Ligand-Binding Specificities of Laminin-Binding Integrins: A Comprehensive 
Survey of Laminin–Integrin Interactions Using Recombinant α3β1, α6β1, α7β1 and α6β4 
Integrins. Matrix biology 25, 189-197. 
 
Noakes PG, Gautam M, Mudd J, Sanes JR & Merlie JP. (1995a). Aberrant Differentiation of 
Neuromuscular Junctions in Mice Lacking s-laminin/laminin β2. Nature 374, 258-262. 
 
Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR & Merlie JP. (1995b). The Renal 
Glomerulus of Mice Lacking S-laminin/laminin β2: Nephrosis Despite Molecular 
Compensation by Laminin β1. Nature Genetics 10, 400-406. 
 
Nonet ML, Staunton JE, Kilgard MP, Fergestad T, Hartwieg E, Horvitz HR, Jorgensen EM & 
Meyer BJ. (1997). Caenorhabditis Elegans rab-3 Mutant Synapses Exhibit Impaired 
Function and are Partially Depleted of Vesicles. Journal of Neuroscience 17, 8061-8073. 
 
Nowycky MC, Fox AP & Tsien RW. (1985). Three types of neuronal calcium channel with 
different calcium agonist sensitivity. Nature 316, 440-443. 
 
Nudler S, Piriz J, Urbano FJ, Rosato‐Siri MD, Renteria ESP & Uchitel OD. (2003). Ca2+ Channels 
and Synaptic Transmission at the Adult, Neonatal, and P/Q‐Type Deficient Neuromuscular 
Junction. Annals of the New York Academy of Sciences 998, 11-17. 
 
O'Malley JP, Waran MT & Balice-Gordon RJ. (1999). In vivo observations of terminal Schwann 
cells at normal, denervated, and reinnervated mouse neuromuscular junctions. Journal of 
Neurobiology 38, 270-286. 
 
178 
 
Ohtsuka T, Takao-Rikitsu E, Inoue E, Inoue M, Takeuchi M, Matsubara K, Deguchi-Tawarada M, 
Satoh K, Morimoto K, Nakanishi H & Takai Y. (2002). CAST: a Novel Protein of the 
Cytomatrix at the Active Zone of Synapses that Forms a Ternary Complex with RIM1 and 
Munc13-1. Journal of Cell Biology 158, 577-590. 
 
Ory S, Brazier H, Pawlak G & Blangy A. (2008). Rho GTPases in osteoclasts: orchestrators of 
podosome arrangement. European Journal of Cell Biology 87, 469-477. 
 
Ozaki N, Shibasaki T, Kashima Y, Miki T, Takahashi K, Ueno H, Sunaga Y, Yano H, Matsuura Y, 
Iwanaga T, Takai Y & Seino S. (2000). cAMP-GEFII is a direct target of cAMP in regulated 
exocytosis. Nature Cell Biology 2, 805-811. 
 
Pagani R, Song M, McEnery M, Qin N, Tsien RW, Toro L, Stefani E & Uchitel OD. (2004). 
Differential expression of alpha 1 and beta subunits of voltage dependent Ca2+ channel at 
the neuromuscular junction of normal and P/Q Ca2+ channel knockout mouse. 
Neuroscience 123, 75-85. 
 
Pansarasa O, Rossi D, Berardinelli A & Cereda C. (2014). Amyotrophic lateral sclerosis and 
skeletal muscle: an update. Molecular Neurobiology 49, 984-990. 
 
Pardo NE, Hajela RK & Atchison WD. (2006). Acetylcholine release at neuromuscular junctions of 
adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) 
Ca2+ channels. The Journal of pharmacology and experimental therapeutics 319, 1009-
1020. 
 
Patton BL. (2000). Laminins of the Neuromuscular System. Microscopy Research and Technique 
51, 247-261. 
 
Patton BL. (2003). Basal lamina and the organization of neuromuscular synapses. Journal of 
neurocytology 32, 883-903. 
 
Patton BL, Chiu AY & Sanes JR. (1998). Synaptic Laminin Prevents Glial Entry into the Synaptic 
Cleft. Nature 393, 698-701. 
 
Patton BL, Cunningham JM, Thyboll J, Kortesmaa J, Westerblad H, Edstrom L, Tryggvason K & 
Sanes JR. (2001). Properly Formed but Improperly Localized Synaptic Specializations in the 
Absence of Laminin α4. Nature Neuroscience 4, 597-604. 
 
Patton BL, Miner JH, Chiu AY & Sanes JR. (1997). Distribution and Function of Laminins in the 
Neuromuscular System of Developing, Adult, and Mutant Mice. Journal of Cell Biology 
139, 1507-1521. 
 
Pedrosa-Domellof F, Tiger CF, Virtanen I, Thornell LE & Gullberg D. (2000). Laminin Chains in 
Developing and Adult Human Myotendinous Junctions. Journal of Histochemistry & 
Cytochemistry 48, 201-209. 
 
Pette D & Staron RS. (2000). Myosin isoforms, muscle fiber types, and transitions. Microscopy 
Research and Technique 50, 500-509. 
 
Phillips WD, Kopta C, Blount P, Gardner PD, Steinbach JH & Merlie JP. (1991). ACh-rich 
receptor membrane domains organized in fibroblasts by recombinant 43-kilo dalton 
protein. Science 251, 568-570. 
179 
 
Phillips WD, Noakes PG, Roberds SL, Campbell KP & Merlie JP. (1993). Clustering and 
immobilization of acetylcholine receptors by the 43-kD protein: a possible role for 
dystrophin-related protein. Journal of Cell Biology 123, 729-740. 
 
Phillips WD, Vladeta D, Han H & Noakes PG. (1997). Rapsyn and agrin slow the metabolic 
degradation of the acetylcholine receptor. Molecular and Cellular Neuroscience 10, 16-
26. 
 
Pieribone VA, Shupliakov O, Brodin L, Hilfiker-Rothenfluh S, Czernik AJ & Greengard P. 
(1995). Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493-
497. 
 
Pilgram GS, Potikanond S, Baines RA, Fradkin LG & Noordermeer JN. (2010). The Roles of 
the Dystrophin-Associated Glycoprotein Complex at the Synapse. Molecular 
Neurobiology 41, 1-21. 
 
Polymenidou M, Lagier-Tourenne C, Hutt KR, Bennett CF, Cleveland DW & Yeo GW. 
(2012). Misregulated RNA processing in amyotrophic lateral sclerosis. Brain 
Research 1462, 3-15. 
 
Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, 
Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett 
CF, Yeo GW & Cleveland DW. (2011). Long pre-mRNA depletion and RNA 
missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature 
Neuroscience 14, 459-468. 
 
Porter BE, Weis J & Sanes JR. (1995). A motoneuron-selective stop signal in the synaptic 
protein S-laminin. Neuron 14, 549-559. 
 
Prakash Y, Miyata H, Zhan WZ & Sieck GC. (1999). Inactivity‐Induced Remodeling of 
Neuromuscular Junctions in Rat Diaphragmatic Muscle. Muscle & Nerve 22, 307-319. 
 
Prakash YS & Sieck GC. (1998). Age-related remodeling of neuromuscular junctions on type-
identified diaphragm fibers. Muscle Nerve 21, 887-895. 
 
Pratt SJ, Valencia AP, Le GK, Shah SB & Lovering RM. (2015). Pre- and postsynaptic changes 
in the neuromuscular junction in dystrophic mice. Frontiers in physiology 6, 252. 
 
Proszynski TJ, Gingras J, Valdez G, Krzewski K & Sanes JR. (2009). Podosomes Are Present 
in a Postsynaptic Apparatus and Participate in its Maturation. Proceedings of the 
National Academy of Sciences of the United States of America 106, 18373-18378. 
 
Proszynski TJ & Sanes JR. (2013). Amotl2 Interacts with LL5β, Localizes to Podosomes 
and Regulates Postsynaptic Differentiation in Muscle. Journal of cell science 126, 
2225-2235. 
 
Ramarao MK & Cohen JB. (1998). Mechanism of nicotinic acetylcholine receptor cluster 
formation by rapsyn. Proceedings of the National Academy of Sciences 95, 4007-4012. 
 
 
 
180 
 
Rasi K, Hurskainen M, Kallio M, Staven S, Sormunen R, Heape AM, Avila RL, Kirschner D, 
Muona A, Tolonen U, Tanila H, Huhtala P, Soininen R & Pihlajaniemi T. (2010). Lack of 
collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 
deficiency, leads to basement membrane abnormalities and sensorimotor dysfunction. 
Journal of Neuroscience 30, 14490-14501. 
 
Reddy LV, Koirala S, Sugiura Y, Herrera AA & Ko C-P. (2003). Glial cells maintain synaptic 
structure and function and promote development of the neuromuscular junction in vivo. 
Neuron 40, 563-580. 
 
Rettig J, Sheng ZH, Kim DK, Hodson CD, Snutch TP & Catterall WA. (1996). Isoform-specific 
interaction of the alpha1A subunits of brain Ca2+ channels with the presynaptic proteins 
syntaxin and SNAP-25. Proceedings of the National Academy of Sciences 93, 7363-7368. 
 
Reynolds ML & Woolf CJ. (1992). Terminal Schwann cells elaborate extensive processes following 
denervation of the motor endplate. Journal of neurocytology 21, 50-66. 
 
Richards DA, Guatimosim C & Betz WJ. (2000). Two endocytic recycling routes selectively fill 
two vesicle pools in frog motor nerve terminals. Neuron 27, 551-559. 
 
Richards DA, Guatimosim C, Rizzoli SO & Betz WJ. (2003). Synaptic Vesicle Pools at the Frog 
Neuromuscular Junction. Neuron 39, 529-541. 
 
Rizzoli SO & Betz WJ. (2004). The Structural Organization of the Readily Releasable Pool of 
Synaptic Vesicles. Science 303, 2037-2039. 
 
Rizzoli SO & Betz WJ. (2005). Synaptic Vesicle Pools. Nature Reviews Neuroscience 6, 57-69. 
 
Robinson KG, Mendonca JL, Militar JL, Theroux MC, Dabney KW, Shah SA, Miller F & Akins 
RE. (2013). Disruption of basal lamina components in neuromotor synapses of children with 
spastic quadriplegic cerebral palsy. PLoS One 8, e70288. 
 
Robitaille R, Adler EM & Charlton MP. (1990). Strategic Location of Calcium Channels at 
Transmitter Release Sites of Frog Neuromuscular Synapses. Neuron 5, 773-779. 
 
Rocha MC, Pousinha PA, Correia AM, Sebastião AM & Ribeiro JA. (2013). Early Changes of 
Neuromuscular Transmission in the SOD1 (G93A) Mice Model of ALS Start Long before 
Motor Symptoms Onset. PLoS One 8, e73846. 
 
Romano M, Feigun F & Buratti E. (2016). TBPH/TDP-43 modulates translation of Drosophila 
Futsch mRNA through an UG-rich sequence within its 5’UTR. Brain Research 1647, 50-56. 
 
Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, Hammer RE, Malenka RC & 
Sudhof TC. (1995). Essential functions of synapsins I and II in synaptic vesicle regulation. 
Nature 375, 488-493. 
 
Rosato-Siri MD, Piriz J, Tropper BAG & Uchitel OD. (2002). Differential Ca2+-dependence of 
transmitter release mediated by P/Q- and N-type calcium channels at neonatal rat 
neuromuscular junctions. European Journal of Neuroscience 15, 1874-1880. 
 
Rosato-Siri MD & Uchitel OD. (1999). Calcium channels coupled to neurotransmitter release at 
neonatal rat neuromuscular junctions. Journal of Physiology (Cambridge) 514, 533-540. 
181 
 
Rosenheimer JL. (1990). Factors affecting denervation-like changes at the neuromuscular junction 
during aging. International Journal of Developmental Neuroscience 8, 643-654. 
 
Roskelley CD, Srebrow A & Bissell MJ. (1995). A hierarchy of ECM-mediated signalling regulates 
tissue-specific gene expression. Current Opinion in Cell Biology 7, 736-747. 
 
Rudolf R, Khan MM, Labeit S & Deschenes MR. (2014). Degeneration of neuromuscular junction 
in age and dystrophy. Frontiers in Aging Neuroscience 6, 99. 
 
Ruff RL. (2003). Neurophysiology of the neuromuscular junction: overview. Annals of the New 
York Academy of Sciences 998, 1-10. 
 
Ruiz R, Biea I & Tabares L. (2014). α-Synuclein A30P Decreases Neurodegeneration and Increases 
Synaptic Vesicle Release Probability in CSPα-Null Mice. Neuropharmacology 76, 106-117. 
 
Ruiz R, Cano R, Casañas JJ, Gaffield MA, Betz WJ & Tabares L. (2011). Active Zones and the 
Readily Releasable Pool of Synaptic Vesicles at the Neuromuscular Junction of the Mouse. 
The Journal of Neuroscience 31, 2000-2008. 
 
Sadakata T, Itakura M, Kozaki S, Sekine Y, Takahashi M & Furuichi T. (2006). Differential 
Distributions of the Ca2+ -Dependent Activator Protein for Secretion Family Proteins (CAPS2 
and CAPS1) in the Mouse Brain. The Journal of comparative neurology 495, 735-753. 
 
Samuel MA, Valdez G, Tapia JC, Lichtman JW & Sanes JR. (2012). Agrin and Synaptic Laminin 
Are Required to Maintain Adult Neuromuscular Junctions. PLoS One 7, e46663. 
 
Sanes JR. (1995). The synaptic cleft of the neuromuscular junction. Seminars in Developmental 
Biology 6, 163-173. 
 
Sanes JR, Engvall E, Butkowski R & Hunter DD. (1990). Molecular Heterogeneity of Basal 
Laminae: Isoforms of Laminin and Collagen IV at the Neuromuscular Junction and 
Elsewhere. Journal of Cell Biology 111, 1685-1699. 
 
Sanes JR & Lichtman JW. (1999). Development of the Vertebrate Neuromuscular Junction. Annual 
Review of Neuroscience 22, 389-442. 
 
Sanes JR, Marshall LM & McMahan UJ. (1978). Reinnervation of muscle fiber basal lamina after 
removal of myofibers. Differentiation of regenerating axons at original synaptic sites. 
Journal of Cell Biology 78, 176-198. 
 
Sasaki M, Kleinman HK, Huber H, Deutzmann R & Yamada Y. (1988). Laminin, a Multidomain 
Protein. The A Chain has a Unique Globular Domain and Homology with the Basement 
Membrane Proteoglycan and the Laminin B Chains. Journal of Biological Chemistry 263, 
16536-16544. 
 
Sasaki M & Yamada Y. (1987). The laminin B2 chain has a multidomain structure homologous to 
the B1 chain. Journal of Biological Chemistry 262, 17111-17117. 
 
Schikorski T & Stevens CF. (1997). Quantitative Ultrastructural Analysis of Hippocampal 
Excitatory Synapses. The Journal of Neuroscience 17, 5858-5867. 
 
182 
 
Schikorski T & Stevens CF. (2001). Morphological Correlates of Functionally Defined Synaptic 
Vesicle Populations. Nature Neuroscience 4, 391-395. 
 
Schittny JC & Yurchenco PD. (1990). Terminal short arm domains of basement membrane laminin 
are critical for its self-assembly. Journal of Cell Biology 110, 825-832. 
 
Schwartz MA, Schaller MD & Ginsberg MH. (1995). Integrins: emerging paradigms of signal 
transduction. Annual Review of Cell and Developmental Biology 11, 549-599. 
 
Sealock R, Wray BE & Froehner SC. (1984). Ultrastructoral localization of the Mr 43,000 protein 
and the acetylcholine receptor in Torpedo postsynaptic membranes using monoclonal 
antibodies. Journal of Cell Biology 98, 2239-2244. 
 
Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, 
Peng J, Moore MJ & Yu G. (2011). Identification of neuronal RNA targets of TDP-43-
containing ribonucleoprotein complexes. Journal of Biological Chemistry 286, 1204-1215. 
 
Shaw PJ. (2006). Comparison of Widefield/Deconvolution and Confocal Microscopy for Three-
Dimensional Imaging. In Handbook Of Biological Confocal Microscopy, ed. Pawley BJ, pp. 
453-467. Springer US, Boston, MA. 
 
Sheng ZH, Rettig J, Cook T & Catterall WA. (1996). Calcium-dependent interaction of N-type 
calcium channels with the synaptic core complex. Nature 379, 451-454. 
 
Sheng ZH, Rettig J, Takahashi M & Catterall WA. (1994). Identification of a Syntaxin-Binding Site 
on N-Type Calcium Channels. Neuron 13, 1303-1313. 
 
Sheng ZH, Westenbroek RE & Catterall WA. (1998). Physical Link and Functional Coupling of 
Presynaptic Calcium Channels and the Synaptic Vesicle Docking/Fusion Machinery. 
Journal of Bioenergetics and Biomembranes 30, 335-345. 
 
Sheng ZH, Yokoyama CT & Catterall WA. (1997). Interaction of the synprint site of N-type Ca2+ 
channels with the C2B domain of synaptotagmin I. Proceedings of the National Academy of 
Sciences 94, 5405-5410. 
 
Shi L, Butt B, Ip FC, Dai Y, Jiang L, Yung WH, Greenberg ME, Fu AK & Ip NY. (2010). 
Ephexin1 is required for structural maturation and neurotransmission at the neuromuscular 
junction. Neuron 65, 204-216. 
 
Shimizu H, Hosokawa H, Ninomiya H, Miner JH & Masaki T. (1999). Adhesion of cultured bovine 
aortic endothelial cells to laminin-1 mediated by dystroglycan. Journal of Biological 
Chemistry 274, 11995-12000. 
 
Shupliakov O, Bloom O, Gustafsson JS, Kjaerulff O, Low P, Tomilin N, Pieribone VA, Greengard P & 
Brodin L. (2002). Impaired recycling of synaptic vesicles after acute perturbation of the presynaptic 
actin cytoskeleton. Proceedings of the National Academy of Sciences 99, 14476-14481. 
 
Siegelbaum SA, Trautmann A & Koenig J. (1984). Single acetylcholine-activated channel currents 
in developing muscle cells. Developmental Biology 104, 366-379. 
 
Sine SM. (2012). End-plate acetylcholine receptor: structure, mechanism, pharmacology, and 
disease. Physiological reviews 92, 1189-1234. 
183 
 
Singer D, Biel M, Lotan I, Flockerzi V, Hofmann F & Dascal N. (1991). The Roles of the Subunits 
in the Function of the Calcium-Channel. Science 253, 1553-1557. 
 
Singhal N & Martin PT. (2011). Role of extracellular matrix proteins and their receptors in the development 
of the vertebrate neuromuscular junction. Developmental Neurobiology 71, 982-1005. 
 
Slater CR. (2008). Structural factors influencing the efficacy of neuromuscular transmission. Annals 
of the New York Academy of Sciences 1132, 1-12. 
 
Sleigh JN, Burgess RW, Gillingwater TH & Cader MZ. (2014). Morphological analysis of 
neuromuscular junction development and degeneration in rodent lumbrical muscles. Journal 
of neuroscience methods 227, 159-165. 
 
Smirnov SP, McDearmon EL, Li S, Ervasti JM, Tryggvason K & Yurchenco PD. (2002). 
Contributions of the LG modules and furin processing to laminin-2 functions. Journal of 
Biological Chemistry 277, 18928-18937. 
 
Smith CL, Mittaud P, Prescott ED, Fuhrer C & Burden SJ. (2001). Src, Fyn, and Yes are not 
required for neuromuscular synapse formation but are necessary for stabilization of agrin-
induced clusters of acetylcholine receptors. Journal of Neuroscience 21, 3151-3160. 
 
Smith DO & Rosenheimer JL. (1982). Decreased sprouting and degeneration of nerve terminals of 
active muscles in aged rats. Journal of Neurophysiology 48, 100-109. 
 
Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M & Edgar D. (1999). Absence of 
basement membranes after targeting the LAMC1 gene results in embryonic lethality due to 
failure of endoderm differentiation. Journal of Cell Biology 144, 151-160. 
 
Snider WD & Harris GL. (1979). A physiological correlate of disuse-induced sprouting at the 
neuromuscular junction. Nature 281, 69-71. 
 
Son Y-J, Trachtenberg JT & Thompson WJ. (1996). Schwann Cells Induce and Guide Sprouting 
and Reinnervation of Neuromuscular Junctions. Trends in neurosciences 19, 280-285. 
 
Sorokin LM, Maley MA, Moch H, von der Mark H, von der Mark K, Cadalbert L, Karosi S, Davies 
MJ, McGeachie JK & Grounds MD. (2000). Laminin α4 and Integrin α6 Are Upregulated in 
Regenerating dy/dy Skeletal Muscle: Comparative Expression of Laminin and Integrin Isoforms 
in Muscles Regenerating after Crush Injury. Experimental cell research 256, 500-514. 
 
Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams 
KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, 
Nicholson G & Shaw CE. (2008). TDP-43 mutations in familial and sporadic amyotrophic 
lateral sclerosis. Science 319, 1668-1672. 
 
Starr TV, Prystay W & Snutch TP. (1991). Primary structure of a calcium channel that is highly 
expressed in the rat cerebellum. Proceedings of the National Academy of Sciences 88, 5621-
5625. 
 
Strochlic L, Cartaud A & Cartaud J. (2005). The synaptic muscle-specific kinase (MuSK) complex: 
new partners, new functions. Bioessays 27, 1129-1135. 
 
184 
 
Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C & Shoesmith C. 
(2007). TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding 
protein. Molecular and Cellular Neuroscience 35, 320-327. 
 
Sudhof TC. (2004). The Synaptic Vesicle Cycle. Annual Review of Neuroscience 27, 509-547. 
 
Sutton RB, Fasshauer D, Jahn R & Brunger AT. (1998). Crystal Structure of a SNARE Complex 
Involved in Synaptic Exocytosis at 2.4 Angstrom Resolution. Nature 395, 347-353. 
 
Suzuki N, Yokoyama F & Nomizu M. (2005). Functional Sites in the Laminin Alpha Chains. 
Connective Tissue Research 46, 142-152. 
 
Takai T, Noda M, Mishina M, Shimizu S, Furutani Y, Kayano T, Ikeda T, Kubo T, Takahashi H, 
Takahashi T & et al. (1985). Cloning, Sequencing and Expression of cDNA for a Novel 
Subunit of Acetylcholine Receptor from Calf Muscle. Nature 315, 761-764. 
 
Takao-Rikitsu E, Mochida S, Inoue E, Deguchi-Tawarada M, Inoue M, Ohtsuka T & Takai Y. 
(2004). Physical and Functional Interaction of the Active Zone Proteins, CAST, RIM1, and 
Bassoon, in Neurotransmitter Release. Journal of Cell Biology 164, 301-311. 
 
Talts JF, Andac Z, Göhring W, Brancaccio A & Timpl R. (1999). Binding of the G Domains of 
Laminin α1 and α2 Chains and Perlecan to Heparin, Sulfatides, α‐dystroglycan and Several 
Extracellular Matrix Proteins. The EMBO journal 18, 863-870. 
 
Talts JF, Sasaki T, Miosge N, Gohring W, Mann K, Mayne R & Timpl R. (2000). Structural and 
Functional Analysis of the Recombinant G Domain of the Laminin α4 Chain and its 
proteolytic Processing in Tissues. Journal of Biological Chemistry 275, 35192-35199. 
 
Talts JF & Timpl R. (1999). Mutation of a basic sequence in the laminin alpha2LG3 module leads 
to a lack of proteolytic processing and has different effects on beta1 integrin-mediated cell 
adhesion and alpha-dystroglycan binding. FEBS letters 458, 319-323. 
 
Tapia JC, Wylie JD, Kasthuri N, Hayworth KJ, Schalek R, Berger DR, Guatimosim C, Seung HS & 
Lichtman JW. (2012). Pervasive Synaptic Branch Removal in the Mammalian 
Neuromuscular System at Birth. Neuron 74, 816-829. 
 
Tarr TB, Dittrich M & Meriney SD. (2013). Are Unreliable Release Mechanisms Conserved from 
NMJ to CNS? Trends in neurosciences 36, 14-22. 
 
Tehrani S, Faccio R, Chandrasekar I, Ross FP & Cooper JA. (2006). Cortactin has an essential and 
specific role in osteoclast actin assembly. Molecular Biology of the Cell 17, 2882-2895. 
 
Theiler K. (1989). The House Mouse: Atlas of Embryonic Development. Springer-Verlag New York. 
 
Thompson WJ. (1985). Activity and synapse elimination at the neuromuscular junction. Cellular and 
Molecular Biology 5, 167-182.   
 
Timpl R, Rohde H, Robey PG, Rennard SI, Foidart J-M & Martin GR. (1979). Laminin--a 
glycoprotein from basement membranes. Journal of Biological Chemistry 254, 9933-9937. 
 
Timpl R, Tisi D, Talts JF, Andac Z, Sasaki T & Hohenester E. (2000). Structure and Function of 
Laminin LG Modules. Matrix Biology 19, 309-317. 
185 
 
Tripathi VB, Baskaran P, Shaw CE & Guthrie S. (2014). Tar DNA-binding protein-43 (TDP-43) 
regulates axon growth in vitro and in vivo. Neurobiology of Disease 65, 25-34. 
 
Tsien RW, Lipscombe D, Madison DV, Bley KR & Fox AP. (1988). Multiple types of neuronal 
calcium channels and their selective modulation. Trends in Neurosciences 11, 431-438. 
 
Tsilibary EC, Koliakos GG, Charonis AS, Vogel AM, Reger LA & Furcht LT. (1988). Heparin type 
IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-
assembly. Journal of Biological Chemistry 263, 19112-19118. 
 
Turner CE, Kramarcy N, Sealock R & Burridge K. (1991). Localization of paxillin, a focal adhesion 
protein, to smooth muscle dense plaques, and the myotendinous and neuromuscular 
junctions of skeletal muscle. Experimental Cell Research 192, 651-655. 
 
Uchitel OD, Protti DA, Sanchez V, Cherksey BD, Sugimori M & Llinas R. (1992). P-type Voltage-
Dependent Calcium Channel Mediates Presynaptic Calcium Influx and Transmitter Release 
in Mammalian Synapses. Proceedings of the National Academy of Sciences of the United 
States of America 89, 3330-3333. 
 
Urbano FJ, Piedras-Renteria ES, Jun KS, Shin HS, Uchitel OD & Tsien RW. (2003). Altered 
Properties of Quantal Neurotransmitter Release at Endplates of Mice Lacking P/Q-type 
Ca2+ Channels. Proceedings of the National Academy of Sciences of the United States of 
America 100, 3491-3496. 
 
Urbano FJ, Rosato-Siri MD & Uchitel OD. (2002). Calcium Channels Involved in Neurotransmitter 
Release at Adult, Neonatal and P/Q-Type Deficient Neuromuscular Junctions (Review). 
Molecular Membrane Biology 19, 293-300. 
 
Valdez G, Tapia JC, Kang H, Clemenson GD, Jr., Gage FH, Lichtman JW & Sanes JR. (2010). 
Attenuation of Age-Related Changes in Mouse Neuromuscular Synapses by Caloric 
Restriction and Exercise. Proceedings of the National Academy of Sciences of the United 
States of America 107, 14863-14868. 
 
Valdez G, Tapia JC, Lichtman JW, Fox MA & Sanes JR. (2012). Shared resistance to aging and 
ALS in neuromuscular junctions of specific muscles. PLoS One 7, e34640. 
 
Valenzuela DM, Stitt TN, Distefano PS, Rojas E, Mattsson K, Compton DL, Nunez L, Park JS, 
Stark JL, Gies DR, Thomas S, Lebeau MM, Fernald AA, Copeland NG, Jenkins NA, 
Burden SJ, Glass DJ & Yancopoulos GD. (1995). Receptor tyrosine kinase specific for the 
skeletal muscle lineage: Expression in embryonic muscle, at the neuromuscular junction, 
and after injury. Neuron 15, 573-584. 
 
Villarroel A & Sakmann B. (1996). Calcium permeability increase of endplate channels in rat 
muscle during postnatal development. Journal of Physiology 496 ( Pt 2), 331-338. 
 
von der Mark H, Durr J, Sonnenberg A, von der Mark K, Deutzmann R & Goodman SL. (1991). 
Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to 
the E8 and T8 fragments of laminin. Journal of Biological Chemistry 266, 23593-23601. 
 
Walker D, Bichet D, Campbell KP & De Waard M. (1998). A β4 Isoform-Specific Interaction Site 
in the Carboxyl-Terminal Region of the Voltage-Dependent Ca2+ Channel α1A Subunit. 
Journal of Biological Chemistry 273, 2361-2367. 
186 
 
Walker D & De Waard M. (1998). Subunit Interaction Sites in Voltage-Dependent Ca2+ Channels: 
Role in Channel Function. Trends in neurosciences 21, 148-154. 
 
Wang Q, Hebert SL, Rich MM & Kraner SD. (2011). Loss of synaptic vesicles from neuromuscular 
junctions in aged MRF4-null mice. Neuroreport 22, 185-189. 
 
Wang Q, Zhang B, Xiong WC & Mei L. (2006). MuSK Signaling at the Neuromuscular Junction. 
Journal of Molecular Neuroscience 30, 223-226. 
 
Wang X, Engisch KL, Li Y, Pinter MJ, Cope TC & Rich MM. (2004). Decreased synaptic activity 
shifts the calcium dependence of release at the mammalian neuromuscular junction in vivo. 
Journal of Neuroscience 24, 10687-10692. 
 
Wang X, Fukuda K, Byeon IJ, Velyvis A, Wu C, Gronenborn A & Qin J. (2008). The structure of 
alpha-parvin CH2-paxillin LD1 complex reveals a novel modular recognition for focal 
adhesion assembly. Journal of Biological Chemistry 283, 21113-21119. 
 
Wang X, Pinter MJ & Rich MM. (2010). Ca2+ dependence of the binomial parameters p and n at 
the mouse neuromuscular junction. Journal of Neurophysiology 103, 659-666. 
 
Wang Y, Okamoto M, Schmitz F, Hofmann K & Sudhof TC. (1997). Rim is a Putative Rab3 
Effector in Regulating Synaptic-Vesicle Fusion. Nature 388, 593-598. 
 
Wang Y, Sugita S & Sudhof TC. (2000). The Rim/Nim Family of Neuronal C2 Domain Proteins- 
Interactions with Rab3 and a New Class of Src Homology 3 Domain Proteins. Journal of 
Biological Chemistry 275, 20033-20044. 
 
Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT & Cooper JA. (2001). 
Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Current 
Biology 11, 370-374. 
 
Werner A, Willem M, Jones LL, Kreutzberg GW, Mayer U & Raivich G. (2000). Impaired axonal 
regeneration in alpha7 integrin-deficient mice. Journal of Neuroscience 20, 1822-1830. 
 
Winder SJ. (2001). The complexities of dystroglycan. Trends in biochemical sciences 26, 118-124. 
 
Winder SJ & Kendrick-Jones J. (1995). Calcium/calmodulin-dependent regulation of the NH2-
terminal F-actin binding domain of utrophin. FEBS letters 357, 125-128. 
 
Witzemann V, Barg B, Nishikawa Y, Sakmann B & Numa S. (1987). Differential regulation of muscle 
acetylcholine receptor gamma- and epsilon-subunit mRNAs. FEBS letters 223, 104-112. 
 
Wokke JH, Jennekens FG, van den Oord CJ, Veldman H, Smit LM & Leppink GJ. (1990). 
Morphological changes in the human end plate with age. Journal of the Neurological 
Sciences 95, 291-310 
 
Wood SJ & Slater CR. (1997). The Contribution of Postsynaptic Folds to the Safety Factor for 
Neuromuscular Transmission in Rat Fast- Aad Slow-Twitch Muscles. Journal of 
Physiology-London 500, 165-176. 
 
Wood SJ & Slater CR. (1998). beta-Spectrin is colocalized with both voltage-gated sodium channels and 
ankyrinG at the adult rat neuromuscular junction. Journal of Cell Biology 140, 675-684. 
187 
 
Wood SJ & Slater CR. (2001). Safety Factor at the Neuromuscular Junction. Progress in 
Neurobiology 64, 393-429. 
 
Wu H, Lu Y, Shen C, Patel N, Gan L, Xiong WC & Mei L. (2012). Distinct roles of muscle and 
motoneuron LRP4 in neuromuscular junction formation. Neuron 75, 94-107.   
 
Wu H, Xiong WC & Mei L. (2010). To Build a Synapse: Signaling Pathways in Neuromuscular 
Junction Assembly. Development 137, 1017-1033. 
 
Wu LG, Westenbroek RE, Borst JG, Catterall WA & Sakmann B. (1999). Calcium channel types 
with distinct presynaptic localization couple differentially to transmitter release in single 
calyx-type synapses. Journal of Neuroscience 19, 726-736. 
 
Wyatt RM & Balice-Gordon RJ. (2003). Activity-dependent elimination of neuromuscular 
synapses. Journal of neurocytology 32, 777-794. 
 
Wyatt RM & Balice-Gordon RJ. (2008). Heterogeneity in synaptic vesicle release at neuromuscular 
synapses of mice expressing synaptopHluorin. Journal of Neuroscience 28, 325–335. 
 
Yang D, Bierman J, Tarumi YS, Zhong YP, Rangwala R, Proctor TM, Miyagoe-Suzuki Y, Takeda 
S, Miner JH, Sherman LS, Gold BG & Patton BL. (2005). Coordinate control of axon 
defasciculation and myelination by laminin-2 and -8. Journal of Cell Biology 168, 655-666. 
 
Yang X, Arber S, William C, Li L, Tanabe Y, Jessell TM, Birchmeier C & Burden SJ. (2001). 
Patterning of muscle acetylcholine receptor gene expression in the absence of motor 
innervation. Neuron 30, 399-410. 
 
Yee WC & Pestronk A. (1987). Mechanisms of postsynaptic plasticity: remodeling of the junctional 
acetylcholine receptor cluster induced by motor nerve terminal outgrowth. Journal of 
Neuroscience 7, 2019-2024. 
 
Yu H & Talts JF. (2003). Beta1 integrin and alpha-dystroglycan binding sites are localized to 
different laminin-G-domain-like (LG) modules within the laminin alpha5 chain G domain. 
The Biochemical journal 371, 289-299. 
 
Yumoto N, Wakatsuki S & Sehara-Fujisawa A. (2005). The acetylcholine receptor gamma-to-
epsilon switch occurs in individual endplates. Biochemical and Biophysical Research 
Communications 331, 1522-1527. 
 
Yurchenco P & Cheng Y-S. (1993). Self-assembly and calcium-binding sites in laminin. A three-
arm interaction model. Journal of Biological Chemistry 268, 17286-17299. 
 
Yurchenco PD & Patton BL. (2009). Developmental and Pathogenic Mechanisms of Basement 
Membrane Assembly. Current Pharmaceutical Design 15, 1277-1294. 
 
Zaitsev AV, Povysheva NV, Lewis DA & Krimer LS. (2007). P/Q-type, But Not N-Type, Calcium 
Channels Mediate Gaba Release from Fast-Spiking Interneurons to Pyramidal Cells in Rat 
Prefrontal Cortex. Journal of Neurophysiology 97, 3567-3573. 
 
 
 
188 
 
Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-
Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher 
W, Maruniak-Chudek I, Lennert T, Neumann LM & Reis A. (2004). Human laminin beta2 
deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye 
abnormalities. Human Molecular Genet 13, 2625-2632. 
 
Zenker M, Pierson M, Jonveaux P & Reis A. (2005). Demonstration of Two Novel LAMB2 
Mutations in the Original Pierson Syndrome Family Reported 42 Years Ago. American 
Journal of Medical Genetics Part A 138, 73-74. 
 
Zhai RG & Bellen HJ. (2004). The architecture of the active zone in the presynaptic nerve terminal. 
Physiology (Bethesda) 19, 262-270. 
 
Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC & Mei L. (2008). LRP4 Serves as a Coreceptor of 
Agrin. Neuron 60, 285-297. 
 
Zhang JF, Randall AD, Ellinor PT, Horne WA, Sather WA, Tanabe T, Schwarz TL & Tsien RW. 
(1993). Distinctive Pharmacology and Kinetics of Cloned Neuronal Ca2+ Channels and their 
Possible Counterparts in Mammalian CNS neurons. Neuropharmacology 32, 1075-1088. 
 
Zhong H, Yokoyama CT, Scheuer T & Catterall WA. (1999). Reciprocal Regulation of P/Q-type 
Ca2+ Channels by SNAP-25, Syntaxin and Synaptotagmin. Nature Neuroscience 2, 939-941. 
 
Zhou H, Glass DJ, Yancopoulos GD & Sanes JR. (1999). Distinct domains of MuSK mediate its 
abilities to induce and to associate with postsynaptic specializations. Journal of Cell Biology 
146, 1133-1146. 
 
Zhou Z & January CT. (1998). Both T- and L-type Ca2+ channels can contribute to excitation-
contraction coupling in cardiac Purkinje cells. Biophysical Journal 74, 1830-1839. 
 
Ziober BL, Vu MP, Waleh N, Crawford J, Lin CS & Kramer RH. (1993). Alternative extracellular 
and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during 
development. Journal of Biological Chemistry 268, 26773-26783. 
 
Zuber B & Unwin N. (2013). Structure and superorganization of acetylcholine receptor-rapsyn 
complexes. Proceedings of the National Academy of Sciences of the United States of 
America 110, 10622-10627. 
189 
 
